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ABSTRACT 
The synthesis of quaternary stereocenters has been a longstanding challenge to 
organic chemists.  These motifs are of paramount importance in the synthesis of natural 
products and other biologically active molecules.  The Stoltz group has pursued the 
asymmetric decarboxylative allylic alkylation reaction using the Pd(PHOX) catalytic 
system as a methodology to this end for over two decades.  More recently, the lactam 
substrate class has been found to proceed with exceptional enantiomeric excess as 
compared to their carbocyclic counterparts.  Herein, we describe a body of work 
furthering the study of this reaction.  We first sought to elucidate the origin of the 
increased selectivity seen in lactams by investigation of novel carbocyclic substrates.  
These studies culminated in the discovery of a novel substrate class, enaminones, which 
match the enantioselectivity of the lactam substrates and have the highest 
enantioselectivity seen in general carbocyclic substrates found with our catalytic system 
to date. 
Applying synthetic methods for the synthesis of quaternary stereocenters of linear 
compounds further adds to the complexity and challenge, due to the lack of rigidity in 
most acyclic systems.  We disclose a development for the formation of de novo 
quaternary stereocenters in acyclic systems applying C2-symmetric biphosphine ligands 
in the palladium-catalyzed decarboxylative allylic alkylation reaction of amide enolates 
with well-defined olefin stereochemistry.  This methodology allowed us to access a 
variety of acyclic compounds bearing quaternary stereocenters with good selectivity. 
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CHAPTER 1
Expanding Insight into the Asymmetric Palladium-Catalyzed
Allylic Alkylation of N-Heterocyclic Molecules and Cyclic Ketones†
1.1 INTRODUCTION AND BACKGROUND
The asymmetric construction of quaternary stereocenters is a topic of great
interest in the organic chemistry community.  Among the available methods that afford
this motif,1 palladium-catalyzed decarboxylative allylic alkylation2,3 has proven
particularly effective and, over the last decade, our group has pursued this strategy
employing chiral phosphinooxazoline (PHOX) ligands.4,5  Our initial efforts in this area
led to the preparation of enantioenriched !-quaternary ketones (e.g., 2a) in good yields
and enantioselectivities using (S)-t-BuPHOX (3)5a–b as a chiral ligand (Scheme 1.1A).6
Since these early results, we have considerably expanded the scope,7 demonstrated
multiple applications,8 and performed mechanistic investigations9 of this powerful
† This research was performed in collaboration with Drs. Nathan Bennett, Jimin Kim, Wen-Bo Liu 
Alexander N. Marziale, Douglas C. Behenna and Scott C. Virgil and has been published.  See: Bennett, N. 
B.‡; Duquette, D. C.‡; Kim, J.; Liu, W.-B.; Marziale, A. N.; Behenna, D. C.; Virgil, S. C.; Stoltz, B. M. 
Chem.—Eur. J. 2013, 19, 4414–4418. ‡N.B.B. and D.C.D contributed equally to this article.
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transformation.  Recently, we discovered that the allylic alkylation of lactams (4a to 5a)
and imides (6a  to 7a) with (S) - (CF3)3-t-BuPHOX (8)
5c consistently proceeds with
enantioselectivities substantially higher than any other substrate class previously
examined in this system (Scheme 1.1B and C).10 This observation prompted us to
investigate which characteristics distinguish these molecules as superior alkylation
substrates.  The basic distinctions between these ketone and N-heterocyclic molecules are
the deviation in electronic nature of the enolate and the identity of the !'-functionality
(i.e., the group flanking the carbonyl at the site opposite of alkylation).  Thus, we have
designed several new alkylation substrates to examine the relative contribution of each
effect.  We have found that the exceptional enantioselectivities observed in the
lactam/imide series are likely not a result of a purely electronic effect, but a combination
of stereoelectronic and steric factors associated with the ! '-substituent.  To provide a
more complete perspective on allylic alkylation selectivity, this chapter also discusses
related research efforts performed by other groups.
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Scheme 1.1.  Comparison of allylic alkylation of ketones, lactams, and imides.
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1.1.1 Pd-Catalyzed Asymmetric Allylic Alkylation Background
Our entry into asymmetric allylic alkylation methodology began in 2004, when
we reported the preparation of !-quaternary cyclic ketones from allyl enol carbonates (9)
and silyl enol ethers (10).6a  Twenty years prior, Tsuji performed the regioselective
allylation of these and other unstabilized enolate precursors under essentially neutral
conditions with Pd(0) catalysts (Scheme 1.2).11  Inspired by Tsuji’s approach, we
screened a series of chiral P,P-, P,O-, and P,N-ligands in the allylic alkylation of allyl
enol carbonate 9a with Pd2(dba)3 as a Pd(0) source.  Gratifyingly, P,N-ligands generate
the desired enantioenriched ketone product in good yield and ee, with (S)-t-BuPHOX (3)
providing the greatest enhancement in selectivity (Scheme 1.3).  Silyl enol ethers (10)
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necessitate the addition of a fluoride source and allyl carbonate, but provide similar
results.6a  We later found that racemic "-ketoesters (1) are also excellent substrates under
the standard enol carbonate conditions.  Notably, "-ketoesters are easy to prepare, are
often more stable than the corresponding allyl enol carbonates, and avoid regioselectivity
issues in enolate formation with ! ,"-unsaturated substrates.  Following our initial
publication, Trost disclosed allylic alkylation conditions for allyl enol carbonates with
their C2-symmetric P,P-ligands (e.g., (R,R)-12, Scheme 1.3).
2a,12 These initial publications
by Stoltz and Trost represent the first examples of the regioselective and enantioselective
alkylation of ketones with multiple acidic sites.  Although not discussed in this chapter,
Hayashi,13 Ito,14 Trost,2a,15 and Hou and Dai16 have also performed asymmetric alkylation
of ketones, however, their approaches require the substrate to possess an occluded !'-
position (i.e., one deprotonation site) or a stabilizing !-group (i.e., favored deprotonation
site).
Scheme 1.2.  Various enolate precursors investigated in the Tsuji reaction.
10a
OAc
O O
O
OTMSO
O
O
Pd(0)
Bu3SnOMe
Pd(0)
–CO2
Pd(0)
–CO2
1a
9a
11a
O
+ PdIILn
, Pd(0), F—RO
O
O
O
2a
allylation
OR
O
O
–CO2
–CO2
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Scheme 1.3.  Pd-catalyzed asymmetric allylic alkylations performed by Stoltz and Trost.
O O
O
O
O
O
9a
1a
10a
OTMS
Pd2(dba)3 (2.5 mol %)
(S)-3 (6.25 mol %)
THF, 25 °C
90% yield, 89% ee
Pd2(dba)3 (2.5 mol %)
(S)-3 (6.25 mol %)
diallyl carbonate, TBAT
THF, 25 °C
95% yield, 87% ee
Pd2(dba)3 (2.5 mol %)
(S)-3 (6.25 mol %)
THF, 25 °C
89% yield, 88% ee
(S)
O
2a
!-quaternary
ketones
O O
O
9a
Pd2(dba)3 (2.5 mol %)
(R,R)-12 (5.5 mol %)
toluene, 23 °C
88% yield, 85% ee (R)-2a
H
N
H
N
O
O
PPh2
Ph2P
(R,R)-12
Ph2P N
O
t-Bu
(S)-t-BuPHOX
3
Stoltz
Trost
As part of our efforts to expand the reaction scope, we explored nitrogen-
containing substrates including lactams.10  Early efforts indicated the N-substituent plays
a significant role in conversion and enantioselectivity.  Notably, electron-rich lactams (N-
group = Me or Bn) exhibit little to no conversion to the desired products and, as such, are
poor alkylation substrates.  We consequently prepared a variety of lactams with electron-
withdrawing functionality (4a–h) and screened these molecules against two electronically
differentiated chiral ligands, (S)-3 and (S)-8, and four solvents of varying polarity:
tetrahydrofuran (THF), tert-butyl methyl ether (TBME), toluene, and 2:1 hexane–toluene
(Table 1.1).  In general, higher enantioselectivities are observed in less polar solvents
with (S)-8 as a ligand.  Among the N-substituent, benzoyl is optimal and provides nearly
perfect selectivity.  The transformation is also tolerant of various !-groups and ring sizes
and additionally provides high ee for cyclic imides.  By comparison, !-quaternary
ketones are formed with approximately 10% lower ee, prompting us to question what
characteristics distinguish lactams and imides as better substrates.
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Table 1.1.  Lactam allylic alkylation screen.a
Ph2P N
O
t-Bu
(4-CF3C6H4)2P N
O
t-Bu
CF3
! (S)-t-BuPHOX ! (S)-(CF3)3-t-BuPHOX
3 8
N
O
O
O
Pd2(dba)3 (5 mol %)
(S)-t-BuPHOX (3) or 
(S)-(CF3)3-t-BuPHOX (8)
(12.5 mol %)
solvent (0.033 M), 40 oC
N
O
4 5
R R
THF TBME Toluene 2:1 Hex–Tol
5d
5f
5h
5g
42
95
86
99
83
99
96
99
57
70
75
72
74
73
77
71
36
80
75
84
75
87
72
83
4
35
26
57
7
37
31
44
46
79
65
85
38
87
45
85
Enantiomeric Excess (% ee)b
5a
52
96
88
99
86
99
96
99
product 5
5c
60
97
91
98
87
99
97
99
5e
5b
20
75
64
91
62
90
83
91
ligand
3
8
3
8
3
8
3
8
3
8
3
8
3
8
3
8
entry
7
8
9
10
11
12
15
16
13
14
3
4
5
6
1
2
4d
4f
4h
4g
4a
substrate 4
4c
4e
4b
Cbz
Tsc
Fmoc
Bz
R
4-MeO-Bz
Bocc
Ac
a Conditions: lactam 4 (1.0 equiv), Pd2(dba)3 (5 mol %), and (S)-t-BuPHOX (3) or (S)-(CF3)3-t-BuPHOX
(8) (12.5 mol %) in solvent (0.033 M) at 40 °C. b!Determined by GC, HPLC, or SFC analysis. Red = with 
(S)-(3) as ligand and blue = with (S)-(8) as ligand. c Reaction performed with Pd2(pmdba)3 at 50 °C.
d
Reaction performed at 60 °C.
4-F-Bz
d d d
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1.2 RESULTS AND DISCUSSION
1.2.1 Electronically Variable Substrates
Initially, we hypothesized that the divergence in enolate electronics between the
substrate classes depicted in Scheme 1.1 could be the major determining factor of the
observed enantioselectivities.  Insight from our previous work9,10 suggested that
selectivity in the alkylation of electron-poor and -rich molecules could be considerably
different.  To investigate the electronic effect of the nitrogen atom on alkylation
selectivity without the influence of !'-functionality, we examined variably functionalized
enaminones (16, i.e., vinylogous amides)17 as electronic analogues of lactams (4, Figure
1.1).  We were particularly drawn to this new class of compounds as our past experience
with vinylogous esters (14)18 and thioesters (15)18b,19 would provide a foundation and
comparison point.20
Figure 1.1. Ketone and lactam enantioselectivity divergence as inspiration for investigation of enolate
electronics using vinylogous systems.
O
O
O
N
R
Bn
enaminones (16)
O
O
O
ketones (1)
N
O
O
O
lactams (4)
role of nitrogen in 
enolate electronics
R
O
O
O
enones (13, R = H)
vinylogous esters (14, R = OR')
and thioesters (15, R = SR')
R
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To this end, we prepared a number of racemic enaminone alkylation precursors 
from vinylogous ester 14a (Scheme 1.4A).  Treatment of vinylogous ester 14a with 
hydrochloric acid in THF selectively removes the vinylogous group without hydrolyzing 
the carboxylic ester, as reported by Desmaële.21  The resulting dione (17) can be 
condensed with an amine under dehydrative conditions to generate enaminones 16a–c, 
which bear electron-donating groups.22,23,24  To prepare substrates with electron-
withdrawing functionality, we explored derivatization of enaminone 16c to acetyl (16d), 
benzoyl (16e), tosyl (16g), and Boc (16f) accessorized products (Scheme 1.4B).  The 
acylation of secondary enaminones using an amine base has previously been 
reported;23a,25 however, exposure of intermediate 16c to diisopropylethylamine (i-Pr2NEt) 
and benzoyl chloride surprisingly produces diene 18 in 90% yield.  We also examined 
other amine bases (e.g., pyridine and Et3N), reagent stoichiometry, and the order of 
reagent addition, but in each case isolated a mixture of over acylated product and 
desired enaminone 16e.26  Similar results were obtained with acetyl chloride.  The use of 
sodium hydride27 eliminates over acylation, but provides enaminone 16e with insufficient 
purity. Nevertheless, these conditions are amenable to the synthesis of tosyl enaminone 
16g, albeit in low yield.28  The acylated and benzoylated enaminones (16d and e) can 
ultimately be obtained from iodoenone 1929 through a Buchwald coupling30 and 
alkylation sequence (Scheme 1.4C).  Boc functionalized enaminone 16f is prepared 
without complication following the precedent of Hiemstra (Scheme 1.4B).31
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Scheme 1.4.  Preparation of enaminone alkylation precursors.
R
N
Bn
O
i-BuO
O
O
HCl (1 M)
THF, 23 °C
78% yield14a 17
O
R
R1NHR2
p-TsOH•H2O
toluene, reflux
Dean–Stark
70% yield16a (R = Me)
31% yield16b (R = Ph)
92% yield16c (R = H)
EDG
substrates
O
O O
O
O
O
O
N
O
O
Bn
H
O
N
Bn
O
O
Ts
45% yield
i. NaH
 THF, 23 °C
ii. TsCl
16c
16g
O
N
Bn
O
O
Boc
90% yield
Boc2O, DMAP
CH2Cl2
0!23 °C
16f
BzO
N
Bn
Bz
90% yield
i. i-Pr2NEt
CH2Cl2, 0 °C
ii. BzCl
0!23 °C
18
O
O
O
N
Bn
Bz
O
O
EWG
substrates
16c
(R = H)
A.
B.
I I
O O
1. LDA, THF
–78 °C; then
18% yield
2 steps
19 20
CuI (10 mol %)
RNH2, Cs2CO3
H
N
N
H
O
N
H
86% yield16h (R = Ac)
70% yield16i (R = Bz)
NaH
DMF, 0 °C
then BnBr
0!23 °C
O
N
Bn
R
71% yield16d (R = Ac)
60% yield16e (R = Bz)
(20 mol%)
H2O/THF, 60 °C
O
O
O
O
O
O
C.
16e not isolated
NC O
O
2. NaH, MeI
THF, 23 °C
With a number of enaminones in hand, we screened a series of palladium-
catalyzed decarboxylative allylic alkylation conditions (Table 1.2).  Enaminone
substrates that possess a hydrogen on the nitrogen (e.g., 16c and i) generate a number of
alkylation products with a Pd(PHOX) system and were consequently excluded from this
study.  The enaminone screen was performed in a manner similar to the previous
investigation of lactams,10,32 employing the ligands (S)-3 and (S)-8 and the same four
solvents: tetrahydrofuran (THF), tert-butyl methyl ether (TBME), toluene, and 2:1
hexane–toluene.
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Table 1.2.  Enaminone allylic alkylation screen.a
Ph2P N
O
t-Bu
(4-CF3C6H4)2P N
O
t-Bu
CF3
! (S)-t-BuPHOX ! (S)-(CF3)3-t-BuPHOX
3 8
O
O
O
Pd2(dba)3 (5 mol %)
(S)-t-BuPHOX (3) or 
(S)-(CF3)3-t-BuPHOX (8)
(12.5 mol %)
solvent (0.033 M), 40 oC
R
O
R
13, 14, or 16 21, 22, or 23
THF TBME Toluene 2:1 Hex–Tol
23b
23e
23g
23f
81
76
87
74
85
82
83
83
89
83
90
85
88
88
88
86
86
80
87
83
88
82
87
83
84
82
83
83
83
83
82
83
87
84
86
84
87
81
82
83
Enantiomeric Excess (% ee)b
22a
85
86
85
86
86
86
87
88
product
23a
61
79
60
78
55
84
52
83
23d
21a
87
85
88
86
87
88
87
85
ligand
3
8
3
8
3
8
3
8
3
8
3
8
3
8
3
8
entry
7
8
9
10
11
12
15
16
13
14
3
4
5
6
1
2
16b
16e
16g
16f
14a
substrate
16a
16d
13a
NPh(Bn)
NBz(Bn)
NTs(Bn)
NBoc(Bn)
Oi-Bu
R
NMe(Bn)
NAc(Bn)
H
a Conditions: enone 13a, vinylogous ester 14a, or enaminone 16a, b, d–g (1.0 equiv), Pd2(dba)3 (5 mol
%), and (S)-t-BuPHOX (3) or (S)-(CF3)3-t-BuPHOX (8) (12.5 mol %) in solvent (0.033 M) at 40 °C.
b
!Determined by GC, HPLC, or SFC analysis. Red = with (S)-(3) as ligand and blue = with (S)-(8) as ligand.
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We made several observations upon analysis of the ligand, solvent, and substrate
trends that distinguished this substrate class considerably from the previously examined
lactams.  First, enaminones are obtained in modestly better selectivity with (S)-3 as a
ligand in most solvents (entries 7–16), with the exception of methyl enaminone 23a,
which significantly favors (S)-8 (entries 5–6).  Second, no significant solvent trend is
observed for enaminones overall.  Third, electron-rich enaminones (i.e., 16a and b)
display decreased enantioselectivities and also require extended reaction times for
completion,33 while enaminones bearing electron-withdrawing substituents (23d–g) are
all generated in 80–90% ee.  By comparison, lactam substrates perform with much higher
enantioselectivity with ligand (S)-8 in non-polar solvents.10,34  Furthermore, the modest
distinction in enantioselectivity for the electron-withdrawing enaminones sharply
contrasts with the corresponding lactam series, where the N-substituent plays a
considerable role, producing significant variation in selectivity.10,35  These differences
suggest that the N-functional group does not contribute to enantioselectivity solely
through a perturbation of enolate electronics.
Beyond these considerations, the most striking feature of the screen is that
enantioselectivities observed for enaminones 23d–g are approximately equivalent to
results obtained for enone 21a,36 vinylogous ester 22a, previously investigated
vinylogous molecules (Table 1.3),18b,19 and even more general ketone substrates.  Of all
the enaminones screened, acetyl variant 23d provides the highest selectivity at 90% ee in
TBME, which is only marginally better than the optimal values for the related vinylogous
systems.  The modest differences between these vinylogous molecules (i.e., 21–23)
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further suggest that the electronic nature of the enolate is not likely the predominant
factor in providing high enantioselectivity for lactams and imides.
Table 1.3.  Alkylation of other vinylogous esters and thioesters.a
R1
O
R2
O
O
n
R1
O
R2 n
yield (%) ee (%)bn
1 86 75
solvent
toluene
entry R1
Me
product
22b
R2
Oi-Bu
substrate
14b1
a Conditions: vinylogous ester 14/24 or vinylogous thioester 15/25, Pd2(pmdba)3 (2.5 mol %), and (S)-t-BuPHOX (3) 
(6.25 mol %) in solvent at temp. b!Determined by HPLC or SFC analysis. c !-Ketoester 15a recovered in 26% yield.
1 85 92tolueneMe 26aSPh15a2
Pd2(pmdba)3 (2.5 mol %)
(S)-t-BuPHOX (3)
(6.25 mol %)
solvent, temp
14/24 and 15/25 22/27 and 26/28
temp (°C)
80
50
1 61c 92benzeneMe 26aSPh15a3 50
1 88 92Me 26aSPh15a4 50THF
1 88 92Me 26aSPh15a5 501,4-dioxane
2 93 8627aOi-Bu24a6
2 86 8928aSPh25a7
30
30
Et2O
Et2O
H
H
ref.
19a
19a
19a
19a
19a
18b
18b
While pursuing enaminones, we also briefly examined the related 2,3-
dihydropyridin-4-ones, which possess the nitrogen within the ring (Table 1.4).  Acylation
and alkylation (or vice versa) of known dihydropyridinones37,38,39 allows preparation of
the reaction precursors 29a–d.  Under our standard palladium-catalyzed conditions, N-
carboxybenzyl substituted product 30a is formed with enantioselectivities similar to
electronically related enaminones.  Electron-rich 2,3-dihydropyridin-4-ones 30b and c are
curiously also generated in the same range.  Even 2,3-dihydropyridin-4-one 30d is
produced in excellent enantioselectivity, despite the highly electron-rich nature of the
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enolate.  These results again allude to other factors beyond enolate electronics that direct
alkylation selectivity.
Table 1.4.  Allylic alkylation of 2,3-dihydropyridin-4-ones.a
N
O
R1
R2
30
Pd2(dba)3 (5 mol %)
(S)-t-BuPHOX (3) or 
(S)-(CF3)3-t-BuPHOX (8)
(12.5 mol %)
toluene, 40 °CN
O
R1
R2
N
O
CO2allyl
MeO
MeO
O
O
29
R3 R3
yield (%) ee (%)bR1
Me
80
98
86
84
ligand
3
8
entry R2
Cbz
product 30
30a
Me
82
94
88
86
3
8Bn 30b
i-Bu
85
81
84
88
3
8Bn 30c
81 9187 30d
R3
H
H
H
substrate 29
29a
29b
29c
29d
1
2
3
4
5
6
a Conditions: 2,3-dihydropyridin-4-ones 29, Pd2(dba)3 (5 mol %), and (S)-t-BuPHOX (3) or (S)-(CF3)3-t-
BuPHOX (8) (12.5 mol %) in toluene (0.033 M) at 40 °C. b!Determined by HPLC or SFC analysis. Red
= with (S)-3 as ligand and blue = with (S)-8 as ligand.
1.2.1.1 Other Reports of Allylic Alkylation on Vinylogous Molecules
Trost has also reported the palladium-catalyzed allylic alkylation of vinylogous
esters and thioesters employing their C2-symmetric P,P-ligands.  In particular, their 2006
study prepares a range of related !-quaternary vinylogous products using (R,R)-12.20a
This effort first focused on the transformation of vinylogous esters into allyl enol
carbonate alkylation precursors.  However, enolate regioselectivity (!  vs. #
deprotonation) is poor for a number of vinylogous alkoxy groups, except benzyl (32b),
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although this carbonate product is formed in low yield (Scheme 1.5A).  Several "-
ketoesters were alternatively examined, but lower conversions were observed with these
substrates than with enol carbonate 32b (Scheme 1.5B).  The best results were obtained
with phenyl and Boc substituted "-ketoesters (14e and f), which have decreased electron-
donating contribution from the vinylogous oxygen.  Trost consequently investigated the
analogous thioesters, reasoning that sulfur would have less orbital overlap.  Vinylogous
thioester 14b performs with good yield and perfect enantioselectivity (Scheme 1.6), and a
variety of other thioesters are also produced with good to excellent ee.  Trost has also
examined exocyclic vinylogous esters and carried the enantioenriched products onto the
natural products hamigeran B20b,c and allocyathin B2.
20d
Scheme 1.5.  Asymmetric allylic alkylation of vinylogous esters performed by Trost.
Pd2(dba)3•CHCl3
(2.5 mol %)
(R,R)-12 (6 mol %)
THF or 1,4-dioxane
23 °C
yield (%)b ee (%)cR1
Et 26 94
entry product 14
14c
Bn 51 9114b
t-Bu 29 9714d
substrate 31
31c
31b
31d
2
1
3
a Conditions: vinylogous ester 16, Pd2(dba)3 (5 mol %), and (R,R)-12 (6 mol %) in solvent (0.1 M) at 23 
°C. b!Isolated yield. c Determined by HPLC analysis. d 1,4-dioxane as solvent. e THF as solvent.
yield (%)b
85
87
85
product 22
22c
22b
22d
Ph 70 9614e31e4 91 22e
Boc 66 9414f31f5 32 22f
d
e
d
d
e
14
RO
O
RO
O
O
O
31
LDA 
THF, –78 °C
then allyl 
chloroformate RO
O
22
Pd2(dba)3•CHCl3
(2.5 mol %)
(R,R)-12 (6 mol %)
THF or 1,4-dioxane
23 °C
32b
BnO
O
BnO
O
31b
LDA, TMEDA
THF, –78 °C
then allyl 
chloroformate
BnO
O
22b
O
O
87% yield, 85% ee
A.
B.
!
"
31% yield
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Scheme 1.6.  Asymmetric allylic alkylation of vinylogous thioesters performed by Trost.
Pd2(dba)3•CHCl3
(2.5 mol %)
(R,R)-12 (6 mol %)
1,4-dioxane, 23 °C
14b
PhS
O
PhS
O
O
O
33
LDA, toluene
–78 °C
then allyl 
chloroformate
–78!23 °C
PhS
O
22b
14 other examples
75% yield, 100% ee
Concurrent with our efforts on enaminones, Lupton40 and Shao41 independently
published sequential reports on the Pd-catalyzed allylic alkylation of two other
vinylogous amide classes, carbazolones (33) and indolones (34) (Scheme 1.7).  The
reaction parameters between the two papers are almost identical (Lupton: 5 mol% ligand,
50 °C; Shao: 6.25 mol % ligand, 70 °C)42 and many of the substrates are also related.  In
these efforts, Lupton selects a Boc N-protecting group, while Shao employs a benzyl
substituent.  The enantioselectivities of the methyl/allyl !-quaternary carbazolones (35a
and b) and indolones (36a) are comparable to our results with enaminones that possess
electron-withdrawing functionality.  Even the N-benzyl carbazolones are produced in
good to excellent ee, unlike the enaminones that bear electron-rich groups (23a and b).
In addition to screening several alkylation precursors, both laboratories advance their
enriched cyanide alkylation products (35g and h) onto (+)-kopsihainanine A (37) through
total and formal synthetic routes, and Shao also completes the alkaloid (–)-
aspidospermidine (38, Scheme 1.8).
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Scheme 1.7.  Alkylation of carbazolone (Lupton, R1 = Boc; Shao, R1 = Bn) and indolone (Lupton)
substrates reported in 2013.
N
R1
O
R2
O
O
carbazolones (33)
and indolones (34)
Pd2(dba)3 (2.5 mol %)
(S)-t-BuPHOX (3) (5–6.25 mol %)
toluene, temp N
R1
O
R2
carbazolones (35)
and indolones (36)
N
R1
O
CN
N
R1
O
CO2Et
N
R1
O
N
R1
O
35a (R1 = Boc)
72% yield, 83% ee
35b (R1 = Bn)
82% yield, 88% ee
CO2Et
N
Boc
O
CN
36f
98% yield, 86% ee
N
Boc
O
CO2Et
36e
73% yield, 85% ee
N
Boc
O
36d
97% yield, 83% ee
N
Boc
O
R2
36a–c
R2 = Me
R2 = Et
R2 = Bn
73% yield, 80% ee
69% yield, 87% ee
79% yield, 82% ee
CO2Et
R1 = Boc: 5 mol % (S)-3, 50 °C
R1 = Bn: 6.25 mol % (S)-3, 70 °C
35c (R1 = Boc)
80% yield, 87% ee
35d (R1 = Bn)
83% yield, 92% ee
35g (R1 = Boc)
90% yield, 94% ee
35h (R1 = Bn)
93% yield, 92% ee
35e (R1 = Boc)
87% yield, 91% ee
35f (R1 = Bn)
80% yield, 85% ee
Scheme 1.8.  Derivatization of cyanides 35g and h to alkaloid natural products.
N
R1
O
CN
35g (R1 = Boc)
35h (R1 = Bn)
N
H
N
H
(–)-aspidospermidine (38)
Shao (R1 = Bn)
10 steps
Lupton (R1 = Boc)
3 steps to 
formal synthesis
Shao (R1 = Bn)
7 steps
N
H
N
(+)-kopsihainanine A (37)
HO
O
H
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1.2.2 !'-Functionalized Substrates
Having investigated the impact of enolate electronics, we diverted our efforts to
study the influence of ! '-functionality on alkylation selectivity (Scheme 1.9).  Our
previous lactam screen identified the benzoyl moiety as the optimal protecting group,10
providing high to nearly perfect enantioselectivities for a variety of lactams (e.g., 5a).
Interestingly, both electron-rich and electron-poor benzoyl lactams (5b–d) as well as
naphthoyl lactams (5e and f) display excellent ee, whereas acetyl lactams (e.g., 5g and h)
provide lower selectivity.  This prompted us to question whether these results are due to a
hybridization or steric effect.  Consequently, we synthesized the bulky sp3 hybridized
cyclohexoyl lactam 4i  and pivaloyl lactam 4j , which proceed in improved
enantioselectivities compared to analogous acetyl lactam 4g, supporting a steric effect.43
Scheme 1.9.  Impact of various sp3 and sp2 acyl groups on allylic alkylation enantioselectivity for
lactams.
N
O
N
OO
5a (R = H)
85% yield
99% ee
5f (2-naphthyl)
82% yield
97% ee
N
O O
O
Pd2(pmdba)3 (5 mol %)
(S)-(CF3)3-t-BuPHOX (8)
(12.5 mol %)
toluene, 40 °C
N
O
N
OO
5i
63% yield
95% ee
N
O
5j
46% yield
96% ee
N
O
R
5g (R = Me)
47% yield
91% ee
4 5
O O
5e (1-naphthyl)
86% yield
99% ee
A.  sp2 hybridized
B.  sp3 hybridized
R
O
R
5c (R = F)
89% yield
99% ee
5b (R = OMe)
93% yield
99% ee
5d (R = Ph)
85% yield
99% ee
O O
5h (R = Bn)
90% yield
88% ee
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In conjunction with our investigation of the asymmetric allylic alkylation of
lactams, we found that N-benzoyl cyclic imides 7a and b are furnished in excellent ee
(Scheme 1.10).  However, we observed that formation of N-methyl imide 7c proceeds
with moderate enantioselectivity and is hampered by low reactivity.43  As this substrate
also generates an intermediate imido enolate (as do lactams 5a–j, Scheme 1.9), this result
further supports our conclusion that enolate electronics do not play a major role in the
enhanced enantioselectivities observed for N-benzoyl lactams.  As such, we examined the
influence of alternate N-substituents in the context of the allylic alkylation with imides.
Scheme 1.10.  Allylic alkylation of cyclic imides.
N
O
O
Me
N
O
O
Bz
N
O
O
BnO
7c
32% yield
76% ee
7a
81% yield
94% ee
7d
99% yield
96% ee
N
O
Et
O
Bz
7b
86% yield
96% ee
N
O
Et
O
BnO
7e
80% yield
98% ee
N
R1
O
R2
O
O N
R1
O
R2
O O
Pd2(pmdba)3 (5 mol %)
(S)-(CF3)3-t-BuPHOX (8)
(12.5 mol %)
toluene, 40 °C
6 7
Gratifyingly, we identified N-benzyloxy imides as excellent substrates for this
methodology, generating imides 7d and e in yields and enantioselectivities comparable to
their N-benzoyl counterparts.  In conjunction with the results obtained for substituted N-
acyl lactams 5g–j, we reason that the nature of the !'-substituent leads to the observed
enhancements in enantioselectivity, though enolate electronics have been shown to
dramatically affect the reaction rate.
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We sought to further probe the ! '-group contribution without the influence of
nitrogen and consequently focused on a series of !'-functionalized enones, including
benzoyl enone 13b  (Scheme 1.11).  Previous research suggested enolization
regioselectivity issues may arise in acylating/alkylating enone 39 (! vs. #, path A),6b
prompting us to pursue approaches to enone 13b through retrosynthetic disconnection of
the benzoyl substituent (path B).  Unfortunately, attempts to acylate and oxidize "-
ketoester 1 a  proved unsuccessful.  Both lithium halogen exchange and
Nozaki–Hiyama–Kishi coupling on iodoenone 41 also failed to install the benzoyl group.
The synthesis of enone 13b is ultimately possible via a Baylis–Hillman44 reaction and
oxidation sequence (Scheme 1.11B).  A number of oxidants were examined in the latter
transformation, but only Dess–Martin periodinane (DMP) proved successful.  Benzoyl
enone 13b is very sensitive to alkene isomerization, and thus the addition of potassium
carbonate as a buffer and the use of triethylamine deactivated silica gel for purification
are necessary.  Although we were able to prepare enone 13b, stability issues make this
molecule a poor alkylation substrate and prohibit the isolation of the desired methyl/allyl
!-quaternary enone under our standard palladium-catalyzed conditions.
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Scheme 1.11.  Retrosynthetic approaches and successful route to benzoyl enone 13b.
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Despite the complications with benzoyl enone 13b, we were able to synthesize
enones 13c and d and diosphenol ethers 45a and b under standard acylation/alkylation
conditions.  To examine the relative merit of the steric and stereoelectronic effects
associated with the ! '-substituent, we subjected these substrates to the palladium-
catalyzed alkylation parameters employed with lactams and imides (Scheme 1.12).  In
this transformation, enones 21c and d are formed in low enantioselectivity.  By contrast,
benzyl diosphenol ether 46a, which differs from 21d only in the substitution of oxygen
for a methylene group, is generated in 92% yield and 94% ee.  This suggests that purely
steric or $-stacking interactions are not the sole contributing factors to enantioselectivity.
Rather, electronic effects of the ! '-substituent exert an important influence on the
stereoselectivity of the reaction.  However, a certain amount of steric bulk appears critical
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in obtaining high enantioselectivity as methyl diosphenol ether 46b is produced in 85%
ee.  In comparison, analogous enone 21a, which bears no !'-functionality, proceeds under
the same conditions to afford enone 21a in 88% ee,36 with vinylogous amides and esters
also in the ~80–90% ee range (vide supra).  Overall, our studies on the role of the !'-
substituent have culminated in the discovery of substrate 45a, which proceeds with the
greatest enantioselectivity observed in a Pd(PHOX) catalyst system for a carbocyclic
substrate bearing an !-methyl and unsubstituted allyl moiety.
Scheme1.12.  Allylic alkylation of !'-functionalized enones and diosphenol ethers.
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1.3 CONCLUDING REMARKS
In summary, we have designed and evaluated a number of novel substrates to
probe the influence of enolate electronics and the role of !'-functionality on selectivity in
the palladium-catalyzed decarboxylative allylic alkylation.  Based on these results, we
reason that the high enantioselectivities observed with lactams and imides are a
consequence of both electronic and steric effects associated with !'-substituents, and that
enolate electronics alone contribute relatively little to the stereochemical outcome of the
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reaction.  These results led to further investigations in our group to determine the nature
and origin of the effect of α'-substitution on this transformation and to use this insight
to improve and expand our methods as described in the following chapter.
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1.4 EXPERIMENTAL SECTION
1.1.1 MATERIALS AND METHODS
Unless otherwise stated, reactions were performed in flame-dried glassware under
an argon or nitrogen atmosphere using dry, deoxygenated solvents.  Solvents were dried
by passage through an activated alumina column under argon.45  Acetone was used
directly from a Sigma-Aldrich ACS reagent grade bottle.  Brine solutions are saturated
aqueous solutions of sodium chloride.  Reagents were purchased from Sigma-Aldrich,
Acros Organics, Strem, or Alfa Aesar and used as received unless otherwise stated.  (S)-t-
BuPHOX (3),
5ab
 (S)-(CF3)3-t-BuPHOX (8),
5c
 and allyl cyanoformate
46
 were prepared by
known methods.
  Reaction temperatures were controlled by an IKAmag temperature
modulator.  Reaction progress was monitored by thin-layer chromatography (TLC).  TLC
was performed using E. Merck silica gel 60 F254 precoated glass plates (0.25 mm) and
visualized by UV fluorescence quenching, p-anisaldehyde, or KMnO4 staining.  ICN
silica gel (particle size 0.032-0.0653 mm) was used for flash column chromatography.
Preparative HPLC purification was performed on an Agilent 1200 Series HPLC using an
Agilent Prep-SIL column (5 µm, 30 x 250 mm) at ambient temperature with a flow rate
of 50 mL/min.  Separation was monitored by UV (% = 254 nm) and fractions were
collected at the valleys between peaks.  1H NMR spectra were recorded on a Varian
Mercury 300 MHz or Varian Inova 500 MHz spectrometer and are reported relative to
residual CHCl3 (& 7.26 ppm) or benzene-d6 (& 7.16 ppm).  
13C NMR spectra are recorded
on a Varian Mercury 300 MHz or Varian Inova 500 MHz spectrometer (75 or 125 MHz
respectively) and are reported relative to CDCl3 (&  77.16 ppm) or benzene-d6 (&  128.06
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ppm).  Variable temperature NMR experiments were performed on a Varian Inova 500
MHz spectrometer and are reported relative to residual DMSO (& 2.50 ppm).  Data for 1H
NMR are reported as follows: chemical shift (&  ppm) (multiplicity, coupling constant
(Hz), integration).  Multiplicities are reported as follows: s = singlet, d = doublet, t =
triplet, q = quartet, p = pentet, sept = septuplet, m = multiplet, dm = doublet of multiplets,
br s = broad singlet, br d = broad doublet, app = apparent. Data for 13C are reported in
terms of chemical shifts (& ppm).  IR spectra were obtained by use of a Perkin Elmer
Spectrum BXII spectrometer using thin films deposited on NaCl plates and reported in
frequency of absorption (cm-1).  Optical rotations were measured with a Jasco P-2000
polarimeter operating on the sodium D-line (589 nm), using a 100 mm path-length cell
and are reported as: [!]D
T (concentration in g/100 mL, solvent, ee).  Analytical chiral
HPLC was performed with an Agilent 1100 Series HPLC utilizing a Chiralpak (AD, AD-
H, or AS) or Chiralcel (OD-H, OJ-H, or OB-H) columns (4.6 mm x 25 cm) obtained from
Daicel Chemical Industries, Ltd.  Analytical chiral SFC was performed with a JASCO
2000 series instrument or a Thar SFC utilizing Chiralpak (AD-H or AS-H) or Chiralcel
(OD-H, OJ-H, or OB-H) columns (4.6 mm x 25 cm), or a Chiralpak IC column (4.6 mm
x 10 cm) obtained from Daicel Chemical Industries, Ltd.  High resolution mass spectra
(HRMS) were obtained from the Caltech Mass Spectral Facility (GC-EI+, EI+, or FAB+)
or Agilent 6200 Series TOF with an Agilent G1978A Multimode source in electrospray
ionization (ESI+), atmospheric pressure chemical ionization (APCI+), or mixed
ionization mode (MM: ESI-APCI+).
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1.4.2 PREPARTIVE PROCEDURES
1.4.2.2 Preparation of Compounds Related to Enaminone Screen
1.4.2.2.1 Enaminone Allylic Alkylation Precursors
O
i-BuO
O
O O
O
O
O
HCl (1 M)
THF, 23 °C
78% yield14a 17
Dione 17.  Procedure adapted from report by Desmaële.21  A 100 mL round-bottom flask
equipped with a magnetic stir bar was charged with vinylogous ester 14a18c (3.08 g, 11.58
mmol, 1.00 equiv), THF (30 mL, 0.39 M), and aq HCl (1 M in H2O, 14.00 mL, 14.00
mmol, 1.21 equiv).  The reaction mixture was initially a suspension that developed into a
solution over time.  After 7 h of vigorous stirring at ambient temperature, the reaction
was diluted with EtOAc (30 mL) and transferred to a separatory funnel where the
aqueous layer was extracted seven times with EtOAc.  The combined organics (400 mL)
were dried over MgSO4, filtered, and concentrated under reduced pressure.  The crude oil
was purified by flash column chromatography (SiO2, 31 x 5 cm, 100%
hexanes'20%'50% EtOAc in hexanes) to afford dione 17 (1.89 g, 11.58 mmol, 78%
yield) as a pale yellow oil; Rf = 0.17 (30% EtOAc in hexanes); 
1H NMR (500 MHz,
CDCl3) and 
13C NMR (125 MHz, CDCl3) mixture of keto-enol tautomers, see spectra
section; IR (Neat Film NaCl) 3500–2500 (broad stretch), 3088, 2983, 2939, 2657, 2591,
1734, 1595, 1457, 1413, 1383, 1358, 1343, 1309, 1272, 1249, 1190, 1114, 986, 932, 853
cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C11H15O4 [M+H]
+: 211.0965, found
211.0966.
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O
O
O
O O
N
O
O
Bn
Me
BnHNMe, p-TsOH•H2O
toluene, reflux, Dean–Stark
70% yield17 16a
Enaminone 16a.  A 50 mL round-bottom flask containing a magnetic stir bar was
charged with dione 17 (465.4 mg, 2.21 mmol, 1.00 equiv), toluene (24 mL, 0.09 M),
benzylmethylamine (320 µL, 2.48 mmol, 1.12 equiv), and p-toluenesulfonic acid
monohydrate (42.3 mg, 0.22 mmol, 10 mol %).  The flask was equipped with a Dean-
–Stark trap and water condenser and was lowered into a preheated oil bath (135 °C).
After 2 h of refluxing, the solution was removed from the oil bath and allowed to cool to
room temperature.  The solution was quenched with a sat. Na2CO3 solution (20 mL) and
transferred to a separatory funnel where the aqueous layer was extracted four times with
CH2Cl2.  The combined organics (200 mL) were dried over MgSO4, filtered, and
concentrated under reduced pressure.  The crude oil was purified by flash column
chromatography (SiO2, 27 x 3 cm, 100% hexanes'20%'50%'60%'70% EtOAc in
hexanes) to afford enaminone 16a (484.8 mg, 1.55 mmol, 70% yield) as a yellow/orange
oil; Rf = 0.24 (50% EtOAc in hexanes); 
1H NMR (500 MHz, CDCl3) & 7.37–7.33 (m, 2H),
7.32–7.27 (m, 1H), 7.09 (d, J = 7.4 Hz, 2H), 5.93–5.83 (m, 1H), 5.29 (dq, J = 17.3, 1.5
Hz, 1H), 5.26 (s, 1H), 5.18 (dq, J = 10.5, 1.4 Hz, 1H), 4.66–4.56 (m, 2H), 4.51 (s, 2H),
2.96 (s, 3H), 2.74–2.63 (m, 1H), 2.56–2.45 (m, 2H), 1.95–1.84 (m, 1H), 1.43 (s, 3H); 13C
NMR (125 MHz, CDCl3) & 193.9, 173.7, 164.3, 132.2, 129.1, 127.8, 126.7, 118.0, 98.1,
65.6, 55.2, 51.1, 38.5, 32.6, 24.4, 21.0; IR (Neat Film NaCl) 3063, 3028, 2933, 2873,
1733, 1615, 1585, 1563, 1557, 1495, 1455, 1415, 1377, 1352, 1332, 1295, 1258, 1222,
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1203, 1174, 1113, 1028, 989, 929, 821, 735 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d
for C19H24NO3 [M+H]
+: 314.1751, found 314.1754.
O
O
O
O O
N
O
O
Bn
Ph
BnHNPh, p-TsOH•H2O
toluene, reflux, Dean–Stark
31% yield17 16b
Enaminone 16b. A 50 mL round-bottom flask containing a magnetic stir bar was
charged with dione 17 (500.3 mg, 2.38 mmol, 1.00 equiv), toluene (24 mL, 0.10 M),
benzylphenylamine (480.0 mg, 2.62 mmol, 1.10 equiv), and p-toluenesulfonic acid
monohydrate (45.6 mg, 0.24 mmol, 10 mol %).  The flask was equipped with a Dean-
–Stark trap and water condenser and was lowered into a preheated oil bath (135 °C).
After 8 h of refluxing, the solution was removed from the oil bath and allowed to cool to
room temperature.  The solution was quenched with a sat. Na2CO3 solution (20 mL) and
transferred to a separatory funnel where the aqueous layer was extracted four times with
CH2Cl2.  The combined organics (200 mL) were dried over MgSO4, filtered, and
concentrated under reduced pressure.  The crude oil was purified twice by flash column
chromatography (SiO2, 26 x 3 cm, 100% hexanes'10%'15%'20%'30%'40%
EtOAc in hexanes then  SiO2, 26.5 x 3 cm, 100% hexanes' 5%'10%'15%
'20%'30%'  50% EtOAc in hexanes) to afford enaminone 16b (276.6 mg, 0.74
mmol, 31% yield) as a yellow oil; Rf = 0.50 (50% EtOAc in hexanes); 
1H NMR (500
MHz, CDCl3) & 7.38–7.33 (m, 2H), 7.33–7.24 (m, 4H), 7.21–7.18 (m, 2H), 7.13–7.10 (m,
2H), 5.90 (dddd, J = 17.2, 10.7, 5.4, 5.4 Hz, 1H), 5.39 (s, 1H), 5.31 (dq, J = 17.2, 1.6 Hz,
1H), 5.21 (dq, J = 10.5, 1.4 Hz, 1H), 4.83 (s, 2H), 4.68–4.63 (m, 1H), 4.62–4.57 (m, 1H),
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2.55–2.47 (m, 1H), 2.42 (ddd, J = 13.3, 6.1, 4.9 Hz, 1H), 2.33–2.27 (m, 1H), 1.84 (ddd, J
= 13.5, 8.7, 4.9 Hz, 1H), 1.42 (s, 3H); 13C NMR (125 MHz, CDCl3) & 194.6, 173.3, 163.9,
144.3, 136.4, 132.2, 129.9, 128.9, 128.0, 127.9, 127.7, 127.1, 118.0, 100.4, 65.6, 56.8,
51.6, 32.9, 25.9, 21.0; IR (Neat Film NaCl) 3061, 3031, 2975, 2933, 2872, 1734, 1623,
1560, 1494, 1453, 1426, 1408, 1377, 1346, 1327, 1293, 1255, 1210, 1174, 1112, 1080,
1061, 1022, 989, 929, 885, 825, 779, 733, 702 cm-1; HRMS (MM: ESI-APCI+) m/z
calc’d for C24H26NO3 [M+H]
+: 376.1907, found 376.1903.
O
O
O
O O
N
O
O
Bn
H
H2NBn, p-TsOH•H2O
toluene, reflux, Dean–Stark
92% yield17 16c
Enaminone 16c.  A 250 mL round-bottom flask containing a magnetic stir bar was
charged with dione 17 (1.89 g, 8.98 mmol, 1.00 equiv), toluene (90 mL, 0.10 M),
benzylamine (1.1 mL, 10.04 mmol, 1.12 equiv), and p-toluenesulfonic acid monohydrate
(169.0 mg, 0.89 mmol, 10 mol %).  The flask was equipped with a Dean–Stark trap and
water condenser and was lowered into a preheated oil bath (135 °C).  After 5.5 h of
refluxing, the solution was removed from the oil bath and allowed to cool to room
temperature.  The solution was quenched with a sat. Na2CO3 solution (50 mL) and
transferred to a separatory funnel where the aqueous layer was extracted once with Et2O
and three times with dichloromethane.  The combined organics were dried over MgSO4,
filtered, and concentrated under reduced pressure.  The crude oil was purified by flash
column chromatography (SiO2, 31 x 5 cm, 100% hexanes'20%'50% EtOAc in
hexanes) to afford enaminone 16c (2.48 g, 8.28 mmol, 92% yield) as a yellow solid; Rf =
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0.27 (30% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) & 7.40–7.30 (m, 3H), 7.29 (s,
2H), 5.95–5.82 (m, 1H), 5.30 (dq, J = 17.2, 1.6 Hz, 1H), 5.22 (s, 1H), 5.20 (dq, J = 10.5,
1.4 Hz, 1H), 4.62 (tt, J = 5.6, 1.5 Hz, 2H), 4.56 (br s, 1H), 4.24 (d, J = 5.0 Hz, 2H), 2.59
(ddd, J = 16.5, 8.8, 4.9 Hz, 1H), 2.50 (ddd, J = 13.3, 6.2, 4.9 Hz, 1H), 2.33 (dt, J = 16.6,
5.3 Hz, 1H), 1.91 (ddd, J = 13.6, 8.8, 5.0 Hz, 1H), 1.44 (s, 3H); 13C NMR (125 MHz,
CDCl3) & 194.4, 173.4, 162.6, 136.7, 132.2, 129.1, 128.2, 128.0, 118.0, 96.7, 65.6, 52.1,
47.5, 32.4, 26.7, 21.1; IR (Neat Film NaCl) 3260, 3064, 2978, 2933, 2868, 1730, 1576,
1545, 1452, 1427, 1375, 1359, 1297, 1253, 1218, 1199, 1172, 1107, 1028, 987, 929, 822,
735 cm-1; HRMS (GC-EI+) m/z calc’d for C18H21NO3 [M+•]
+: 299.1521, found 299.1522.
O
N
O
O
Bn
H
BzO
N
O
O
Bn
Bz
90% yield
i. i-Pr2NEt
   CH2Cl2, 0 °C
ii. BzCl
    0!23 °C
16c 18
Diene 18.  A 1 dram (4 mL) vial equipped with a stir bar and Teflon septa was charged
with enaminone 16c (49.9 mg, 0.167 mmol, 1.00 equiv) and lowered into a 0 °C bath
(ice/water).  Dichloromethane (1.7 mL, 0.10 M), i-Pr2NEt (150 µL, 0.861 mmol, 5.17
equiv), and benzoyl chloride (40 µL, 0.345 mmol, 2.07 equiv) were added and the
reaction was allowed to warm to room temperature over time.  After 13 h, TLC analysis
indicated consumption of starting material.  The reaction was subsequently quenched
with water (5 mL) and the aqueous layer was extracted four times with dichloromethane.
The combined organics (50 mL) were dried over MgSO4, filtered, and concentrated under
reduced pressure.  The resulting crude oil was purified by flash chromatography (SiO2, 26
x 1 cm, 5%'10%'15% EtOAc in hexanes) to afford diene 18 (75.8 mg, 0.149 mmol,
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90% yield) as a yellow oil; Rf = 0.77 (50% EtOAc in hexanes); 
1H NMR (500 MHz,
CDCl3) & 8.07–8.02 (m, 2H), 7.65–7.59 (m, 1H), 7.56–7.51 (m, 2H), 7.50–7.45 (m, 2H),
7.39 (s, 2H), 7.37–7.32 (m, 3H), 7.32–7.30 (m, 2H), 7.28–7.24 (m, 1H), 6.20 (s, 1H),
5.81–5.72 (m, 1H), 5.22 (dt, J = 17.2, 1.4 Hz, 1H), 5.13 (dt, J = 10.3, 1.3 Hz, 1H),
4.97–4.79 (m, 3H), 4.56–4.43 (m, 2H), 2.75 (dd, J = 17.4, 4.6 Hz, 1H), 2.03 (dd, J = 17.4,
4.7 Hz, 1H), 1.21 (s, 3H); 13C NMR (125 MHz, CDCl3) & 173.6, 170.7, 164.0, 150.5,
137.2, 136.2, 136.1, 133.9, 131.7, 130.2, 130.0, 129.4, 129.0, 128.8, 128.5, 128.3, 128.1,
127.5, 120.2, 118.6, 113.4, 66.1, 50.6, 46.4, 35.1, 20.4; IR (Neat Film NaCl) 3062, 3030,
2981, 2934, 1740, 1646, 1600, 1577, 1495, 1451, 1400, 1349, 1326, 1244, 1176, 1145,
1112, 1077, 1050, 1023, 1001, 980, 935, 824, 797, 755 cm-1; HRMS (MM: ESI-APCI+)
calc’d for C32H30O5N [M+H]
+: 508.2118, found 508.2122.
O
N
O
O
Bn
H
O
N
O
O
Bn
Boc
90% yield
Boc2O, DMAP
CH2Cl2, 0!23 °C
16c 16f
Enaminone 16f.  A flame-dried 25 mL round-bottom flask containing a magnetic stir bar
was loaded with enaminone 16c  (300.1 mg, 1.00 mmol, 1.00 equiv) and 4-
dimethylaminopyridine (9.5 mg, 0.078 mmol, 7.8 mol %).  The flask was charged with
dichloromethane (10 mL, 0.10 M) and lowered into a 0 °C bath (ice/water).  Di-tert-butyl
dicarbonate (252.7 mg, 1.16 mmol, 1.15 equiv) was added, and the solution transitioned
from yellow to clear.  The ice bath was allowed to expire as the reaction was stirred
overnight.  After 22 h, the stir bar was removed from the flask, the reaction contents were
concentrated under reduced pressure, and the resulting crude oil was purified by flash
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column chromatography (SiO2, 26.5 x 3 cm, 100% hexanes'5%'10%'15%'20%
EtOAc in hexanes) to afford enaminone 16f (360.0 mg, 0.90 mmol, 90% yield) as a pale
yellow oil; Rf = 0.79 (50% EtOAc in hexanes); 
1H NMR (500 MHz, CDCl3) & 7.34–7.28
(m, 2H), 7.26–7.21 (m, 1H), 7.16–7.12 (m, 2H), 5.85 (dddd, J = 17.2, 10.5, 5.5, 5.5 Hz,
1H), 5.73 (t, J = 0.9 Hz, 1H), 5.27 (dq, J = 17.2, 1.6 Hz, 1H), 5.20 (dq, J = 10.5, 1.3 Hz,
1H), 4.80 (s, 2H), 4.58 (dddd, J = 5.6, 2.8, 1.5, 1.5 Hz, 2H), 2.92–2.77 (m, 2H), 2.45 (dt,
J = 13.5, 5.3 Hz, 1H), 1.86 (ddd, J = 13.5, 7.7, 5.7 Hz, 1H), 1.42 (s, 9H), 1.38 (s, 3H); 13C
NMR (125 MHz, CDCl3) & 196.8, 172.6, 162.2, 152.9, 137.2, 131.9, 128.8, 127.5, 126.3,
118.3, 114.8, 83.0, 65.8, 53.0, 52.5, 33.6, 28.1, 27.5, 20.4; IR (Neat Film NaCl) 3090,
3064, 3034, 2978, 2935, 2873, 1718, 1662, 1654, 1595, 1497, 1453, 1425, 1369, 1344,
1317, 1300, 1248, 1210, 1150, 1113, 1029, 989, 937, 856, 815, 769, 737 cm-1; HRMS
(MM: ESI-APCI+) m/z calc’d for C23H30NO5 [M+H]
+: 400.2118, found 400.2127.
O
N
O
O
Bn
H
O
N
O
O
Bn
Ts
45% yield
i. NaH, THF, 23 °C
ii. TsCl
16c 16g
Enaminone 16g.  A flame-dried 25 mL round-bottom flask containing a magnetic stir bar
was cycled into a glove box and loaded with sodium hydride (95% by weight, 32.6 mg,
1.29 mmol, 1.29 equiv).  The flask was removed from the glove box, reconnected to an
Ar-filled manifold, and charged with THF (6 mL).  Enaminone 16c (300.3 mg, 1.00
mmol, 1.00 equiv) was added in one portion and the grey suspension bubbled and became
a yellow solution over time.  The flask was rinsed with additional THF (4 mL, 10 mL
total, 0.10 M).  The reaction was stirred vigorously for 70 min before p-toluenesulfonyl
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chloride (287.6 mg, 1.51 mmol, 1.50 equiv) was added in one portion.  After 6 h, the
flask was lowered into a 0 °C bath (ice/water) and quenched with water (reaction mixture
bubbled).  The mixture was transferred to a separatory funnel where the aqueous layer
was extracted four times with CH2Cl2.  The combined organics (100 mL) were dried over
MgSO4, filtered, and concentrated under reduced pressure.  The crude oil was purified by
flash column chromatography (SiO2, 27 x 3 cm, 100% hexanes'5%'10%'15%'
50% EtOAc in hexanes) to afford enaminone 16g (203.8 mg, 0.45 mmol, 45% yield) as a
yellow oil; Rf = 0.68 (30% EtOAc in hexanes); 
1H NMR (500 MHz, CDCl3) & 7.69 (d, J =
8.3 Hz, 2H), 7.35 (d, J = 8.0 Hz, 2H), 7.33–7.25 (m, 3H), 7.23 (d, J = 6.6 Hz, 2H), 5.75
(dddd, J = 17.3, 10.8, 5.6, 5.6 Hz, 1H), 5.68 (t, J = 1.1 Hz, 1H), 5.24–5.15 (m, 2H),
4.81–4.69 (m, 2H), 4.48 (dddd, J = 13.5, 5.6, 1.4, 1.4 Hz, 1H), 4.40 (dddd, J = 13.2, 5.6,
1.4, 1.4 Hz, 1H), 2.67–2.55 (m, 2H), 2.46 (s, 3H), 2.32 (dt, J = 13.9, 5.2 Hz, 1H), 1.69
(ddd, J = 13.8, 8.0, 5.9 Hz, 1H), 1.22 (s, 3H); 13C NMR (125 MHz, CDCl3) & 196.0,
171.9, 158.4, 144.8, 135.6, 135.3, 131.7, 130.2, 128.9, 128.1, 127.6, 127.5, 119.5, 118.5,
65.9, 53.0, 52.2, 32.4, 27.9, 21.8, 20.0; IR (Neat Film NaCl) 3064, 3032, 2981, 2935,
2873, 1735, 1669, 1596, 1496, 1454, 1424, 1359, 1321, 1292, 1255, 1164, 1115, 1089,
1058, 1028, 984, 910, 883, 816, 773, 743 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for
C25H28NSO5 [M+H]
+: 454.1683, found 454.1691.
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I I
O O
O
O1. LDA, THF, –78 °C
then allyl cyanoformate
2. NaH, MeI, THF, 23 °C
18% yield, 2 steps
19 20
"-Iodoenone 20.  A 200 mL round-bottom flask equipped with a magnetic stir bar was
charged with diisopropyl amine (1.52 mL, 10.85 mmol, 1.19 equiv) and THF (36 mL).
The flask was lowered into a 0 °C bath (ice/water) and n-BuLi (4.5 mL, 2.3 M in
hexanes, 10.35 mmol, 1.14 equiv) was added dropwise over several minutes.  The
reaction was stirred for 15 min before the ice bath was removed and replaced with a –78
°C bath (dry ice/acetone).  "-Iodoenone 1929 (2.00 g, 9.09 mmol, 1.00 equiv) was
transferred via cannula to the flask using several THF rinses (1 x 14 mL and 2 x 5 mL
rinses, total added = 60 mL, 0.15 M), producing a yellow solution that transitioned to red
over time.  The reaction was stirred for 1 h before allyl cyanoformate (1.12 mL, 10.38
mmol, 1.14 equiv) was added dropwise.  After 2.25 h, the reaction was quenched with
sat. NH4Cl solution and allowed to warm to room temperature.  The reaction contents
were transferred to a separatory funnel where the aqueous phase was extracted four times
with Et2O.  The combined organics were dried over MgSO4, filtered, and concentrated
under reduced pressure.  The resulting crude oil was filtered through a short silica gel
plug to afford an orange oil.
A 50 mL round-bottom flask equipped with a magnetic stir bar was cycled into a
glove box and loaded with sodium hydride (161.0 mg, 95% by weight, 6.37 mmol, 1.21
equiv).  The flask was removed from the glove box, reconnected to an Ar-filled manifold,
and charged with THF (6 mL).  The crude orange oil from the previous step (1.61 g, 5.27
mmol, 1.00 equiv) was transferred via cannula to the flask using several THF rinses (1 x
CHAPTER 1 — Expanding Insight into Asymmetric Palladium-Catalyzed Allylic Alkylation 34
5 mL + 3 x 2 mL, total added = 21.0 mL, 0.25 M).  The grey suspension bubbled and
became a yellow solution that transitioned to red over time.  The reaction was stirred for
30 min before methyl iodide (400 µL, 6.43 mmol, 1.22 equiv) was added dropwise.
After 3.5 h, the reaction was quenched with water and extracted four times with
dichloromethane.  The combined organics were dried over MgSO4, filtered, and
concentrated under reduced pressure.  The resulting crude oil was purified by flash
column chromatography (SiO2, 28.5 x 4 cm, 100% hexanes'5% EtOAc in hexanes) to
afford "-Iodoenone 20 (536.3 mg, 1.68 mmol, 18% yield over two steps) as a yellow oil;
Rf = 0.72 (30% EtOAc in hexanes); 
1H NMR (500 MHz, CDCl3) & 6.81 (dd, J = 2.2, 1.2
Hz, 1H), 5.94–5.79 (m, 1H), 5.32–5.26 (m, 1H), 5.24 (dt, J = 10.5, 1.1 Hz, 1H),
4.67–4.56 (m, 2H), 3.05–2.96 (m, 1H), 2.93–2.85 (m, 1H), 2.43 (dt, J = 13.8, 4.9 Hz,
1H), 1.95 (ddd, J = 14.0, 9.0, 5.3 Hz, 1H), 1.39 (s, 3H); 13C NMR (125 MHz, CDCl3) &
192.6, 171.7, 139.6, 131.6, 125.5, 118.8, 66.1, 52.7, 38.6, 35.0, 20.3; IR (Neat Film
NaCl) 3084, 2982, 2936, 2868, 1732, 1682, 1597, 1455, 1424, 1378, 1333, 1295, 1246,
1169, 1098, 1033, 986, 926, 852, 770, 737 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for
C11H14O3I [M+H]
+: 320.9982, found 320.9981.
O O
O
CuI (10 mol %)
AcNH2, Cs2CO3, H2O
THF, 60 °C
86% yield20
I
H
N
N
H
(20 mol %) O O
O
N
H
16h
Ac
Enaminone 16h.  Adapted from procedure by Buchwald.30  CuI (24 mg, 0.13 mmol, 0.10
equiv), Cs2CO3 (624 mg, 1.92  mmol, 1.50 equiv)  and acetamide (91 mg, 1.5  mmol, 1.2
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equiv) were added to a 25 mL Schlenck bomb equipped with a stir bar under argon
atmosphere. The Schlenck bomb was evacuated and backfilled with argon three times.  A
solution of vinyl iodide 2 0  (409 mg, 1.28 mmol, 1.00 equiv), N , N ' -
dimethylethylenediamine (23 mg, 0.26 mmol, 0.20 equiv) and nanopure water (23 mg,
1.3 mmol, 1.0 equiv) in THF (2.6 mL, 0.5 M) was added via syringe.  The reaction flask
was lowered into a 60 °C oil bath.  After 12 h of stirring, TLC analysis indicated
complete conversion of starting material.  The reaction was subsequently diluted with 15
mL CH2Cl2, transferred to a separatory funnel and washed twice with 5% aqueous
NH4OH (10 mL).  The combined aqueous layers were extracted twice with CH2Cl2 (15
mL).  The combined organics were washed with brine (20 mL), dried over Na2SO4,
filtered, and concentrated under reduced pressure.  The resulting crude oil was purified
by flash chromatography (SiO2, 12 x 3 cm, 20'33'50'67% EtOAc in hexanes) to
afford enaminone 16h (276 mg, 1.10 mmol, 86% yield) as a pale yellow oil; Rf = 0.10
(50% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) & 8.30 (s, 1H), 6.60 (s, 1H),
5.90–5.77 (m, 1H), 5.27 (dq, J = 17.2, 1.5 Hz, 1H), 5.19 (dq, J = 10.5, 1.2 Hz, 1H), 4.58
(dq, J = 5.6, 1.3 Hz, 2H), 2.78 – 2.64 (m, 1H), 2.62–2.43 (m, 1H), 2.54–2.45 (m, 1H),
2.11 (s, 3H), 2.02–1.83 (m, 1H), 1.39 (s, 3H); 
13
C NMR (125 MHz, CDCl3) & 197.8,
172.5, 169.9, 155.9, 131.7, 118.5, 110.1, 65.9, 52.3, 31.9, 25.7, 25.0, 20.6; IR (Neat Film
NaCl) 3299, 3135, 2937, 1728, 1626, 1520, 1456, 1426, 1370, 1259, 1220, 1184, 1114,
999, 939, 877 cm–1; HRMS (MM: ESI-APCI+) m/z calc'd for C13H18NO4 [M+H]
+:
252.1230, found 252.1219.
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NaH, DMF, 0 °C
then BnBr, 0!23 °C
71% yield
O O
O
N
Ac
O O
O
N
H
16h
Ac
Bn
16d
Enaminone 16d.  In a 5 mL round bottom flask equipped with a stir bar under nitrogen
atmosphere, enaminone 16h (63 mg, 0.25 mmol, 1.0 equiv) was taken up in dry DMF
(2.8 mL, 0.089 M) and cooled to 0 °C with an ice/water bath.  Sodium hydride (60%
suspension in mineral oil, 12 mg, 0.30 mmol, 1.2 equiv) was added to the mixture,
accompanied by the formation of bubbles.  The reaction was stirred for 1 h before the
dropwise addition of benzyl bromide (36 µL, 0.30 mmol, 1.2 equiv) by syringe.  The
reaction temperature was maintained at 0 °C for 5 h before allowing the ice bath to
gradually expire.  After an additional 6 h at 23 °C, TLC analysis indicated complete
conversion of starting material.  The reaction was subsequently diluted with EtOAc (10
mL) and sat. NH4Cl sol. (10 mL) and transferred to a separatory funnel.  The organic
layer was separated from the aqueous layer, and the aqueous layer was extracted twice
with EtOAc (2 x 10 mL).  The combined organics were washed with brine (15 mL), dried
over MgSO4, filtered, and concentrated under reduced pressure.  The resulting crude oil
was purified by flash chromatography (SiO2, 15 x 3 cm, 20% acetone in hexanes) to
afford enaminone 16d (61 mg, 0.18 mmol, 71% yield) as a yellow oil; 1H NMR (500
MHz, CDCl3) & 7.34–7.29 (m, 2H), 7.29–7.24 (m, 1H), 7.19–7.16 (m, 2H), 5.87–5.79 (m,
1H), 5.78 (s, 1H), 5.27 (dt, J = 17.2, 1.4 Hz, 1H), 5.21 (dt, J = 10.5, 1.3 Hz, 1H),
4.89–4.84 (m, 1H), 4.78–4.72 (m, 1H), 4.56 (dt, J = 5.7, 1.3 Hz, 2H), 2.58 (ddd, J = 9.3,
4.9, 1.6 Hz, 1H), 2.56–2.48 (m, 1H), 2.44 (dtd, J = 13.8, 4.8, 1.2 Hz, 1H), 2.16 (s, 3H),
1.87–1.78 (m, 1H), 1.36 (s, 3H); 13C NMR (125 MHz, CDCl3) & 196.2, 172.0, 170.0,
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160.8, 136.5, 131.6, 129.0, 127.9, 127.5, 123.8, 1190, 66.1, 52.6, 50.8, 32.8, 27.3, 23.2,
20.2; IR (Neat Film NaCl) 3063, 3030, 2981, 2937, 2873, 1731, 1667, 1624, 1496, 1454,
1424, 1387, 1375, 1344, 1312, 1250, 1190, 1113, 1029, 986, 948, 882, 738 cm-1; HRMS
(MM: ESI-APCI+) m/z calc’d for C20H24O4N [M+H]
+: 342.1700, found 342.1705.
O O
O
CuI (10 mol %)
BzNH2, Cs2CO3, H2O
THF, 60 °C
70% yield20
I
H
N
N
H
(20 mol %) O O
O
N
H
Bz
16i
Enaminone 16i.  Adapted from procedure by Buchwald.30  Prepared from 20 in an
analogous manner to 16h.  Purified by flash chromatography (SiO2, 12 x 3 cm,
20'33'50% EtOAc in hexanes) to afford enaminone 16i (220 mg, 0.702 mmol, 70%
yield) as a pale yellow oil that solidified to a pale yellow amorphous solid upon standing
at –20 °C; Rf = 0.10 (50% EtOAc in hexanes); 
1
H NMR (500 MHz, CDCl3) & 8.31 (s,
1H), 7.83 – 7.74 (m, 2H), 7.56–7.47 (m, 1H), 7.47–7.40 (m, 2H), 6.70 (s, 1H), 5.88–5.75
(m, 1H), 5.25 (dq, J = 17.2, 1.6 Hz, 1H), 5.17 (dq, J = 10.5, 1.4 Hz, 1H), 4.55 (dq, J =
5.5, 1.5 Hz, 2H), 2.92–2.82 (m, 1H), 2.79–2.69 (m, 1H), 2.53 (dt, J = 13.7, 5.4 Hz, 1H),
1.99–1.87 (m, 1H), 1.38 (s, 3H); 13C NMR (125 MHz, CDCl3) & 197.2, 172.5, 166.5,
155.6, 133.8, 132.7, 131.7, 128.9, 127.5, 118.4, 111.1, 65.8, 52.3, 32.0, 25.9, 20.5; IR
(Neat Film NaCl) 3334, 2936, 1732, 1694, 1621, 1514, 1492, 1376, 1258, 1185, 1115,
1071, 1023, 931, 710 cm–1; HRMS (MM: ESI-APCI+) m/z calc'd for C18H20NO4 [M+H]
+:
314.1387, found 314.1381.
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NaH, DMF, 0 °C
then BnBr, 0!23 °C
60% yield
O O
O
N
Bz
O O
O
N
H
16i
Bz
Bn
16e
Enaminone 16e.  Prepared from 16i in an analogous manner to 16d.  Purified by flash
chromatography (SiO2, 15 x 3 cm, 20% acetone in hexanes) to afford enaminone 16e
(134 mg, 0.332 mmol, 60% yield) as a yellow oil; Rf = 0.63 (50% EtOAc in hexanes); 
1
H
NMR (500 MHz, CDCl3) & 7.65–7.55 (m, 2H), 7.52–7.43 (m, 1H), 7.43–7.37 (m, 2H),
7.36–7.26 (m, 5H), 5.84 (s, 1H), 5.83–5.71 (m, 1H), 5.28–5.15 (m, 2H), 5.10–4.98 (m,
2H), 4.58–4.38 (m, 2H), 2.38–2.26 (m, 1H), 2.26–2.13 (m, 2H), 1.56 (s, 6H), 1.24 (s,
3H); 13C NMR (125 MHz, CDCl3) & 195.9, 171.8, 161.8, 136.8, 136.0, 131.8, 131.6,
128.9, 128.8, 128.2, 127.9, 127.7, 127.7, 121.4, 118.5, 65.9, 52.8, 52.4, 32.6, 28.8, 20.2;
IR (Neat Film NaCl) 2936, 1733, 1661, 1601, 1496, 1447, 1377, 1344, 1300, 1253, 1174,
1111, 974, 794, 724 cm–1; HRMS (MM: ESI-APCI+) m/z calc'd for C25H26NO4 [M+H]
+:
404.1856, found 404.1850.
O
O
O
O O
H2N
O
O
85% yield
NH4OAc
MeOH/CH3CN, 45 °C
17 16j
Enaminone 16j.  A flame-dried 50 mL round-bottom flask containing a stir bar was
cycled into a glove box and loaded with ammonium acetate (185.3 mg, 2.40 mmol, 1.16
equiv).  The flask was removed from the glove box, reconnected to an Ar-filled manifold,
and charged with MeOH (1.5 mL).  Dione 17 (437.5 mg, 2.08 mmol, 1.00 equiv) was
transferred to the flask via cannula using MeOH (5 mL, total added = 6.5 mL, 0.32 M)
and CH3CN (6.5 mL, 0.32 M) rinses.  The flask was lowered into a preheated oil bath (45
CHAPTER 1 — Expanding Insight into Asymmetric Palladium-Catalyzed Allylic Alkylation 39
°C) and the reaction was heated for five days before TLC analysis indicated consumption
of starting material.  The reaction was cooled to room temperature and the contents were
concentrated under reduced pressure.  The resulting crude material was recrystallized
twice with toluene to produce enaminone 16j (369.0 mg, 1.76 mmol, 85% yield) as a
white crystal; Rf = 0.18 (EtOAc); 
1H NMR (500 MHz, CDCl3) & 5.88 (dddd, J = 17.2,
10.4, 5.5, 5.5 Hz, 1H), 5.29 (dq, J = 17.2, 1.6 Hz, 1H), 5.25 (d, J = 0.8 Hz, 1H), 5.20 (dq,
J = 10.5, 1.4 Hz, 1H), 4.61 (dddd, J = 5.4, 3.9, 1.5, 1.5 Hz, 2H), 4.53 (broad s, 2H),
2.60–2.52 (m, 1H), 2.49 (ddd, J = 13.3, 5.8, 5.0 Hz, 1H), 2.35–2.28 (m, 1H), 1.93–1.86
(m, 1H), 1.42 (s, 3H); 13C NMR (125 MHz, CDCl3) & 194.7, 173.3, 163.7, 132.1, 118.1,
99.9, 65.7, 51.6, 32.3, 26.0, 21.0; IR (Neat Film NaCl) 3338, 3189, 3064, 2983, 2934,
2873, 1735, 1654, 1551, 1437, 1383, 1358, 1291, 1253, 1216, 1194, 1175, 1103, 989,
930, 841, 824 cm-1; HRMS (MM: ESI-APCI+) calc’d for C11H16O3N [M+H]
+: 210.1125,
found 210.1119.
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1.4.2.2.2 General Procedure for Screening Reactions
THF TBME Toluene 2:1 Hex–Tol
23b
23e
23g
23f
81
76
87
74
85
82
83
83
89
83
90
85
88
88
88
86
86
80
87
83
88
82
87
83
84
82
83
83
83
83
82
83
87
84
86
84
87
81
82
83
Enantiomeric Excess (% ee)b
22a
85
86
85
86
86
86
87
88
product
23a
61
79
60
78
55
84
52
83
23d
21a
87
85
88
86
87
88
87
85
ligand
3
8
3
8
3
8
3
8
3
8
3
8
3
8
3
8
entry
7
8
9
10
11
12
15
16
13
14
3
4
5
6
1
2
16b
16e
16g
16f
14a
substrate
16a
16d
13a
NPh(Bn)
NBz(Bn)
NTs(Bn)
NBoc(Bn)
Oi-Bu
R
NMe(Bn)
NAc(Bn)
H
a Conditions: enone 13a, vinylogous ester 14a, or enaminone 16a, b, d–g (1.0 equiv), Pd2(dba)3 (5 mol
%), and (S)-t-BuPHOX (3) or (S)-(CF3)3-t-BuPHOX (8) (12.5 mol %) in solvent (0.033 M) at 40 °C.
b
!Determined by GC, HPLC, or SFC analysis. Red = with (S)-(3) as ligand and blue = with (S)-(8) as ligand.
Ph2P N
O
t-Bu
(4-CF3C6H4)2P N
O
t-Bu
CF3
! (S)-t-BuPHOX ! (S)-(CF3)3-t-BuPHOX
3 8
O
O
O
Pd2(dba)3 (5 mol %)
(S)-t-BuPHOX (3) or 
(S)-(CF3)3-t-BuPHOX (8)
(12.5 mol %)
solvent (0.033 M), 40 oC
R
O
R
13, 14, or 16 21, 22, or 23
Enone 13a Screen Procedure.  Pd2(dba)3 (2.4 mg, 0.00262 mmol, 0.05 equiv) and the
appropriate PHOX ligand ((S)-t-BuPHOX (3): 2.5 mg, 0.00645 mmol, 0.125 equiv or
(S)-(CF3)3-t-BuPHOX (8): 3.8 mg, 0.00643 mmol, 0.125 equiv) were added to an oven-
dried 1 dram vial equipped with a magnetic stir bar.  A separate oven-dried 1 dram vial
was charged with enone 13a6 (10.0 mg, 0.0515 mmol, 1.00 equiv) and both vials were
cycled into a nitrogen-filled glove box.  The palladium/ligand vial was charged with
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solvent (THF, TBME, toluene: 360 µL or 2:1 hexanes/toluene: 120 µL toluene and 340
µL hexanes) and stirred at ambient glove box temperature.  After 30 min, enone 9a was
transferred to the reaction vial with several solvent rinses (THF, TBME, toluene: 3 x 400
µL, 1.56 mL total, 0.033 M or 2:1 hexanes/toluene: 400 µL toluene and 400 µL + 300 µL
hexanes, 1.56 mL solvent total, 0.033 M).  The vials were tightly sealed with a teflon
lined cap and electrical tape, removed from the glove box, and lowered into a heating
block set to 40 °C.  After 2 days, the reaction were either loaded directly onto a column
(toluene and 2:1 hexanes/toluene) or filtered through a celite plug and concentrated prior
to chromatography (THF and TBME).  All reactions were purified by flash column
chromatography (SiO2, ~22 x 1 cm, 2%'3% Et2O in pentane), resuspended in Et2O for
analysis, and analyzed for enantiomeric excess with chiral GC.  Characterization data for
enone 21a matches that previously reported.6  As part of the screen, the yield was
determined for enone 21a with (S)-8 in toluene (6.0 mg, 0.040 mmol, 78% yield).
Vinylogous Ester 14a and Enaminone Symyx Core Module Screen Procedure.  All
reagents were dispensed as solutions using a Symyx Core Module within a nitrogen-filled
glovebox.  Oven-dried half-dram vials were charged with a solution of the palladium
source (Pd2(dba)3, 1.65 µmol, 0.05 equiv) in THF (400 µL).  The palladium solutions
were evaporated to dryness under reduced pressure using a Genevac centrifugal
evaporator within the glovebox, and stirbars were added to the vials.  The reaction vials
were then charged with a solution of the PHOX ligand (4.13 µmol, 0.125 equiv) in the
reaction solvent (300 µL) and stirred at 20 °C.  After 30 min, a solution of vinylogous
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ester 14a or the enaminone substrate (16, 33.0 µmol, 1.0 equiv) in the reaction solvent
(700 µL) were added.  The reaction vials were tightly capped and heated to the desired 
temperature (40 °C).  The consumption of the starting material was observed by 
colorimetric change (from light yellow/green to red/orange) and after 5 days, the 
reactions were removed from the glovebox, filtered through a short silica gel plug 
(rinsing with EtOAc), concentrated under reduced pressure, resuspended in an 
appropriate solvent for analysis (HPLC: hexanes or SFC: MeOH), and analyzed for 
enantiomeric excess (see Methods for the Determination of Enantiomeric Excess). 
Characterization data for vinylogous ester 22a matches that previously reported.18c 
Experimental procedures and characterization data for enaminones 23a, b, d–g follow.
1.4.2.2.3 Enaminone Allylic Alkylation Products
O
N
O
O O
N
Bn
Me
(S)-t-BuPHOX (12.5 mol %)
Pd2(dba)3 (5.0 mol %)
toluene, 40!60 °C
68% yield
16a 23a
81% ee
Me
Bn
Ph2P N
O
t-Bu3
Enaminone 23a.  Pd2(dba)3 (14.6 mg, 0.0159 mmol, 5.0 mol %) and (S)-t-BuPHOX (3,
15.5 mg, 0.0400 mmol, 12.5 mol %) were added to an oven-dried scintillation vial
equipped with a magnetic stir bar and the vial was cycled into a glove box.  The vial was
charged with toluene (2 mL) and heated at 30 °C for 30 min, generating a red/orange
solution.  Enaminone 16a (1 M in toluene, 320 µL, 0.320 mmol, 1.00 equiv) and
additional toluene (7.35 mL, total added = 9.67 mL, 0.033 M) were added, producing a
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green solution.  The vial was sealed with a Teflon-lined cap, removed from the glove
box, and lowered into a heating block (40 °C).  After 5 days, the temperature was raised
to 60 °C and heated for an additional day before the reaction mixture transitioned back to
a red/orange solution.  The reaction was filtered through a silica gel plug, rinsed with
EtOAc, and concentrated under reduced pressure.  The crude oil was purified twice by
flash column chromatography (SiO2, 27.5 x 2 cm, 100% hexanes'20%'30%'50%
EtOAc in hexanes' 100% EtOAc then  SiO2, 26.5 x 1.5 cm, 100%
hexanes'20%'30%'40% EtOAc in hexanes) to afford enaminone 23a (58.9 mg,
0.219 mmol, 68% yield) as a pale yellow oil; Rf = 0.12 (50% EtOAc in hexanes); 
1H
NMR (500 MHz, CDCl3) & 7.38–7.33 (m, 2H), 7.31–7.26 (m, 1H), 7.10 (d, J = 7.2 Hz,
2H), 5.84–5.74 (m, 1H), 5.17 (s, 1H), 5.07–5.00 (m, 2H), 4.51 (s, 2H), 2.95 (s, 3H),
2.58–2.44 (m, 2H), 2.38 (dddd, J = 13.7, 7.1, 1.2, 1.2 Hz, 1H), 2.23–2.18 (m, 1H), 1.93
(ddd, J = 13.2, 7.5, 5.5 Hz, 1H), 1.71 (ddd, J = 13.7, 6.9, 5.4 Hz, 1H), 1.09 (s, 3H); 13C
NMR (125 MHz, CDCl3) & 201.2, 163.7, 136.9, 135.2, 129.1, 127.7, 126.3, 117.5, 98.1,
55.0, 42.1, 41.8, 38.5, 32.8, 24.0, 22.6; IR (Neat Film NaCl) 3066, 3029, 2958, 2926,
2867, 1728, 1615, 1557, 1495, 1451, 1412, 1373, 1354, 1333, 1315, 1297, 1276, 1253,
1204, 1156, 1103, 1077, 1029, 1001, 924, 823, 792, 733 cm-1; HRMS (EI+) m/z calc’d for
C18H23ON [M+•]
+: 269.1780, found 269.1782; [!]D
25.0 –24.18 (c 1.04, CHCl3, 81% ee);
JASCO SFC conditions: 5% MeOH in CO2, 5 mL/min, Chiralcel OD-H column, % = 210
nm, tR (min): major = 10.45, minor = 9.60.
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O
N
O
O O
N
Bn
Ph
(S)-t-BuPHOX (12.9 mol %)
Pd2(dba)3 (5.0 mol %)
toluene, 40 °C
78% yield
16b 23b
83% ee
Ph
Bn
Ph2P N
O
t-Bu3
Enaminone 23b.  Pd2(dba)3 (3.5 mg, 0.00382 mmol, 5.0 mol %) and (S)-t-BuPHOX (3,
3.8 mg, 0.00981 mmol, 12.9 mol %) were added to an oven-dried scintillation vial
equipped with a magnetic stir bar and the vial was cycled into a glove box.  The vial was
charged with toluene (0.5 mL) and heated at 30 °C for 30 min, generating a red/orange
solution.  Enaminone 16b (28.6 mg, 0.0762 mmol, 1.00 equiv) was transferred to the
flask with several toluene rinses (1 x 0.81 mL + 2 x 0.5 mL, total added = 2.31 mL, 0.033
M), producing a green solution.  The vial was sealed with a Teflon-lined cap, removed
from the glove box, and lowered into a heating block (40 °C).  After 4 days, the reaction
mixture transitioned back to an orange solution.  Subsequently, the reaction was filtered
through a silica gel plug, rinsed with EtOAc, and concentrated under reduced pressure.
The crude oil was purified twice by flash column chromatography (SiO2, 19.5 x 1.5 cm,
100% hexanes'50% EtOAc in hexanes'100% EtOAc then SiO2, 23.5 x 1 cm, 100%
hexanes'10%'20%'30%'40% EtOAc in hexanes) to afford enaminone 23b (19.7
mg, 0.0594 mmol, 78% yield) as a frosty colorless oil; Rf = 0.63 (50% EtOAc in
hexanes); 1H NMR (500 MHz, CDCl3) & 7.37–7.33 (m, 2H), 7.33–7.29 (m, 2H),
7.29–7.22 (m, 2H), 7.22–7.18 (m, 2H), 7.15–7.11 (m, 2H), 5.76 (dddd, J = 15.8, 11.3,
7.8, 7.0 Hz, 1H), 5.29 (s, 1H), 5.05–5.00 (m, 2H), 4.83 (s, 2H), 2.38 (dddd, J = 13.8, 7.1,
1.3, 1.3 Hz, 1H), 2.35–2.31 (m, 2H), 2.19 (dddd, J = 13.7, 7.8, 1.1, 1.1 Hz, 1H),
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1.90–1.83 (m, 1H), 1.65 (ddd, J = 13.5, 6.5, 5.6 Hz, 1H), 1.08 (s, 3H); 13C NMR (125
MHz, CDCl3) & 201.8, 163.3, 144.6, 136.7, 135.0, 129.8, 128.8, 128.0, 127.6, 127.5,
127.0, 117.6, 100.5, 56.7, 42.2, 42.0, 33.0, 25.5, 22.6; IR (Neat Film NaCl) 3063, 3031,
2959, 2926, 2863, 1622, 1563, 1494, 1453, 1426, 1404, 1374, 1351, 1329, 1275, 1204,
1156, 1078, 1060, 1028, 1002, 911, 830, 730 cm-1; HRMS (EI+) m/z calc’d for C23H26ON
[M+H]
+: 332.2009, found 332.1999; [!]D
25.0 –29.79 (c 1.91, CHCl3, 83% ee); JASCO
SFC conditions: 5% MeOH in CO2, 5 mL/min, Chiralpak AS-H column, % = 254 nm, tR
(min): major = 8.60, minor = 6.48.
O
N
O
O O
N
Bn
Ac
(S)-t-BuPHOX (12.3 mol %)
Pd2(dba)3 (5.0 mol %)
toluene, 40 °C
71% yield
16d 23d
86% ee
Ac
Bn
Ph2P N
O
t-Bu3
Enaminone 23d.  Pd2(dba)3 (2.6 mg, 0.00284 mmol, 5.0 mol %) and (S)-t-BuPHOX (3,
2.7 mg, 0.00697 mmol, 12.3 mol %) were added to an oven-dried scintillation vial
equipped with a magnetic stir bar and the vial was cycled into a glove box.  The vial was
charged with toluene (0.51 mL) and heated at 30 °C for 30 min, generating a red/orange
solution.  Enaminone 16d (19.3 mg, 0.0565 mmol, 1.00 equiv) was transferred to the
flask with several toluene rinses (4 x 0.3 mL, total added = 1.71 mL, 0.033 M), producing
a yellow solution.  The vial was sealed with a Teflon-lined cap, removed from the glove
box, and lowered into a heating block (40 °C).  After 2 days, the reaction mixture
transitioned back to an orange solution.  Subsequently, the reaction was filtered through a
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silica gel plug, rinsed with EtOAc, and concentrated under reduced pressure.  The crude
oil was purified by flash column chromatography (SiO2, 19.5 x 1.5 cm,
5%'10%'20%'30% EtOAc in hexanes) to afford enaminone 23d (12.0 mg, 0.0404
mmol, 71% yield) as a yellow oil; Rf = 0.46 (50% EtOAc in hexanes); 
1H NMR (500
MHz, CDCl3) & 7.32 (ddt, J = 8.1, 6.7, 1.2 Hz, 2H), 7.30–7.23 (m, 1H), 7.19 (ddt, J = 7.3,
1.4, 0.7 Hz, 2H), 5.68 (t, J = 1.3 Hz, 1H), 5.66 (ddt, J = 16.9, 10.1, 7.3 Hz, 1H), 5.05 (ddt,
J = 10.1, 1.9, 0.9 Hz, 1H), 4.99 (ddt, J = 17.0, 2.1, 1.4 Hz, 1H), 4.81 (s, 2H), 2.50–2.39
(m, 2H), 2.21 (ddt, J = 13.8, 7.3, 1.2 Hz, 1H), 2.17 (s, 3H), 2.10 (ddt, J = 13.8, 7.5, 1.1
Hz, 1H), 1.87 (dt, J = 13.8, 5.9 Hz, 1H), 1.69 (ddd, J = 13.8, 6.6, 5.7 Hz, 1H), 1.01 (s,
3H); 13C NMR (125 MHz, CDCl3) & 203.1, 169.7, 160.1, 136.6, 133.6, 128.9, 127.9,
127.7, 123.8, 118.6, 50.9, 43.6, 40.8, 32.6, 27.1, 23.2, 21.5; IR (Neat Film NaCl) 3066,
2926, 2854, 1663, 1624, 1496, 1453, 1387, 1371, 1189, 991, 916 cm-1; HRMS (FAB+)
m/z calc’d for C19H24NO2 [M+H]
+: 298.1807, found 298.1794; [!]D
25.0 –14.12 (c 1.20,
CHCl3, 86% ee); Thar SFC conditions: 5% MeOH in CO2, 3 mL/min, Chiralpak AD-H
column, % = 254 nm, tR (min): major = 8.45, minor = 10.35.
O
N
O
O O
N
Bn
Bz
(S)-t-BuPHOX (12.4 mol %)
Pd2(dba)3 (5.0 mol %)
toluene, 40 °C
71% yield
16e 23e
84% ee
Bz
Bn
Ph2P N
O
t-Bu3
Enaminone 23e.  Pd2(dba)3 (4.6 mg, 0.00502 mmol, 5.0 mol %) and (S)-t-BuPHOX (3,
4.8 mg, 0.0124 mmol, 12.4 mol %) were added to an oven-dried scintillation vial
CHAPTER 1 — Expanding Insight into Asymmetric Palladium-Catalyzed Allylic Alkylation 47
equipped with a magnetic stir bar and the vial was cycled into a glove box.  The vial was
charged with toluene (0.93 mL) and heated at 30 °C for 30 min, generating a red/orange
solution.  Enaminone 16e (1 M in toluene, 100 µL, 0.100 mmol, 1.00 equiv) was
transferred to the flask with more toluene (1 mL, total added including enaminone
solution = 3.03 mL, 0.033 M), producing a yellow/orange solution.  The vial was sealed
with a Teflon-lined cap, removed from the glove box, and lowered into a heating block
(40 °C).  After 2 days, the reaction mixture transitioned back to an orange solution.
Subsequently, the reaction was filtered through a silica gel plug, rinsed with EtOAc, and
concentrated under reduced pressure.  The crude oil was purified by flash column
chromatography (SiO2, 19.5 x 1.5 cm, 5%'10%'15% EtOAc in hexanes) to afford
enaminone 23e (26.3 mg, 0.0713 mmol, 71% yield, 95% purity) as a yellow oil; Rf = 0.57
(30% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) & 7.63–7.59 (m, 2H), 7.50–7.43
(m, 1H), 7.39 (ddt, J = 8.2, 6.6, 1.1 Hz, 2H), 7.35–7.29 (m, 4H), 7.29–7.25 (m, 1H), 5.74
(t, J = 1.1 Hz, 1H), 5.54 (ddt, J = 17.3, 10.1, 7.4 Hz, 1H), 5.09 (d, J = 15.3 Hz, 1H), 5.00
(d, J = 15.3 Hz, 1H), 4.98 (dm, J = 9.9 Hz, 1H), 4.86 (dm, J = 17.0 Hz, 1H), 2.11–2.08
(m, 2H), 2.03 (dd, J = 14.2, 7.9 Hz, 1H), 1.95 (ddt, J = 13.8, 7.3, 1.2 Hz, 1H), 1.59 (ddd, J
= 13.7, 6.5, 5.4 Hz, 1H), 1.41 (ddd, J = 13.4, 6.8, 5.3 Hz, 1H), 0.88 (s, 3H); 13C NMR
(125 MHz, CDCl3) & 202.7, 170.8, 160.9, 136.8, 136.2, 133.6, 131.6, 128.9, 128.7, 128.1,
128.0, 127.9, 122.3, 118.4, 52.5, 43.3, 40.6, 32.4, 28.4, 21.3; IR (Neat Film NaCl) 3063,
3030, 2961, 2928, 2855, 1655, 1610, 1496, 1447, 1384, 1374, 1347, 1324, 1273, 1189,
1140, 1076, 1028, 1001, 974, 919, 792 cm-1; HRMS (FAB+) m/z calc’d for C24H26NO2
[M+H]
+: 360.1964, found 360.1956; [!]D
25.0 –26.61 (c 1.87, CHCl3, 84% ee); Thar SFC
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conditions: 7% MeOH in CO2, 2.5 mL/min, Chiralpak AD-H column, % = 254 nm, tR
(min): major = 18.14, minor = 20.28.
O
N
O
O O
N
Bn
Boc
(S)-t-BuPHOX (12.5 mol %)
Pd2(dba)3 (5.0 mol %)
toluene, 40 °C
82% yield
16f 23f
82% ee
Boc
Bn
Ph2P N
O
t-Bu3
Enaminone 16f.  Pd2(dba)3 (11.5 mg, 0.0126 mmol, 5.0 mol %) and (S)-t-BuPHOX (3,
12.1 mg, 0.0312 mmol, 12.5 mol %) were added to an oven-dried scintillation vial
equipped with a magnetic stir bar and the vial was cycled into a glove box.  The vial was
charged with toluene (2 mL) and heated at 30 °C for 30 min, generating a red/orange
solution.  Enaminone 16f (1 M in toluene, 250 µL, 0.250 mmol, 1.00 equiv) and
additional toluene (6.34 mL, total added = 7.59 mL, 0.033 M) were added, producing a
green solution.  The vial was sealed with a Teflon-lined cap, removed from the glove
box, and lowered into a heating block (40 °C).  After 2 days, the reaction mixture
transitioned back to an orange solution.  Subsequently, the reaction was filtered through a
silica gel plug, rinsed with EtOAc, and concentrated under reduced pressure.  The crude
oil was purified by flash column chromatography (SiO2, 28 x 3 cm, 100%
hexanes'5%'10% EtOAc in hexanes) to afford enaminone 23f (72.6 mg, 0.204 mmol,
82% yield) as a pale yellow oil; Rf = 0.65 (30% EtOAc in hexanes); 
1H NMR (500 MHz,
CDCl3) & 7.33–7.29 (m, 2H), 7.26–7.22 (m, 1H), 7.17–7.14 (m, 2H), 5.69 (dddd, J = 16.8,
10.2, 7.4, 7.4 Hz, 1H), 5.63 (t, J = 0.9 Hz, 1H), 5.07–4.99 (m, 2H), 4.78 (s, 2H), 2.75 (tm,
CHAPTER 1 — Expanding Insight into Asymmetric Palladium-Catalyzed Allylic Alkylation 49
J = 6.1 Hz, 2H), 2.29 (dddd, J = 13.7, 7.3, 1.2, 1.2 Hz, 1H), 2.13 (dddd, J = 13.7, 7.5, 1.2,
1.2 Hz, 1H), 1.90–1.84 (m, 1H), 1.71–1.65 (m, 1H), 1.43 (s, 9H), 1.04 (s, 3H); 13C NMR
(125 MHz, CDCl3) & 203.6, 161.6, 153.0, 137.4, 134.1, 128.8, 127.4, 126.4, 118.2, 115.4,
82.6, 52.9, 43.2, 41.2, 33.5, 28.2, 27.2, 21.9; IR (Neat Film NaCl) 3066, 3031, 3004,
2976, 2931, 2868, 1716, 1656, 1598, 1497, 1455, 1428, 1382, 1368, 1350, 1326, 1302,
1243, 1209, 1192, 1153, 1076, 1030, 998, 946, 916, 858, 779, 767, 734 cm-1; HRMS
(MM: ESI-APCI+) m/z calc’d for C22H30O3N [M+H]
+: 356.2229, found 356.2220; [!]D
25.0
–23.61 (c 0.92, CHCl3, 82% ee); JASCO SFC conditions: 7% MeOH in CO2, 5 mL/min,
Chiralpak AD-H column, % = 210 nm, tR (min): major = 4.04, minor = 2.20.
O
N
O
O O
N
Bn
Ts
(S)-t-BuPHOX (12.7 mol %)
Pd2(dba)3 (5.1 mol %)
toluene, 40 °C
71% yield
16g 23g
84% ee
Ts
Bn
Ph2P N
O
t-Bu3
Enaminone 23g.  Pd2(dba)3 (10.2 mg, 0.0111 mmol, 5.1 mol %) and (S)-t-BuPHOX (3,
10.8 mg, 0.0279 mmol, 12.7 mol %) were added to an oven-dried scintillation vial
equipped with a magnetic stir bar and the vial was cycled into a glove box.  The vial was
charged with toluene (2 mL) and heated at 30 °C for 30 min, generating a red/orange
solution.  Enaminone 16g (1 M in toluene, 220 µL, 0.220 mmol, 1.00 equiv) and
additional toluene (5.46 mL, total added = 6.68 mL, 0.033 M) were added, producing a
green solution.  The vial was sealed with a Teflon-lined cap, removed from the glove
box, and lowered into a heating block (40 °C).  After 2 days, the reaction mixture
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transitioned back to an orange solution.  Subsequently, the reaction was filtered through a
silica gel plug, rinsed with EtOAc, and concentrated under reduced pressure.  The crude
oil was purified by flash column chromatography (SiO2, 27 x 2 cm, 100%
hexanes'5%'10%'15% EtOAc in hexanes) to afford enaminone 23g (64.1 mg, 0.157
mmol, 71% yield) as a pale yellow oil; Rf = 0.55 (30% EtOAc in hexanes); 
1H NMR (500
MHz, CDCl3) & 7.70 (dm, J = 8.3 Hz, 2H), 7.35 (dm, J = 8.6 Hz, 2H), 7.33–7.26 (m, 3H),
7.25–7.22 (m, 2H), 5.60–5.50 (m, 2H), 4.98 (dm, J = 10.2 Hz, 1H), 4.86 (dm, J = 17.0
Hz, 1H), 4.74 (d, J = 15.0 Hz, 1H), 4.66 (d, J = 15.0 Hz, 1H), 2.56–2.44 (m, 2H), 2.46 (s,
3H), 1.99–1.86 (m, 2H), 1.70 (ddd, J = 13.9, 6.6, 5.3 Hz, 1H), 1.55 (ddd, J = 13.9, 7.2,
5.5 Hz, 1H), 0.85 (s, 3H); 13C NMR (125 MHz, CDCl3) & 202.9, 157.74, 144.7, 135.4,
135.3, 133.7, 130.1, 128.9, 128.1, 127.9, 127.5, 120.7, 118.3, 53.1, 43.2, 40.6, 32.2, 27.9,
21.8, 21.3; IR (Neat Film NaCl) 3066, 3027, 2963, 2928, 2868, 1663, 1654, 1597, 1496,
1453, 1424, 1355, 1306, 1164, 1089, 1055, 1028, 1001, 912, 859, 814, 745 cm-1; HRMS
(MM: ESI-APCI+) m/z calc’d for C24H28O3NS [M+H]
+: 410.1784, found 410.1792;
[!]D
25.0 –33.05 (c 0.37, CHCl3, 84% ee); JASCO SFC conditions: 10% MeOH, 5 mL/min,
AD-H column, % = 210 nm, tR (min): major = 5.60, minor = 4.73.
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1.4.2.3 Preparation of 2,3-Dihydropyridin-4-ones
1.1.1.1.4 2,3-Dihydropyridin-4-one Allylic Alkylation Precursors
N
Cbz
O
1. LDA, THF, –78 °C
then allyl cyanoformate
2. K2CO3, MeI
acetone, 50 °C
43% yield, 2 steps
N
Cbz
O
O
O
47a 29a
2,3-Dihydropyridin-4-one 29a.  A 100 mL round-bottom flask equipped with a
magnetic stir bar was charged with diisopropyl amine (442 µL, 3.01 mmol, 1.20 equiv)
and THF (28 mL).  The flask was cooled to –78 °C bath (dry ice/IPA) and n-BuLi (1.30
mL, 3.01 mmol, 2.32 M in hexanes, 1.20 equiv) was added.  The reaction was allowed to
warm to 0 °C over 1 h.  The solution was cooled back to –78 °C and added dropwise to a
solution of 2,3-dihydropyridin-4-one 47a37 (580 mg, 2.51 mmol, 1.0 equiv) in THF (40
mL) at –78 °C using positive pressure cannulation.  The reaction was stirred for 1 h at
this temperature before allyl cyanoformate (300 µL, 2.88 mmol, 1.15 equiv) was added
dropwise.  The flask was removed from the bath, allowed to warm to room temperature
slowly, and stirred overnight.  The reaction was quenched with water and sat. NH4Cl
solution.  The phases were separated and the aqueous phase was extracted three times
with EtOAc.  The combined organic layers were dried over MgSO4, filtered, and
concentrated under reduce pressure.  The resulting yellow oil was purified by flash-
chromatography (2:1 Et2O/hexanes).
The yellow oil was transferred to an argon filled 25 mL Schlenk tube equipped
with a magnetic stir bar using several acetone rinses (3 x 2 mL).  K2CO3 (252 mg, 1.83
mmol, 2.0 equiv) and methyl iodide (115 µL, 1.84 mmol, 2.02 equiv) were added to the
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reaction.  The resulting suspension was heated to 50 °C and vigorously stirred for 14 h.
Upon completion, the reaction was allowed to cool to room temperature and filtered
through a plug of celite.  The resulting yellow solution was concentrated under reduced
pressure and purified by flash-chromatography (1:1 Et2O/hexanes) to afford 2,3-
Dihydropyridin-4-one 29a (210 mg, 0.64 mmol, 43% yield over two steps) as a yellow
oil; Rf = 0.38 (1:1 Et2O/hexanes); 
1H NMR (500 MHz, CDCl3) & 7.83 (br s, J = 22.5 Hz,
1H), 7.45–7.31 (m, 5H), 5.82 (ddt, J = 17.2, 10.4, 5.6 Hz, 1H), 5.37 (br s, 1H), 5.27 (s,
2H), 5.26 (dq, J = 17.1, 1.5 Hz, 1H), 5.20 (dq, J = 10.5, 1.3 Hz, 1H), 4.64 (dd, J = 13.5,
0.9 Hz, 1H), 4.59 (dt, J = 5.6, 1.5 Hz, 2H), 3.63 (d, J = 13.5 Hz, 1H), 1.40 (s, 3H); 13C
NMR (125 MHz, CDCl3) & 190.9, 170.1, 152.5, 142.7, 134.8, 131.3, 128.8, 128.7, 128.4,
118.6, 106.2, 69.2, 66.1, 51.6, 50.5, 17.9; IR (Neat Film, NaCl) 3076, 3034, 2965, 2929,
2360, 2922, 1729, 1668, 1605, 1498, 1456, 1418, 1393, 1344, 1302, 1205, 1157, 1101,
1029, 966, 917, 814, 763 cm-1; HRMS (MM: ESI/APCI+) m/z calc’d for C18H20NO5
[M+H]+: 330.1335, found 330.1335.
N
O
Bn
LDA, THF, –78 °C
then allyl cyanoformate
–78 ! 23 °C
N
O
O
O
Bn
47b 48b44% yield
2,3-Dihydropyridin-4-one 48b.  To a flame-dried 50 mL Schlenk round-bottom flask
equipped with a magnetic stir bar was added 2,3-dihydropyridin-4-one 47b38 (162.0 mg,
0.87 mmol) and THF (10 mL).  The solution was cooled to –78 °C and LDA (0.1 M in
THF, 9.10 mL, 0.91 mmol, 1.05 equiv) was added dropwise by syringe.  After 1 h at –78
°C, allyl cyanoformate (105.2 mg, 0.96 mmol, 1.10 equiv) was added, and the reaction
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was stirred for another 3 h and then quenched with a sat. NH4Cl sol.  The reaction was
transferred to a separatory funnel where the aqueous layer was extracted with CH2Cl2 (4 x
30 mL). The combined organics were washed with brine, dried over MgSO4, fitered, and
concentrated under reduced pressure.  The resulting crude mixture was purified by flash
chromatography (SiO2, 10 x 2.5 cm, 30% EtOAc ' 50% EtOAc in hexanes) to afford
2,3-dihydropyridin-4-one 48b (104.8 mg, 0.38 mmol, 44% yield) as a yellow oil; Rf =
0.30 (50% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) & 7.45–7.31 (m, 3H),
7.28–7.23 (m, 2H), 7.17 (d, J = 7.5 Hz, 1H), 5.87 (ddt, J = 17.2, 10.5, 5.7 Hz, 1H), 5.32
(dq, J = 17.2, 1.5 Hz, 1H), 5.22 (dq, J = 10.4, 1.3 Hz, 1H), 5.06 (d, J = 7.5 Hz, 1H),
4.69–4.55 (m, 2H), 4.40 (d, J = 2.5 Hz, 2H), 3.76 (dd, J = 13.3, 8.7 Hz, 1H), 3.51 (dd, J =
13.3, 5.9 Hz, 1H), 3.40 (dd, J = 8.7, 5.9 Hz, 1H); 13C NMR (125 MHz, CDCl3) & 185.2,
168.8, 153.6, 135.1, 131.6, 129.1, 128.5, 127.8, 118.6, 97.7, 66.0, 60.0, 50.5, 48.4; IR
(Neat Film NaCl) 3029, 2935, 2853, 1732, 1641, 1588, 1494, 1455, 1393, 1361, 1321,
1204, 1154, 1078, 1028, 991, 967, 935, 78, 731 cm-1; HRMS (MM: ESI-APCI+) m/z
calc’d for C16H18NO3 [M+H]
+: 272.1287, found 272.1314.
N
O
O
O
Bn
48b
N
O
O
O
Bn
NaH, MeI
THF, 0 °C
29b
86% yield
2,3-Dihydropyridin-4-one 29b.   To a flame-dried 25 mL round-bottom flask equipped
with a magnetic stir bar was cycled into a glove box and loaded with sodium hydride (9.3
mg, 0.39 mmol, 1.00 equiv).  The flask was removed from the glove box, reconnected to
an Ar-filled manifold, charged with THF (3 mL), and cooled to 0 °C.  A solution of 2,3-
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dihydropyridin-4-one 48b (104.2 mg, 0.39 mmol, 1.00 equiv) was added by syringe and
the mixture was stirred at 0 °C for 30 min.  The reaction was quenched with water,
transferred to a separatory funnel, and extracted four times with CH2Cl2.  The combined
organics were washed with brine, dried over MgSO4, filtered, and concentrated under
reduced pressure.  The crude oil was purified by flash chromatography (SiO2, 10 x 2.5
cm, 30% EtOAc in hexanes) to afford 2,3-dihydropyridin-4-one 29b (95.9 mg, 0.34
mmol, 86% yield) as a colorless oil; Rf = 0.40 (50% EtOAc in hexanes); 
1H NMR (500
MHz, CDCl3) & 7.43–7.30 (m, 3H), 7.25–7.20 (m, 2H), 7.13 (d, J = 7.4 Hz, 1H), 5.83
(ddt, J = 17.1, 10.8, 5.5 Hz, 1H), 5.27 (dq, J = 17.2, 1.6 Hz, 1H), 5.19 (dq, J = 10.5, 1.3
Hz, 1H), 5.01 (d, J = 7.4 Hz, 1H), 4.56 (qdt, J = 13.4, 5.5, 1.5 Hz, 2H), 4.46–4.30 (m,
2H), 3.78 (d, J = 13.2 Hz, 1H), 3.15 (d, J = 13.3 Hz, 1H), 1.30 (s, 3H); 13C NMR (125
MHz, CDCl3) & 189.1, 171.7, 152.8, 135.2, 131.8, 129.1, 128.5, 128.1, 118.2, 97.1, 65.9,
60.1, 55.1, 51.4, 18.6; IR (Neat Film NaCl) 3029, 2979, 2934, 2871, 1732, 1642, 1592,
1494, 1455, 1393, 1372, 1359, 1343,  1295, 1223, 1166, 1115, 1028, 975, 937, 792, 732
cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C17H20NO3 [M+H]
+: 286.1443, found
286.1480.
N
O
Bn
N
O
Bn
47b 48c
LDA, THF, –78 °C
I
7% yield
–78!23 °C
then
2,3-Dihydropyridin-4-one 48c.  To a flame-dried 100 mL Schlenk round-bottom flask
equipped with a magnetic stir bar was added 2,3-dihydropyridin-4-one 47b38 (0.68 g, 3.63
mmol) and THF (30 mL).  The solution was cooled to –78 °C and LDA (19.0 mL, 3.80
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mmol, 1.05 equiv, 0.2 M in THF) was added dropwise by syringe.  After 1 h at –78 °C,
1-iodo-2-methylpropane (0.87 g, 4.73 mmol, 1.30 equiv) was added, and the reaction was
stirred for another 1 h at –78 °C, brought to room temperature, and stirred overnight.  The
reaction was quenched with a sat. NH4Cl sol., transferred to a separatory funnel, and
extracted with CH2Cl2 (50 mL x 3). The combined organics were washed with brine,
dried over MgSO4, fitered, and concentrated. The crude mixture was purified by flash
chromatography (SiO2, 10 x 3 cm, 30% EtOAc in hexanes) to afford 2,3-dihydropyridin-
4-one 48c (58.2 mg, 0.24 mmol, 7% yield) as a yellow oil; Rf = 0.50 (50% EtOAc in
hexanes); 1H NMR (500 MHz, CDCl3) & 7.46–7.32 (m, 3H), 7.29–7.25 (m, 2H), 7.12 (d,
J = 7.4 Hz, 1H), 4.96 (d, J = 7.4 Hz, 1H), 4.43–4.28 (m, 2H), 3.38 (dd, J = 13.0, 5.4 Hz,
1H), 3.08 (dd, J = 13.0, 7.7 Hz, 1H), 2.29 (ddt, J = 10.1, 7.6, 5.2 Hz, 1H), 1.56 (ddd, J =
14.0, 9.3, 5.0 Hz, 1H), 1.37 (dpd, J = 9.3, 6.6, 5.2, 1H), 1.18 (ddd, J = 13.7, 9.6, 5.3 Hz,
1H), 0.82 (d, J = 6.5 Hz, 3H), 0.78 (d, J = 6.6 Hz, 3H); 13C NMR (125 MHz, CDCl3) &
195.0, 152.8, 135.8, 128.9, 128.3, 127.8, 97.7, 60.0, 50.4, 42.0, 37.5, 25.0, 23.3, 21.4; IR
(Neat Film NaCl) 3029, 2954, 2868, 1633, 1593, 1494, 1463, 1455, 1385, 1361, 1302,
1210, 1161, 1077, 778, 730 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C16H22NO
[M+H]+: 244.1701, found 244.1707.
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N
O
Bn
48c
N
O
Bn
29c
CO2allylLDA, THF, –78 °C
then allyl cyanoformate
–78!23 °C
30% yield
2,3-Dihydropyridin-4-one 29c.  To a flame-dried 25 mL Schlenk tube equipped with a
magnetic stir bar was added 2,3-dihydropyridin-4-one 48c (50.5 mg, 0.21 mmol) and
THF (5 mL).  After the solution was cooled to -78 °C, LDA (2.2 mL, 0.22 mmol, 1.06
equiv, 0.1 M in THF) was added dropwise by syringe.  The mixture was stirred for 1 h at
-78 °C and allyl cyanoformate (26.4 mg, 0.24 mmol, 1.20 equiv) was added.  The
reaction was stirred for another 3 h and quenched with saturated NH4Cl aqueous.  The
aqueous layer was extracted with CH2Cl2 (30 mL x 4) and the combined organics were
washed with brine, dried over MgSO4, and concentrated.  The crude mixture was purified
by flash chromatography (SiO2, 10 x 1 cm, 30% EtOAc in hexanes) to afford 29c (19.8
mg, 0.06 mmol, 30% yield) as a yellow oil; Rf = 0.30 (30% EtOAc in hexanes); 
1H NMR
(500 MHz, CDCl3) & 7.45–7.31 (m, 3H), 7.29–7.19 (m, 2H), 7.07 (d, J = 7.4 Hz, 1H),
5.86 (ddt, J = 17.2, 10.4, 5.6 Hz, 1H), 5.32 (dq, J = 17.2, 1.6 Hz, 1H), 5.20 (dq, J = 10.5,
1.3 Hz, 1H), 4.96 (d, J = 7.3 Hz, 1H), 4.67–4.51 (m, 2H), 4.43 (s, 2H), 3.82 (d, J = 13.4
Hz, 1H), 3.27 (d, J = 13.4 Hz, 1H), 2.03 (dd, J = 14.2, 7.1 Hz, 1H), 1.64–1.45 (m, 2H),
0.85 (d, J = 6.5 Hz, 3H), 0.80 (d, J = 6.5 Hz, 3H); 13C NMR (125 MHz, CDCl3) & 187.7,
170.9, 152.2, 135.1, 131.7, 129.0, 128.1, 118.4, 96.7, 65.8, 60.1, 54.4, 52.6, 40.4, 24.6,
24.3, 23.2; IR (Neat Film NaCl) 3029, 2957, 2870, 1729, 1644, 1593, 1455, 1360, 1267,
1215, 1159, 1132, 1077, 1029, 971, 778, 735 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d
for C20H26NO3 [M+H]
+: 328.1913, found 328.1947.
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N
O
MeO
MeO
47c
N
O
MeO
MeO
48d
LDA, THF, –78 °C
I
21 % yield
39% recovered 47c
then
2,3-Dihydropyridin-4-one 48d.  To a cooled (–78 °C) solution of 47c39 (0.67 g, 2.6
mmol, 1 equiv) in THF (25 mL) was added LDA (30 mL, 0.1 M, in THF, 30 mmol, 1.15
equiv) dropwise over 10 min.  The reaction was stirred for 1 h before 1-iodo-2-
methylpropane (0.57 g, 3.1 mmol, 1.20 equiv) was added dropwise.  After 2 h, the
reaction was brought to room temperature and stirred overnight.  The reaction was
quenched with sat. NH4Cl sol. and transferred to a separatory funnel where the aqueous
phase was extracted four times with CH2Cl2.  The combined organics were washed with
brine, dried over MgSO4, filtered, and concentrated under reduced pressure.  The
resulting crude mixture purified by flash column chromatography (SiO2, 15 x 3 cm, 50%
EtOAc in hexanes'100% EtOAc) to afford recovered 47c (0.26 g, 1.01 mmol, 39%
recovered) and also 48d (0.17 g, 0.54 mmol, 21% yield) as a yellow solid; Rf = 0.20
(50% EtOAc in hexanes).  Spectral data matches that reported previously.47  NMR data is
included to assist the reader.  1H NMR (300 MHz, CDCl3) & 7.14 (s, 1H), 6.65 (s, 1H),
5.62 (s, 1H), 3.90 (s, 3H), 3.86 (s, 3H), 3.64 (dd, J = 12.5, 5.3 Hz, 1H), 3.45–3.24 (m,
3H), 2.94 (td, J = 6.3, 3.5 Hz, 2H), 2.51–2.35 (m, 1H), 1.80–1.59 (m, 2H), 1.36–1.19 (m,
1H), 0.96 (d, J = 6.2 Hz, 3H), 0.91 (d, J = 6.2 Hz, 3H); 13C NMR (75 MHz, CDCl3) &
195.5, 156.6, 151.5, 148.1, 129.0, 120.9, 110.5, 108.4, 94.4, 56.1, 55.9, 49.2, 42.1, 37.6,
28.6, 25.6, 23.6, 21.9.
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N
O
MeO
MeO
48d
62% yield
N
O
MeO
MeO
CO2allyl
29d
LDA, THF, –78 °C
then allyl cyanoformate
2,3-Dihydropyridin-4-one 29d.  A solution of 48d (149.1 mg, 0.47 mmol in 15 mol of
THF) was cooled to –78 °C and LDA (5.2 mL, 0.1 M in THF, 0.52 mmol, 1.10 equiv)
was added dropwise.  The reaction was stirred for 1 h before allyl cyanoformate (60.2
mg, 0.54 mmol, 1.15 equiv) was added dropwise.  After 12 h, the reaction was quenched
with sat. NH4Cl sol. and allowed to warm to room temperature.  The reaction contents
were transferred to a separatory funnel where the aqueous phase was extracted four times
with CH2Cl2.  The combined organics were washed with brine, dried over MgSO4,
filtered, and concentrated under reduced pressure.  The resulting crude mixture was
purified by flash column chromatography (SiO2, 15 x 3 cm, 50% EtOAc in hexanes) to
afford 2,3-dihydropyridin-4-one 29d (116.0 mg, 0.29 mmol, 62% yield) as a yellow
solid; Rf = 0.40 (50% EtOAc in hexanes); 
1H NMR (500 MHz, CDCl3) & 7.13 (s, 1H),
6.66 (s, 1H), 5.87 (ddt, J = 17.2, 10.3, 5.6 Hz, 1H), 5.59 (s, 1H), 5.30 (dq, J = 17.2, 1.6
Hz, 1H), 5.17 (dq, J = 10.4, 1.3 Hz, 1H), 4.61 (ddt, J = 5.6, 2.7, 1.4 Hz, 2H), 4.05 (d, J =
13.0 Hz, 1H), 3.91 (s, 3H), 3.87 (s, 3H), 3.62 (d, J = 13.1 Hz, 1H), 3.55 (ddd, J = 12.1,
8.1, 5.7 Hz, 1H), 3.43 (ddd, J = 12.2, 6.9, 5.4 Hz, 1H), 3.00–2.77 (m, 2H), 2.23–2.06 (m,
1H), 1.79–1.60 (m, 2H), 0.96 (d, J = 6.2 Hz, 3H), 0.90 (d, J = 6.2 Hz, 3H);  13C NMR
(125 MHz, CDCl3) & 188.1, 171.0, 155.7, 151.6, 148.0, 131.8, 129.0, 120.5, 118.3, 110.3,
108.4, 92.8, 65.7, 56.5, 56.0, 56.0, 54.5, 48.6, 40.4, 28.3, 25.0, 24.4, 23.5;   IR (Neat Film
NaCl) 2955, 1720, 1625, 1583, 1544, 1495, 1343, 1237, 1211, 1167, 11523, 1120, 1016
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cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C23H30NO5 [M+H]
+: 400.2124, found
400.2110.
1.4.2.3.5 2,3-Dihydropyridin-4-one Allylic Alkylation Products
N
Cbz
O
O
O
29a
(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(dba)3 (5 mol %)
toluene, 40 °C
98% yield
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
30a
84% ee
N
Cbz
O
2,3-Dihydropyridin-4-one 30a.  2,3-Dihydropyridin-4-one 29a (27.6 mg, 0.084 mmol,
1.0 equiv) was preloaded in a 1 dram vial and cycled into a glove box.  A separate 1 dram
vial was loaded with (S)-(CF3)3-t-Bu-PHOX (8, 4.1 mg, 10.5 µmol, 0.125 equiv),
Pd2(dba)3 (3.9 mg, 4.20 µmol, 0.05 equiv), and a magnetic stir-bar.  Toluene (1.6 mL)
was added and the black suspension was stirred at 30 °C in a heating block for 30 min.
2,3-Dihydropyridin-4-one 29a was dissolved in 1 mL of toluene and added to the orange
catalyst solution, causing an immediate color change to olive green.  The vial was capped
with a Teflon screw cap and the reaction was stirred for 14 h at 40 °C in the glove box.
Upon completion of the reaction, the vial was allowed to cool to room temperature and
removed from the glove box.  The reaction was concentrated under reduced pressure and
the resulting brown oil was purified by flash-chromatography (1:1 Et2O/hexanes) to
afford 2,3-dihydropyridin-4-one 30a (23.7 mg, 0.083 mmol, 98%) as a colorless oil; Rf =
0.73 (1:1 Et2O/hexanes); 
1H NMR (500 MHz, CDCl3) & 7.78 (s, 1H), 7.42–7.36 (m, 5H),
5.69 (td, J = 17.3, 7.5 Hz, 1H), 5.27 (d, J = 2.7 Hz, 3H), 5.05 (dd, J = 29.7, 13.4 Hz, 2H),
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3.91 (d, J = 13.4 Hz, 1H), 3.58 (d, J = 11.8 Hz, 1H), 2.22 (ddd, J = 46.4, 13.8, 7.5 Hz,
2H), 1.07 (s, 3H); 13C NMR (125 MHz, CDCl3) & 198.3, 152.7, 141.7, 135.0, 132.6, 128.8,
128.7, 128.4, 119.2, 106.4, 69.1, 51.4, 43.4, 39.4, 19.5; IR (Neat Film, NaCl) 2922, 1728,
1673, 1602, 1498, 1453, 1416, 1381, 1342, 1305, 1232, 1200, 1144, 1119, 1088, 956,
913, 813, 761 c m-1; HRMS (MM: ESI/APCI+) m/z calc’d for C17H20NO3 [M+H]
+:
286.1443, found 286.1438; [!]D
25.0 +9.88 (c 1.15, CHCl3, 84% ee); Thar SFC conditions:
10% MeOH in CO2, 3 mL/min, Chiralpak AD-H column, % = 254 nm, tR (min): major =
2.80, minor = 3.13.
30b
86% ee
29b
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(dba)3 (5.0 mol %)
toluene, 40 °C
94% yield
N
O
O
O
Bn
N
O
Bn
2,3-Dihydropyridin-4-one 30b.  In a glove box, Pd2(dba)3 (2.3 mg, 0.0025 mmol, 5.0
mol %) and (S)-(CF3)3-t-BuPHOX (8, 3.7 mg, 0.00625 mmol, 12.5 mol %) were added to
a scintillation vial equipped with a stir bar.  The vial was charged with toluene (0.5 mL)
and heated at 40 °C for 30 min.  2,3-Dihydropyridin-4-one 29b (14.3 mg, 0.050 mmol,
1.00 equiv) and additional toluene (1.0 mL, total added = 1.5 mL, 0.033 M) were added,
producing a green solution.  The vial was sealed and stirred at 40 °C until the starting
material was fully converted, determined by LCMS.  The reaction was filtered through a
celite pad, rinsed with EtOAc, and concentrated under reduced pressure.  The crude oil
was purified by flash chromatography (SiO2, 5 x 1 cm, 30% EtOAc in hexanes) to afford
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2,3-dihydropyridin-4-one 30b (11.3 mg, 0.047 mmol, 94% yield) as a yellow oil; Rf =
0.30 (30% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) & 7.38–7.25 (m, 3H),
7.24–7.14 (m, 2H), 7.03 (d, J = 7.4 Hz, 1H), 5.54 (ddt, J = 17.4, 10.1, 7.4 Hz, 1H), 4.94
(ddt, J = 9.9, 1.9, 0.9 Hz, 1H), 4.91–4.81 (m, 2H), 4.27 (d, J = 3.1 Hz, 2H), 3.07 (d, J =
13.0 Hz, 1H), 2.90 (d, J = 13.0 Hz, 1H), 2.22–1.97 (m, 2H), 0.90 (s, 3H); 13C NMR (125
MHz, CDCl3) & 196.5, 152.3, 135.6, 133.6, 129.0, 129.0, 129.0, 128.3, 128.0, 118.3, 96.9,
60.1, 55.9, 42.7, 39.7, 20.1, 20.0; IR (Neat Film NaCl) 3067, 3029, 2962, 2926, 1634,
1593, 1455, 1359, 1321, 1204, 1172, 1076, 1001, 916, 795 cm-1; HRMS (MM: ESI-
APCI+) m/z calc’d for C18H20NO [M+H]
+: 242.1545, found 242.1553; [!]D
25.0 +86.46 (c
1.16, CHCl3, 86% ee); HPLC conditions: 10% IPA in hexanes, 1 mL/min, Chiralcel OJ
column, % = 210 nm, tR (min): major = 18.77, minor = 21.21.
30c
88% ee
29c
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(dba)3 (5.0 mol %)
toluene, 40 °C
81% yield
N
O
O
O
Bn
N
O
Bn
2,3-Dihydropyridin-4-one 30c.  In a glove box, Pd2(dba)3 (1.4 mg, 0.0015 mmol, 5.0
mol %) and (S)-(CF3)3-t-BuPHOX (8, 2.2 mg, 0.00375 mmol, 12.5 mol %) were added to
a scintillation vial equipped with a stir bar.  The vial was charged with toluene (0.5 mL)
and heated at 40 °C for 30 min.  2,3-Dihydropyridin-4-one 29c (9.8 mg, 0.030 mmol,
1.00 equiv) and additional toluene (0.5 mL, total added = 1.0 mL, 0.030 M) were added,
producing a green solution.  The vial was sealed and stirred at 40 °C until the starting
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material was fully converted, determined by TLC.  The reaction was filtered through a
celite pad, rinsed with EtOAc, and concentrated under reduced pressure.  The crude oil
was purified by flash chromatography (SiO2, 5 x 1 cm, 30% EtOAc in hexanes) to afford
2,3-dihydropyridin-4-one 30c (6.9 mg, 0.024 mmol, 81% yield) as a yellow oil; Rf = 0.40
(30% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) & 7.45–7.32 (m, 3H), 7.29–7.22
(m, 2H), 7.05 (d, J = 7.4 Hz, 1H), 5.62 (dddd, J = 17.1, 10.1, 7.8, 7.0 Hz, 1H), 5.00 (ddt,
J = 10.1, 2.1, 1.0 Hz, 1H), 4.97–4.91 (m, 2H), 4.33 (s, 2H), 3.13 (d, J = 3.2 Hz, 2H),
2.34–2.24 (m, 1H), 2.16 (ddt, J = 14.1, 7.8, 1.1 Hz, 1H), 1.61 (qd, J = 6.7, 5.6 Hz, 1H),
1.47 (dd, J = 14.2, 6.3 Hz, 1H), 1.33 (dd, J = 14.2, 5.5 Hz, 1H), 0.84 (d, J = 6.6 Hz, 3H),
0.82 (d, J = 6.6 Hz, 3H); 13C NMR (125 MHz, CDCl3) & 196.7, 152.4, 135.7, 133.7,
129.1, 128.5, 128.1, 118.4, 97.1, 60.2, 56.0, 42.8, 39.8, 20.2.; IR (Neat Film NaCl) 3072,
3029, 2954, 2867, 1633, 1593, 1494, 1455, 1385, 1361, 1296, 1205, 1173, 1105, 1076,
1028, 998, 793, 736 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C19H26NO [M+H]
+:
284.2014, found 284.2023; [!]D
25.0 +50.23 (c 0.65, CHCl3, 88% ee); HPLC conditions:
7% IPA in hexanes, 1 mL/min, Chiralcel OJ column, % = 210 nm, tR (min): major =
11.44, minor = 14.80.
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N
O
MeO
MeO
30d
90% ee
N
O
CO2allyl
MeO
MeO
29d
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(dba)3 (5.0 mol %)
toluene, 40 °C
81% yield
2,3-Dihydropyridin-4-one 30d.  Pd2(dba)3 (1.4 mg, 0.0015 mmol, 5.0 mol %) and (S)-
(CF3)3-t-BuPHOX (8, 2.2 mg, 0.00375 mmol, 12.5 mol %) were added to an oven-dried
Schlenk tube equipped with a magnetic stir bar, and the tube was backfilled with argon 3
times.  The tube was charged with toluene (1 mL) and heated at 40 °C for 30 min,
generating a red/orange solution.  2,3-Dihydropyridin-4-one 29d (11.9 mg, 0.03 mmol,
1.00 equiv) were added and the tube was lowered into a heating block (40 °C).  After 3 h,
TLC analysis indicated the reaction was complete.  Consequently, the reaction was
filtered through a silica gel plug, rinsed with EtOAc, and concentrated under reduced
pressure.  The crude mixture was purified by flash column chromatography (SiO2, 10 x 2
cm, 50% EtOAc in hexanes) to afford dihydropyridine-4-one 30d (8.6 mg, 0.0242 mmol,
81% yield) as yellow oil; Rf = 0.50 (50% EtOAc in hexanes); 
1H NMR (500 MHz,
CDCl3) & 7.16 (s, 1H), 6.66 (s, 1H), 5.82 (ddt, J = 17.4, 10.2, 7.4 Hz, 1H), 5.62 (s, 1H),
5.10–5.03 (m, 2H), 3.91 (s, 3H), 3.87 (s, 3H), 3.39 (s, 2H), 3.37 (td, J = 6.5, 1.5 Hz, 2H),
2.99–2.89 (m, 2H), 2.43 (ddt, J = 13.9, 7.2, 1.3 Hz, 1H), 2.25 (ddt, J = 14.0, 7.7, 1.1 Hz,
1H), 1.74 (hd, J = 6.6, 5.0 Hz, 1H), 1.66 (dd, J = 14.1, 6.5 Hz, 1H), 1.44 (dd, J = 14.1, 5.1
Hz, 1H), 0.94 (d, J = 6.6 Hz, 3H), 0.90 (d, J = 6.5 Hz, 3H); 13C NMR (125 MHz, CDCl3)
& 196.3, 155.6, 151.4, 148.0, 134.7, 128.7, 120.8, 117.9, 110.4, 108.3, 94.3, 58.9, 56.0,
48.9, 46.1, 41.7, 39.2, 28.4, 25.1, 24.5, 24.1; IR (Neat Film NaCl) 2953, 1622, 1586,
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1549, 1495, 1464, 1342, 1212, 1173, 1110, 1016, 913, 794 cm-1; HRMS (MM: ESI-
APCI+) m/z calc’d for C22H30NO3 [M+H]
+: 356.2147, found 356.2221; [!]D
25.0 +32.49 (c
0.71, CHCl3, 90% ee); HPLC conditions: 30% IPA in hexanes, 1 mL/min, Chiralpak AD
column, % = 254 nm, tR (min): major = 21.87, minor = 18.59.
1.4.2.4 Preparation of Lactams
1.4.2.4.6 Lactam Allylic Alkylation Precursors
HN
O
O
O
Et3N, DMAP
THF, 0!23 °C
Cl
O
N
O
O
OO
49 4i89% yield
Lactam 4i.  Lactam 4910 (117.8 mg, 0.597 mmol, 1.00 equiv) was transferred to a flame-
dried 15 mL round-bottom flask using THF (4 x 0.5 mL + 1 x 0.4 mL rinses, total = 2.4
mL, 0.25 M).  Et3N (250 µL, 1.79 mmol, 3.00 equiv) and DMAP (9.3 mg, 0.0761 mmol,
13 mol%) were added and the flask was lowered into a 0 °C bath (ice/water).
Cyclohexanecarbonyl chloride (160 µL, 1.20 mmol, 2.00 equiv) was added dropwise, and
the reaction mixture transitioned from a solution to a white slurry.  The ice bath expired
gradually as the reaction was stirred overnight.  After 15 h of stirring, no starting material
remained by TLC analysis.  The reaction was subsequently quenched with brine (15 mL)
and transferred to a separatory funnel where the aqueous layer was extracted four times
with EtOAc.  The combined organics (100 mL) were rinsed twice with brine (20 mL),
dried over Na2SO4, filtered, and concentrated under reduced pressure.  The resulting
crude oil was purified by flash column chromatography (SiO2, 27.5 x 2 cm, 100%
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hexanes'10% EtOAc in hexanes) to afford lactam 4i (163.5 mg, 0.532 mmol, 89%
yield) as a yellow oil; Rf = 0.60 (30% EtOAc in hexanes); 
1H NMR (500 MHz, CDCl3) &
5.88 (dddd, J = 17.1, 10.4, 5.8, 5.8 Hz, 1H), 5.32 (dq, J = 17.2, 1.5 Hz, 1H), 5.25 (dq, J =
10.4, 1.2 Hz, 1H), 4.64 (ddt, J = 5.8, 2.5, 1.3 Hz, 2H), 3.77 (ddd, J = 13.1, 7.7, 5.1 Hz,
1H), 3.58 (dddd, J = 13.4, 7.0, 5.0, 1.1 Hz, 1H), 3.27 (tt, J = 11.4, 3.2 Hz, 1H), 2.42
(dddd, J = 13.4, 6.0, 4.9, 0.9 Hz, 1H), 1.95 (dtd, J = 10.5, 3.5, 1.8 Hz, 1H), 1.92–1.80 (m,
3H), 1.79–1.70 (m, 3H), 1.67 (dtt, J = 10.8, 3.2, 1.5 Hz, 1H), 1.52 (s, 3H), 1.47–1.34 (m,
2H), 1.34–1.16 (m, 3H); 13C NMR (125 MHz, CDCl3) & 181.3, 173.5, 172.7, 131.4,
119.2, 66.4, 53.5, 45.7, 44.6, 33.1, 30.1, 29.6, 26.1, 25.9, 25.8, 23.0, 20.3; IR (Neat Film
NaCl) 3086, 2931, 2855, 1738, 1694, 1652, 1479, 1451, 1378, 1330, 1301, 1249, 1218,
1196, 1159, 1134, 1073, 1053, 1032, 981, 957, 939, 896, 887, 842, 796, 773 cm-1; HRMS
(MM: ESI-APCI+) m/z calc’d for C17H26O4N [M+H]
+: 308.1856, found 308.1871.
HN
O
O
O
Et3N, DMAP, PivCl
THF, 0!23 °C
N
O
O
OO
49 4j89% yield
Lactam 4j.  Lactam 499 (480 mg, 2.4 mmol, 1.0 equiv) in a 25 mL round-bottom flask
equipped with a magnetic stir bar was taken up in THF (9.6 mL, 0.25 M).  Et3N (1.0 mL,
7.2  mmol, 3.0 equiv) and DMAP (29 mg, 0.24 mmol, 0.10 equiv) were added and the
flask was lowered into a 0 °C bath (ice/water).  Pivaloyl chloride (0.59 mL, 4.8 mmol,
2.0 equiv) was added dropwise and the reaction mixture transitioned from a solution to a
white slurry.  The ice bath expired gradually as the reaction was stirred overnight.  After
24 h of stirring, TLC analysis indicated that conversion had ceased at approximately
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90%.  The reaction was subsequently diluted with 20 mL EtOAc, quenched with brine
(20 mL), and transferred to a separatory funnel where the aqueous layer was extracted
three times with EtOAc (20 mL).  The combined organics were washed twice with brine
(20 mL), dried over Na2SO4, filtered, and concentrated under reduced pressure.  The
resulting crude oil was purified by flash column chromatography (SiO2, 11 x 3 cm, 20%
EtOAc in hexanes) to afford lactam 4j (612 mg, 2.18 mmol, 89% yield) as a pale yellow
oil; Rf = 0.37 (20% EtOAc in hexanes); 
1
H NMR (500 MHz, CDCl3) & 5.90 (ddt, J =
17.2, 10.4, 5.9 Hz, 1H), 5.33 (dq, J = 17.2, 1.5 Hz, 1H), 5.25 (dq, J = 10.4, 1.3 Hz, 1H),
4.70–4.59 (m, 2H), 3.62 (ddd, J = 12.8, 8.2, 4.9 Hz, 1H), 3.45 (dddd, J = 12.4, 6.2, 4.9,
1.0 Hz, 1H), 2.40 (dddd, J = 13.6, 7.1, 4.0, 1.0 Hz, 1H), 2.01–1.83 (m, 2H), 1.74 (ddd, J
= 13.7, 9.5, 4.1 Hz, 1H), 1.52 (s, 3H), 1.29 (s, 9H); 
13
C NMR (125 MHz, CDCl3) & 190.8,
172.5, 131.7, 119.2, 66.4, 52.5, 47.9, 44.5, 33.6, 28.0, 22.8, 20.3; IR (Neat Film NaCl)
3434, 2090, 1650, 1257, 1125 cm–1; HRMS (MM: ESI-APCI+) m/z calc'd for C15H24NO4
[M+H]+: 282.1700, found 282.1705.
1.4.2.4.7 Lactam Allylic Alkylation Products
(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(dba)3 (5 mol %)
toluene, 40 °C
63% yield
N
OO
5i
95% ee
N
O
O
OO
4i
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
Lactam 5i.  Pd2(dba)3 (16.4 mg, 0.0150 mmol, 5.0 mol %) and (S)-(CF3)3-t-BuPHOX (8,
22.1 mg, 0.0374 mmol, 12.5 mol %) were added to an oven-dried scintillation vial
equipped with a magnetic stir bar and the vial was cycled into a glove box.  The vial was
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charged with toluene (2.06 mL) and stirred at ambient temperature for 30 min, generating 
a red/orange solution. Lactam 4i (91.9 mg, 0.299 mmol, 1.00 equiv) was transferred to 
the scintillation vial with toluene (3 x 2 mL + 1 x 1 mL rinses, total = 9.06 mL, 0.033 M,) 
producing a green solution.  The vial was sealed with a Teflon-lined cap, removed from 
the glove box, and lowered into a heating block (40 °C).  After 7 days, the reaction was 
filtered through a silica gel plug, rinsed with EtOAc, and concentrated under reduced 
pressure.  The crude oil was purified by flash column chromatography (SiO2, 27.5 x 2 
cm, 100% hexanes'5%'10% EtOAc in hexanes) to afford recovered lactam 4i (17.2 
mg, 0.0560 mmol, 19% recovered) and lactam 5i (49.8 mg, 0.189 mmol, 63% yield, 78%
yield based on recovered lactam 4i) as a yellow oil; Rf = 0.73 (30% EtOAc in hexanes); 
1H NMR (500 MHz, CDCl3) & 5.74 (dddd, J = 16.6, 10.4, 7.8, 6.9 Hz, 1H), 5.13–5.06 (m, 
2H), 3.76–3.67 (m, 1H), 3.57–3.49 (m, 1H), 3.18 (tt, J = 11.4, 3.3 Hz, 1H), 2.51 (ddt, J = 
13.6, 6.9, 1.2 Hz, 1H), 2.27 (ddt, J = 13.6, 7.8, 1.1 Hz, 1H), 1.90 (dddd, J = 12.7, 5.5, 2.9, 
1.4 Hz, 1H), 1.87–1.72 (m, 7H), 1.67 (dtt, J = 10.8, 3.5, 1.5 Hz, 1H), 1.62–1.56 (m, 1H), 
1.42 (dtdd, J = 12.9, 12.0, 11.2, 3.2 Hz, 2H), 1.35–1.19 (m, 2H), 1.26 (s, 3H); 13C NMR 
(125 MHz, CDCl3) & 181.9, 179.5, 133.5, 118.9, 46.1, 45.8, 45.0, 44.5, 33.3, 30.0, 30.0, 
26.1, 25.9, 25.9, 25.8, 19.8; IR (Neat Film NaCl)  3076, 2930, 2854, 1690, 1478, 1451, 
1375, 1329, 1313, 1286, 1246, 1198, 1158, 1136, 1089, 1072, 1031, 996, 975, 919, 759 
cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C16H26O2N [M+H]
+: 264.1958, found 
264.1945; [!]D
25.0 –96.13 (c 1.06, CHCl3, 95% ee); JASCO SFC conditions: 1% IPA in 
CO2, 5 mL/min, Chiralcel OJ-H column, % = 222 nm, tR (min): major = 2.53, minor =
2.13.
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(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(dba)3 (5 mol %)
toluene, 40 °C
46% yield
N
OO
5j
96% ee
N
O
O
OO
4j
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
Lactam 5j.  Pd2(pmdba)3 (27 mg, 25 µmol, 5.0 mol %) and (S)-(CF3)3-t-BuPHOX (8, 37
mg, 63 µmol, 12.5 mol %) were added to an oven-dried 20 mL scintillation vial equipped
with a magnetic stir bar in a glove box.  The vial was charged with toluene (12 mL) and
stirred at ambient temperature (28 °C) for 30 min, resulting in a deep orange solution.
Lactam 4j (140  mg, 0.50 mmol, 1.0 equiv) was transferred to the scintillation vial with
toluene (2 mL, total = 15 mL, 0.033 M), producing a light green solution.  The vial was
sealed with a Teflon-lined cap and lowered into a heating block (40 °C).  After 16 days,
TLC analysis indicated that conversion had ceased at approximately 50% and the vial
was removed from the glove box and the reaction was filtered through a silica gel plug,
rinsed with Et2O, and concentrated under reduced pressure.  The crude oil was purified
by flash column chromatography (SiO2, 15 x 2.5 cm, 5% EtOAc in hexanes) to afford
lactam 5j (54 mg, 0.23 mmol, 46% yield) as a colorless oil; Rf = 0.58 (20% EtOAc in
hexanes); 
1
H NMR (500 MHz, CDCl3) & 5.77 (dddd, J = 17.1, 10.2, 7.8, 7.0 Hz, 1H),
5.16–5.05 (m, 2H), 3.53–3.38 (m, 2H), 2.51 (ddt, J = 13.7, 7.0, 1.3 Hz, 1H), 2.28 (ddt, J
= 13.7, 7.7, 1.1 Hz, 1H), 1.92–1.80 (m, 3H), 1.61–1.58 (m, 1H), 1.27 (s, 9H), 1.25 (s,
3H); 
13
C NMR (125 MHz, CDCl3) & 191.5, 179.0, 133.7, 118.9, 48.5, 44.2, 43.4, 43.3,
33.4, 28.1, 25.0, 19.8; IR (Neat Film NaCl) 2963, 1684, 1482, 1457, 1391, 1282, 1259,
1156, 917 cm
–1
; HRMS (MM: ESI-APCI) m/z calc'd for C14H24NO2 [M+H]
+
: 238.1802,
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found 238.1809; [!]D
25.0
 –7.13 (c 2.45, CHCl3, 96% ee); HPLC conditions: 5% IPA in
hexanes, 1 mL/min, Chiralcel OD-H column, % = 210 nm, tR (min): major = 7.95, minor
= 6.52.
1.4.2.5 Preparation of Imides
1.4.2.5.8 Imide Allylic Alkylation Precursors
N
O
O
N
O
O
O
O
50 6c
1. LiHMDS, THF, –78 °C ! – 30 °C
    then allyl cyanoformate, –78 °C
2.  NaH, THF, 0 °C ! 23  °C
     then MeI, 0 °C ! 23  °C
50% yield, 2 steps
N-Methyl imide 6c. A flame-dried 200 mL round-bottom flask containing a magnetic
stir bar was cycled into a glove box and loaded with LiHMDS (5.69 g, 34.0 mmol, 1.7
equiv).  The flask was removed from the glove box, reconnected to a manifold, and
charged with THF (100 mL, 0.2 M) and lowered into a –78 °C bath.  Imide 5048 (2.54 g,
20.0 mmol, 1.0 equiv) was added neat.  After 1 h at –78 °C, the solution was warmed to
30 °C and stirred for 30 min before cooling back to –78 °C.  Allyl cyanoformate (2.67 g,
24.0 mmol, 1.2 equiv) was added neat and the reaction was stirred for 1.5 h before TLC
analysis indicated consumption of starting material.  The reaction was subsequently
quenched with brine and transferred to a separatory funnel where the aqueous layer was
extracted with EtOAc (4 x 50 mL).  The combined organics were rinsed twice with brine,
dried over Na2SO4, filtered, and concentrated under reduced pressure.  The resulting
crude oil was purified by flash column chromatography (SiO2, 5 cm x 7 inches,
25%'30%'40% EtOAc in hexanes) to afford an intermediate oil (2.63 g, 0.45 mmol,
62% yield) that was moved on to the next step.
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A flame-dried 200 mL flask equipped with a magnetic stir bar was charged with
sodium hydride (60% in mineral oil, 312.5 mg, 7.81 mmol, 1.1 equiv) and THF (71 mL,
0.1 M) and cooled to 0 °C.  A portion of the oil from the previous step (1.5 g, 7.10 mmol,
1.0 equiv) was added neat.  After 1.5 h at 0 °C, the reaction was warmed to room
temperature and stirred for 1 h before cooling back to 0 °C.  Methyl iodide (886 µL,
14.20 mmol, 2.0 equiv) was added and the reaction was stirred for 2 h before warming to
room temperature.  After 15 h, the reaction was poured over a mixture of water and brine
and transferred to a separatory funnel where the aqueous layer was extracted with EtOAc
(4 x 50 mL).  The combined organics were rinsed twice with aq. Na2S2O3 (sat. solution
half diluted) and twice with brine, dried over Na2SO4, filtered, and concentrated under
reduced pressure.  The resulting crude oil was purified by flash column chromatography
(SiO2, 5 cm x 8 inches, 10% '20% EtOAc in hexanes) to afford imide 6c (1.28 g, 5.69
mmol, 80% yield, 50% yield over two steps); Rf = 0.32 (35% EtOAc in hexanes); 
1H
NMR (500 MHz, CDCl3) & 5.85 (ddt, J = 17.2, 10.5, 5.7 Hz, 1H), 5.29 (dq, J = 17.2, 1.5
Hz, 1H), 5.25 (dq, J = 10.5, 1.2 Hz, 1H), 4.63 (ddt, J = 5.6, 4.1, 1.4 Hz, 2H), 3.18 (s, 3H),
2.72 (ddd, J = 18.1, 5.4, 4.4 Hz, 1H), 2.64 (ddd, J = 17.9, 11.6, 5.4 Hz, 1H), 2.35 (ddd, J
= 13.9, 5.4, 4.4 Hz, 1H), 1.89 (ddd, J = 13.9, 11.6, 5.4 Hz, 1H), 1.56 (s, 3H); 13C NMR
(125 MHz, CDCl3) & 172.0, 171.8, 171.3, 131.2, 119.3, 66.5, 50.9, 30.0, 28.7, 27.3, 21.9;
IR (Neat Film NaCl) 2987, 2943, 1726, 1678, 1458, 1416, 1381, 1356, 1305, 1261, 1247,
1182, 1106, 1036, 993, 938 cm–1; HRMS (MM: ESI-APCI+) m/z calc’d for C11H18NO4
[M+H]
+: 226.1074, found 226.1078.
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i. BnONH2, CH2Cl2
ii. AcCl, EtOAc, reflux
63% yield
O
O
O
N
O
BnO
O
50
N-benzyloxyimide 50.  Benzyloxyamine hydrochloride (3.15 g, 19.7 mmol) in a 100 mL
round-bottom flask was taken up in dichloromethane (30 mL) and saturated aqueous
K2CO3 (30 mL) and stirred for 30 min.  The mixture was transferred to a separatory
funnel and the phases were separated.  The aqueous phase was extracted twice with
dichloromethane (30 mL), the combined organic phases were dried over Na2SO4, filtered,
and concentrated under reduced pressure.  A portion of the resulting crude colorless oil
(1.23 g, 10.0 mmol, 1.00 equiv) was diluted with dichloromethane (10 mL, 1.0 M) in a 50
mL round-bottom flask and glutaric anhydride (1.14 g, 10.0 mmol, 1.00 equiv) was
added.  An exotherm was observed, and the mixture was immediately concentrated under
reduced pressure.  The resulting residue was taken up in EtOAc (13 mL, 0.75 M) and
acetyl chloride (2.00 mL, 2.81 mmol, 2.81 equiv) was added.  A water condenser was
affixed and the reaction was heated to a gentle reflux (oil bath, 85 °C) for 18 h.  The
reaction was diluted with EtOAc (30 mL), dried over Na2SO4, filtered, and concentrated
under reduced pressure.  The crude solid was purified by flash column chromatography
(SiO2, 6 x 5 cm, 20% EtOAc in hexanes'50% Et2O in dichloromethane) to afford N-
benzyloxyimide 50 (1.37 g, 6.25 mmol, 63% yield) as a white solid; Rf = 0.64 (20% Et2O
in methylene chloride); 
1
H NMR (500 MHz, CDCl3) & 7.56–7.45 (m, 2H), 7.41–7.29 (m,
3H), 5.01 (s, 2H), 2.74–2.60 (m, 4H), 1.94–1.85 (m, 2H); 
13
C NMR (125 MHz, CDCl3) &
168.48 , 133.95 , 130.09 , 129.23 , 128.51 , 78.17 , 33.47 , 17.05; IR (Neat Film NaCl)
3033, 2957, 2902, 1689, 1457, 1381, 1350, 1331, 1251, 1175, 1134, 1087, 1056, 999,
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968, 919, 893, 838, 759 cm
–1
; HRMS (MM: ESI-APCI) m/z calc'd for C12H14NO3
[M+H]
+
: 220.0968, found 220.0971.
N
BnO
O
O
N
BnO
O
O
O
O
50 6d73% yield, 2 steps
1. LiHMDS, THF, –78 °C
    then allyl cyanoformate
2.  Cs2CO3, MeI
     MeCN, 50 °C
N-Benzyloxy imide 6d.  Acylation performed in manner analogous to N-methyl imide 6c
at –78 °C using N-benzyloxy imide 50 as starting material.  Alkylation performed in
manner analogous to "-ketoester 45a at 50 °C.  N-Benzyloxy imide 6d was isolated after
flash column chromatography (SiO2, 17 to 25% EtOAc in hexanes) as a colorless oil
(73% yield over two steps); Rf = 0.20 (20% EtOAc in hexanes); 1H NMR (500 MHz,
CDCl3) & 7.53 (m, 2H), 7.37 (m, 3H), 5.87 (ddt, J = 17.2, 10.4, 5.9 Hz, 1H), 5.33 (dq, J =
17.2, 1.5 Hz, 1H), 5.28 (dq, J = 10.4, 1.2 Hz, 1H), 5.01 (s, 2H), 4.66 (ddt, J = 13.0, 5.9,
1.3 Hz, 1H), 4.65 (ddt, J = 13.0, 5.9, 1.3 Hz, 1H), 2.72 (m, 2H), 2.30 (ddd, J = 14.1, 5.2,
4.0 Hz, 1H), 1.86 (ddd, J = 14.1, 11.8, 5.5 Hz, 1H), 1.56 (s, 3H); 13C NMR (125 MHz,
CDCl3) & 170.7, 167.9, 167.4, 133.9, 130.9, 130.1, 129.2, 128.5, 119.9, 77.9, 66.9, 52.1,
30.5, 28.5, 21.6; IR (Neat Film NaCl) 2943, 1738, 1733, 1708, 1451, 1255, 1200, 1168,
976 cm–1; HRMS (MM: ESI-APCI) m/z calc'd for C17H20NO5 [M+H]
+: 318.1336, found
318.1339.
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N
BnO
O
O
N
BnO
O
O
Et
O
O
50 6e54% yield, 2 steps
1. LiHMDS, THF, –78 °C
    then allyl cyanoformate
2.  Cs2CO3, EtI
     MeCN, 85 °C
N-Benzyloxy imide 6e.  Acylation performed in manner analogous to N-methyl imide 6c
at –78 °C using N-benzyloxy imide 50 as starting material.  Alkylation performed in
manner analogous to "-ketoester 45a at 85 °C using ethyl iodide.  N-Benzyloxy imide 6e
was isolated after flash column chromatography (SiO2, 14 to 20% EtOAc in hexanes) as a
colorless oil (54% yield over two steps); Rf = 0.24 (20% EtOAc in hexanes); 1H NMR
(500 MHz, CDCl3) & 7.53 (m, 2H), 7.37 (m, 3H), 5.87 (ddt, J = 17.2, 10.4, 5.9 Hz, 1H),
5.34 (dq, J = 17.2, 1.5 Hz, 1H), 5.27 (dq, J = 10.4, 1.2 Hz, 1H), 5.0 (s, 2H), 4.66 (dt, J =
5.9, 1.3 Hz, 2H), 2.74 (m, 2H), 2.22 (ddd, J = 14.0, 5.2, 3.5 Hz, 1H), 2.05(m, 2H), 1.96
(ddd, J = 14.0, 12.3, 5.4 Hz, 1H), 0.95 (t, J = 7.4 Hz, 3H); 13C NMR (125 MHz, CDCl3)
& 170.2, 167.5, 167.1, 134.0, 131.0, 130.1, 129.3, 128.6, 120.0, 77.9, 66.8, 56.2, 30.4,
28.3, 24.8, 9.0; IR (Neat Film NaCl) 2943, 1733, 1713, 1648, 1454, 1237, 1190, 1168,
976, 752 cm–1; HRMS (MM: ESI-APCI) m/z calc'd for C18H22NO5 [M+H]
+: 332.1492,
found 332.1493.
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1.4.2.5.9 Imide Allylic Alkylation Products
N
O
O
O
O
6c
N
O
O
7c
76% ee
(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(dba)3 (5 mol %)
toluene, 40 °C, 20 d
32% yield
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
N-Methyl imide 7c.  Prepared in a manner analogous to lactam 5h using N-methyl imide
6c as starting material.  After 20 d, the reaction was filtered, concentrated, and N-Methyl
imide 7c was isolated following flash column chromatography (SiO2, 3 cm x 10 inches,
5%'7%'9%'10% '12% EtOAc in hexanes) as an oil (32% yield); Rf = 0.36 (20%
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) & 5.71 (dddd, J = 17.1, 10.2, 7.6, 7.1
Hz, 1H), 5.15–5.08 (m, 2H), 3.12 (s, 3H), 2.75–2.62 (m, 2H), 2.47 (ddt, J = 13.8, 7.1, 1.2
Hz, 1H), 2.29 (ddt, J = 13.8, 7.7, 1.1 Hz, 1H), 1.92 (ddd, J = 14.3, 8.6, 5.9 Hz, 1H), 1.66
(ddd, J = 14.0, 7.1, 5.8 Hz, 1H), 1.24 (s, 3H); 13C NMR (125 MHz, CDCl3) & 177.6,
172.5, 132.8, 119.5, 42.6, 41.7, 29.3, 27.8, 27.0, 23.4; IR (Neat Film NaCl) 2971, 2937,
2876, 1723, 1674, 1464, 1415, 1378, 1356, 1291, 1240, 1110, 1036, 998, 919 cm–1;
HRMS (MM: ESI-APCI) m/z calc'd for C10H16NO2 [M+H]
+: 182.1176, found 182.1178;
[!]D
25.0
 –54.19 (c 1.64, CHCl3, 76% ee); HPLC conditions: 3% IPA in hexanes, 1
mL/min, Chiralpak AD column, % = 210 nm, tR (min): major = 11.94, minor = 17.86.
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N
BnO
O
O
O
O
6d
N
BnO
O
O
7d
96% ee
(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(dba)3 (5 mol %)
toluene, 40 °C
99% yield
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
N-Benzyloxy imide 7d.  Prepared in a manner analogous to lactam 5h using N-
benzyloxy imide 6d as starting material.  N-Benzyloxy imide 7d was isolated after flash
column chromatography (SiO2, 20% EtOAc in hexanes) as a colorless oil (99% yield); Rf
= 0.29 (20% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) & 7.51 (m, 2H), 7.36 (m,
3H), 5.64 (dddd, J = 17.2, 10.2, 7.7, 7.1 Hz, 1H), 5.09–5.15 (m, 2H), 5.0 (s, 2H),
2.66–2.77 (m, 2H), 2.43 (ddt, J = 13.9, 7.1, 1.2 Hz, 1H), 2.26 (ddt, J = 13.9, 7.7, 1.2 Hz,
1H), 1.87 (ddd, J = 14.3, 8.5, 5.9 Hz, 1H), 1.60 (ddd, J = 14.3, 7.0, 5.7 Hz, 1H), 1.21 (s,
3H); 13C NMR (125 MHz, CDCl3) &  173.4, 168.1, 133.9, 132.3, 130.3, 129.2, 128.5,
119.9, 78.0, 43.1, 42.3, 29.7, 27.6, 23.1; IR (Neat Film NaCl) 3067, 2974, 2935, 1740,
1703, 1700, 1456, 1172, 978, 748 cm–1; HRMS (MM: ESI-APCI) m/z  calc'd for
C16H20NO3 [M+H]
+: 274.1438, found 274.1437; [!]D
25.0
 –58.59 (c 1.26, CHCl3, 96% ee);
Thar SFC conditions: 5% MeOH in CO2, 3 mL/min, Chiralcel OJ-H column, % = 210 nm,
tR (min): major = 4.03, minor = 3.64.
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N
BnO
O
O
Et
O
O
6e
N
BnO
O
O
Et
7e
98% ee
(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(dba)3 (5 mol %)
toluene, 40 °C
80% yield
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
N-Benzyloxy imide 7e.  Prepared in a manner analogous to lactam 5h using N-benzyloxy
imide 6e as starting material.  N-Benzyloxy imide 7e was isolated after flash column
chromatography (SiO2, 20% EtOAc in hexanes) as a colorless oil (80% yield); Rf = 0.20
(20% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) & 7.51 (m, 2H), 7.36 (m, 3H),
5.63 (dddd, J = 17.3, 10.3, 7.7, 6.9 Hz, 1H), 5.08–5.10 (m, 2H), 4.99 (s, 2H), 2.67–2.76
(m, 2H), 2.46 (ddt, J = 14.0, 6.9, 1.3 Hz, 1H), 2.27 (ddt, J = 14.0, 7.7, 1.1 Hz, 1H), 1.80
(ddd, J = 14.2, 7.9, 6.4 Hz, 1H), 1.76–1.71 (m, 1H), 1.70 (dq, J = 14.2, 7.5 Hz, 1H), 1.62
(dq, J = 14.2, 7.5 Hz, 1H), 0.86 (t, J = 7.5 Hz, 3 H); 13C NMR (125 MHz, CDCl3) &
172.6, 168.0, 134.0, 132.6, 130.2, 129.2, 128.5, 119.6, 78.0, 46.5, 40.0, 29.5, 28.6, 24.7,
8.2; IR (Neat Film NaCl) 3033, 2972, 1739, 1702, 1699, 1455, 1169, 977, 751 cm–1;
HRMS (MM: ESI-APCI) m/z calc'd for C17H22NO3 [M+H]
+
: 288.1594, found 288.1591;
[!]D
25.0
 –35.98 (c 1.98, CHCl3, 98% ee); Thar SFC conditions: 1% MeOH in CO2, 2.5
mL/min, Chiralcel OB-H column, % = 210 nm, tR (min): major = 14.34, minor = 13.39.
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1.4.2.6 Preparation of Enones and Diosphenol Ethers
1.4.2.6.10 Enone and Diosphenol Ether Allylic Alkylation Precursors
O
O
OTMPDA (43)
benzaldehyde
THF/H2O, 23 °C
13a 44
1:1 d.r.
OH
N N
O
O
O
32% yield
63% recovered 13a
Alcohol 44.  Procedure adapted from the literature precedent of Kim.44  A 15 mL round-
bottom flask equipped with a stir bar was charged with enone 13a (852.1 mg, 4.39 mmol,
1.94 equiv), THF (1.4 mL, 1.6 M), benzaldehyde (230 µL, 2.26 mmol, 1.00 equiv), H2O
(1.4 mL, 1.6 M), and TMPDA (43, 380 µL, 2.27 mmol, 1.00 equiv).  The reaction
mixture was a yellow suspension that transitioned to orange over time.  After 6 days, the
reaction was diluted with H2O (10 mL) and transferred to a separatory funnel where the
aqueous phase was extracted four times with CH2Cl2.  The combined organics were dried
over MgSO4, filtered, and concentrated under reduced pressure.  The resulting crude oil
was purified by flash chromatography (SiO2, 25.5 x 3 cm, 100%
hexanes'5%'10%'15%'20% EtOAc in hexanes) to afford recovered enone 13a
(536.0 mg, 2.76 mmol, 63% recovered) pale yellow oil and alcohol 44 (217.7 mg, 0.725
mmol, 32% yield, 45% yield based on recovered enone 13a) as a yellow oil; Rf = 0.28
(30% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) ~1:1 mixture of diastereomers,
see Figure 1.42.1; IR (Neat Film NaCl) 3503 (broad), 3061, 3030, 2980 2934, 1735,
1672, 1492, 1452, 1424, 1379, 1291, 1246, 1187, 1165, 1111, 1018, 982, 936, 760 cm-1;
HRMS (EI+) calc’d for C18H20O4 [M+•]
+: 300.1362, found 300.1376.
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O
O
O
K2CO3, DMP
CH2Cl2, 23 °C
69% yield 13b
OO
O
O
44
1:1 d.r.
OH
Enone 13b.  A scintillation vial containing alcohol 44 (44.5 mg, 0.148 mmol, 1.00 equiv)
was equipped with a stir bar, connected to a manifold, backfilled with Ar, and charged
with CH2Cl2 (1 mL, 0.15 M).  K2CO3 (62.5 mg, 0.452 mmol, 3.05 equiv) and DMP (96.3
mg, 0.227 mmol, 1.53 equiv) were added simultaneously to the vial.  After 2 h of stirring,
no starting material was detected by TLC analysis.  Consequently, the reaction was
diluted with CH2Cl2 (1 mL), filtered through a short celite plug rinsing with CH2Cl2, and
concentrated under reduced pressure.  The resulting crude oil was purified by flash
chromatography (SiO2, 27 x 1 cm, 0.1% Et3N in hexanes'0.1% Et3N and 10% EtOAc in
hexanes) to afford enone 13b (30.4 mg, 0.102 mmol, 69% yield) as a yellow oil; Rf =
0.43 (30% EtOAc in hexanes); 1H NMR (500 MHz, C6D6) & 8.11–8.07 (m, 2H),
7.15–7.08 (m, 3H), 6.62 (ddd, J = 5.0, 2.9, 1.2 Hz, 1H), 5.61 (ddt, J = 17.1, 10.3, 5.7 Hz,
1H), 5.05 (dq, J = 17.2, 1.5 Hz, 1H), 4.92 (dq, J = 10.4, 1.3 Hz, 1H), 4.37 (dt, J = 5.7, 1.4
Hz, 2H), 2.11 (dddd, J = 13.5, 4.8, 3.4, 1.2 Hz, 1H), 2.04 (dddd, J = 20.1, 9.6, 5.1, 2.9 Hz,
1H), 1.59 (dtdd, J = 20.1, 5.1, 3.4, 1.4 Hz, 1H), 1.36–1.27 (m, 1H), 1.32 (s, 3H); 13C
NMR (125 MHz, C6D6) & 194.0, 193.6, 172.1, 150.9, 141.4, 137.6, 133.1, 132.0, 129.9,
128.5, 118.5, 65.9, 53.8, 33.5, 23.6, 20.6; IR (Neat Film NaCl) 3063, 3027, 2981, 2935,
2873, 2855, 2280, 1732, 1668, 1621, 1598, 1581, 1449, 1423, 1378, 1358, 1293, 1265,
1244, 1178, 1157, 1111, 988, 940, 814, 769, 712; HRMS (FAB+) cal’d for C18H18O4
[M+•]
+: 298.1205, found 298.1219.
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O
I
O
I
O
O1. LDA, THF, –78 °C
    then allyl cyanoformate
2. K2CO3, MeI
    acetone, 50 °C
31% yield, 2 steps
42 41
!-Iodoenone 41.  A 50 mL round-bottom flask equipped with a stir bar was charged with
diisopropyl amine (450 µL, 3.21 mmol, 1.10 equiv) and THF (7 mL).  The flask was
lowered into a 0 °C bath (water/ice) and n-BuLi (1.26 mL, 2.43 M in hexanes, 3.06
mmol, 1.05 equiv) was added dropwise over several minutes.  The reaction was stirred
for 15 min before the ice bath was removed and replaced with a –78 °C bath (acetone/dry
ice).  !-Iodoenone 42 (641.3 mg, 2.91 mmol, 1.00 equiv) was transferred via cannula to
the flask using several THF rinses (1 x 6 mL and 2 x 1 mL rinses, total added = 15 mL,
0.19 M), producing a yellow solution.  The reaction was stirred for 1 h before allyl
cyanoformate (330 µL, 3.06 mmol, 1.05 equiv) was added dropwise.  After 2.5 h, no
starting material was observed by 1H NMR analysis and the reaction was subsequently
quenched after an additional hour with sat. NH4Cl solution (10 mL) and allowed to warm
to room temperature.  The reaction contents were transferred to a separatory funnel where
the aqueous phase was extracted four times with Et2O.  The combined organics (100 mL)
were dried over MgSO4, filtered, and concentrated under reduced pressure.  The resulting
crude oil was purified by flash chromatography (SiO2, 27.5 x 3 cm, 100%
hexanes'5%'10% EtOAc in hexanes) to afford a yellow oil (Rf = 0.52, 30% EtOAc in
hexanes) that was moved on to the next step.
The resulting yellow oil was transferred to an argon filled 25 mL Schlenk bomb
(14/20 joint off of an 8 mm Kontes valve) equipped with a magnetic stir bar using several
acetone rinses (ACS reagent grade, 5 x 2 mL).  Additional acetone (3.2 mL, total added =
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13.2 mL, 0.10 M), K2CO3 (367.6 mg, 2.66 mmol, 2.01 equiv), and MeI (170 µL, 2.73
mmol, 2.06 equiv) were added to the bomb.  The Kontes valve was sealed, the bomb was
lowered into a preheated oil bath (50 °C), and the reaction was stirred vigorously.  After
18 h, 1H NMR analysis indicated residual starting material, and consequently more MeI
(90 µL, total added = 260 µL, 4.18 mmol, 3.15 equiv) was added.  After an additional 21
h, no starting material remained by 1H NMR analysis.  Subsequently, the bomb was
removed from the oil bath and allowed to cool to room temperature.  The reaction
contents were filtered through a celite plug rinsing with EtOAc and concentrated under
reduced pressure.  The resulting crude oil was purified by flash chromatography (SiO2, 28
x 2 cm, 100% hexanes'5% EtOAc in hexanes) to afford !-iodoenone 41 (277.8 mg,
0.868 mmol, 31% yield over two steps) as a pale yellow oil; Rf = 0.63 (30% EtOAc in
hexanes); 1H NMR (500 MHz, CDCl3) & 7.64 (ddd, J = 4.7, 3.3, 1.0 Hz, 1H), 5.85 (dddd,
J = 17.2, 10.8, 5.5, 5.5 Hz, 1H), 5.28 (dq, J = 17.2, 1.5 Hz, 1H), 5.22 (dm, J = 10.5 Hz,
1H), 4.64 (dddd, J = 11.5, 6.3, 4.8, 1.5 Hz, 1H), 4.57 (dddd, J = 11.4, 6.2, 4.7, 1.5 Hz,
1H), 2.60–2.51 (m, 2H), 2.42–2.33 (m, 1H), 2.02–1.95 (m, 1H), 1.45 (s, 3H); 13C NMR
(125 MHz, CDCl3) & 190.4, 171.6, 158.1, 131.4, 118.7, 102.0, 66.1, 53.5, 33.3, 27.9,
21.3; IR (Neat Film NaCl) 3085, 2982, 2936, 2874, 2826, 1735, 1696, 1648, 1595, 1457,
1422, 1378, 1323, 1293, 1244, 1178, 1142, 1110, 1089, 1051, 966, 956, 930, 890, 864,
833, 782, 730 cm-1; HRMS (FAB+) calc’d for C11H14O3I [M+H]
+: 320.9988, found
320.9993.
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O
O
OO 1. LHMDS, THF, –78 °C
    then diallyl carbonate
2. K2CO3, MeI
    acetone, 50 °C
57% yield, 2 steps51a 13c
Enone 13c.  A 25 mL round-bottom flask equipped with a magnetic stir bar was cycled
into a glove box, loaded with LHMDS (527.6 mg, 3.15 mmol, 2.10 equiv), removed from
the glove box, and connected to an Ar-filled manifold.  The flask was charged with THF
(1 mL) and lowered into a 0 °C bath (ice/water).  Enone 51a
49
 (279.0 mg, 1.50 mmol,
1.00 equiv) was cannula transferred slowly from a scintillation vial to the flask using
several THF rinses (1 x 4 mL + 2 x 0.5 mL, total added = 6 mL, 0.25 M), generating a
bright red/pink solution.  After the addition was complete, the 0 °C bath was removed
and the reaction was allowed to warm to room temperature.  After 30 min, the flask was
lowered back into the 0 °C bath and diallyl carbonate (230 µL, 1.60 mmol, 1.07 equiv)
was added dropwise, generating an orange solution.  The bath was allowed to expire
overnight.  After 18 h, the reaction was quenched with sat. NH4Cl sol. (10 mL) and
transferred to a separatory funnel where the aqueous layer was extracted five times with
Et2O.  The combined organics (75 mL) were dried over MgSO4, filtered, and
concentrated under reduced pressure.  The resulting crude oil was purified by flash
column chromatography (SiO2, 21 x 2 cm, 100% hexanes' 5%'10% EtOAc in
hexanes) to afford a yellow oil.
The resulting yellow oil (285.8 mg, 1.06 mmol, 1.00 equiv) was transferred to an
Ar-filled 25 mL Schlenk bomb (14/20 joint off of an 8 mm Kontes valve) equipped with
a magnetic stir bar using several acetone rinses (1 x 1.5 mL + 3 x 0.5 mL, total added = 3
mL, 0.35 M).  K2CO3 (292.7 mg, 2.12 mmol, 2.00 equiv) and methyl iodide (180 µL,
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2.89 mmol, 2.73 equiv) were added to the bomb.  The Kontes valve was sealed, the bomb
was lowered into a preheated oil bath (50 °C), and the reaction was stirred vigorously.
After 11 h, 1H NMR analysis indicated residual starting material, and consequently more
methyl iodide (130 µL, total added = 310 µL, 4.98 mmol, 4.71 equiv) was added.  After
an additional 8.5 h, no starting material remained by 1H NMR analysis.  Subsequently,
the bomb was removed from the oil bath and allowed to cool to room temperature.  The
reaction contents were filtered through a celite plug rinsing with CH2Cl2 and concentrated
under reduced pressure.  The resulting crude oil was purified by flash column
chromatography (SiO2, 26.5 x 1.5 cm, 100% hexanes'5% EtOAc in hexanes) to afford
enone 13c (271.2 mg, 0.954 mmol, 64% yield over two steps, 90% purity) as a yellow oil.
This yellow oil was diluted in EtOAc (50 mg/mL) and purified further by preparative
HPLC (10% EtOAc in hexanes) to afford analytically pure enone 13c (242.8 mg, 0.851
mmol, 57% yield over two steps) as a pale yellow oil; Rf = 0.59 (30% EtOAc in hexanes);
1
H NMR (500 MHz, CDCl3) & 7.29–7.25 (m, 2H), 7.21–7.14 (m, 3H), 6.50–6.45 (m, 1H),
5.78 (ddt, J = 17.2, 10.5, 5.6 Hz, 1H), 5.24 (dq, J = 17.2, 1.5 Hz, 1H), 5.19 (dq, J = 10.5,
1.1 Hz, 1H), 4.53 (dm, J = 5.6 Hz, 2H), 3.58 (dq, J = 15.7, 1.7 Hz, 1H), 3.51 (dq, J =
15.6, 1.7 Hz, 1H), 2.52–2.40 (m, 2H), 2.34–2.24 (m, 1H), 1.94–1.86 (m, 1H), 1.40 (s,
3H); 
13
C NMR (125 MHz, CDCl3) & 196.6, 172.6, 145.1, 139.5, 138.8, 131.8, 129.3,
128.5, 126.2, 118.4, 65.8, 53.6, 36.0, 33.7, 23.6, 20.6; IR (Neat Film NaCl) 3084, 3061,
3027, 2980, 2934, 1734, 1685, 1603, 1496, 1453, 1430, 1375, 1292, 1246, 1166, 1111,
1077, 1029, 984, 747 cm
–1
; HRMS (MM: ESI-APCI) m/z calc'd for C18H21O3 [M+H]
+
:
285.1485, found 285.1482.
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O
O
OO 1. LHMDS, THF, –78 °C
    then diallyl carbonate
2. K2CO3, MeI
    acetone, 50 °C
30% yield, 2 steps51b 13d
Enone 13d.  A 25 mL round-bottom flask equipped with a magnetic stir bar was cycled
into a glove box, loaded with LHMDS (215.6 mg, 1.29 mmol, 2.12 equiv), removed from
the glove box, and connected to an Ar-filled manifold.  The flask was charged with THF
(0.5 mL) and lowered into a 0 °C bath (ice/water).  Enone 51b
49
 (122.0 mg, 0.609 mmol,
1.00 equiv) was cannula transferred slowly from a scintillation vial to the flask using
several THF rinses (1 x 1 mL + 2 x 0.5 mL, total added = 2.5 mL, 0.24 M), generating a
bright pink solution.  After the addition was complete, the 0 °C bath was removed and the
reaction was allowed to warm to room temperature.  After 30 min, the flask was lowered
back into the 0 °C bath and diallyl carbonate (100 µL, 0.697 mmol, 1.14 equiv) was
added dropwise.  The bath was allowed to expire overnight.  After 18 h, the reaction was
quenched with sat. NH4Cl sol. (5 mL) and transferred to a separatory funnel where the
aqueous layer was extracted five times with Et2O.  The combined organics (70 mL) were
dried over MgSO4, filtered, and concentrated under reduced pressure.  The resulting
crude oil was purified by flash column chromatography (SiO2, 27 x 1.5 cm, 100%
hexanes'5% EtOAc in hexanes) to afford a yellow oil.
The resulting yellow oil (84.6 mg, 0.298 mmol, 1.00 equiv) was transferred to an
Ar-filled 25 mL Schlenk bomb (14/20 joint off of an 8 mm Kontes valve) equipped with
a magnetic stir bar using several acetone rinses (4 x 0.5 mL, total added = 2 mL, 0.15 M).
K2CO3 (87.0 mg, 0.630 mmol, 2.12 equiv) and methyl iodide (100 µL, 1.61 mmol, 5.40
equiv) were added to the bomb.  The Kontes valve was sealed, the bomb was lowered
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into a preheated oil bath (50 °C), and the reaction was stirred vigorously.  After 16 h, 1H
NMR analysis indicated residual starting material, and consequently more methyl iodide
(130 µL, total added = 310 µL, 4.98 mmol, 4.71 equiv) was added.  After an additional
8.5 h, no starting material remained by 1H NMR analysis.  Subsequently, the bomb was
removed from the oil bath and allowed to cool to room temperature.  The reaction
contents were filtered through a celite plug rinsing with CH2Cl2 and concentrated under
reduced pressure.  The resulting crude oil was purified by flash column chromatography
(SiO2, 28 x 1.5 cm, 100% hexanes'2% EtOAc in hexanes) to afford enone 13d (75.6
mg, 0.253 mmol, 42% yield over two steps, 80% purity) as a yellow oil.  This yellow oil
was diluted with EtOAc (50 mg/mL) and purified further by preparative HPLC (10%
EtOAc in hexanes, 50 mL/min) to afford analytically pure enone 13d (54.1 mg, 0.181
mmol, 30% yield over two steps) as a pale yellow oil; Rf = 0.67 (30% EtOAc in hexanes);
1
H NMR (500 MHz, CDCl3) & 7.29–7.24 (m, 2H), 7.20–7.15 (m, 3H), 6.53 (ddq, J = 4.6,
3.3, 1.0 Hz, 1H), 5.87 (ddt, J = 17.2, 10.5, 5.6 Hz, 1H), 5.29 (dq, J = 17.2, 1.5 Hz, 1H),
5.22 (dq, J = 10.5, 1.3 Hz, 1H), 4.65–4.57 (m, 2H), 2.74 (ddd, J = 13.4, 9.7, 6.1 Hz, 1H),
2.67 (ddd, J = 13.4, 9.3, 6.1 Hz, 1H), 2.57 (dddq, J = 13.8, 9.2, 6.4, 1.5 Hz, 1H),
2.52–2.37 (m, 2H), 2.29 (qt, J = 4.9, 1.3 Hz, 1H), 2.25 (ddt, J = 9.9, 4.8, 1.3 Hz, 1H), 1.88
(ddd, J = 13.4, 8.4, 5.3 Hz, 1H), 1.41 (s, 3H); 
13
C NMR (125 MHz, CDCl3) & 196.9,
172.7, 144.5, 142.0, 138.2, 131.8, 128.7, 128.4, 126.0, 118.5, 65.8, 53.6, 34.9, 33.6, 32.5,
23.5, 20.6; IR (Neat Film NaCl) 3026, 2930, 1733, 1683, 1603, 1495, 1456, 1377, 1244,
1167, 1109, 985, 931, 748 cm
–1
; HRMS (MM: ESI-APCI) m/z calc'd for C19H23O3
[M+H]
+
: 299.1642, found 299.1638.
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O
O
O
41% yield, 2 steps
1.  LDA, THF, —78 °C;
     allyl chloroformate
2.  Cs2CO3, MeI
     MeCN, 80 °C
52a
BnO
45a
O
BnO
"-ketoester 45a.  Diisopropylamine (390 µL, 2.78 mmol, 4.46 equiv) in a 10 mL round-
bottom flask equipped with a magnetic stir bar was taken up in 2.0 mL THF and lowered
into a 0 °C bath (ice/water).  To the stirring solution was added n-butyl lithium (4.7 M
solution in hexanes, 0.583 mL, 2.74 mmol, 4.40 equiv).  This solution was stirred for 30
min before transferring the flask to a –78 °C bath (dry ice/acetone) and stirring the
mixture for another 15 min.  Benzyl diosphenol ether 52a
50
 (126 mg, 0.623 mmol, 1.00
equiv) in 1.1 mL THF (total = 3.1 mL, 0.2 M) was added dropwise by syringe, and the
solution was stirred for 2 h.  Allyl cyanoformate (270 µL, 2.49 mmol, 4.00 equiv) was
added dropwise by syringe, and the reaction was stirred for 8 h until analysis by TLC
showed complete consumption of starting material.  The reaction was diluted with 2 mL
EtOAc and quenched with 1.5 mL each saturated aqueous NH4Cl and water.  The –78 °C
bath was removed and the biphasic mixture was warmed to room temperature.  The
mixture was transferred to a separatory funnel and the phases were separated.  The
aqueous phase was extracted twice with EtOAc (5 mL).  The combined organic phases
were dried over MgSO4, filtered and concentrated under reduced pressure.  The resulting
crude yellow oil was taken up in acetonitrile (2.0 mL, 0.3 M) in a flame-dried 2-dram vial
equipped with a magnetic stir bar.  Cs2CO3 (264 mg, 0.810 mmol, 1.30 equiv) and methyl
iodide (116 µL, 1,86 mmol, 3.00 equiv) were added, and the reaction was blanketed
under argon and sealed with a Teflon-lined cap.  The vial was placed in a heating block
(80 °C) and stirred for 8 h until analysis by TLC showed complete consumption of
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starting material.  The reaction was diluted with 5 mL EtOAc, filtered and concentrated
under reduced pressure.  The resulting crude oil was purified by flash column
chromatography (SiO2, 12 x 1.5 cm, 20% Et2O in hexanes) to afford "-ketoester 45a (77
mg, 0.26 mmol, 41% yield over two steps) as a colorless oil; Rf = 0.34 (40% Et2O in
hexanes);
 1
H NMR (500 MHz, CDCl3) & 7.41–7.29 (m, 5H), 5.93–5.79 (m, 2H), 5.30 (dq,
J = 17.2, 1.6 Hz, 1H), 5.23 (dq, J = 10.5, 1.3 Hz, 1H), 4.95–4.83 (m, 2H), 4.67–4.52 (m,
2H), 2.50–2.41 (m, 2H), 2.39–2.27 (m, 1H), 1.96–1.83 (m, 1H), 1.46 (s, 3H); 
13
C NMR
(125 MHz, CDCl3) & 192.0, 172.3, 149.7, 136.7, 131.7, 128.6, 128.0, 127.3, 118.8, 118.5,
70.1, 65.9, 54.3, 33.7, 21.7, 20.6; IR (Neat Film NaCl) 3394, 2916, 2167, 1996, 1692,
1627, 1455, 1251, 1153, 1110, 1056 cm
–1
; HRMS (MM: ESI-APCI) m/z calc'd for
C18H21O4 [M+H]
+
: 301.1434, found 301.1422.
O
O
O
27% yield, 2 steps
1.  LDA, THF, —78 °C;
     allyl chloroformate
2.  Cs2CO3, MeI
     MeCN, 80 °C
52b
MeO
45b
O
MeO
Diosphenol ether 45b.  Prepared from 52b
51
 in an analogous manner to 45a.  Purified by
flash chromatography (SiO2, 15 x 3 cm, 20'40% Et2O in hexanes) to afford diosphenol
ether 45b (57 mg, 0.25 mmol, 27% yield over two steps) as a colorless oil; Rf = 0.54
(50% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) & 5.96–5.80 (m, 1H), 5.78 (d, J =
4.5 Hz, 1H), 5.27 (dq, J = 17.2, 1.6 Hz, 1H), 5.20 (dq, J = 10.5, 1.3 Hz, 1H), 4.67–4.55
(m, 2H), 3.60 (s, 3H), 2.56–2.43 (m, 2H), 2.42–2.32 (m, 1H), 1.95–1.85 (m, 1H), 1.43 (s,
3H); 
13
C NMR (125 MHz, CDCl3) & 192.0, 172.2, 150.7, 131.7, 118.4, 115.2, 65.9, 55.2,
54.3, 33.9, 21.5, 20.6; IR (Neat Film NaCl) 2936, 2839, 1734, 1696, 1631, 1455, 1378,
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1365, 1252, 1231, 1174, 1110, 1081, 1064, 979, 935, 824 cm
–1
; HRMS (MM: ESI-
APCI+) m/z calc'd for C12H17O4 [M+H]
+
: 225.1121, found 225.1122.
1.4.2.6.11 Diosphenol Ether and Enone Allylic Alkylation Products
(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(pmdba)3 (5 mol %)
toluene, 40 °C
77% yield
OO
O
O
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
13c 21c
52% ee
Enone 21c.  Prepared from 13c in an analogous manner to 46a.  Purified by flash column
chromatography (SiO2, 12 x 2 cm, 10'20% Et2O in hexanes) to afford enone 21c (68
mg, 0.28 mmol, 77% yield) as a colorless oil and recovered enone 13c (19 mg, 18%
recovered); Rf = 0.70 (40% Et2O in hexanes); 
1
H NMR (500 MHz, CDCl3) & 7.31–7.20
(m, 2H), 7.23 – 7.10 (m, 3H), 6.46 (d, J = 4.0 Hz, 1H), 5.75 – 5.60 (m, 1H), 5.08 – 4.93
(m, 2H), 3.50 (dq, J = 3.3, 1.6 Hz, 2H), 2.41 – 2.23 (m, 3H), 2.16 (ddt, J = 13.7, 7.6, 1.2
Hz, 1H), 1.89 (ddd, J = 13.7, 6.4, 5.5 Hz, 1H), 1.74 (ddd, J = 13.6, 6.9, 5.5 Hz, 1H), 1.06
(s, 3H); 
13
C NMR (125 MHz, CDCl3) & 203.06 , 144.55 , 140.04 , 137.98 , 134.25 ,
129.19 , 128.45 , 126.11 , 118.09 , 44.49 , 41.21 , 36.03 , 33.41 , 23.03 , 21.90; IR (Neat
Film NaCl) 3063, 3027, 2964, 2924, 1668, 1640, 1495, 1453, 1430, 1376, 1174, 1077,
996, 915, 749 cm
–1
; [!]D
25.0
 –200.23 (c 3.86, CHCl3, 52% ee); HRMS (MM: ESI-APCI+)
m/z calc'd for C17H21O [M+H]
+
: 241.1587, found 241.1575; JASCO SFC conditions: 3%
MeOH in CO2, 5 mL/min, Chiralcel OJ-H column, % = 210 nm, tR (min): major = 2.40,
minor = 2.11.
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(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(pmdba)3 (5 mol %)
toluene, 40 °C
50% yield
OO
O
O
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
13d 21d
68% ee
Enone 21d.  Prepared from 13d in an analogous manner to 46a.  Purified by flash
column chromatography (SiO2, 12 x 2 cm, 10'20% Et2O in hexanes) to afford enone
13c (17 mg, 67 !mol, 50% yield) as a colorless oil and recovered enone 13d (8 mg, 20%
recovered); Rf = 0.73 (40% Et2O in hexanes); 
1
H NMR (500 MHz, CDCl3) & 7.32–7.21
(m, 2H), 7.22–7.13 (m, 3H), 6.50 (t, J = 4.1 Hz, 1H), 5.74 (ddt, J = 16.8, 10.3, 7.4 Hz,
1H), 5.12–5.00 (m, 2H), 2.76–2.62 (m, 2H), 2.59–2.41 (m, 2H), 2.40–2.12 (m, 4H), 1.89
(ddd, J = 13.6, 6.7, 5.5 Hz, 1H), 1.72 (ddd, J = 13.6, 6.7, 5.5 Hz, 1H), 1.07 (s, 3H); 
13
C
NMR (125 MHz, CDCl3) & 203.4, 144.2, 142.1, 137.4, 134.4, 128.7, 128.3, 125.9, 118.1,
44.4, 41.3, 35.2, 33.4, 32.4, 23.0, 22.0; IR (Neat Film NaCl) 3062, 3026, 2962, 2924,
2855, 1669, 1639, 1496, 1453, 1430, 1377, 1175, 1078, 995, 914, 747 cm
–1
; [!]D
25.0
–32.55 (c 1.24, CHCl3, 68% ee); HRMS (MM: ESI-APCI+) m/z calc'd for C18H23O
[M+H]
+
: 255.1743, found 255.1730; JASCO SFC conditions: 3% MeOH in CO2, 5
mL/min, Chiralcel OJ-H column, % = 210 nm, tR (min): major = 2.41, minor = 2.17.
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(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(pmdba)3 (5 mol %)
toluene, 40 °C
92% yield
O
BnO
O
O
O
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
BnO
45a 46a
94% ee
Diosphenol ether 46a.  Pd2(pmdba)3 (4.2 mg, 3.8 µmol, 5.0 mol %) and (S)-(CF3)3-t-
BuPHOX (8, 5.7 mg, 9.6 µmol, 12.5 mol %) were added to an oven-dried 2-dram vial
equipped with a magnetic stir bar in a glove box.  The vial was charged with toluene (1.8
mL) and stirred at ambient temperature (28 °C) for 30 min, resulting in a deep orange
solution.  "-ketoester 45a (23 mg, 77 µmol, 1.0 equiv) was transferred to the scintillation
vial with toluene (0.5 mL, total = 2.3 mL, 0.033 M), producing a light green solution.
The vial was sealed with a Teflon-lined cap and lowered into a heating block (40 °C).
After 6 days, the reaction was complete by TLC and colorimetric analysis (the reaction
mixture had reverted to an orange color) and was removed from the glove box.  The
reaction was filtered through a silica gel plug, rinsed with Et2O, and concentrated under
reduced pressure.  The crude oil was purified by flash column chromatography (SiO2, 15
x 1.5 cm, 5%'10% Et2O in hexanes) to afford diosphenol ether 46a (18 mg, 70 µmol,
92% yield) as a colorless oil; Rf = 0.56 (40% Et2O in hexanes); 
1
H NMR (500 MHz,
CDCl3) & 7.39–7.26 (m, 5H), 5.83 (t, J = 4.5 Hz, 1H), 5.74 (ddt, J = 16.7, 10.3, 7.4 Hz,
1H), 5.12–5.03 (m, 2H), 4.85 (s, 2H), 2.42–2.33 (m, 3H), 2.21 (ddt, J = 13.8, 7.6, 1.2 Hz,
1H), 1.89 (ddd, J = 13.7, 6.7, 5.6 Hz, 1H), 1.71 (ddd, J = 13.7, 6.6, 5.4 Hz, 1H), 1.11 (s,
3H); 
13
C NMR (125 MHz, CDCl3) & 198.5, 149.0, 136.8, 134.1, 128.6, 127.9, 127.4,
118.4, 118.0, 70.0, 45.4, 41.2, 33.1, 21.9, 20.9; IR (Neat Film NaCl) 2918, 2360, 1684,
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1628, 1457, 1220, 1204, 1094, 1050, 914, 736 cm
–1
; [!]D
25.0
 –12.01 (c 0.50, CHCl3, 94%
ee); HRMS (MM: ESI-APCI) m/z calc'd for C17H21O2 [M+H]
+
: 257.1536, found
257.1529; HPLC conditions: 7% IPA in hexanes, 1 mL/min, Chiralcel OD-H column, % =
254 nm, tR (min): major = 7.24, minor = 8.27.
(S)-(CF3)3-t-BuPHOX (12.5 mol %)
Pd2(pmdba)3 (5 mol %)
toluene, 40 °C
99% yield
O
MeO
O
O
O
(4-CF3C6H4)2P N
O
t-Bu
CF3
8
MeO
45b 46b
85% ee
Diosphenol ether 46b.  Prepared from 45b in an analogous manner to 46a.  Purified by
flash column chromatography (SiO2, 10 x 3 cm, 5'10% Et2O in hexanes) to afford
diosphenol ether 45b (111 mg, 0.616 mmol, 99% yield) as a colorless oil; Rf = 0.23 (40%
Et2O in hexanes); 
1
H NMR (500 MHz, CDCl3) & 5.79–5.65 (m, 2H), 5.12–5.01 (m, 2H),
3.58 (s, 3H), 2.47–2.34 (m, 3H), 2.20 (ddt, J = 13.7, 7.6, 1.1 Hz, 1H), 1.91 (ddd, J = 13.7,
6.8, 5.5 Hz, 1H), 1.72 (ddd, J = 13.7, 6.5, 5.4 Hz, 1H), 1.11 (s, 3H); 13C NMR (125 MHz,
CDCl3) & 198.6, 150.0, 134.0, 118.4, 114.5, 55.1, 45.4, 41.2, 33.2, 21.9, 20.8; IR (Neat
Film NaCl) 2929, 1687, 1631, 1455, 1375, 1225, 1095, 1056, 913 cm
–1
; [!]D
25.0
 –27.47 (c
6.00, CHCl3, 85% ee); HRMS (MM: ESI-APCI+) m/z calc'd for C11H17O2 [M+H]
+
:
181.1223, found 181.1222; HPLC conditions: 2% IPA in hexanes, 1 mL/min, Chiralcel
OD-H column, % = 254 nm, tR (min): major = 13.41, minor = 12.23.
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1.4.2.7 Determination of Enantiomeric Excess
Table 1.5.  Methods for the determination of enantiomeric excess (chiral HPLC and SFC).
entry product
retention time
of major
isomer (min)
% ee
1 81
retention time
of minor
isomer (min)
assay
conditions
10.45 9.60
5 824.04 2.20
2 838.60 6.48
3 868.45 10.35
4 878.04 8.97
6 845.60 4.73
842.80 3.137
SFC
Chiralpak AD-H
10% MeOH in CO2
isocratic, 3.0 mL/min
254 nm
SFC
Chiralcel OD-H
5% MeOH in CO2
isocratic, 5.0 mL/min
210 nm
SFC
Chiralpak AS-H
5% MeOH in CO2
isocratic, 5.0 mL/min
254 nm
SFC
Chiralpak AD-H
5% MeOH in CO2
isocratic, 3.0 mL/min
254 nm
SFC
Chiralpak AD-H
7% MeOH in CO2
isocratic, 5.0 mL/min
210 nm
SFC
Chiralpak AD-H
7% MeOH in CO2
isocratic, 5.0 mL/min
210 nm
SFC
Chiralpak AD-H
10% MeOH in CO2
isocratic, 5.0 mL/min
210 nm
O
N
Bn
Me
23a
O
N
Bn
Ph
23b
O
N
Bn
Ac
23d
O
N
Bn
Bz
23e
O
N
Bn
Boc
23f
O
N
Bn
Ts
23g
Cbz
N
O
30a
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8 8618.77 21.21
HPLC
Chiralcel OJ
10% IPA in hexanes
isocratic, 1.0 mL/min
210 nm
Bn
N
O
30b
entry product
retention time
of major
isomer (min)
% ee
12 96
retention time
of minor
isomer (min)
assay
conditions
7.95 6.52
13 7611.94 17.86
14 964.03 3.64
15 9814.34 13.39
HPLC
Chiralcel OD-H
5% IPA in hexanes
isocratic, 1.0 mL/min
210 nm
HPLC
Chiralpak AD
3% IPA in hexanes
isocratic, 1.0 mL/min
210 nm
SFC
Chiralcel OJ-H
1% MeOH in CO2
isocratic, 3.0 mL/min
210 nm
SFC
Chiralcel OB-H
1% MeOH in CO2
isocratic, 2.5 mL/min
210 nm
N
OO
5i
N
O
O 7c
N
BnO
O
O 7d
N
BnO
O
O
Et
7e
9021.87 18.5910
11 952.53 2.13
HPLC
Chiralpak AD
30% IPA in hexanes
isocratic, 1.0 mL/min
254 nm
SFC
Chiralcel OJ-H
1% IPA in CO2
isocratic, 5.0 mL/min
222 nm
N
O
MeO
MeO
30d
N
OO
5h
9 8811.44 14.80
HPLC
Chiralcel OJ
7% IPA in hexanes
isocratic, 1.0 mL/min
210 nm
Bn
N
O
30c
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16 522.40 2.11
SFC
Chiralcel OJ-H
3% MeOH in CO2
isocratic, 5.0 mL/min
210 nm
O
21c
entry product
retention time
of major
isomer (min)
% ee
retention time
of minor
isomer (min)
assay
conditions
19 8513.41 12.23
HPLC
Chiralcel OD-H
2% IPA in hexanes
isocratic, 1.0 mL/min
254 nm
MeO
O
46b
18 947.24 8.27
HPLC
Chiralcel OD-H
7% IPA in hexanes
isocratic, 1.0 mL/min
254 nm
BnO
O
46a
17 682.41 2.17
SFC
Chiralcel OJ-H
3% MeOH in CO2
isocratic, 5.0 mL/min
210 nm
O
21d
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O
O
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O
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CH2Cl2
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Infrared spectrum (thin film/NaCl) of compound 17. 
13C NMR (125 MHz, CDCl3) of compound 17. 
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Infrared spectrum (thin film/NaCl) of compound 16a. 
13C NMR (125 MHz, CDCl3) of compound 16a. 
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Infrared spectrum (thin film/NaCl) of compound 16b. 
13C NMR (125 MHz, CDCl3) of compound 16b. 
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Infrared spectrum (thin film/NaCl) of compound 16c. 
13C NMR (125 MHz, CDCl3) of compound 16c. 
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Infrared spectrum (thin film/NaCl) of compound 18. 
13C NMR (125 MHz, CDCl3) of compound 18. 
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Infrared spectrum (thin film/NaCl) of compound 16f. 
13C NMR (125 MHz, CDCl3) of compound 16f. 
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 Infrared spectrum (thin film/NaCl) of compound 16g. 
13C NMR (125 MHz, CDCl3) of compound 16g. 
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Infrared spectrum (thin film/NaCl) of compound 20. 
13C NMR (125 MHz, CDCl3) of compound 20. 
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Infrared spectrum (thin film/NaCl) of compound 16h. 
13C NMR (125 MHz, CDCl3) of compound 16h. 
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Infrared spectrum (thin film/NaCl) of compound 16d. 
13C NMR (125 MHz, CDCl3) of compound 16d. 
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Infrared spectrum (thin film/NaCl) of compound 16i. 
13C NMR (125 MHz, CDCl3) of compound 16i. 
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Infrared spectrum (thin film/NaCl) of compound 16e. 
13C NMR (125 MHz, CDCl3) of compound 16e. 
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Infrared spectrum (thin film/NaCl) of compound 16j. 
13C NMR (125 MHz, CDCl3) of compound 16j. 
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Infrared spectrum (thin film/NaCl) of compound 23a. 
13C NMR (125 MHz, CDCl3) of compound 23a. 
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Infrared spectrum (thin film/NaCl) of compound 23b. 
13C NMR (125 MHz, CDCl3) of compound 23b. 
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Infrared spectrum (thin film/NaCl) of compound 23d. 
13C NMR (125 MHz, CDCl3) of compound 23d. 
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 Infrared spectrum (thin film/NaCl) of compound 23e. 
13C NMR (125 MHz, CDCl3) of compound 23e. 
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Infrared spectrum (thin film/NaCl) of compound 23f. 
13C NMR (125 MHz, CDCl3) of compound 23f. 
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Infrared spectrum (thin film/NaCl) of compound 23g. 
13C NMR (125 MHz, CDCl3) of compound 23g. 
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Infrared spectrum (thin film/NaCl) of compound 29a. 
13
C NMR (125 MHz, CDCl3) of compound 29a. 
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Infrared spectrum (thin film/NaCl) of compound 48b. 
13C NMR (125 MHz, CDCl3) of compound 48b. 
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Infrared spectrum (thin film/NaCl) of compound 29b. 
13C NMR (125 MHz, CDCl3) of compound 29b. 
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Infrared spectrum (thin film/NaCl) of compound 48c. 
13C NMR (125 MHz, CDCl3) of compound 48c. 
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 Infrared spectrum (thin film/NaCl) of compound 29c. 
13C NMR (125 MHz, CDCl3) of compound 29c. 
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13C NMR (125 MHz, CDCl3) of compound 48d. 
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Infrared spectrum (thin film/NaCl) of compound 29d. 
13C NMR (125 MHz, CDCl3) of compound 29d. 
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Infrared spectrum (thin film/NaCl) of compound 30a. 
13C NMR (125 MHz, CDCl3) of compound 30a. 
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Infrared spectrum (thin film/NaCl) of compound 30b. 
13C NMR (125 MHz, CDCl3) of compound 30b. 
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Infrared spectrum (thin film/NaCl) of compound 30c. 
13C NMR (125 MHz, CDCl3) of compound 30c. 
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Infrared spectrum (thin film/NaCl) of compound 30d. 
13C NMR (125 MHz, CDCl3) of compound 30d. 
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Infrared spectrum (thin film/NaCl) of compound 4i. 
13C NMR (125 MHz, CDCl3) of compound 4i. 
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Infrared spectrum (thin film/NaCl) of compound 4j. 
13C NMR (125 MHz, CDCl3) of compound 4j. 
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Infrared spectrum (thin film/NaCl) of compound 5i. 
13C NMR (125 MHz, CDCl3) of compound 5i. 
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Infrared spectrum (thin film/NaCl) of compound 5j. 
13C NMR (125 MHz, CDCl3) of compound 5j. 
APPENDIX 1 — Spectra Relevant to Chapter 1  172 
1
H
 N
M
R
 (
5
0
0
 M
H
z,
 C
D
C
l 3
) 
o
f 
co
m
p
o
u
n
d
 6
c
. 
N
O
O
O
O
6
c
!
"
#
$
%
&
'
(
)
*
+
+
,
APPENDIX 1 — Spectra Relevant to Chapter 1  173 
!"!#!$!%!&!!&"!&#!&$!&%!"!!""!
''(
Infrared spectrum (thin film/NaCl) of compound 6c. 
13C NMR (125 MHz, CDCl3) of compound 6c. 
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Infrared spectrum (thin film/NaCl) of compound 50. 
13C NMR (125 MHz, CDCl3) of compound 50. 
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Infrared spectrum (thin film/NaCl) of compound 6d. 
13C NMR (125 MHz, CDCl3) of compound 6d. 
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Infrared spectrum (thin film/NaCl) of compound 6e. 
13C NMR (125 MHz, CDCl3) of compound 6e. 
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Infrared spectrum (thin film/NaCl) of compound 7c. 
13C NMR (125 MHz, CDCl3) of compound 7c. 
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 Infrared spectrum (thin film/NaCl) of compound 7d. 
13C NMR (125 MHz, CDCl3) of compound 7d. 
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Infrared spectrum (thin film/NaCl) of compound 7e. 
13C NMR (125 MHz, CDCl3) of compound 7e. 
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Infrared spectrum (thin film/NaCl) of compound 44. 
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Infrared spectrum (thin film/NaCl) of compound 13b. 
13C NMR (125 MHz, C6D6) of compound 13b. 
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Infrared spectrum (thin film/NaCl) of compound 41. 
13C NMR (125 MHz, CDCl3) of compound 41. 
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Infrared spectrum (thin film/NaCl) of compound 13c. 
13C NMR (125 MHz, CDCl3) of compound 13c. 
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Infrared spectrum (thin film/NaCl) of compound 13d. 
13C NMR (125 MHz, CDCl3) of compound 13d. 
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Infrared spectrum (thin film/NaCl) of compound 45a. 
13C NMR (125 MHz, CDCl3) of compound 45a. 
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Infrared spectrum (thin film/NaCl) of compound 45b. 
13C NMR (125 MHz, CDCl3) of compound 45b. 
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Infrared spectrum (thin film/NaCl) of compound 21c. 
13C NMR (125 MHz, CDCl3) of compound 21c. 
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Infrared spectrum (thin film/NaCl) of compound 21d. 
13C NMR (125 MHz, CDCl3) of compound 21d. 
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Infrared spectrum (thin film/NaCl) of compound 46a. 
13C NMR (125 MHz, CDCl3) of compound 46a. 
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Infrared spectrum (thin film/NaCl) of compound 46b. 
13C NMR (125 MHz, CDCl3) of compound 46b. 
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CHAPTER 2 
Highly Enantioselective Palladium-Catalyzed 
Decarboxylative Allylic Alkylation of Enaminones† 
 
2.1  INTRODUCTION AND BACKGROUND 
The asymmetric palladium-catalyzed decarboxylative allylic alkylation (DAA) 
reaction has long been an area of interest in our group (see Chapter 1.1).1  Although 
carbocycles 1 were the first successful substrates to be utilized in this reaction with the 
ligand (S)-t-BuPHOX (3), enantioselectivity of this transformation was limited to the 
high 70% to low 90% ee range until the discovery that reaction of lactam substrates 5 
utilizing trifluoromethylated ligand (S)-(CF3)3-t-BuPHOX (8) furnish products in 
enantioselectivities ranging from 93% to 99% (Scheme 2.1).2 
  
                                                
†  This research was performed in collaboration with Louise Lefoulon and Dr. Jared A. 
Moore. 
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Scheme 2.1.  Assymetric allylic alkylation carbocyclic and lactam substrates. 
 
 This prompted us to consider what distinguished the lactam substrate class, and if 
we could apply those properties to carbocyclic substrates to increase the reaction 
selectivity.  Our initial efforts focused on enolate electronics, postulating that it was the 
electron-rich nature of the substrate favoring an inner-sphere alkylation mechanism 
thereby leading to increased selectivity.3  Prior theoretical studies have supported the 
Pd(PHOX) catalytic system favoring an inner-sphere reaction mechanism, specifically 
noting that this reaction mechanism is favored due to the basic nature of the enolate 
electrophile leading to apical attack on the intermediate palladium π-allyl complex 
(Figure 2.1).4 
  
O
O
O
Decarboxylative allylic alkylation of carbocycles (77-99% yield and 79-92% ee):
Pd2(dba)3 (5 mol%)
(S)-t-BuPHOX 3 (12.5 mol%)
THF, 30 °C
O
2a
85% yield, 88% ee
BzN
O
O
O
Pd2(pmdba)3 (5 mol%)
(S)-(CF3)3-t-Bu-PHOX 8 (12.5 mol%)
toluene, 40 °C
BzN
O
5a
85% yield, 99% ee
Decarboxylative allylic alkylation of lactams (60-99% yield and 93-99% ee):
Ph3P N
O
3, (S)-t-Bu-PHOX
t-Bu
1a
4a
(p-CF3C6H4)2P N
O
8, (S)-(CF3)3-t-Bu-PHOX
t-Bu
CF3
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Figure 2.1.  Comparison of inner- and outer-sphere alkylation mechanisms in the 
DAA reaction. 
 
Investigation of vinylogous amides (Figure 2.2, 16) as carbocyclic lactam mimics, 
however, yielded enantioselectivities in the ordinary range for carbocyclic substrates.  
Despite this, we discovered that diosphenol ether substrate 46a gave moderately higher 
enantioselectivities than previously investigated carbocycles.  This result, combined with 
no trend correlating the steric bulk of the αʹ-substituent to the stereoselectivity of the 
transformation led us to postulate that there might be a stereoelectronic effect governing 
the differences in observed enantioselectivity (see Chapter 1.2).  As such, we turned to 
the substrate class of en-2-aminones (Figure 2.2, 65) to investigate if a stronger 
coordinating group at the αʹ-position would have the desired effect on the reaction 
selectivity. 
  
Pd
P
N
O
t-Bu
Ph
Ph
O-
Enolate association, inner-sphere alkylation:
Highly enantioselective
Outer-sphere alkylation:
Poorly enantioselective
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Figure 2.2.  Rationale for choice of enaminones as substrates. 
 
 
2.2  RESULTS AND DISCUSSION 
2.2.1  Reaction Optimization 
 The enaminone class of substrates was readily accessible by standard 
acylation/alkylation protocols (see supporting information for details).  The first substrate 
we investigated was morpholine-derived enaminone 65a.  To our delight, the 
corresponding product 66a was furnished in 93% yield and 97% ee using (S)-(CF3)3-t-
BuPHOX (8) (Table 2.1, entry 1).  This result prompted us to perform an optimization for 
reaction medium, as previous reactions had proven to be somewhat variable according to 
the solvent used.1,2  We were pleased to discover that the reaction retained its high 
enantioselectivity in a wide variety of solvents.  Though we briefly investigated the effect 
of temperature on outcome of the reaction, we found that lowering the reaction 
temperature to 30 °C had no effect on the resulting ee (result not shown). 
  
N
O
Ph
O
5a
99% ee
O
N
R
Bn
O
BnO
O
R2N
66
16
52–90% ee
46a
94% ee
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Table 2.1.  Initial solvent screen for enaminone substrates. 
 
 To our surprise, when we utilized the standard (S)-t-BuPHOX ligand (3) instead 
of its trifluoromethylated counterpart, the reaction retained its high enantioselectivity 
(Table 2.2).  We determined ethyl acetate to be the optimal reaction medium, as a cheap, 
easy to work with, and relatively environmentally benign solvent. 
Table 2.2 Solvent screen using ligand 3. 
 
  
)solvent(
2:1 
hex:tol
benzene
THF
DME
dioxane
Et  O
MeCN
% ee (chiral HPLC)
94
95
95
95
94
97
88
O
N
O
O
Pd2(dmdba)3 (5 mol %)
(S)-(CF3)3-t-Bu-PHOX 8 (12.5 mol %)
solvent (0.033 M), 40 °C, 12 h
O
N
O O
)solvent(
toluene
TBME
CPME
2-MeTHF
i-BuOAc
i-PrOAc
EtOAc
% ee (chiral HPLC)
97
95
97
96
92
96
98
2
)entry(
1
2
3
4
5
6
7
)entry(
8
9
10
11
12
13
14
65a 66a
O
N
O
O
Pd2(dmdba)3 (5 mol %)
(S)-t-Bu-PHOX 3 (12.5 mol %)
solvent (0.033 M), 40 °C, 12 h
O
N
O O
)solvent(
EtOAc
toluene
CPME
% ee (chiral HPLC)
98
94
98
)entry(
1
2
3
65a 66a
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2.2.2  Substrate Scope 
 With optimized reaction conditions at hand, we desired to determine the 
generality of this substrate class as exceptional among carbocycles (Table 2.3).  
Substitution of the methyl group for a slightly larger ethyl group was unsurprisingly well 
tolerated, furnishing the product in 99% yield and 98% ee (66b, Table 2.3, entry 2).  
Substrates bearing larger alkyl chain substituents such as TBS ethers (66c and 66d, Table 
2.3, entries 3 and 4) also resulted in high yields and excellent enantioselectivity. 
Table 2.3.  Substrate scope of enaminones in the asymmetric DAA. 
 
  
Substrates with alkyl chains bearing electron-withdrawing ester, ketone and nitrile 
groups also performed admirably in the reaction (66e-g, Table 2.3, entries 8–10), with 
)R(
Me
Et
CH OTBS
CH CH OTBS
CH CH CO Me
CH CH C(O)Me
CH CH CN
Bn
p-(OMe)-Bn
p-(CF )-Bn
Me
Me
% ee)
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99
99
97
94
94
96
95
92
99
99
O
N
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O
O
Pd2(dmdba)3 (5 mol %)
(S)-t-Bu-PHOX 3 (12.5 mol %)
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O
N
R1
O O
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3
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2 2
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enantioselectivities in the range of 94–97%.  Benzyl substitution was somewhat well-
tolerated, with benzyl, para-methoxybenzyl and para-trifluoromethylbenzyl substrates 
furnishing products in 96%, 95% and 92% ee respectively (66h–j, Table 2.3, entries 5–7). 
Satisfied that the reaction was quite general with respect to the alkyl substitution, 
we found that substitution at the 2-position of the allyl group also furnished product with 
excellent selectivity, as in 2-chloro and 2-methylallyl products 66k and 66l (Table 2.3, 
entries 11 and 12), although product 66k was obtained in significantly lower yield.  
Moreover, we found that this reaction was imminently scalable.  Increasing the reaction 
scale from 0.465 mmol to 12.3 mmol, with a corresponding increase in concentration 
from 0.033 M to 0.33 M and decrease in catalyst loading from 5 mol % to 0.5 mol %, we 
maintained an excellent yield of 93% and no loss of enantioselectivity (Table 2.4). 
Table 2.4.  Increasing scale and reducing catalyst loading of the reaction. 
 
2.2.3  Derivitization of Enaminone Products 
Given the excellent results with this class of substrates, we desired to determine 
the utility of the products for access to alternative building blocks in organic synthesis.  
Treatment of enaminone 66a with hydrochloric acid in a methanol-water mixture 
catalyst loading
(mol % Pd2(dmdba)3)
% ee
(chiral HPLC or SFC)
Pd2(dmdba)3 (x mol %)
(S)-t-Bu-PHOX (2.5•x mol %)
EtOAc, 40 °C, 12 h
% yield
(isolated)concentration (M)
scale
(amount isolated 
product)
0.465 mmol
(104 mg)
5.41 mmol
(1.19 g)
12.3 mmol
(2.69 g)
0.033
0.1
0.33
5
1.67
0.5
95
94
93
98
99
98
O
N
O
O
O
N
O O
65a 66a
1
2
3
entry
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revealed the latent 1,2-diketone functionality (Scheme 2.2), yielding diketone 67 in 79% 
yield.  Treatment with NBS resulted in bromination at the nucleophilic 3-position, 
yielding vinyl bromide 68 in 60% yield.  This vinyl bromide proved to be an excellent 
substrate for the Suzuki–Miyaura cross-coupling, as reaction with phenyl boronic acid 
and PdCl2dppf provided arylated enamine 69 in 96% yield. 
Scheme 2.2. Derivitization of enaminone products by hydrolysis and by 
bromination and Suzuki–Miyaura cross-coupling. 
 
2-Morpholine substituted enaminones have been shown to undergo 
transamination, and have been used to in the synthesis of N,N-imino-enaminido ligands 
for hafnium and zirconium polymerization catalysts.5  Reaction of 66a with aniline 
yielded the transaminated product 70 in a modest 35% yield (Scheme 2.3).  Reaction with 
more nucleophilic phenyl hydrazine, however, followed by treatment under Fischer 
indole conditions resulted in indole 71 in 99% yield over two steps.  This result is 
HCl
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O
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72% yield
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O
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O
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O
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O
N
O
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DME
60 °C, 2 h
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interesting, as it furnished the carbazolone with opposite connectivity between the 
cyclohexanone and indole systems as compared to the vinylogous amides previously 
investigated by our group (Chapter 1, Scheme 1.7), and used in the total syntheses of (+)-
kosihainanine A and (–)-aspidospermidine by Lupton and Shao.6 
Scheme 2.3. Derivitization of enaminone products by transamination and 
heterocycle formation 
 
2-Morpholine substituted enaminones have also been used en route to pyrazole-
based inhibitors of blood coagulation factor Xa by reaction with para-
methoxyphenylchlorohydrazones.7  Accordingly, we treated enaminone 66a with reagent 
73, yielding corresponding pyrazole 72 in 46% yield (Scheme 2.3).  Thus, the 
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functionality of our enaminone products can be used to access a variety of nucleophilic 
and electrophilic reactivities, and converted in various useful heterocyclic structures.  
2.2.4  Insight from Related Structures 
 Although we had found an exceptional substrate class for our reaction, we desired 
to determine if this reflected a stereoelectronic effect as postulated.  We began by testing 
piperidyl substrate 74 to determine if the distil oxygen of the morpholine substituent had 
any influence over the selectivity of the reaction (Table 2.5, entry 1).  Piperidyl product 
75 was obtained in 99% yield and 99% ee, indicating that the oxygen of the morpholine 
ring is not required for our observed selectivities. 
Table 2.5. Asymmetric DAA of substrates related to enaminones 65. 
 
% ee
(chiral HPLC
or SFC)
% yield
(isolated)productsubstrateentry
O
N
O
O
O
N
74 75
1 99 99
O
N
O
O
O
N
O O
76 77
2 52 90
78 79
3 94 83
O O
O
O
80 81
4 93 72
O
N
O
O
N
O
O
O
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As we hypothesized the existence of a stereoelectronic interaction between the αʹ-
substituent and the catalyst, we sought to perturb this effect by making changes to the 
steric environment of the amine functionality of the enaminone.  Adding a methyl group 
to the 3-position of the enone prolonged the reaction time greatly, resulting in a 52% 
yield after reaction for seven days, and a marked decrease in enantioselectivity to 90% 
(77, Table 2.5, entry 2).8  While this result is ambiguous, it could be due to a steric clash 
with the morpholine group in the transition state of the favored enantiomer, indicating 
that the geometrical arrangement of this group in the transition state of the 
enantiodetermining step is potentially crucial. 
Five-membered enaminone 79 was obtained in good yield, but with a notably 
lower 83% ee (Table 2.5, entry 3).  We note that the bond angles and distances between 
the enolate oxygen (bound to palladium in the inner-sphere reaction mechanism) and the 
morpholine group are considerably different, with the cyclopentenone-derived substrate 
having a morpholine group calculated to be approximately 0.3 Å further away (Figure 
2.3).  Should an interaction between the morpholine nitrogen and the palladium catalyst 
be the cause of increased enantioselectivity, this increase in distance and angle between 
enamine nitrogen and enolate oxygen could potentially account for the underperformance 
of enaminone 78. 
Figure 2.3. Calculated structures for 5- and 6-membered enaminone enolates.9 
 
O-
N
O
O-
N
Od d
α1
α1
α2
d = 3.02 Å
α1 = 125°
α2 = 123°
d = 2.74 Å
α1 = 116°
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Calculated structures (H-F, 6-31 G**):
α2
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Lastly, to ensure that the observed effects were not simply steric, 2-cyclohexyl-
cyclohexenone substrate 80 was subjected to reaction conditions, resulting in a 93% yield 
but a poor 72% ee (Table 2.5, entry 4).  This indicates to us that the observed increase in 
enantioselectivity observed for enaminone substrate 65 is indeed electronic or 
stereoelectronic nature, and not the result of a simple steric clash. 
Based on these results, we hypothesize that the αʹ-substituent has a reinforcing 
effect on the stereochemical outcome of the reaction by either an electronic attraction 
between the nitrogen lone pair and the palladium center of the catalyst, as in a Lewis 
acid-Lewis base interaction, or by an orbital overlap between the nitrogen lone pair and 
the vacant palladium 5pz orbital, as in an associative ligand substitution reaction (Figure 
2.4).  
Figure 2.4. Mechanistic rationale for observed high enantioselectivities of 
enaminones. 
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Theoretical and experimental studies4 of the Pd(PHOX) catalytic system in the 
asymmetric DAA reaction have shown that coordination of the enolate to the palladium 
π-allyl complex is followed by an enantiodetermining internal rearrangement to form a 
square-planar, η-1-bound palladium allyl complex.  In the intermediate following the (Si) 
transition state (Figure 2.4, A), this rearrangement would place the morpholine moiety in 
the space formerly occupied by the enolate oxygen, i.e. with a good arrangement for 
interaction with the Pd metal center.  In the intermediate following the (Re) transition 
state, the morpholine moiety would be distant from the metal center and therefore unable 
to interact with it (Figure 2.4, B).  This model would also account for the observed 
increase in selectivity of lactam substrates2 (through interaction of the exocyclic amide 
nitrogen with Pd) and the high performance of ligand (S)-(CF3)3-t-BuPHOX (8) in that 
context, by generating a more electron-poor Pd metal center.  We hope that future 
mechanistic and theoretical studies may be performed on this and related substrate classes 
in order to refine this mechanistic hypothesis and determine the nature and origin of the 
observed high enantioselectivity in this reaction. 
2.3  CONCLUDING REMARKS 
In conclusion, we designed a novel substrate class for the palladium-catalyzed 
decarboxylative allylic alkylation based on observations made on previous lactam and 
vinylogous amide substrates.  These enaminone substrates proved to be superlative in the 
reaction, resulting in generally high yields and enantioselectivities of 92–99%, with most 
products being above 95% ee. The products were shown to be versatile building blocks, 
demonstrating both nucleophilic and electrophilic reactivity as well as being amenable to 
conversion to various heterocyclic structures.  Finally, by comparison to results from 
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substrates with different skeletal composition, we determined that the observed 
enantioselectivities are not due to a steric effect, and proposed a model invoking a 
potential interaction between the amine nitrogen of the enaminone and the Pd center of 
the catalyst during the enantiodetermining step of the transformation.  It is our hope that 
further investigation of this and related substrate classes may provide further insight into 
the origin of the observed enantioselectivities, allowing for the design of further 
exceptional substrate classes or refinement of the catalytic system to improve the 
enantioselectivity for general substrates. 
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2.4  EXPERIMENTAL SECTION 
2.4.1  Materials and Methods 
Unless otherwise stated, reactions were performed in flame-dried glassware under an 
argon or nitrogen atmosphere using dry, deoxygenated solvents.  Solvents were dried by 
passage through an activated alumina column under argon.10 Acetone was used directly 
from a Sigma-Aldrich ACS reagent grade bottle.  Brine solutions are saturated aqueous 
solutions of sodium chloride.  Reagents were purchased from Sigma-Aldrich, Acros 
Organics, Strem, or Alfa Aesar and used as received unless otherwise stated.  (S)-t- 
BuPHOX (3),1a,b and allyl cyanoformate11 were prepared by known methods.  Reaction 
temperatures were controlled by an IKAmag temperature modulator.  Reaction progress 
was monitored by thin-layer chromatography (TLC).  TLC was performed using E.  
Merck silica gel 60 F254 precoated glass plates (0.25 mm) and visualized by UV 
fluorescence quenching, p-anisaldehyde, I2, or KMnO4 staining.  ICN silica gel (particle 
size 0.032-0.0653 mm) was used for flash column chromatography. 1H NMR spectra 
were recorded on a Varian Mercury 300 MHz or Varian Inova 500 MHz spectrometer 
and are reported relative to residual CHCl3 (δ 7.26 ppm).  13C NMR spectra are recorded 
on a Varian Mercury 300 MHz or Varian Inova 500 MHz spectrometer (75 or 125 MHz 
respectively) and are reported relative to CDCl3 (δ 77.16 ppm).  Data for 1H NMR are 
reported as follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), 
integration).  Multiplicities are reported as follows: s = singlet, d = doublet, t = triplet, q = 
quartet, p = pentet, sept = septuplet, m = multiplet, dm = doublet of multiplets, br s = 
broad singlet, br d = broad doublet, app = apparent.  Data for 13C are reported in terms of 
chemical shifts (δ ppm).  IR spectra were obtained by use of a Perkin Elmer Spectrum 
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BXII spectrometer using thin films deposited on NaCl plates and reported in frequency of 
absorption (cm-1).  Optical rotations were measured with a Jasco P-2000 polarimeter 
operating on the sodium D-line (589 nm), using a 100 mm path-length cell and are 
reported as: [α]D25 (concentration in g/100 mL, solvent, ee).  Analytical chiral HPLC was 
performed with an Agilent 1100 Series HPLC utilizing a Chiralpak (AD, AD- H, or AS) 
or Chiralcel (OD-H, OJ-H, or OB-H) columns (4.6 mm x 25 cm) obtained from Daicel 
Chemical Industries, Ltd.  Analytical chiral SFC was performed with a Mettler SFC 
supercritical CO2 analytical chromatography system with Chiralpak AD-H column, OD-
H column, and OJ-H column obtained from Daicel Chemical Industries, Ltd.  High 
resolution mass spectra (HRMS) were obtained from the Caltech Mass Spectral Facility 
(GC-EI+, EI+, or FAB+) or Agilent 6200 Series TOF with an Agilent G1978A 
Multimode source in electrospray ionization (ESI+), atmospheric pressure chemical 
ionization (APCI+), or mixed ionization mode (MM: ESI-APCI+).   
2.4.2  Substrate Synthesis 
 
 
 
Allyl 1-methyl-3-morpholino-2-oxocyclohex-3-ene-1-carboxylate (65a) 
General procedure A:  Diisopropylamine (1.77 mL, 12.7 mmol, 1.29 equiv) was taken 
up in 50 mL THF, cooled to 0 °C and 5.51 mL of a 2.19 M solution of n-butyllithium in 
hexanes (12.1 mmol, 1.22 equiv) was added dropwise.  The mixture was stirred for 30 
minutes and cooled to 78 °C.  2-morpholinocyclohex-2-en-1-one12 (1.79 g, 9.88 mmol, 
O
N
O
1.  LDA, THF, –78 °C;
     allyl chloroformate
2.  MeI, K2CO3
     acetone, 50 °C
O
N
O
65a
O
O
CHAPTER 2 – Highly Enantioselective Palladium-Catalyzed Allylic Alkylation of Enaminones 
 
224 
1.00 equiv) in 8 mL THF (0.17 M total) was added dropwise.  The mixture was stirred for 
90 minutes, quenched with 50 mL each of saturated aqueous NH4Cl and water, diluted 
with 100 mL EtOAc and the phases were separated.  The aqueous portion was again 
extracted with 100 mL EtOAc, and the combined organic fractions were dried over 
Na2SO4 and concentrated in vacuo yielding 2.00 g of a pale yellow oil confirmed to be 
the desired acylated compound by crude 1H NMR analysis.  A 531 mg portion (2.00 
mmol, 1.00 equiv) of this intermediate was taken up in 10 mL acetone (0.2 M) and 
K2CO3 (553 mg, 4.00 mmol, 2.0 equiv) and MeI (149 µL, 2.40 mmol, 1.20 equiv) were 
added.  The reaction mixture was heated to 50 °C for 10 hours, cooled to room 
temperature, filtered using a fritted funnel and rinsed with 10 mL Et2O.  The reaction 
mixture was concentrated in vacuo and purified by column chromatography (SiO2, 2.5 x 
12 cm, 4→6→8% acetone in hexanes) to yield enaminone 65a (347 mg, 1.24 mmol, 62% 
yield over 2 steps) as a pale yellow oil; Rf = 0.45 (50% EtOAc in hexanes); 1H NMR 
(500 MHz, CDCl3) δ 5.84 (ddt, J = 17.2, 10.4, 5.8 Hz, 2H), 5.29 (dq, J = 17.2, 1.5 Hz, 
1H), 5.23 (dq, J = 10.4, 1.2 Hz, 1H), 4.65 – 4.53 (m, 2H), 3.80 (qdd, J = 11.3, 6.3, 3.0 
Hz, 4H), 3.04 – 2.96 (m, 2H), 2.63 – 2.56 (m, 2H), 2.56 – 2.49 (m, 1H), 2.46 (dddd, J = 
13.6, 5.1, 3.1, 1.1 Hz, 1H), 2.38 (dtd, J = 19.1, 5.4, 3.1 Hz, 1H), 1.86 (ddd, J = 13.6, 9.7, 
5.6 Hz, 1H), 1.39 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 193.9, 172.4, 131.6, 118.9, 
66.9, 66.0, 54.2, 50.0, 33.3, 22.7, 20.6; IR (Neat Film, NaCl): 3447 (broad), 2955, 2855, 
2067, 1733, 1695, 1617, 1450, 1378, 1264, 1248, 1222, 1175, 1145, 1119, 1020, 992, 948 
cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C15H22NO4 [M+H]+ 280.1543, found 
280.1554. 
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Allyl 1-ethyl-3-morpholino-2-oxocyclohex-3-ene-1-carboxylate (65b) 
Synthesized according to general procedure A using ethyl iodide.  The product was 
purified by column chromatography (SiO2, 3.5 x 15 cm, 4→6→8→10→20% EtOAc in 
hexanes) to yield enaminone 65b (468 mg, 1.60 mmol, 74% yield over 2 steps) as a pale 
yellow oil.  Rf = 0.53 (50% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 5.83 (ddt, 
J = 17.2, 10.4, 5.8 Hz, 1H), 5.73 (ddd, J = 4.5, 3.5, 1.2 Hz, 1H), 5.27 (dq, J = 17.2, 1.5 
Hz, 1H), 5.21 (dq, J = 10.4, 1.2 Hz, 1H), 4.57 (dq, J = 5.8, 1.5 Hz, 2H), 3.78 (qdd, J = 
11.3, 6.3, 3.0 Hz, 4H), 2.95 (ddd, J = 11.9, 6.3, 3.1 Hz, 2H), 2.55 (tddd, J = 8.9, 6.8, 5.2, 
2.4 Hz, 3H), 2.46 – 2.32 (m, 2H), 1.95 (dq, J = 13.9, 7.5 Hz, 1H), 1.90 – 1.73 (m, 2H), 
0.92 (t, J = 7.5 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 193.6, 171.3, 146.8, 131.7, 
128.2, 123.5, 119.0, 67.0, 65.8, 57.9, 50.0, 29.8, 27.0, 22.6, 9.1; IR (Neat Film, NaCl): 
2961, 2855, 1732, 1694, 1617, 1448, 1378, 1300, 1264, 1220, 1167, 1120, 957, 934 cm-1; 
HRMS (MM: ESI-APCI) m/z calc’d for C16H24NO4 [M+H]+ 294.1700, found 294.1690. 
 
 
Allyl 1-(((tert-butyldimethylsilyl)oxy)methyl)-3-morpholino-2-oxocyclohex-3-ene-1-
carboxylate (65c) 
Diisopropylamine (1.77 mL, 12.7 mmol, 1.29 equiv) was taken up in 50 mL THF, cooled 
to 0 °C and 5.51 mL of a 2.19 M solution of n-butyllithium in hexanes (12.1 mmol, 1.22 
O
N
O
Et
O
O
O
N
O
O
O
OTBS
CHAPTER 2 – Highly Enantioselective Palladium-Catalyzed Allylic Alkylation of Enaminones 
 
226 
equiv) was added dropwise.  The mixture was stirred for 30 minutes and cooled to 78 °C.  
2-morpholinocyclohex-2-en-1-one (1.79 g, 9.88 mmol, 1.00 equiv) in 8 mL THF (0.17 M 
total) was added dropwise.  The mixture was stirred for 90 minutes, quenched with 50 
mL each of saturated aqueous NH4Cl and water, diluted with 100 mL EtOAc and the 
phases were separated.  The aqueous portion was again extracted with 100 mL EtOAc, 
and the combined organic fractions were dried over Na2SO4 and concentrated in vacuo 
yielding 2.00 g of a pale yellow oil confirmed to be the desired acylated compound by 
crude 1H NMR analysis.  A 218 mg portion (0.822 mmol, 1.00 equiv) of this intermediate 
was taken up in 1.6 mL THF (0.5 M), cooled to 0 °C and and K2CO3 (247 mg, 2.47 
mmol, 3.00 equiv) and 37% aqueous formaldehyde (156 µL, 5.67 mmol, 6.9 equiv) were 
added.  The reaction was warmed to 23 °C and stirred for 4 hours, extracted with 2 x 5 
mL EtOAc, dried over Na2SO4, concentrated in vacuo and purified by column 
chromatography (SiO2, 3 x 12 cm, 20→35% acetone in hexanes) to yield 133 mg of a 
pale yellow oil.  This intermediate alcohol was taken up in CH2Cl2 (4.5 mL, 0.1 M) and 
TBSCl (75 mg, 0.49 mmol, 1.1 equiv) and imidazole (61 mg, 0.90 mmol, 2.0 equiv) were 
added.  The reaction mixture was stirred for 8 hours, concentrated in vacuo and purified 
by column chromatography (SiO2, 2.5 x 14 cm, 20→35% EtOAc in hexanes) to yield 
enaminone 65c (106 mg, 0.257 mmol, 29% yield over 3 steps) as a pale yellow oil; Rf = 
0.25 (25% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 5.90 – 5.82 (m, 2H), 5.27 
(dq, J = 17.2, 1.5 Hz, 1H), 5.20 (dq, J = 10.4, 1.3 Hz, 1H), 4.57 (qdt, J = 13.2, 5.7, 1.4 
Hz, 2H), 4.08 (d, J = 9.8 Hz, 1H), 3.88 (d, J = 9.8 Hz, 1H), 3.78 (qdd, J = 11.3, 6.1, 3.1 
Hz, 4H), 2.92 – 2.84 (m, 2H), 2.70 – 2.61 (m, 2H), 2.60 (dd, J = 6.2, 3.3 Hz, 1H), 2.52 
(dddd, J = 13.8, 5.4, 3.0, 1.1 Hz, 1H), 2.40 (dtd, J = 19.2, 5.6, 2.9 Hz, 1H), 2.02 (ddd, J = 
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13.8, 10.0, 5.8 Hz, 1H), 0.85 (s, 9H), 0.09 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 192.0, 
169.6, 146.7, 131.7, 125.0, 118.8, 66.9, 66.6, 66.0, 65.4, 59.9, 50.0, 29.8, 28.0, 25.9, 25.8, 
22.5, 18.3, -5.5; IR (Neat Film, NaCl): 2955, 2929, 2894, 2856, 1734, 1690, 1616, 1462, 
1448, 1379, 1262, 1217, 1120, 964 cm-1; HRMS (APCI) m/z calc’d for C21H36NO5Si 
[M+H]+ 410.2357, found 410.2342. 
 
 
 
Allyl 1-(2-((tert-butyldimethylsilyl)oxy)ethyl)-3-morpholino-2-oxocyclohex-3-ene-1-
carboxylate (65d) 
Synthesized according to general procedure A using (2-bromoethoxy)(tert-
butyl)dimethylsilane and cesium carbonate.  The product was purified by column 
chromatography (SiO2, 3.5 x 15 cm, 5→10→20% EtOAc in hexanes) to yield enaminone 
65d (184 mg, 0.434 mmol, 49% yield over 2 steps) as a pale tan oil; Rf = 0.23 (20% 
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 5.83 (ddt, J = 17.2, 10.4, 5.9 Hz, 1H), 
5.75 (s, 1H), 5.27 (dq, J = 17.1, 1.5 Hz, 1H), 5.21 (dq, J = 10.4, 1.3 Hz, 1H), 4.63 – 4.50 
(m, 2H), 3.85 – 3.62 (m, 6H), 2.99 – 2.90 (m, 2H), 2.61 – 2.45 (m, 4H), 2.38 (dtd, J = 
19.0, 5.5, 2.9 Hz, 1H), 2.14 (ddd, J = 13.9, 7.6, 6.1 Hz, 1H), 2.00 – 1.86 (m, 2H), 0.86 (s, 
9H), 0.14 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 193.3, 171.0, 131.7, 119.1, 66.9, 66.0, 
59.7, 56.5, 50.0, 36.8, 30.8, 26.0, 22.7, 18.4, -5.2; IR (Neat Film, NaCl): 2955, 2928, 
2855, 1733, 1695, 1616, 1447, 1378, 1263, 1209, 1120, 1100, 981, 935 cm-1; HRMS 
(ESI) m/z calc’d for C22H38NO5Si [M+H]+ 424.2514, found 424.2521. 
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Allyl 1-(3-methoxy-3-oxopropyl)-3-morpholino-2-oxocyclohex-3-ene-1-carboxylate 
(65e) 
Synthesized according to general procedure A using methyl acrylate.  The product was 
purified by column chromatography (SiO2, 3 x 12 cm, 10→20% acetone in hexanes) to 
yield enaminone 65e (223 mg, 0.635 mmol, 58% yield over 2 steps) as a yellow oil; Rf = 
0.42 (50% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 5.80 (ddt, J = 17.3, 10.4, 
5.9 Hz, 1H), 5.73 – 5.67 (m, 1H), 5.25 (dq, J = 17.2, 1.5 Hz, 1H), 5.19 (dq, J = 10.3, 1.2 
Hz, 1H), 4.60 – 4.48 (m, 2H), 3.80 – 3.67 (m, 4H), 3.62 (s, 3H), 2.92 (ddd, J = 11.6, 6.3, 
3.0 Hz, 2H), 2.56 – 2.26 (m, 7H), 2.18 (ddd, J = 14.0, 10.6, 5.6 Hz, 1H), 2.04 (ddd, J = 
14.1, 10.8, 5.4 Hz, 1H), 1.84 (ddd, J = 14.5, 9.9, 6.1 Hz, 1H); 13C NMR (125 MHz, 
CDCl3) δ 193.0, 173.4, 170.9, 146.6, 131.4, 123.3, 119.2, 66.8, 66.1, 56.7, 51.7, 49.8, 
30.7, 29.5, 28.9, 22.5; IR (Neat Film, NaCl): 2953, 2854, 2820, 1733, 1694, 1616, 1447, 
1377, 1264, 1209, 1177, 1120, 983, 957 cm-1; HRMS (MM: ESI-APCI) m/z calc’d for 
C18H26NO6 [M+H]+ 352.1755, found 352.1771. 
 
 
Allyl 3-morpholino-2-oxo-1-(3-oxobutyl)cyclohex-3-ene-1-carboxylate (65f) 
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Synthesized according to general procedure A using methyl vinyl ketone.  The product 
was purified by column chromatography (SiO2, 3 x 12 cm, 20→35→50→65% EtOAc in 
hexanes) to yield enaminone 65f (537 mg, 1.60 mmol, 74% yield over 2 steps) as a pale 
yellow oil that solidified on storage at –20 °C; Rf = 0.28 (50% EtOAc in hexanes); 1H 
NMR (500 MHz, CDCl3) δ 5.81 (ddt, J = 17.2, 10.4, 5.9 Hz, 1H), 5.75 – 5.69 (m, 1H), 
5.26 (dq, J = 17.2, 1.5 Hz, 1H), 5.20 (dq, J = 10.4, 1.2 Hz, 1H), 4.61 – 4.48 (m, 2H), 3.81 
– 3.68 (m, 4H), 2.93 (ddd, J = 11.8, 6.3, 3.1 Hz, 2H), 2.66 – 2.31 (m, 7H), 2.15 – 2.04 
(m, 4H), 1.98 (ddd, J = 14.2, 10.3, 5.3 Hz, 1H), 1.84 (ddd, J = 13.1, 10.0, 5.4 Hz, 1H); 
13C NMR (125 MHz, CDCl3) δ 207.7, 193.4, 171.2, 146.7, 131.4, 123.5, 119.3, 66.9, 
66.0, 56.7, 49.9, 38.9, 31.1, 30.0, 30.0, 27.7, 22.6; IR (Neat Film, NaCl): 2956, 2854, 
1721, 1615, 1447, 1372, 1299, 1264, 1209, 1179, 1120, 1095, 982, 939 cm-1; HRMS 
(MM: ESI-APCI) m/z calc’d for C18H26NO5 [M+H]+ 336.1805, found 336.1803. 
 
 
Allyl 1-(2-cyanoethyl)-3-morpholino-2-oxocyclohex-3-ene-1-carboxylate (65g) 
Synthesized according to general procedure A using acrylonitrile.  The product was 
purified by column chromatography (SiO2, 3 x 12 cm, 10→20% acetone in hexanes) to 
yield enaminone 65g (247 mg, 0.776 mmol, 71% yield over 2 steps) as a colorless oil; Rf 
= 0.29 (50% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 5.83 (ddt, J = 16.5, 10.4, 
6.0 Hz, 1H), 5.77 – 5.73 (m, 1H), 5.33 – 5.21 (m, 2H), 4.66 – 4.54 (m, 2H), 3.83 – 3.69 
(m, 4H), 2.95 (ddd, J = 11.8, 6.4, 3.0 Hz, 2H), 2.55 (dtt, J = 13.3, 9.9, 6.6 Hz, 4H), 2.41 
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(dqd, J = 14.7, 5.9, 5.4, 3.4 Hz, 3H), 2.21 (ddd, J = 14.0, 9.5, 5.9 Hz, 1H), 2.07 (ddd, J = 
14.0, 9.6, 6.3 Hz, 1H), 1.94 – 1.84 (m, 1H); 13C NMR (125 MHz, Chloroform-d) δ 192.6, 
170.1, 170.1, 146.5, 131.0, 123.7, 119.8, 119.3, 66.8, 66.4, 56.4, 56.4, 49.8, 31.0, 30.1, 
22.4, 13.2; IR (Neat Film, NaCl): 2956, 2854, 2247, 1734, 1690, 1617, 1448, 1375, 1264, 
1208, 1119, 982, 947 cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C17H23N2O4 [M+H]+ 
319.1652, found 319.1668. 
 
 
Allyl 1-benzyl-3-morpholino-2-oxocyclohex-3-ene-1-carboxylate (65h) 
Synthesized according to general procedure A using benzyl bromide.  The product was 
purified by column chromatography (SiO2, 2.5 x 15 cm, 4→6→8→10% acetone in 
hexanes) to yield enaminone 65h (498 mg, 1.40 mmol, 65% yield over 2 steps) as a 
colorless oil; Rf = 0.23 (20% acetone in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.28 – 
7.13 (m, 5H), 5.79 (ddt, J = 17.3, 10.4, 5.9 Hz, 1H), 5.71 (ddd, J = 4.5, 3.2, 1.2 Hz, 1H), 
5.31 – 5.22 (m, 2H), 4.52 (dq, J = 5.9, 1.5 Hz, 2H), 3.87 – 3.72 (m, 4H), 3.26 (d, J = 13.7 
Hz, 1H), 3.14 (d, J = 13.7 Hz, 1H), 2.96 (ddd, J = 11.9, 6.4, 3.0 Hz, 2H), 2.60 – 2.49 (m, 
3H), 2.41 – 2.33 (m, 2H), 1.82 – 1.72 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 192.6, 
170.5, 146.8, 136.4, 131.5, 130.7, 128.2, 128.2, 126.9, 123.9, 119.2, 66.9, 66.1, 58.7, 
49.9, 39.8, 30.0, 22.7; IR (Neat Film, NaCl): 2956, 2854, 1734, 1691, 1615, 1447, 1377, 
1263, 1207, 1176, 1118, 1085, 980, 937 cm-1; HRMS (MM: ESI-APCI) m/z calc’d for 
C21H26NO4 [M+H]+ 356.1856, found 356.1857. 
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Allyl 1-(4-methoxybenzyl)-3-morpholino-2-oxocyclohex-3-ene-1-carboxylate (65i) 
Synthesized according to general procedure A using p-methoxybenzyl chloride.  The 
product was purified by column chromatography (SiO2, 3 x 15 cm, 5→10% acetone in 
hexanes) to yield enaminone 65i (86 mg, 0.22 mmol, 21% yield over 2 steps) as a pale 
yellow oil; Rf = 0.72 (20% Et2O in CH2Cl2); 1H NMR (500 MHz, CDCl3) δ 7.12 – 7.03 
(m, 2H), 6.82 – 6.74 (m, 2H), 5.80 (ddt, J = 17.2, 10.4, 5.9 Hz, 1H), 5.72 (t, J = 4.2 Hz, 
1H), 5.28 (q, J = 1.5 Hz, 1H), 5.26 – 5.18 (m, 1H), 4.53 (dq, J = 5.9, 1.5 Hz, 2H), 3.87 – 
3.70 (m, 6H), 3.21 – 3.08 (m, 2H), 2.96 (ddt, J = 11.6, 6.3, 2.5 Hz, 2H), 2.60 – 2.48 (m, 
3H), 2.39 – 2.33 (m, 1H), 2.31 (td, J = 5.7, 2.2 Hz, 1H), 1.76 (ddd, J = 14.2, 10.4, 6.2 Hz, 
1H); 13C NMR (125 MHz, Chloroform-d) δ 192.7, 170.6, 158.6, 146.8, 131.7, 131.6, 
128.3, 123.9, 119.2, 113.6, 66.9, 66.1, 58.8, 55.3, 50.0, 38.9, 30.0, 22.7; IR (Neat Film, 
NaCl): 2954, 2853, 1734, 1691, 1612, 1512, 1445, 1262, 1248, 1208, 1178, 1119, 1034, 
981, 938 cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C22H28NO5 [M+H]+ 386.1962, 
found 386.1948. 
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Allyl 3-morpholino-2-oxo-1-(4-(trifluoromethyl)benzyl)cyclohex-3-ene-1-carboxylate 
(65j) 
Synthesized according to general procedure A using p-trifluoromethylbenzyl bromide.  
The product was purified by column chromatography (SiO2, 3 x 25 cm, 2:1:1→2:2:1 
hexanes:DCM:acetone) to yield enaminone 65j (276 mg, 0.652 mmol, 60% yield over 2 
steps) as a pale yellow oil; Rf = 0.78 (20% Et2O in CH2Cl2); 1H NMR (500 MHz, CDCl3) 
δ 7.54 – 7.47 (m, 2H), 7.35 – 7.26 (m, 2H), 5.81 – 5.69 (m, 2H), 5.28 – 5.18 (m, 2H), 
4.51 (dq, J = 5.9, 1.5 Hz, 2H), 3.80 (dddd, J = 30.5, 11.4, 6.4, 2.9 Hz, 4H), 3.32 – 3.16 
(m, 2H), 2.97 (ddd, J = 11.8, 6.4, 3.0 Hz, 2H), 2.61 – 2.48 (m, 3H), 2.40 – 2.29 (m, 2H), 
1.78 (ddd, J = 14.2, 10.4, 6.1 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 192.3, 170.3, 
146.8, 140.7, 131.3, 131.2, 129.2 (q, J = 32.4 Hz), 125.3, 125.1 (q, J = 3.8 Hz), 123.8, 
123.3, 119.5, 66.9, 66.3, 58.7, 49.9, 39.6, 30.4, 22.7; IR (Neat Film, NaCl): 2957, 2855, 
1732, 1694, 1618, 1447, 1418, 1323, 1263, 1209, 1162, 1116, 1066, 1019, 981, 938 cm-1; 
HRMS (MM: ESI-APCI) m/z calc’d for C22H25NO4F [M+H]+ 424.1730, found 424.1737. 
 
 
2-Chloroallyl 1-methyl-3-morpholino-2-oxocyclohex-3-ene-1-carboxylate (65k) 
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Synthesized according to general procedure A using 2-chloroallyl cyanoformate (83a, see 
section 2.4.6).  Product purified by flash chromatography (20→22% EtOAc/hexanes) to 
yield enaminone 65k as a slightly yellow oil (470 mg, 1.50 mmol, 37% yield over 2 
steps);  1H NMR (500 MHz, CDCl3) δ 5.84 – 5.79 (m, 1H), 5.46 – 5.43 (m, 1H), 5.41 – 
5.39 (m, 1H), 4.75 – 4.68 (m, 1H), 4.67 – 4.59 (m, 1H), 3.87 – 3.73 (m, 4H), 3.04 – 2.95 
(m, 2H), 2.65 – 2.58 (m, 2H), 2.58 – 2.35 (m, 3H), 1.94 – 1.84 (m, 1H), 1.43 (s, 3H); 13C 
NMR (125 MHz, CDCl3) δ 193.5, 171.9, 146.3, 135.4, 124.3, 115.8, 66.9, 66.7, 54.2, 
49.9, 33.3, 22.6, 20.6; IR (Neat Film, NaCl) 2954, 2855, 1741, 1693, 1450, 1377 cm-1; 
HRMS (ESI) m/z calc’d for C15H21NClO4 [M+H]+: 314.1154, found 314.1156. 
 
 
2-Methylallyl 1-methyl-3-morpholino-2-oxocyclohex-3-ene-1-carboxylate (65l) 
Synthesized according to general procedure A using 2-methylallyl cyanoformate (83b, 
see section 2.4.6).  Product purified by flash chromatography (20→24% EtOAc/hexanes) 
to yield enaminone 65l  as a slightly yellow oil (808 mg, 2.76 mmol, 56% yield over 2 
steps).  1H NMR (500 MHz, CDCl3) δ 5.79 (ddd, J = 5.0, 3.5, 1.0 Hz, 1H), 4.94 – 4.92 
(m, 1H), 4.92 – 4.90 (m, 1H), 4.55 – 4.47 (m, 2H), 3.86 – 3.74 (m, 4H), 3.04 – 2.96 (m, 
2H), 2.62 – 2.50 (m, 3H), 2.50 – 2.44 (m, 1H), 2.43 – 2.35 (m, 1H), 1.87 (ddd, J = 13.5, 
9.7, 5.6 Hz, 1H), 1.71 (s, 3H), 1.41 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 193.7, 172.3, 
146.3, 139.4, 123.9, 113.5, 68.4, 66.8, 54.1, 49.8, 33.3, 22.6, 20.6, 19.5; IR (Neat Film, 
NaCl) 2936, 2854, 1737, 1694, 1615, 1450, 1175, 1119, cm-1; HRMS (ESI) m/z calc’d for 
C16H24NO4 [M+H]+: 294.1700, found 294.1705. 
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Allyl 1-methyl-2-oxo-3-(piperidin-1-yl)cyclohex-3-ene-1-carboxylate (74) 
Synthesized according to general procedure A using 2-(piperidin-1-yl)cyclohex-2-en-1-
one.  The product was purified by column chromatography (SiO2, 3 x 15 cm, 
8→12→16% Et2O in hexanes) to yield enaminone 74 (427 mg, 1.54 mmol, 59% yield 
over 2 steps) as a pale tan oil; Rf = 0.32 (40% Et2O in hexanes); 1H NMR (500 MHz, 
CDCl3) δ 5.83 – 5.74 (m, 1H), 5.74 – 5.66 (m, 1H), 5.21 (dt, J = 17.2, 1.5 Hz, 1H), 5.19 – 
5.10 (m, 1H), 4.59 – 4.45 (m, 2H), 2.81 (ddd, J = 11.2, 7.2, 3.6 Hz, 2H), 2.45 (tdd, J = 
9.3, 7.5, 4.3 Hz, 3H), 2.37 (dddd, J = 13.5, 5.0, 3.2, 1.1 Hz, 1H), 2.29 (dtd, J = 19.0, 5.4, 
3.2 Hz, 1H), 1.77 (ddd, J = 13.4, 9.6, 5.6 Hz, 1H), 1.67 – 1.50 (m, 4H), 1.44 (p, J = 6.0 
Hz, 2H), 1.31 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 194.0, 172.3, 147.5, 131.6, 123.3, 
118.5, 65.7, 54.0, 50.8, 33.2, 25.9, 24.3, 22.6, 20.5; IR (Neat Film, NaCl): 2934, 2851, 
2802, 1735, 1696, 1613, 1452, 1387, 1248, 1222, 1175, 1110, 987, 943 cm-1; HRMS 
(MM: ESI-APCI) m/z calc’d for C16H24NO3 [M+H]+ 278.1751, found 278.1747. 
 
 
Allyl 1,4-dimethyl-3-morpholino-2-oxocyclohex-3-ene-1-carboxylate (76) 
Synthesized according to general procedure A using 3-methyl-2-morpholinocyclohex-2-
en-1-one.  The product was purified by column chromatography (SiO2, 3 x 13 cm, 
5→10→20% EtOAc in hexanes) to yield enaminone 76 (772 mg, 2.63 mmol, 74% yield 
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over 2 steps) as a pale yellow oil; Rf = 0.34 (20% EtOAc in hexanes); 1H NMR (500 
MHz, CDCl3) δ 5.81 (ddt, J = 17.2, 10.5, 5.6 Hz, 1H), 5.24 (dq, J = 17.2, 1.6 Hz, 1H), 
5.18 (dq, J = 10.5, 1.3 Hz, 1H), 4.55 (qdt, J = 13.3, 5.6, 1.5 Hz, 2H), 3.72 – 3.61 (m, 4H), 
2.94 (dt, J = 9.8, 4.4 Hz, 2H), 2.85 (dt, J = 11.4, 4.3 Hz, 2H), 2.49 (dddd, J = 19.2, 9.8, 
5.3, 1.1 Hz, 1H), 2.38 (ddd, J = 13.6, 5.3, 3.6 Hz, 1H), 2.33 – 2.23 (m, 1H), 1.95 (d, J = 
0.9 Hz, 3H), 1.79 (ddd, J = 13.6, 9.7, 5.5 Hz, 1H), 1.33 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δ 194.8, 172.5, 153.2, 142.1, 131.8, 118.4, 67.9, 65.7, 53.9, 50.3, 32.3, 29.2, 20.5, 
19.6; IR (Neat Film, NaCl): 2935, 2848, 1734, 1680, 1452, 1375, 1259, 1190, 1168, 
1114, 1070, 989 cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C16H24NO4 [M+H]+ 
294.1700, found 294.1701.   
 
  
Allyl 1-methyl-3-morpholino-2-oxocyclopent-3-ene-1-carboxylate (78) 
Synthesized according to general procedure A using 2-morpholinocyclopent-2-en-1-one.  
The product was purified by column chromatography (SiO2, 3.5 x 12 cm, 
2→4→6→8→10% EtOAc in DCM) to yield enaminone 78 (151 mg, 0.570 mmol, 21% 
yield over 2 steps) as a pale orange oil; Rf = 0.33 (10% EtOAc in CH2Cl2); 1H NMR (500 
MHz, CDCl3) δ 6.39 (t, J = 3.2 Hz, 1H), 5.92 – 5.78 (m, 1H), 5.32 – 5.22 (m, 1H), 5.20 
(dq, J = 10.5, 1.3 Hz, 1H), 4.64 – 4.54 (m, 2H), 3.84 – 3.68 (m, 4H), 3.24 – 3.11 (m, 2H), 
3.07 – 2.96 (m, 3H), 2.38 (dd, J = 18.2, 3.2 Hz, 1H), 1.42 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δ 201.8, 171.6, 148.6, 131.9, 131.8, 118.3, 66.6, 65.9, 54.1, 48.5, 37.8, 21.1; IR 
(Neat Film, NaCl): 2962, 2933, 2855, 1740, 1707, 1612, 1452, 1379, 1263, 1178, 1120, 
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1068, 1022, 994 cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C14H20NO4 [M+H]+ 
266.1387, found 266.1391. 
 
 
Allyl 3-methyl-2-oxo-[1,1'-bi(cyclohexan)]-6-ene-3-carboxylate (80) 
Synthesized according to general procedure A using [1,1'-bi(cyclohexan)]-6-en-2-one.13  
The product was purified by column chromatography (SiO2, 1.5 x 12 cm, 10% Et2O in 
DCM) to yield enone 80 (51 mg, 0.185 mmol, 30% yield over 2 steps) as a pale yellow 
oil; Rf = 0.33 (10% Et2O in hexanes); 1H NMR (500 MHz, CDCl3) δ 6.54 – 6.48 (m, 1H), 
5.85 (ddt, J = 17.2, 10.5, 5.6 Hz, 1H), 5.27 (dq, J = 17.2, 1.6 Hz, 1H), 5.20 (dq, J = 10.5, 
1.3 Hz, 1H), 4.64 – 4.52 (m, 2H), 2.59 – 2.50 (m, 1H), 2.50 – 2.40 (m, 2H), 2.38 – 2.26 
(m, 1H), 1.92 – 1.81 (m, 1H), 1.80 – 1.60 (m, 5H), 1.55 (s, 1H), 1.40 – 1.22 (m, 5H), 1.21 
– 1.04 (m, 2H), 1.04 – 0.92 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 196.8, 172.8, 144.2, 
140.9, 131.9, 118.5, 65.8, 53.6, 36.8, 33.4, 32.8, 32.3, 26.9, 26.8, 26.5, 23.6, 20.6; IR 
(Neat Film, NaCl): 2925, 2851, 1734, 1684, 1379, 1351, 1299, 1247, 1167, 1110, 981, 
935 cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C17H25O3 [M+H]+ 277.1798, found 
277.1791. 
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2.4.3  Asymmetric Decarboxylative Allylic Alkylation of Enaminone 
Substrates 
 
(S)-6-allyl-6-methyl-2-morpholinocyclohex-2-en-1-one (66a) 
General procedure B:  In a glove box under an atmostphere of N2, Pd2dmdba3 (29.7 mg, 
23.3 µmol, 5 mol %) and (S)-t-Bu PHOX (3, 22.5 mg, 58.2 µmol, 12.5 mol %) were 
taken up in 12 mL EtOAc.  The catalystic was allowed to preform at 40 °C for 30 
minutes, as indicated by the reaction mixture turning orange.  At this point, enaminone 
substrate 65a (130 mg, 0.465 mmol, 1.00 equiv) in 2 mL EtOAc (total concentration = 
0.033 M) was added, causing the reaction mixture to turn green.  The reaction mixture 
was sealed, removed from the glove box and stirred at 40 °C for 9 hours, until the 
reaction was complete as indicated by the mixture returning to an orange color (and 
confirmed by TLC analysis).  The reaction mixture was filtered through a short plug of 
silica and rinsed with 25 mL EtOAC, concentrated in vacuo, and purified by column 
chromatography (SiO2, 3 x 12 cm, 5→10% acetone in hexanes) to yield enaminone 66a 
(104 mg, 0.442 mmol, 95% yield) as a colorless oil; Rf = 0.22 (20% acetone in hexanes); 
1H NMR (500 MHz, CDCl3) δ 7.26 (s, 1H), 5.88 (t, J = 4.5 Hz, 1H), 5.80 – 5.67 (m, 1H), 
5.09 – 5.00 (m, 2H), 3.80 (ddd, J = 5.8, 3.5, 2.2 Hz, 4H), 2.82 (dt, J = 9.8, 4.5 Hz, 2H), 
2.74 – 2.66 (m, 2H), 2.51 – 2.37 (m, 2H), 2.37 – 2.30 (m, 1H), 2.22 (ddq, J = 13.7, 7.6, 
1.0 Hz, 1H), 1.88 (dt, J = 13.7, 6.0 Hz, 1H), 1.73 (ddd, J = 13.9, 6.9, 5.7 Hz, 1H), 1.09 (d, 
O
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J = 0.7 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 200.5, 145.7, 134.2, 125.1, 118.2, 67.0, 
50.6, 45.6, 41.4, 33.3, 22.0, 22.0; IR (Neat Film, NaCl): 2960, 2918, 2853, 2813, 1679, 
1615, 1447, 1376, 1262, 1208, 1120, 1099, 1001, 990, 915 cm-1; HRMS (MM: ESI-
APCI) m/z calc’d for C14H22NO2 [M+H]+ 236.1645, found 236.1641; [α]25 –315.66 (c 
13.57, CHCl3, 99% ee). 
 
 
(S)-6-allyl-6-ethyl-2-morpholinocyclohex-2-en-1-one (66b) 
Synthesized according to general procedure B using substrate 65b. The product was 
purified by column chromatography (SiO2, 3 x 12 cm, 5→10% acetone in hexanes) to 
yield enaminone 66b (116 mg, 0.465 mmol, quantitative yield) as a colorless oil; Rf = 
0.25 (40% Et2O in hexanes); 1H NMR (500 MHz, CDCl3) δ 5.83 (t, J = 4.4 Hz, 1H), 5.76 
– 5.64 (m, 1H), 5.06 – 4.97 (m, 2H), 3.78 (ddd, J = 5.2, 3.8, 1.0 Hz, 4H), 2.81 – 2.75 (m, 
2H), 2.75 – 2.66 (m, 2H), 2.40 (tdd, J = 5.9, 4.5, 1.4 Hz, 2H), 2.34 (ddt, J = 14.0, 6.9, 1.3 
Hz, 1H), 2.23 (ddt, J = 14.0, 7.9, 1.1 Hz, 1H), 1.81 (t, J = 6.2 Hz, 2H), 1.59 (qd, J = 7.5, 
1.3 Hz, 2H), 0.80 (t, J = 7.5 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 200.2, 145.9, 134.4, 
124.7, 117.9, 67.0, 50.6, 48.6, 38.8, 30.4, 27.0, 21.8, 8.4; IR (Neat Film, NaCl): 2962, 
2933, 2854, 2814, 1678, 1616, 1447, 1377, 1263, 1208, 1120, 1070, 1099, 998 cm-1; 
HRMS (MM: ESI-APCI) m/z calc’d for C15H24NO2 [M+H]+ 250.1802, found 250.1813; 
[α]25 5.52 (c 7.45, CHCl3, 98% ee). 
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(S)-6-allyl-6-(((tert-butyldimethylsilyl)oxy)methyl)-2-morpholinocyclohex-2-en-1-one 
(66c) 
 
Synthesized according to general procedure B using substrate 65c.  The product was 
purified by column chromatography (SiO2, 3 x 12 cm, 20% acetone in hexanes) to yield 
enaminone 66c (164 mg, 0.445 mmol, 96% yield) as a pale tan oil; Rf = 0.33 (20% 
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 5.87 (t, J = 4.5 Hz, 1H), 5.76 – 5.64 
(m, 1H), 5.06 – 4.98 (m, 2H), 3.79 (t, J = 4.6 Hz, 4H), 3.68 (d, J = 9.7 Hz, 1H), 3.62 (d, J 
= 9.7 Hz, 1H), 2.74 (t, J = 4.6 Hz, 4H), 2.47 – 2.35 (m, 3H), 2.26 (ddt, J = 13.7, 7.8, 1.1 
Hz, 1H), 1.96 (ddd, J = 13.3, 7.1, 6.0 Hz, 1H), 1.89 (dt, J = 13.7, 5.9 Hz, 1H), 0.85 (s, 
9H), 0.06 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 198.8, 146.4, 134.1, 125.1, 118.0, 67.0, 
66.1, 51.0, 50.5, 37.2, 28.5, 26.0, 21.7, 18.3, -5.4, -5.5; IR (Neat Film, NaCl): 2953, 
2855, 1677, 1639, 1615, 1472, 1463, 1447, 1378, 1299, 1262, 1208, 1121, 973, 917 cm-1; 
HRMS (MM: ESI-APCI) m/z calc’d for C20H36NO3Si [M+H]+ 366.2459, found 
366.2466; [α]25 –111.67 (c 10.25, CHCl3, 99% ee). 
 
 
(S)-6-allyl-6-(2-((tert-butyldimethylsilyl)oxy)ethyl)-2-morpholinocyclohex-2-en-1-one 
(66d) 
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Synthesized according to general procedure B using substrate 65d.  The product was 
purified by column chromatography (SiO2, 3 x 12 cm, 20% acetone in hexanes) to yield 
enaminone 66d (165 mg, 0.432 mmol, 93% yield) as a colorless oil; Rf = 0.31 (20% 
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 5.87 (d, J = 4.5 Hz, 1H), 5.74 (dddd, 
J = 16.5, 10.5, 7.8, 6.9 Hz, 1H), 5.09 – 5.00 (m, 2H), 3.80 (t, J = 4.7 Hz, 4H), 3.70 (ddd, 
J = 10.2, 8.4, 6.1 Hz, 1H), 3.57 (ddd, J = 10.3, 8.6, 5.9 Hz, 1H), 2.76 (q, J = 3.5 Hz, 4H), 
2.52 – 2.41 (m, 2H), 2.38 (ddt, J = 14.0, 6.8, 1.3 Hz, 1H), 2.27 (ddt, J = 14.0, 7.8, 1.1 Hz, 
1H), 1.94 – 1.81 (m, 3H), 1.75 (ddd, J = 14.0, 8.4, 5.9 Hz, 1H), 0.87 (s, 9H), 0.03 (s, 3H), 
0.02 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 199.6, 145.8, 134.2, 125.0, 118.3, 67.0, 
59.5, 50.6, 47.8, 39.5, 37.0, 31.3, 26.1, 21.9, 18.4, -5.1, -5.2; IR (Neat Film, NaCl): 2953, 
2928, 2855, 2817, 1679, 1616, 1448, 1262, 1207, 1121, 1098, 1030, 977, 914 cm-1; 
HRMS (APCI) m/z calc’d for C21H38NO3Si [M+H]+ 380.2615, found 380.2618; [α]25 –
9.38 (c 3.48, CHCl3, 99% ee). 
 
 
Methyl (R)-3-(1-allyl-3-morpholino-2-oxocyclohex-3-en-1-yl)propanoate (66e) 
Synthesized according to general procedure B using substrate 65e.  The product was 
purified by column chromatography (SiO2, 3 x 15 cm, 5→10→15→20→30→50% 
EtOAc in hexanes) to yield enaminone 66e (140 mg, 0.456 mmol, 98% yield) as a 
colorless oil; Rf = 0.31 (20% EtOAc in hexanes); Rf = 0.40 (50% EtOAc in hexanes); 1H 
NMR (500 MHz, CDCl3) δ 5.88 (s, 1H), 5.70 (dddd, J = 16.6, 10.4, 7.7, 7.0 Hz, 1H), 5.11 
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– 5.02 (m, 2H), 3.83 – 3.77 (m, 3H), 3.65 (s, 3H), 2.81 – 2.73 (m, 3H), 2.45 (td, J = 6.1, 
4.4 Hz, 2H), 2.39 – 2.29 (m, 2H), 2.29 – 2.23 (m, 1H), 2.23 – 2.15 (m, 1H), 1.95 (ddd, J 
= 14.1, 11.2, 5.4 Hz, 1H), 1.90 – 1.77 (m, 3H); 13C NMR (125 MHz, CDCl3) δ 199.2, 
174.1, 145.8, 133.5, 125.1, 118.7, 77.4, 77.2, 76.9, 66.9, 51.8, 50.5, 50.4, 47.9, 39.1, 30.7, 
29.4, 29.0, 21.7; IR (Neat Film, NaCl): 2950, 2853, 1735, 1676, 1617, 1437, 1375, 1263, 
1207, 1174, 1119 cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C17H26NO4 [M+H]+ 
308.1856, found 308.1859; [α]25 34.36 (c 16.49, CHCl3, 97% ee). 
 
 
(R)-6-allyl-2-morpholino-6-(3-oxobutyl)cyclohex-2-en-1-one (66f) 
Synthesized according to general procedure B using substrate 65f.  The product was 
purified by column chromatography (SiO2, 3 x 12 cm, 20→35→50%) to yield enaminone 
66f (122 mg, 0.419 mmol, 90% yield) as a colorless oil; Rf = 0.35 (50% EtOAc in 
hexanes); 1H NMR (500 MHz, CDCl3) δ 5.89 (t, J = 4.5 Hz, 1H), 5.69 (ddt, J = 16.7, 
10.4, 7.3 Hz, 1H), 5.10 – 5.01 (m, 2H), 3.79 (t, J = 4.7 Hz, 4H), 2.78 (dt, J = 11.7, 4.7 
Hz, 2H), 2.70 (dt, J = 11.5, 4.7 Hz, 2H), 2.54 – 2.44 (m, 2H), 2.44 – 2.39 (m, 1H), 2.38 – 
2.27 (m, 2H), 2.25 (ddt, J = 14.0, 7.6, 1.2 Hz, 1H), 2.12 (s, 3H), 1.92 – 1.73 (m, 4H); 13C 
NMR (125 MHz, CDCl3) δ 208.6, 199.6, 145.9, 133.6, 118.7, 67.0, 50.7, 47.9, 39.3, 38.4, 
31.0, 30.2, 30.2, 28.0, 21.8; IR (Neat Film, NaCl): 2921, 2853, 2814, 1716, 1674, 1615, 
1446, 1369, 1262, 1206, 1167, 1119, 978, 922 cm-1; HRMS (MM: ESI-APCI) m/z calc’d 
for C17H26NO3 [M+H]+ 292.1907, found 292.1914; [α]25 15.98 (c 10.28, CHCl3, 94% ee). 
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(R)-3-(1-allyl-3-morpholino-2-oxocyclohex-3-en-1-yl)propanenitrile (66g) 
Synthesized according to general procedure B using substrate 65g.  The product was 
purified by column chromatography (SiO2, 3 x 15 cm, 5→10→15→20→30→50% 
EtOAc in hexanes) to yield enaminone 66g (217 mg, 0.465 mmol, quantitative yield) as a 
colorless oil; Rf = 0.30 (50% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 5.94 (s, 
1H), 5.66 (ddt, J = 16.9, 10.1, 7.4 Hz, 1H), 5.19 – 5.06 (m, 2H), 3.86 – 3.75 (m, 4H), 2.85 
(dt, J = 9.7, 4.4 Hz, 2H), 2.68 (d, J = 12.3 Hz, 2H), 2.58 – 2.47 (m, 2H), 2.47 – 2.34 (m, 
2H), 2.34 – 2.24 (m, 3H), 2.10 (ddd, J = 14.0, 10.1, 5.9 Hz, 1H), 1.96 – 1.83 (m, 2H), 
1.80 (ddd, J = 14.1, 10.2, 5.8 Hz, 1H); 13C NMR (125 MHz, Chloroform-d) δ 198.5, 
145.7, 132.4, 125.4, 120.1, 119.5, 77.4, 77.2, 76.9, 66.9, 50.5, 48.0, 48.0, 38.8, 30.5, 30.3, 
21.6, 12.3; IR (Neat Film, NaCl): 2929, 2854, 1675, 1448, 1263, 1205, 1118, 1000, 924 
cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C16H23N2O2 [M+H]+ 275.1754, found 
275.1753; [α]25 29.26 (c 11.02, CHCl3, 94% ee). 
 
 
(S)-6-allyl-6-benzyl-2-morpholinocyclohex-2-en-1-one (66h) 
Synthesized according to general procedure B using substrate 65h.  The product was 
purified by column chromatography (SiO2, 3 x 15 cm, 5→10→20% acetone in hexanes) 
O
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to yield enaminone 66h (217 mg, 0.442 mmol, 95% yield) as a colorless oil; Rf = 0.20 
(40% Et2O in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.28 – 7.22 (m, 2H), 7.22 – 7.17 
(m, 1H), 7.17 – 7.08 (m, 2H), 5.88 (t, J = 4.5 Hz, 1H), 5.77 (dddd, J = 16.9, 10.2, 8.0, 6.6 
Hz, 1H), 5.12 – 5.00 (m, 2H), 3.80 (dd, J = 5.2, 4.2 Hz, 4H), 3.07 (d, J = 13.5 Hz, 1H), 
2.81 – 2.69 (m, 5H), 2.50 – 2.37 (m, 3H), 2.15 (ddt, J = 14.0, 8.1, 1.2 Hz, 1H), 1.80 (dt, J 
= 13.9, 5.8 Hz, 1H), 1.76 – 1.67 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 199.2, 146.3, 
137.6, 134.1, 130.9, 128.1, 126.5, 125.2, 118.6, 67.0, 50.6, 49.9, 40.7, 39.8, 29.8, 21.9; 
IR (Neat Film, NaCl): 2919, 2854, 2814, 1675, 1614, 1447, 1263, 1205, 1119, 981, 923 
cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C20H26NO2 [M+H]+ 312.1958, found 
312.1967; [α]25 –95.78 (c 4.69, CHCl3, 96% ee).   
 
 
(S)-6-allyl-6-(4-methoxybenzyl)-2-morpholinocyclohex-2-en-1-one (66i) 
Synthesized according to general procedure B using substrate 65i.  The product was 
purified by column chromatography (SiO2, 3 x 15 cm, 5→10→20% acetone in hexanes) 
to yield enaminone 66i (159 mg, 0.465 mmol, quantitative yield) as a colorless oil; Rf = 
0.17 (40% Et2O in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.07 – 6.98 (m, 2H), 6.83 – 
6.73 (m, 2H), 5.87 (t, J = 4.5 Hz, 1H), 5.76 (dddd, J = 16.8, 10.2, 8.0, 6.6 Hz, 1H), 5.10 – 
4.99 (m, 2H), 3.80 (t, J = 4.7 Hz, 3H), 3.68 (s, 3H), 3.01 (d, J = 13.8 Hz, 1H), 2.81 – 2.70 
(m, 4H), 2.66 (d, J = 13.7 Hz, 1H), 2.47 – 2.38 (m, 3H), 2.13 (ddt, J = 13.9, 7.9, 1.1 Hz, 
1H), 1.80 (dt, J = 13.9, 5.9 Hz, 1H), 1.71 (dt, J = 13.9, 6.5 Hz, 1H); 13C NMR (125 MHz, 
CDCl3) δ 199.3, 158.3, 146.3, 134.1, 131.8, 129.5, 125.3, 118.5, 113.5, 67.0, 55.3, 55.2, 
O
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50.6, 50.0, 39.9, 39.8, 29.7, 21.9; IR (Neat Film, NaCl): 2930, 2853, 1675, 1611, 1512, 
1447, 1263, 1248, 1205, 1178, 1119, 1035, 981, 923 cm-1; HRMS (MM: ESI-APCI) m/z 
calc’d for C21H28NO3 [M+H]+ 342.2064, found 342.2064; [α]25 –316.96 (c 12.93, CHCl3, 
95% ee). 
 
 
 (S)-6-allyl-2-morpholino-6-(4-(trifluoromethyl)benzyl)cyclohex-2-en-1-one (66j) 
Synthesized according to general procedure B using substrate 65j.  The product was 
purified by column chromatography (SiO2, 3 x 15 cm, 5→10→20% acetone in hexanes) 
to yield enaminone 66j (154 mg, 0.406 mmol, 87% yield) as a pale yellow oil; Rf = 0.20 
(40% Et2O in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.49 (d, J = 8.0 Hz, 2H), 7.25 (d, J 
= 8.8 Hz, 2H), 5.88 (t, J = 4.5 Hz, 1H), 5.77 (dddd, J = 17.0, 10.2, 7.8, 6.8 Hz, 1H), 5.16 
– 5.04 (m, 2H), 3.86 – 3.75 (m, 4H), 3.20 (d, J = 13.5 Hz, 1H), 2.83 – 2.75 (m, 2H), 2.75 
– 2.66 (m, 3H), 2.54 – 2.43 (m, 1H), 2.43 – 2.33 (m, 2H), 2.22 (ddt, J = 14.0, 7.8, 1.2 Hz, 
1H), 1.79 (dt, J = 13.8, 5.3 Hz, 1H), 1.70 (ddd, J = 13.9, 8.5, 5.6 Hz, 1H); 13C NMR (125 
MHz, CDCl3) δ 198.6, 146.2, 142.1, 133.5, 131.2, 128.7 (q, J = 32.3 Hz), 127.7, 125.5, 
125.3, 124.9 (q, J = 3.8 Hz), 123.3, 119.1, 66.9, 50.6, 50.0, 40.4, 39.8, 29.9, 21.8; IR 
(Neat Film, NaCl): 2928, 2855, 2817, 1678, 1616, 1448, 1325, 1263, 1163, 1119, 1067, 
1019, 982, 923 cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C21H25NO2F [M+H]+ 
380.1832, found 380.1835; [α]25 –22.43 (c 8.54, CHCl3, 92% ee).   
 
O
N
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(S)-6-(2-chloroallyl)-6-methyl-2-morpholinocyclohex-2-en-1-one (66k) 
Synthesized according to general procedure B using substrate 65k.  The product was 
purified by column chromatography (20% EtOAc in hexanes) to afford enaminone 66k as 
a colorless oil (25 mg, 93 µmol, 58% yield); 1H NMR (500 MHz, CDCl3) δ 5.91 (t, J = 
4.5 Hz, 1H), 5.28 (dd, J = 1.1, 0.4 Hz, 1H), 5.16 – 5.15 (m, 1H), 3.86 – 3.76 (m, 4H), 
2.94 – 2.88 (m, 2H), 2.85 (dd, J = 14.3, 0.9 Hz, 1H), 2.72 – 2.65 (m, 2H), 2.53 (d, J = 
14.3 Hz, 1H), 2.49 – 2.44 (m, 2H), 2.04 (ddd, J = 13.6, 7.4, 6.2 Hz, 1H), 1.86 – 1.78 (m, 
1H), 1.17 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 199.1, 145.6, 138.9, 125.1, 116.7, 67.0, 
50.5, 46.1, 45.6, 32.8, 22.5, 21.8; IR (Neat Film, NaCl) 2931, 2855, 1679, 1263, 1120cm-
1; HRMS (ESI) m/z calc’d for C14H21NClO2 [M+H]+: 270.1261, found 270.1259; [α]25 –
7.5 (c 0.8, CHCl3, 99% ee). 
 
 
(S)-6-methyl-6-(2-methylallyl)-2-morpholinocyclohex-2-en-1-one (66l) 
Synthesized according to general procedure B using substrate 65l.  The product was 
purified by column chromatography (20% EtOAc in hexanes) to afford enaminone 66l as 
a colorless oil (25 mg, 100 µmol 92% yield); 1H NMR (500 MHz, CDCl3) δ 5.91 (t, J = 
4.5 Hz, 1H), 5.28 (dd, J = 1.1, 0.4 Hz, 1H), 5.16 – 5.15 (m, 1H), 3.86 – 3.76 (m, 4H), 
2.94 – 2.88 (m, 2H), 2.85 (dd, J = 14.3, 0.9 Hz, 1H), 2.72 – 2.65 (m, 2H), 2.53 (d, J = 
O
N
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14.3 Hz, 1H), 2.49 – 2.44 (m, 2H), 2.04 (ddd, J = 13.6, 7.4, 6.2 Hz, 1H), 1.86 – 1.78 (m, 
1H), 1.17 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 199.1, 145.6, 138.9, 125.1, 116.7, 67.0, 
50.5, 46.1, 45.6, 32.8, 22.5, 21.8; IR (Neat Film, NaCl) 2931, 2855, 1679, 1263, 1120cm-
1; HRMS (ESI) m/z calc’d for C14H21NClO2 [M+H]+: 270.1261, found 270.1259; [α]25 –
7.5 (c 0.8, CHCl3, 99% ee). 
 
 
 (S)-6-allyl-6-methyl-2-(piperidin-1-yl)cyclohex-2-en-1-one (75) 
Synthesized according to general procedure B using substrate 74.  The product was 
purified by column chromatography (SiO2, 3 x 15 cm, 10→20% acetone in hexanes) to 
yield enaminone 75 (107 mg, 0.459 mmol, 99% yield) as a colorless oil; Rf = 0.37 (40% 
Et2O in hexanes); 1H NMR (500 MHz, CDCl3) δ 5.84 (t, J = 4.5 Hz, 1H), 5.73 (ddt, J = 
15.1, 10.1, 7.5 Hz, 1H), 5.06 – 4.98 (m, 2H), 2.70 (dt, J = 10.9, 5.2 Hz, 2H), 2.60 (dt, J = 
11.2, 5.1 Hz, 2H), 2.47 – 2.29 (m, 3H), 2.21 (dd, J = 13.8, 7.7 Hz, 1H), 1.84 (dt, J = 12.7, 
6.0 Hz, 1H), 1.67 (qq, J = 14.2, 8.2, 7.3 Hz, 5H), 1.49 (p, J = 6.0 Hz, 2H), 1.07 (s, 3H); 
13C NMR (125 MHz, CDCl3) δ 200.8, 147.0, 134.4, 124.6, 118.0, 51.6, 45.5, 41.4, 33.4, 
26.1, 24.5, 22.1, 22.0; IR (Neat Film, NaCl): 2931, 2852, 2798, 1680, 1613, 1451, 1384, 
1217, 1093, 996, 913 cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C15H24NO [M+H]+ 
234.1852, found 234.1847; [α]25 –172.28 (c 6.64, CHCl3, 99% ee). 
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 (S)-6-allyl-3,6-dimethyl-2-morpholinocyclohex-2-en-1-one (77) 
Synthesized according to general procedure B using substrate 76.  The product was 
purified by column chromatography (SiO2, 3 x 12 cm, 10→20% Et2O in hexanes) to 
yield enaminone 77 (60.2 mg, 0.241 mmol, 52% yield) as a pale yellow oil; Rf = 0.35 
(29% Et2O in hexanes); 1H NMR (500 MHz, CDCl3) δ 5.72 (ddt, J = 16.8, 10.2, 7.4 Hz, 
1H), 5.08 – 4.99 (m, 2H), 3.71 – 3.63 (m, 4H), 2.97 – 2.85 (m, 4H), 2.45 – 2.30 (m, 2H), 
2.27 (ddt, J = 13.6, 7.2, 1.2 Hz, 1H), 2.18 (ddt, J = 13.6, 7.5, 1.2 Hz, 1H), 1.99 (d, J = 0.9 
Hz, 3H), 1.82 (ddd, J = 13.7, 6.4, 5.6 Hz, 1H), 1.67 (ddd, J = 13.7, 7.2, 5.6 Hz, 1H), 1.04 
(s, 3H); 13C NMR (125 MHz, CDCl3) δ 202.0, 153.4, 141.6, 134.3, 118.0, 77.4, 77.2, 
76.9, 68.1, 50.6, 44.9, 41.3, 32.5, 28.7, 21.8, 19.8; IR (Neat Film, NaCl): 2912, 2847, 
1664, 1452, 1374, 1294, 1259, 1190, 1114, 988, 911 cm-1; HRMS (MM: ESI-APCI) m/z 
calc’d for C15H24NO2 [M+H]+ 250.1802, found 250.1803; [α]25 30.71 (c 3.52, CHCl3, 
90% ee). 
 
 
(R)-5-allyl-5-methyl-2-morpholinocyclopent-2-en-1-one (79) 
Synthesized according to general procedure B using substrate 78.  The product was 
purified by column chromatography (SiO2, 3 x 10 cm, 10% acetone in hexanes) to yield 
enaminone 79 (97 mg, 0.438 mmol, 94% yield) as a pale tan oil; Rf = 0.23 (20% acetone 
in hexanes); 1H NMR (500 MHz, CDCl3) δ 6.25 (t, J = 3.1 Hz, 1H), 5.68 – 5.55 (m, 1H), 
O
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5.07 – 4.97 (m, 2H), 3.80 – 3.74 (m, 4H), 3.12 – 2.96 (m, 4H), 2.49 (dt, J = 18.2, 2.1 Hz, 
1H), 2.27 – 2.16 (m, 2H), 2.12 (dd, J = 13.6, 7.9 Hz, 1H), 1.09 (d, J = 1.4 Hz, 3H); 13C 
NMR (125 MHz, CDCl3) δ 209.1, 149.3, 133.9, 131.6, 118.2, 66.7, 48.6, 46.8, 42.7, 37.2, 
24.0; IR (Neat Film, NaCl): 2960, 2913, 2853, 1703, 1611, 1451, 1380, 1261, 1120, 
1020, 993 cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C13H20NO2 [M+H]+ 222.1489, 
found 222.1490; [α]25 –263.53 (c 6.76, CHCl3, 83% ee). 
 
  
(S)-3-allyl-3-methyl-[1,1'-bi(cyclohexan)]-6-en-2-one (81) 
Synthesized according to general procedure B using substrate 80.  The product was 
purified by column chromatography (SiO2, 1 x 12 cm, 5% Et2O in hexanes) to yield 
enaminone 81 (11 mg, 47 µmol, 93% yield) as a pale yellow oil; Rf = 0.43 (5% Et2O in 
hexanes); 1H NMR (500 MHz, CDCl3) δ 6.50 (td, J = 4.1, 1.0 Hz, 1H), 5.73 (ddt, J = 
16.9, 10.4, 7.4 Hz, 1H), 5.08 – 4.99 (m, 2H), 2.52 (ttd, J = 12.0, 3.2, 1.4 Hz, 1H), 2.43 – 
2.33 (m, 2H), 2.33 – 2.25 (m, 1H), 2.17 (ddt, J = 13.7, 7.5, 1.2 Hz, 1H), 1.91 – 1.81 (m, 
1H), 1.78 – 1.60 (m, 6H), 1.34 (qt, J = 12.2, 3.1 Hz, 2H), 1.21 – 0.95 (m, 6H); 13C NMR 
(125 MHz, CDCl3) δ 203.2, 143.4, 140.5, 134.5, 117.9, 44.4, 41.4, 36.4, 33.3, 33.1, 32.7, 
26.9, 26.9, 26.6, 23.0, 22.0; IR (Neat Film, NaCl): 2922, 2849, 1669, 1448, 1175, 911 
cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C16H25O [M+H]+ 233.1900, found 
233.1892; [α]25 –1.176 (c 0.43, CHCl3, 72% ee). 
 
  
O
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2.4.4  Determination of Enantiomeric Excess 
Table 2.6. Methods for the determination of enantiomeric excess. 
  
compound assay methodand conditions
retention time
of major isomer
(min)
retention time
of minor isomer
(min)
%eeentry
1 SFC, 5% iPrOH in CO22.5 mL/min, AD-H col.
5.91 5.62 99
O
N
O
66a
2 HPLC, 5% iPrOH in hexanes1 mL/min, OD-H col.
8.77 9.14 98
O
Et
N
O
66b
3 SFC, 3% iPrOH in CO22.5 mL/min, AD-H col.
4.45 3.95 99
O
N
O
66c
4 SFC, 2% iPrOH in CO22.5 mL/min, OD-H col.
3.59 4.10 99
O
N
O
66d
5 SFC, 10% MeOH in CO25 mL/min, AD-H col.
3.43 1.75 97
O
N
O
66e
6 SFC, 10% iPrOH in CO25 mL/min, AD-H col.
2.27 1.81 94
O
N
O
66f
CO2Me
OTBS
OTBS
O
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compound assay methodand conditions
retention time
of major isomer
(min)
retention time
of minor isomer
(min)
%eeentry
7 SFC, 10% iPrOH in CO25 mL/min, AD-H col.
2.19 2.40 94
O
N
O
66g
8 SFC, 8% MeOH in CO25 mL/min, OJ-H col.
2.41 2.63 96
O
Bn
N
O
66h
9 SFC, 5% MeOH in CO25 mL/min, OD-H col.
6.29 6.99 95
66i
CN
O
N
O
OMe
10 SFC, 5% iPrOH in CO25 mL/min, OJ-H col.
3.88 4.52 92
66j
O
N
O
CF3
13 HPLC, 3% EtOH in hexanes1 mL/min, AD col.
9.01 9.84 99
O
N
75
12 SFC, 5% iPrOH in hexanes2.5 mL/min, AD-H col.
10.2 9.4 99
O
N
O
66l
11 SFC, 5% iPrOH in hexanes2.5 mL/min, OD-H col.
8.6 7.8 99
O
N
O
66k
Cl
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2.4.5  Derivatization of Enaminone Products 
 
 
(S)-6-allyl-2-hydroxy-6-methylcyclohex-2-en-1-one (67) 
Enaminone 66a  (297 mg, 1.26 mmol) was diluted in MeOH:water (4:1).  HCl (0.1 mL, 
37%) was added by syringe.  The reaction mixture was stirred at 60°C under nitrogen for 
2h.  The mixture was cooled to room temperature and partitioned between H2O and 
CH2Cl2.  The aqueous layer was extracted with CH2Cl2 two additional times.  The 
organic layers were combined, dried with Na2SO4, filtered, and concentrated.  The 
residue was purified by flash column chromatography (1→2% EtOAc/hexanes) to give 
diketone 21 (166 mg, 1.00 mmol, 79% yield) as a yellow oil.  1H NMR (300 MHz, 
CDCl3) δ 6.10 – 5.97 (m, 1H), 5.80 – 5.58 (m, 1H), 5.15 – 4.94 (m, 2H), 2.45 – 2.29 (m, 
2H), 2.18 (ddt, J = 13.8, 7.6, 1.1 Hz, 1H), 1.91 – 1.83 (m, 1H), 1.72 (ddd, J = 13.7, 6.5, 
compound assay methodand conditions
retention time
of major isomer
(min)
retention time
of minor isomer
(min)
%eeentry
14 HPLC, 1.5% iPrOH in hexanes1 mL/min, OD-H col.
8.99 8.40 90
O
N
O
77
15 HPLC, 3% iPrOH in hexanes1 mL/min, OD-H col.
14.22 17.7 83
77
O
N
O
16 SFC, 10% iPrOH in CO22.5 mL/min, AD col.
3.08 3.52 72
O
81
O
HO
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5.5 Hz, 1H), 1.09 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 200.2, 145.4, 133.4, 118.6, 
116.8, 43.9, 40.9, 33.5, 21.7, 20.2; IR (Neat Film, NaCl): 3428, 3076, 2975, 2935, 1721, 
1640, 1455, 1217 cm-1; HRMS (FAB+) m/z calc’d for C10H13O2 [M+H–H2]+ 165.0916, 
found 165.0916; [α]25 –5.95 (c 4.45, CHCl3). 
 
 
  
(6S) 3-bromo-6-methyl-2-(morpholin-4-yl)-6-(prop-2-en-1-yl)cyclohex-2-en-1-one 
(68) 
Enaminone 66a (120 mg, 0.51 mmol, 1.0 equiv) was dissolved in CH2Cl2 (4.5 mL, 0.1 
M).  The reaction mixture was cooled to –78 °C.  NBS (91 mg, 0.51 mmol, 1.0 equiv), 
dissolved in CH2Cl2 (4.5 mL), was added drop-wise to the solution by syringe.  The 
reaction mixture was stirred at –78 °C for 25 min.  The solution was quenched with a 
solution of 10% K2CO3 (3 mL).  The mixture was warmed to room temperature and 
extracted with 3 x CH2Cl2.  The organic layers were combined, dried, filtered, and 
concentrated.  The residue was purified by flash column chromatography (3% 
EtOAc/hexanes) to give the desired compound as a yellow oil (96 mg, 0.31 mmol, 60% 
yield).  1H NMR (500 MHz, CDCl3) δ 5.68 (ddt, J = 16.7, 10.2, 7.4 Hz, 1H), 5.10 – 5.01 
(m, 2H), 3.71 (ddd, J = 5.3, 3.8, 1.3 Hz, 4H), 3.06 – 2.99 (m, 2H), 2.97 – 2.92 (m, 2H), 
2.93 – 2.83 (m, 2H), 2.28 (ddt, J = 13.8, 7.3, 1.2 Hz, 1H), 2.21 (ddt, J = 13.8, 7.5, 1.2 Hz, 
1H), 1.88 (ddd, J = 13.8, 6.3, 5.7 Hz, 1H), 1.74 (ddd, J = 13.9, 7.2, 5.8 Hz, 1H), 1.07 (s, 
3H); 13C NMR (125 MHz, CDCl3) δ 199.4, 143.8, 141.9, 133.5, 118.7, 67.7, 50.2, 45.8, 
O
N
O
Br
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40.9, 33.7, 33.3, 21.5; IR (Neat Film, NaCl) 2958, 2851, 1678, 1606, 1451, 1261, 1212, 
1113, 1049, 920 cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C14H21BrNO2 [M+H]+ 
314.0750, found 314.0742; [α]25 –1.56 (c 1.68, CHCl3). 
 
 
(S)-4-allyl-4-methyl-2-morpholino-5,6-dihydro-[1,1'-biphenyl]-3(4H)-one (69) 
Compound 68 (54 mg, 0.17 mmol, 1.0 equiv) was dissolved in 7 mL of DME and 0.72 
mL (4.5 equiv) of 1 M K3PO4.  Phenylboronic acid (29 mg, 0.24 mmol, 1.5 equiv) and of 
PdCl2(dppf) (26 mg, 32 µmol, 0.19 equiv) were added to the reaction mixture.  The 
mixture was heated to 60 °C under nitrogen for 2h.  The reaction mixture was cooled to 
room temperature and then extracted with 3x ethyl ether.  The organic layers were 
combined, dried with Na2SO4, filtered, and concentrated.  The reaction mixture was 
purified by flash column chromatography (3→6% EtOAc/hexanes) to give the product as 
bright yellow-orange oil (51 mg, 0.16 mmol, 96% yield).  1H NMR (500 MHz, CDCl3) δ 
7.41 – 7.35 (m, 2H), 7.34 – 7.28 (m, 1H), 7.26 – 7.21 (m, 2H), 5.79 (ddt, J = 16.6, 10.4, 
7.4 Hz, 1H), 5.12 – 5.04 (m, 2H), 3.53 (t, J = 4.6 Hz, 4H), 2.83 – 2.57 (m, 6H), 2.42 – 
2.26 (m, 2H), 1.96 (dt, J = 13.7, 5.7 Hz, 1H), 1.85 (ddd, J = 13.5, 6.9, 6.2 Hz, 1H), 1.15 
(s, 3H); 13C NMR (125 MHz, CDCl3) δ 202.5, 145.5, 141.0, 140.4, 134.1, 129.6, 128.1, 
127.9, 127.8, 118.1, 115.3, 67.4, 51.1, 44.6, 41.2, 32.1, 28.9, 21.8; IR (Neat Film, NaCl): 
2916, 2850, 2358, 1669, 1457, 1374, 1261, 1210, 1112, 1029, 978, 757, 698 cm-1; HRMS 
(MM: ESI-APCI) m/z calc’d for C20H26NO2 [M+H]+ 312.1958, found 312.1968; [α]25 
0.00 (c 0.76, CHCl3). 
O
N
O
Ph
CHAPTER 2 – Highly Enantioselective Palladium-Catalyzed Allylic Alkylation of Enaminones 
 
254 
 
 
(S)-6-allyl-6-methyl-2-(phenylamino)cyclohex-2-en-1-one (70) 
Compound 66a (52 mg, 0.21 mmol, 1.0 equiv) was dissolved in 1.3 mL of toluene (0.16 
M).  PTSA monohydrate (39 mg, 0.21 mmol, 1.0 equiv) and aniline (20 µL, 0.22 mmol, 
1.0 equiv) were added.  The mixture was heated to 50°C for 3.5 h.  Then the solution was 
diluted with ethyl acetate and washed 3 times with saturated aqueous NaHCO3.  The 
organic layer was combined, dried with Na2SO4, filtered, and concentrated.  The reaction 
mixture was purified by flash column chromatography (2% EtOAc in hexanes) to yield 
compound 70 (18 mg, 75 µmol, 35% yield).  1H NMR (500 MHz, CDCl3) δ 7.29 – 7.23 
(m, 2H), 7.06 – 7.00 (m, 2H), 6.91 (tt, J = 7.4, 1.1 Hz, 1H), 6.33 (t, J = 4.7 Hz, 1H), 5.75 
(ddq, J = 16.8, 10.3, 7.5 Hz, 1H), 5.14 – 5.03 (m, 2H), 2.54 – 2.39 (m, 3H), 2.26 (ddt, J = 
13.7, 7.6, 1.2 Hz, 1H), 1.98 (ddd, J = 13.6, 6.8, 5.4 Hz, 1H), 1.80 (ddd, J = 13.5, 6.8, 5.3 
Hz, 1H), 1.17 (s, 3H) (N-H not observed); 13C NMR (125 MHz, CDCl3) δ 200.0, 142.3, 
134.8, 134.0, 133.9, 121.1, 118.8, 118.5, 115.0, 44.4, 41.5, 33.1, 22.2, 21.0; IR (Neat 
Film, NaCl): 3364, 2926, 1668, 1634, 1600, 1515, 1442, 1306, 1203, 1014, 997, 916, 
750, 691 cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C16H20NO [M+H]+ 242.1539, 
found 242.1535; [α]25 –4.72 (c 2.18, CHCl3). 
 
 
O
PhHN
O
H
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(S)-2-allyl-2-methyl-2,3,4,9-tetrahydro-1H-carbazol-1-one (71) 
Enaminone 66a (118 mg, 0.500 mmol, 1.00 equiv) was taken up in toluene (2 mL, 0.25 
M) and PTSA monohydrate (95 mg, 0.50 mmol, 1.0 equiv) and phenyl hydrazine (54 mg, 
0.50 mmol, 1.0 equiv) were added.  The reaction was heated to 60 °C and stirred for 4 
hours, cooled to room temperature, diluted with 1 mL saturated aqueous NH4Cl and 
extracted with 3 x 5 mL EtOAc.  The combined organic fractions were dried over Na2SO4 
and concentrated in vacuo.  The crude intermediate was taken up in 5 mL 4:1 AcOH:12 
M HCl (0.1 M), stirred for 2 hours and ice (approx. 10 g) was added.  The ice/reaction 
mixture was quenched with 5.0 M NaOH until a pH of 9–10 was achieved.  The mixture 
was extracted with 3x20 mL EtOAc.  The combined organic fractions were dried over 
Na2SO4 and concentrated in vacuo. The product was purified by column chromatography 
(SiO2, 3 x 10 cm, 5→10→15% EtOAc in hexanes) to yield indole 71 (120 mg, 0.500 
mmol, quantitative yield over 2 steps) as a yellow oil; Rf = 0.54 (20% EtOAc in hexanes); 
1H NMR (500 MHz, CDCl3) δ 9.75 (s, 1H), 7.66 (dq, J = 8.1, 0.9 Hz, 1H), 7.49 (dt, J = 
8.4, 0.9 Hz, 1H), 7.38 (ddd, J = 8.3, 7.0, 1.1 Hz, 1H), 7.15 (ddd, J = 8.0, 6.9, 1.0 Hz, 1H), 
5.87 (ddt, J = 16.6, 10.4, 7.4 Hz, 1H), 5.17 – 5.08 (m, 2H), 3.12 – 2.96 (m, 2H), 2.57 
(ddt, J = 13.8, 7.2, 1.2 Hz, 1H), 2.38 (ddt, J = 13.8, 7.5, 1.2 Hz, 1H), 2.24 (ddd, J = 13.6, 
7.1, 5.2 Hz, 1H), 2.05 (ddd, J = 13.6, 7.0, 5.2 Hz, 1H), 1.29 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δ 196.3, 138.7, 134.4, 130.3, 128.0, 126.9, 125.9, 121.4, 120.4, 118.3, 112.9, 
45.5, 41.5, 35.7, 22.1, 18.4; IR (Neat Film, NaCl): 3279, 3076, 2963, 2926, 1638, 1573, 
1545, 1473, 1331, 1224, 1014, 992, 977, 916 cm-1; HRMS (MM: ESI-APCI) m/z calc’d 
for C16H18NO [M+H]+ 240.1383, found 240.1383; [α]25 –131.65 (c 7.84, CHCl3). 
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Ethyl (S)-6-allyl-1-(4-methoxyphenyl)-6-methyl-7-oxo-4,5,6,7-tetrahydro-1H-
indazole-3-carboxylate (72) 
Enaminone 66a (31 mg, 0.13 mmol, 1.0 equiv) and ethyl (Z)-2-chloro-2-(2-(4-
methoxyphenyl)hydrazono)acetate7 (73, 50 mg, 0.19 mmol, 1.5 equiv) were diluted in 0.4 
mL of toluene (0.033M).  Then, TEA (0.15 mL, 0.11 mmol, 0.83 equiv) was added.  The 
reaction mixture was heated at the reflux for 17 h.  The reaction mixture was cooled, 
quenched with water, extracted with ethyl acetate, washed with brine, and dried with 
Na2SO4.  The product was purified by flash column chromatography (5→15% 
EtOAc/hexanes) to give the compound 72 as a yellow-orange oil (22 mg, , 6.0 µmol, 46% 
yield); 1H NMR (500 MHz, CDCl3) δ 7.39 – 7.33 (m, 2H), 6.98 – 6.89 (m, 2H), 5.76 (ddt, 
J = 17.2, 10.1, 7.4 Hz, 1H), 5.15 – 5.02 (m, 2H), 4.44 (q, J = 7.1 Hz, 2H), 3.85 (s, 3H), 
3.20 – 3.04 (m, 2H), 2.42 (ddt, J = 13.8, 7.1, 1.2 Hz, 1H), 2.27 (ddt, J = 13.8, 7.6, 1.1 Hz, 
1H), 2.13 (ddd, J = 14.0, 6.7, 5.5 Hz, 1H), 1.98 (ddd, J = 13.9, 7.3, 5.5 Hz, 1H), 1.42 (t, J 
= 7.1 Hz, 3H), 1.18 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 192.7, 162.3, 160.1, 140.0, 
135.2, 133.6, 132.9, 132.8, 127.1, 118.8, 113.8, 61.3, 55.7, 46.7, 40.8, 34.9, 21.6, 19.0, 
14.6; IR (Neat Film, NaCl): 2917, 2357, 2340, 1691, 1515, 1301, 1251, 1195, 1127, 
1026, 935 cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C21H25N2O4 [M+H]+ 369.1809, 
found 369.1791; [α]25 –7.56 (c 0.45, CHCl3). 
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2.4.6  Synthesis of Substituted Allyl Cyanoformates 
 
2-methylallyl carbonochloridate (82) 
Prepared as reported for the 2-chloroallyl substrate from the report by Stoltz and 
coworkers.14  The product was vacuum distilled (45–47 °C, 20 torr) to provide the 
product as a clear oil (7.48 g, 60% yield).  Spectral data matches that reported in the 
literature.15  1H NMR (500 MHz, CDCl3) δ 5.10 – 5.07 (m, 1H), 5.07 – 5.04 (m, 1H), 
4.71 (s, 2H), 1.81 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 150.4, 137.9, 115.8, 75.0, 19.2. 
 
2-chloroallyl carbonocyanidate (83a) 
Prepared according to literature precedent.14  Product vacuum distilled (62–65°C, 20 torr) 
to afford the product as a clear oil (6.13 g, 90% yield).  1H NMR (500 MHz, CDCl3) δ 
5.62 – 5.59 (m, 1H), 5.57 (d, J = 2.1 Hz, 1H), 4.88 (d, J = 0.9 Hz, 2H); 13C NMR (125 
MHz, CDCl3) δ 143.5, 132.9, 118.5, 108.9, 69.7; IR (Neat Film, NaCl) 2249, 1759, 1640, 
1230, 1180, 918 cm-1; Anal.  Calc’d for C5H4NO2Cl: C, 41.26%; H, 2.77%; N, 9.62%; 
Cl, 24.36% ;Found: C, 41.22%; H, 2.79%, N, 9.49%; Cl, 24.18%. 
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2-methylallyl carbonocyanidate (83b) 
Prepared according to procedure for cyanoformate 83a from chloroformate 82.  Product 
vacuum distilled (60°C, 35 torr) to afford the product as a clear oil (3.61 g, 81% yield).  
1H NMR (500 MHz, CDCl3) δ 5.12 – 5.06 (m, 2H), 4.73 (s, 2H), 1.81 (s, 3H); 13C NMR 
(125 MHz, CDCl3) δ 144.1, 137.2, 116.4, 109.3, 72.0, 19.3; IR (Neat Film, NaCl) 2246, 
1762, 1227, 1242, 918 cm-1; Anal.  Calc’d for C6H7NO2: C, 57.59%; H, 5.64%; N, 
11.19%; Found: C, 57.59%; H, 5.49%; N, 11.11%. 
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Spectra Relevant to Chapter 2: 
Highly Enantioselective Palladium-Catalyzed 
      Asymmetric Decarboxylative Allylic Alkylation of Enaminones 
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Infrared spectrum (Thin Film, NaCl) of compound 65a. 
 
 13C NMR (125 MHz, CDCl3) of compound 65a. 
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Infrared spectrum (Thin Film, NaCl) of compound 65b. 
 
 13C NMR (125 MHz, CDCl3) of compound 65b. 
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 13C NMR (125 MHz, CDCl3) of compound 65c. 
 
Infrared spectrum (Thin Film, NaCl) of compound 65c. 
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Infrared spectrum (Thin Film, NaCl) of compound 65d. 
 
 13C NMR (125 MHz, CDCl3) of compound 65d. 
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 13C NMR (125 MHz, CDCl3) of compound 65e. 
 
Infrared spectrum (Thin Film, NaCl) of compound 65e. 
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Infrared spectrum (Thin Film, NaCl) of compound 65f. 
 
 13C NMR (125 MHz, CDCl3) of compound 65f. 
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 13C NMR (125 MHz, CDCl3) of compound 65g. 
 
Infrared spectrum (Thin Film, NaCl) of compound 65g. 
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Infrared spectrum (Thin Film, NaCl) of compound 65h
 13C NMR (125 MHz, CDCl3) of compound 65h. 
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 13C NMR (125 MHz, CDCl3) of compound 65i. 
 
Infrared spectrum (Thin Film, NaCl) of compound 65i. 
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Infrared spectrum (Thin Film, NaCl) of compound 65j. 
 
 13C NMR (125 MHz, CDCl3) of compound 65j. 
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 13C NMR (125 MHz, CDCl3) of compound 65k. 
 
Infrared spectrum (Thin Film, NaCl) of compound 65k. 
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Infrared spectrum (Thin Film, NaCl) of compound 65l
 13C NMR (125 MHz, CDCl3) of compound 65l. 
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Infrared spectrum (Thin Film, NaCl) of compound 66a. 
 
 13C NMR (125 MHz, CDCl3) of compound 66a. 
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 13C NMR (125 MHz, CDCl3) of compound 66b. 
 
Infrared spectrum (Thin Film, NaCl) of compound 66b. 
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Infrared spectrum (Thin Film, NaCl) of compound 66c. 
 
 13C NMR (125 MHz, CDCl3) of compound 66c. 
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 13C NMR (125 MHz, CDCl3) of compound 66d. 
 
Infrared spectrum (Thin Film, NaCl) of compound 66d. 
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Infrared spectrum (Thin Film, NaCl) of compound 66e. 
 
 13C NMR (125 MHz, CDCl3) of compound 66e. 
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 13C NMR (125 MHz, CDCl3) of compound 66f. 
 
Infrared spectrum (Thin Film, NaCl) of compound 66f. 
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Infrared spectrum (Thin Film, NaCl) of compound 66g. 
 
 13C NMR (125 MHz, CDCl3) of compound 66g. 
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 13C NMR (125 MHz, CDCl3) of compound 66h. 
 
Infrared spectrum (Thin Film, NaCl) of compound 66h. 
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 13C NMR (125 MHz, CDCl3) of compound 66i. 
 
Infrared spectrum (Thin Film, NaCl) of compound 66i. 
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Infrared spectrum (Thin Film, NaCl) of compound 66j. 
 
 13C NMR (125 MHz, CDCl3) of compound 66j. 
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 13C NMR (125 MHz, CDCl3) of compound 66k. 
 
Infrared spectrum (Thin Film, NaCl) of compound 66k. 
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Infrared spectrum (Thin Film, NaCl) of compound 66l. 
 
 13C NMR (125 MHz, CDCl3) of compound 66l. 
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Infrared spectrum (Thin Film, NaCl) of compound 67. 
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Infrared spectrum (Thin Film, NaCl) of compound 68. 
 
 13C NMR (125 MHz, CDCl3) of compound 68. 
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Infrared spectrum (Thin Film, NaCl) of compound 69. 
 
 13C NMR (125 MHz, CDCl3) of compound 69. 
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 13C NMR (125 MHz, CDCl3) of compound 70. 
 
Infrared spectrum (Thin Film, NaCl) of compound 70. 
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Infrared spectrum (Thin Film, NaCl) of compound 71. 
 
 13C NMR (125 MHz, CDCl3) of compound 71. 
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 13C NMR (125 MHz, CDCl3) of compound 72. 
 
Infrared spectrum (Thin Film, NaCl) of compound 72. 
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Infrared spectrum (Thin Film, NaCl) of compound 74. 
 
 13C NMR (125 MHz, CDCl3) of compound 74. 
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 13C NMR (125 MHz, CDCl3) of compound 75. 
 
Infrared spectrum (Thin Film, NaCl) of compound 75. 
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Infrared spectrum (Thin Film, NaCl) of compound 76. 
 
 13C NMR (125 MHz, CDCl3) of compound 76. 
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 13C NMR (125 MHz, CDCl3) of compound 77. 
 
Infrared spectrum (Thin Film, NaCl) of compound 77. 
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Infrared spectrum (Thin Film, NaCl) of compound 78. 
 
 13C NMR (125 MHz, CDCl3) of compound 78. 
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 13C NMR (125 MHz, CDCl3) of compound 79. 
 
Infrared spectrum (Thin Film, NaCl) of compound 79. 
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Infrared spectrum (Thin Film, NaCl) of compound 80. 
 
 13C NMR (125 MHz, CDCl3) of compound 80. 
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 13C NMR (125 MHz, CDCl3) of compound 81. 
 
Infrared spectrum (Thin Film, NaCl) of compound 81. 
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 13C NMR (125 MHz, CDCl3) of compound 82. 
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 13C NMR (125 MHz, CDCl3) of compound 83a. 
 
Infrared spectrum (Thin Film, NaCl) of compound 83a. 
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Infrared spectrum (Thin Film, NaCl) of compound 83b. 
 
 13C NMR (125 MHz, CDCl3) of compound 83b. 
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CHAPTER 3 
The Palladium-Catalyzed Asymmetric Decarboxylative Allylic 
Alkylation for Formation of De Novo Acyclic Quaternary Stereocenters† 
 
3.1  INTRODUCTION AND BACKGROUND 
As discussed in previous chapters, synthesis of all-carbon quaternary 
stereocenters represents an important challenge to organic chemists.  While methods for 
access to all-carbon to quaternary centers in cyclic systems are limited, synthesis of such 
moieties in acyclic systems is particularly challenging due to the lack of rigidity that can 
be utilized to establish a favored stereochemical outcome.  Only a handful of methods 
exist to access all-carbon quaternary stereocenters from simple starting materials in an 
enantioselective manner.1,2  Despite the recent surge in development of alternative 
surrogates2e,2f the prevailing majority of these approaches rely on either the use of 
stereodefined trisubstituted alkenes as substrates2a–d or the regioselective in situ formation 
of fully-substituted intermediates bearing heteroaromatic substitution3 such as 
                                                
†  This research was performed in collaboration with Drs. Pavel Starkov and Jared A. 
Moore and Prof. Ilan Marek. 
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enamines2g–I and enolates2j,3k as well as ester,2l,2m thioester,3n and amide2o,2p,4,6 enolates 
(Scheme 3.1). 
Scheme 3.1.  Asymetric allylic alkylation of amide enolates. 
 
 
In acyclic systems, typical synthetic strategies (e.g. the use of sterically-hindered 
bases, directing groups or cyclic starting materials to favor E or Z-enolate formation by 
deprotonation or decarboxylation) may set distinct limits to the range of substrates 
relevant to the method.  Therefore, developing more general routes to access 
differentially substituted enolates is an important challenge for the synthesis of all-carbon 
quaternary stereocenters in acyclic systems. 
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Scheme 3.2.  One-pot method for the synthesis of stereodefined amide enolates. 
 
 
To this end, the Marek group has developed methods for the addition of 
organocuprates to ynecarbamates 85 to form vinyl cuprate intermediates in a 
stereodefined fashion (Scheme 3.2).4  These intermediates may be trapped under 
oxidative conditions, maintaining stereochemical control, resulting in fully-substituted 
amide enolates 86 with well-defined stereochemistry.  In particular, trapping with tert-
butyl peroxide and allyl chloroformate yields a product which is particularly attractive as 
a substrate for the palladium-catalyzed decarboxylative allylic alkylation (DAA) 
reaction.5,6  Given our group’s experience and success with this reaction, we decided to 
pursue these substrates as a general entry into all-carbon quaternary centers in acyclic 
systems. 
 
  
N
R2
CO2R3
R1
85
R42CuLi
(1.0 – 1.2 equiv)
–30 to –20 °C
Et2O, 1 h
R4
[Cu]
R1
N
CO2R3
R2
(i) tBuOOH 
    (1.0 – 1.2 equiv.)
    –78 °C, 30 min
(ii) AllocCl 
     (2.4 – 4.0 equiv)
R4
O
R1
N
CO2R3
R2
86
Me
O
nBu
N
CO2Me
Bn
Me
O
nBu
N
O
O
70% yield
86a
nBu
O
Me
N
O
O
O
O
Me
O
nBu
N
O
O
O
O
52% yield
86b
49% yield
86c
17% yield
86d
O
O
O
O
O
O
CHAPTER 3 – Palladium-Catalyzed Allylic Alkylation to form Acyclic Quaternary Stereocenters 
 
348 
3.2  RESULTS AND DISCUSSION 
3.2.1  Initial Screening Efforts 
Our investigations began with a screen of a number of model substrates (Scheme 
3.2) provided by the Marek group using the phosphinooxazoline (PHOX) ligand system 
previously found to be successful in our group (Table 3.1, next page).  Due to the lack of 
a strong chromophore and difficulty in separation of some products (87), we found it to 
be necessary to perform an olefin cross-metathesis with methyl acrylate on the products 
of the DAA before analysis by chiral HPLC or SFC (88).  While the tris(trifluoromethyl)-
tert-butyl PHOX ligand 8 proved superior to the standard tert-butyl PHOX ligand 3 in all 
cases, neither ligand provided satisfactory enantioselectivity despite the wide range of 
solvents screened.  The largest ee value obtained was with oxazolidinone substrate 86b 
and CF3-PHOX ligand 8, with a value of 50% and 52% ee in THF and toluene 
respectively (Table 3.1, entries 10 and 11).  Benzoxazolidinone substrate 86c failed to 
produce material of higher than 10% ee under any conditions, while acyclic carbamate 
86d fared slightly better, delivering an ee of 38% in toluene with ligand 8 (Table 3.1, 
entry 24).  Notably, reversing the enolate geometry resulted in an inversion of the 
stereochemical outcome of the reaction (i.e. between substrates 86a and 86b), indicating 
that the stereochemical information of the enolate was retained throughout the 
transformation. 
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Table 3.1. Initial screening efforts with PHOX ligands. 
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Given the lack of success with the P,N-PHOX ligands, we turned to the C2-
symmetric, biphosphine ligands developed and employed by Trost and coworkers.  In 
particular, these ligands were deemed promising due to the substantial difference in 
mechanism of enantioinduction established between the two systems.7  While the PHOX 
ligands have been determined to react via a metal-bound, inner sphere Pd-enolate 
intermediate, the biphosphine class of ligands has been found to react via an outer sphere 
mechanism in which the enolate is not bound to the palladium allyl complex. 
Gratifyingly, the diamine-linked P,P-ligands provided enhanced 
enantioselectivities compared to those observed with the PHOX ligands (Table 3.2, next 
page).  Additionally, ethyl acetate, tetrahydrofuran, and dioxane were determined to be 
promising solvents for the reaction, while MTBE and acetonitrile provided far lower 
enantioselectivity, and dichloromethane resulted in poor conversion (not shown in table 
3.2). 
Out of the diamine scaffolds examined in our initial screens, anthracene-based 
ligand 92 gave consistently better results.  Accordingly, we prepared and evaluated two 
additional derivatives to test the effect of additional steric bulk (93) and modulating the 
ligand electronics (94), akin to the differences observed between standard PHOX 3 and 
tris(trifluoromethyl)-PHOX ligand 8. Multifunctional, bulky ligand 94 unfortunately 
hindered reactivity (Table 3.2, entries 10 and 25).  Electron-deficient ligand 93, however, 
gratifyingly furnished products with good selectivity, and in particular acyclic carbamate 
86d was found to proceed with 94% ee in ethyl acetate using this ligand (Table 3.2, entry 
24).  Also notable, with this ligand system acyclic carbamate 86d outperformed the 
oxazolidinone substrate 86a. 
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Table 3.2. Screening Results with P,P-Trost ligands. 
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3.2.2  Substrate Scope 
Given the success of substrate 86d, the Marek group was able to furnish a number 
of additional amide enolate substrates for investigation (Table 3.3, next page).8  
Generally, these substrates yielded products with high enantioselectivities (≥90 ee%) and 
in moderate yield over the two-step DAA-metathesis sequence.  Alteration of the 
substituent on the carbamate oxygen (88d-g) and nitrogen (88h) as well as simple 
changes to the larger substituent on the alkene (88i, 88j) was well tolerated and did not 
result in a substantial change in the observed ee.  Phenyl substitution on the alkene, 
however, resulted in a dramatic decrease in ee to 76% (88k).  Changing the (E)-methyl 
substituent to an ethyl group (88l) resulted in a slight loss of ee to 82%, but 
enantioselectivity was recovered upon enlarging the (Z)-butyl group to a hexyl group 
(88m).  Adding further bulk to the (E)-substituent again resulted in a significant loss of 
enantioselectivity (88n).  As noted in our previous screen, the enantioselectivity observed 
for cyclic carbamates 86o and 86p was also substantially diminished. 
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Table 3.3. Substrate scope for synthesis of linear quaternary stereocenters by DAA. 
 
  
O
N
Bn
CO2Me
Me
Bu
MeO2C
88d
O
N
Bn
CO2Et
Me
Bu
MeO2C
88e
O
N
Bn
CO2tBu
Me
Bu
MeO2C
88f
O
N
Bn
CO2Bn
Me
Bu
MeO2C
88g
O
N
Ar
CO2Me
Me
Bu
MeO2C
88h, Ar = 4-ClPh
O
N
Bn
CO2Me
Me
Hex
MeO2C
88i
O
N
Bn
CO2Me
Me
MeO2C
88j
O
N
Bn
CO2Me
Me
Ph
MeO2C
88k
O
N
Bn
CO2Me
Et
Bu
MeO2C
88l
TBSO
O
N
Bn
CO2Me
Et
Hex
MeO2C
88m
O
N
Bn
CO2Me
Hex
MeO2C
88n
Ph
O
N
Et
Bu
MeO2C
88ob
O
N
Et
Hex
MeO2C
88pb
OO
O O
R1
R4
O
N
R2
CO2R3
O
O 1. Pd(dba)2 (2.5 mol %)
    L6B (7 mol %)
    EtOAc or THF, rt, 24h
2. methyl acrylate (10 equiv.)
    Grubbs' Gen II (5 mol %)
    CH2Cl2, 40 °C
O
N
R2
CO2R3
R4
R1
MeO2C
86 88a
68% yield
92 ee%
53% yield
94 ee%
70% yield
90 ee%
40% yield
93 ee%
50% yield
90 ee%
58% yield
94 ee%
60% yield
94 ee%
60% yield
76 ee%
65% yield
82 ee%
54% yield
93 ee%
47% yield
76 ee%
52% yield
69 ee %
59% yield
73% ee
aTwo-step yield. bAbsolute stereochemistry not determined
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3.2.3  Determination of Absolute Stereochemistry 
In order to determine the absolute stereochemistry of the products, we converted 
acyclic product 87 to 96, which allowed comparison by derivatization of known6a allylic 
alkylation product 97 (Scheme 3.3).  Comparison of optical rotations allowed us to 
estabilish absolute stereochemistry as shown in Scheme 3.3, i.e. that reaction with the 
(R,R)-Trost ligands gave the (S)-quaternary linear carbamate. 
Scheme 3.3. Determination of absolute stereochemistry. 
 
 
 
 
 
3.3  CONCLUDING REMARKS 
In conclusion, we developed a new method for the preparation of versatile 
building blocks containing a de novo created all-carbon quaternary stereocenter in 
unbiased acyclic systems.  This was achieved through the use of the carbometalation-
oxidation strategy developed by the Marek group to access fully-substituted, 
stereodefined amide enolates from ynecarbamates, testing various catalytic systems in the 
MeO N
Bn
O O
Me
OTBS
87j
87% ee
from 92
BnHN (S)
O
Me
OH
95
(ii) TBAF
90% yield
(i) MsCl, TEA
(ii) NaHMDS
46% yield
two-steps
BnN
O
Me
96
Path A
Path B
BzN
O
Me
O
O
Pd2dba3 (5 mol %)
L2 (12.5 mol %)
PhMe, 40 °C
90% yield
ref [7a]
(R)BzN
O
Me
97 98
98% ee
NaOH
MeOH
(R)HN
O
Me
(i) NaOH
58% yield
99
0 °C
92% yield
Path A: [a] = +26° (S)
Path B: [a] = –30° (R)
NaH, BnBr
59% yield
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asymmetric DAA reaction, and improvement upon existing ANDEN Trost ligands by 
modulation of ligand electronics.  It is our hope that this method will prompt further 
investigation of these substrates for the synthesis of stereocenters in acyclic systems, use 
of the products of this reaction in total synthesis efforts, and further use of the newly 
developed electron-deficient ligand in other catalytic reactions. 
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3.4  EXPERIMENTAL SECTION 
3.4.1  Materials and Methods 
Unless stated otherwise, reactions were performed at ambient temperature (23 °C) in 
flame-dried glassware under an nitrogen atmosphere using dry, deoxygentated solvents 
(distilled or passed over a column of activated alumina).9 Commercially available 
reagents were used as received.  Reactions requiring external heat were modulated to the 
specified temperatures using an IKAmag temperature controller.  Thin-layer 
chromatography (TLC) was performed using E. Merck silica gel 60 F254 pre-coated 
plates (250 nm) and visualized by UV fluorescence quenching, potassium permanganate, 
or p-anisaldehyde staining.  Silicycle SiliaFlash P60 Academic Silica gel (particle size 
40- 63 nm) was used for flash chromatography.  (S)-t-BuPHOX,10 (S)-(CF3)-t-BuPHOX,11 
and Bis(dibenzylideneacetone) palladium(0) (Pd(dba)2) were prepared by known 
methods.  Commercially available C-2 symmetric ligands ((R,R)-DACH-naphthyl Trost 
ligand, (R,R)-DACH-phenyl Trost ligand, (R,R)-ANDEN-Phenyl Trost Ligand) were 
purchased from Sigma Aldrich, used as received, and stored in a glovebox.  Grubbs’s 
Generation II catalyst was purchased from Materia inc. and used as received.  1H and 13C 
NMR spectra were recorded on a Varian Inova 500 (500 MHz and 126 MHz, 
respectively) and are reported in terms of chemical shift relative to CHCl3 (δ 7.26 and 
77.16, respectively).  Data for 1H NMR spectra are reported as follows: chemical shift (δ 
ppm) (multiplicity, coupling constant (Hz), integration). Infrared (IR) spectra were 
recorded on a Perkin Elmer Paragon 1000 Spectrometer and are reported in frequency of 
absorption (cm-1).  Analytical chiral SFC was performed with a Mettler SFC supercritical 
CO2 analytical chromatography system with Chiralpak AD-H column, OD-H column, 
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and OJ-H column obtained from Daicel Chemical Industries, Ltd. High resolution mass 
spectra (HRMS) were obtained from the Caltech Mass Spectral Facility using a JEOL 
JMS-600H High Resolution Mass Spectrometer in fast atom bombardment (FAB+) or 
electron ionization (EI+) mode, or from the Caltech Center for Catalysis and Chemical 
Synthesis using an Agilent 6200 series TOF with an Agilent G1978A Multimode source 
in mixed (Multimode ESI/APCI) ionization mode.  Optical rotations were measured on a 
Jasco P-2000 polarimeter using a 100 mm path-length cell at 589 nm.  
 
3.4.2  Ligand Synthesis 
 
Br
F3C
OHO
Br
F3C
OMeO
MeO2C
P
F3C
O
CF3
CF3
MeO2C
P
F3C
CF3
CF3
HO2C
P
F3C
CF3
CF3
100 101
103
102
104
93
N
H
N
H
O O
F3C
PAr2 Ar2P
CF3
Ar = 4-CF3-C6H4
MeI (1.20 equiv)
K2CO3 (1.10 equiv)
DMF, 23 °C, 16h
81% yield 78% yield
PhMe, 110 °C, 24h
sealed flask
(p-CF3-C6H4)2PHO
(1.0 equiv)
CuI (20 mol%)
(S)-α-phenethylamine
(20 mol%)
K2CO3 (2.0 equiv)
TEA (4.35 equiv)
Cl3SiH (4.2 equiv)
PhMe, 110 °C, 16h
sealed flask
LiOH•H2O
 (20 equiv)
87% yield
THF, H2O, 70 °C, 12h
92% yield
DCC (1.0 equiv)
(R,R)-S6 (0.47 equiv)
DMAP (cat.)
CH2Cl2, 0 °C to rt, 16h
64% yield
NH2H2N
105 reference 18
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Methyl 2-bromo-5-(trifluoromethyl)benzoate (101) 
To an oven-dried round-bottom flask and magnetic stir bar was added 2-bromo-5-
(trifluoromethyl)benzoic acid (101)12 (1.91 g, 7.10 mmol) followed by anhydrous DMF 
(20.0 mL).  The solution was stirred under nitrogen at room temperature.  Solid 
potassium carbonate (1.08 g, 7.81 mmol) was added all at once followed by methyl 
iodide (0.53 mL, 8.52 mmol) dropwise by syringe.  The reaction was stirred at room 
temperature for 16h.  Afterward, the reaction mixture was poured into water (300 mL) 
and extracted with ethyl acetate (3 x 80 mL).  The combined organic layers were washed 
with brine (50 mL), dried with sodium sulfate, filtered, and concentrated in vacuo to 
afford the product (1.83 g, 91% yield), which was not purified further.  Characterization 
data matched literature values:13 1H NMR (300 MHz, CDCl3) δ 8.07 (s, 1H), 7.81 (d, J = 
8.0 Hz, 1H), 7.59 –7.56 (m, 1H), 3.97 (s, 3H). 
 
 
Methyl 2-(bis(4-(trifluoromethyl)phenyl)phosphoryl)-5-(trifluoromethyl)benzoate 
(102) 
Procedure adapted from Stankevič and Włodarcyk.14 To an oven dried Schlenk tube 
equipped with a magnetic stir bar was added CuI (0.145 g, 0.761 mmol).  The tube was 
Br
F3C
OMeO
MeO2C
P
F3C
O
CF3
CF3
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purged with nitrogen and (S)-α-phenylethylamine (0.100 mL, 0.760 mmol) was added 
with a micro-syringe followed by 101 (1.09 g, 3.8 mmol) dissolved in toluene (19.0 mL) 
with a syringe.  The reaction mixture was stirred under nitrogen for 5 minutes at room 
temperature.  Bis(4-(trifluoromethyl)phenyl)phosphine oxide (1.30 g, 3.84 mmol) was 
added to the reaction mixture all at once and stirring continued for five minutes.  
Potassium carbonate (1.05 g, 7.60 mmol) was added to the reaction mixture and the tube 
was sealed with a Teflon cap and electrical tape and heated to 110 °C behind a blast 
shield for 24 hours.  The mixture was cooled to room temperature and the mixture was 
filtered through a pad of celite, eluting with dichloromethane.  This mixture was 
concentrated in vacuo and purified by flash chromatography (30:70 to 35/65, 
EtOAc/hexanes) to provide the product as an amorphous white solid (1.61 g, 78% yield); 
1H NMR (500 MHz, CDCl3) δ 8.27 – 8.22 (m, 1H), 7.95 – 7.87 (m, 2H), 7.84 – 7.73 (m, 
8H), 3.59 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 165.7 (d, J = 2.5 Hz), 136.7 – 136.6 
(m), 136.2 (d, J = 6.3 Hz), 135.8 (d, J = 10.4 Hz), 135.8 (m), 134.9 (qd, J = 34.2, 2.4 Hz), 
134.2 (qd, J = 32.9, 3.0 Hz), 132.3 (d, J = 10.4 Hz), 128.5 (dq, J = 11.9, 3.6 Hz), 127.9 
(dq, J = 7.2, 3.5 Hz), 125.7 (dq, J = 12.8, 3.7 Hz), 123.5 (q, J = 272.6 Hz), 123.0 (q, J = 
273.1 Hz), 53.1; 19F NMR (282 MHz, CDCl3) δ -63.2, -63.4; 31P NMR (121 MHz, 
CDCl3) δ 28.7; IR (Neat Film, NaCl) 1737, 1440, 1324, 1269, 1131, 715 cm-1; HRMS 
(MM: ESI-APCI) m/z calc’d for C23H15F9O3P [M+H]+: 541.0610, found 541.0616. 
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Methyl 2-(bis(4-(trifluoromethyl)phenyl)phosphanyl)-5-(trifluoromethyl)benzoate 
(103) 
To an oven-dried Schlenk flask equipped with a magnetic stir bar was added 102 (0.650 
g, 1.20 mmol) in toluene (17.5 mL).  The mixture was stirred under flow of nitrogen at 
room temperature.  Triethylamine (0.730 mL, 5.22 mmol) was added to the reaction 
mixture followed by trichlorosilane (0.510 mL, 5.04 mmol) with a syringe.  At this stage, 
the reaction mixture was heated to 110 °C behind a blast shield for 16 hours.  The 
reaction mixture was cooled to room temperature, diluted with ethyl acetate (40 mL), and 
quenched with a solution of saturated sodium bicarbonate (0.5 mL).  The mixture was 
filtered through celite and eluted with ethyl acetate followed by drying with sodium 
sulfate.  The mixture was filtered, concentrated in vacuo, and purified by flash 
chromatography (2:98 to 4:96, EtOAc/hexanes) to provide the product as a slightly 
yellow oil that solidified at –20 °C and remained solid at room temperature (0.55 g, 87% 
yield).  The purified product slowly oxidizes in the time it takes to characterize; 1H NMR 
(500 MHz, CDCl3) δ 8.38 (ddt, J = 3.6, 2.1, 0.7 Hz, 1H), 7.68 (dd, J = 8.3, 1.9 Hz, 1H), 
7.64 – 7.59 (m, 4H), 7.36 (dddd, J = 7.3, 6.5, 1.7, 0.8 Hz, 4H), 7.02 (ddt, J = 8.1, 3.3, 0.7 
Hz, 1H), 3.84 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 165.9 (d, J = 2.4 Hz), 143.9 (d, J = 
29.8 Hz), 141.4 (d, J = 13.7 Hz), 135.8 (d, J = 10.5 Hz), 134.9, 134.2 (d, J = 21.3 Hz), 
131.5 (q, J = 32.6 Hz), 131.5 (q, J = 33.2 Hz), 128.9 (q, J = 3.5 Hz), 128.1 – 127.8 (m), 
125.7 (dq, J = 7.5, 3.7 Hz), 124.0 (q, J = 272.4 Hz), 123.5 (q, J = 272.7 Hz), 53.0; 19F 
MeO2C
P
F3C
CF3
CF3
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NMR (282 MHz, CDCl3) δ –62.9, –63.1; 31P NMR (121 MHz, CDCl3) δ –5.0; IR (Neat 
Film, NaCl) 1723, 1324, 1257, 1128, 832 cm-1; HRMS (MM: ESI-APCI) m/z calc’d for 
C23H15F9O2P [M+H]
+: 525.0660, found 525.0646. 
 
 
 
2-(Bis(4-(trifluoromethyl)phenyl)phosphanyl)-5-(trifluoromethyl)benzoic acid (104):  
Compound 103 (0.550 g, 1.05 mmol) was charged into a round bottom flask equipped 
with a magnetic stir bar and was dissolved in THF (4.2 mL) at room temperature.  Water 
(4.2 mL) was added to this solution followed by lithium hydroxide monohydrate (0.882 
g, 21.0 mmol).  The reaction mixture was sealed with a Teflon cap, stirred, and heated to 
70 °C for 12 hours.  The mixture was cooled to room temperature and diluted with ethyl 
acetate (50 mL).  This mixture was added to a 10% aqueous citric acid solution (50 mL) 
and this phase was extracted with ethyl acetate (2 x 50 mL).  The combined organic 
phases were washed with brine, dried with sodium sulfate, filtered, and concentrated in 
vacuo.  The crude material was purified by flash chromatography (3:97 to 5:95, 
MeOH:CH2Cl2) to provide the product as a white amorphous solid (0.492 g, 92% yield); 
1H NMR (300 MHz, CD3OD) δ 8.39 (s, 1H), 7.76 (d, J = 8.2 Hz, 1H), 7.68 (d, J = 8.0 
Hz, 4H), 7.43 (t, J = 7.6 Hz, 4H), 7.07 (dd, J = 8.1, 3.4 Hz, 1H); 13C NMR (126 MHz, 
CD3OD) δ 168.5 (d, J = 5.1 Hz), 145.4 (d, J = 30.2 Hz), 143.9 (d, J = 14.6 Hz), 137.2 (d, 
J = 20.7 Hz), 136.0, 135.5 (d, J = 21.6 Hz), 132.1 (q, J = 32.3 Hz), 132.1 (q, J = 33.0 
HO2C
P
F3C
CF3
CF3
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Hz), 129.5 (q, J = 3.4 Hz), 128.7 – 128.5 (m), 126.5 (dq, J = 7.4, 3.7 Hz), 125.5 (q, J = 
271.5 Hz), 125.1 (q, J = 271.6 Hz); 19F NMR (282 MHz, cd3od) δ -64.3, -64.5; 31P NMR 
(121 MHz, MeOD) δ -4.9; IR (Neat Film, NaCl) 1698, 1324, 1127, 832 cm-1; HRMS 
(MM: ESI-APCI) m/z calc’d for C22H11F9O2P [M-H]-: 509.0358, found 509.0369. 
 
 
Electron deficient C-2 symmetric ligand (93): 
To an oven-dried flask equipped with a magnetic stir bar was added chiral diamine 10515 
(0.035 g, 0.149 mmol) and dichloromethane (2.6 mL) at room temperature under 
nitrogen.  Benzoic acid 104 (0.160 g, 0.313 mmol) was added to the reaction and an 
insoluble mixture was formed.  The reaction mixture was cooled to 0 °C and a single 
crystal of DMAP was added.  DCC (0.065 g, 0.313 mmol) was added all at once and the 
mixture was slowly allowed to warm to room temperature overnight (12 hours).  At this 
time, the cloudy mixture was filtered through celite, eluting with dichloromethane, and 
concentrated.  The crude material was suspended in a small amount of diethylether and 
filtered once again through a pad of celite.  This mixture was concentrated and purified 
by flash chromatography (8:92 to 10:90, EtOAc:hexanes) to provide the product as a 
white amorphous solid (0.116 g, 64% yield); 1H NMR (500 MHz, CDCl3) δ 7.64 – 7.58 
(m, 8H), 7.56 (d, J = 8.0 Hz, 4H), 7.40 (dd, J = 7.3, 1.3 Hz, 2H), 7.34 – 7.28 (m, 10H), 
7.25 – 7.15 (m, 4H), 7.08 (dd, J = 8.1, 3.1 Hz, 2H), 5.82 (d, J = 7.7 Hz, 2H), 4.49 (d, J = 
N
H
N
H
O O
F3C
PAr2 Ar2P
CF3
Ar = 4-CF3-C6H4
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2.4 Hz, 2H), 4.15 – 4.08 (m, 2H); 13C NMR (126 MHz, CDCl3) δ 167.2, 141.7 (d, J = 
28.3 Hz), 141.1 (dd, J = 25.5, 14.6 Hz), 140.6 , 140.3 (d, J = 25.0 Hz), 138.5, 135.5, 
133.9 (dd, J = 20.8, 7.0 Hz), 131.9 (q, J = 33.3 Hz), 131.5 (qd, J = 32.6, 1.3 Hz), 127.5 
(q, J = 3.4 Hz), 127.4, 127.1, 125.9, 125.7 (dt, J = 6.9, 3.6 Hz), 125.3, 124.3 – 123.9 (m), 
123.97 (qd, J = 272.3, 5.8 Hz), 123.3 (q, J = 272.8 Hz), 57.8, 48.9; 19F NMR (282 MHz, 
CDCl3) δ –62.9, –62.9, –63.1; 31P NMR (121 MHz, CDCl3) δ –10.70; IR (Neat Film, 
NaCl) 1659, 1509, 1397, 1325, 1172, 1130, 1061, 832 cm-1; HRMS (MM: ESI-APCI) m/z 
calc’d for C60H37F18N2O2P2 [M+H]+: 1221.2037, found 1221.2039; [α]25 –55.0 (c 3.17 
CHCl3). 
 
 	  
N
H
N
H
O O
PAr2 Ar2P
94: Ar = 2-CH3-C6H4
CH2Cl2, 0 °C to rt
16h NH2H2N
105 reference 18
H
P
Me
Me
KHMDS
(1.65 equiv)
THF, –78 °C
3h
+
F
CO2Me
106 107
(1.5 equiv) (1.0 equiv)
P
Me
Me CO2Me
10868% yield
LiOH•H2O
(20 equiv)
H2O, THF
–78 °C, 12h
P
Me
Me CO2H
109
DCC (1.0 equiv)
(R,R)-S6
(0.47 equiv)
DMAP (cat.)
90% yield
74% yield
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Methyl 2-(di-o-tolylphosphanyl)benzoate (108): 
In a nitrogen filled glove box, an oven-dried round-bottom flask equipped with a 
magnetic stir bar was charged with di-(o-tolyl)phosphine (106) (0.321 g, 1.50 mmol).  
The flask was sealed with a cap equipped with a septa and electrical tape and removed 
from the glove box.  The flask was then charged with THF (8.0 mL) under positive 
nitrogen pressure.  This mixture was cooled to –78 °C in a dry ice/acetone bath. A freshly 
prepared solution of KHMDS (2.00 mL, 1.65 mmol, 0.825 M) was added to the mixture 
dropwise by syringe.  The reaction mixture was stirred at this temperature for 30 min and 
then warmed to room temperature.  Methyl-2-fluorobenzoate (107) (0.13 mL, 1.0 mmol) 
was added dropwise and the mixture was stirred for 2.5 hours.  A precipitate formed and 
the reaction turned black in color.  The mixture was quenched and diluted with water (10 
mL).  The aqueous phase was extracted with ethyl acetate (3 x 30 mL) and the combined 
organic layers were dried with sodium sulfate, filtered, and evaporated in vacuo.  The 
crude material was purified by flash chromatography (5:95, EtOAc:hexanes) to provide 
the product as a white amorphous solid (0.238 g, 68% yield); 1H NMR (300 MHz, 
CDCl3) δ 8.10 (ddd, J = 7.2, 3.9, 1.8 Hz, 1H), 7.42 (pd, J = 7.4, 1.7 Hz, 2H), 7.33 – 7.21 
(m, 4H), 7.08 (td, J = 7.0, 6.5, 2.3 Hz, 2H), 6.97 (ddt, J = 7.7, 3.6, 1.6 Hz, 1H), 6.75 (ddd, 
J = 7.5, 4.3, 1.2 Hz, 2H), 3.77 (s, 3H), 2.44 (d, J = 1.7 Hz, 6H); 13C NMR (126 MHz, 
CDCl3) δ 167.3 (d, J = 1.9 Hz), 142.6 (d, J = 27.7 Hz), 139.5 (d, J = 25.4 Hz), 136.1 (d, J 
= 11.4 Hz), 134.9 (d, J = 20.3 Hz), 134.5, 133.2, 132.2, 131.0 (d, J = 3.0 Hz), 130.2 (d, J 
P
Me
Me CO2Me
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= 4.8 Hz), 128.8, 128.4, 126.2, 52.2, 21.4 (d, J = 22.6 Hz); 31P NMR (121 MHz, CDCl3) δ 
–20.4; IR (Neat Film, NaCl) 3055, 1721, 1452, 1269, 1107, 749 cm-1; HRMS (MM: ESI-
APCI) m/z calc’d for C22H22O2P [M+H]+: 349.1352, found 349.1362. 
 
 
2-(Di-o-tolylphosphanyl)benzoic acid (109): 
Compound 108 (0.238 g, 0.683 mmol) was charged into a round bottom flask equipped 
with a magnetic stir bar and was dissolved in THF (2.8 mL) at room temperature.  Water 
(2.8 mL) was added to this solution followed by lithium hydroxide monohydrate (0.574 
g, 13.7 mmol).  The reaction mixture was sealed with a Teflon cap, stirred and heated to 
70 °C for 12 hours.  The mixture was cooled to room temperature and diluted with ethyl 
acetate (30 mL).  This mixture was added to a 10% aqueous citric acid solution (50 mL) 
and this phase was extracted with ethyl acetate (2 x 30 mL).  The combined organic 
phases were washed with brine, dried with sodium sulfate, filtered, and concentrated in 
vacuo.  The crude material was purified by flash chromatography (40:60, 
EtOAc:hexanes) to provide the product as a white amorphous solid (0.205 g, 90% yield).  
Characterization data matched literature values.16 1H-NMR (500 MHz, CDCl3) δ 8.14–
8.20 (m, 1H), 7.38–7.45 (m, 2H), 7.18–7.27 (m, 4H), 7.05 (t, J = 7.5 Hz, 2H), 6.96–7.01 
(m, 1H), 6.68–6.72 (m, 2H), 2.40 (s, 6H); HRMS (MM: ESI-APCI) m/z calc’d for 
C21H18O2P [M-H]
-: 333.1044, found 333.1050. 
 
P
Me
Me CO2H
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Sterically hindered C2-symmetric ligand (94): 
To an oven-dried flask equipped with a magnetic stir bar was added 10515 (0.050 g, 0.212 
mmol) and dichloromethane (3.0 mL) at room temperature under nitrogen.  Benzoic acid 
109 (0.150 g, 0.450 mmol) was added to the reaction and an insoluble mixture was 
formed.  The reaction mixture was cooled to 0 °C and a single crystal of DMAP was 
added.  DCC (0.093 g, 0.45 mmol) was added all at once and the mixture was slowly 
allowed to warm to room temperature overnight (12 hours).  At this time, the cloudy 
mixture was filtered through celite, eluting with dichloromethane, and concentrated.  The 
crude material was suspended in a small amount of diethylether and filtered once again 
through a pad of celite.  This mixture was concentrated and purified by flash 
chromatography (20:80 to 40:60, Et2O:pentane) to provide the product as a white 
amorphous solid (0.136 g, 74% yield); 1H NMR (300 MHz, CDCl3) δ 7.55 – 7.48 (m, 
2H), 7.39 – 7.20 (m, 14H), 7.15 – 7.06 (m, 4H), 7.04 – 6.93 (m, 6H), 6.88 (ddd, J = 7.5, 
4.2, 1.3 Hz, 2H), 6.75 – 6.68 (m, 2H), 6.65 (dd, J = 7.6, 4.3 Hz, 2H), 5.74 (d, J = 7.1 Hz, 
2H), 4.36 (s, 2H), 3.83 (d, J = 7.0 Hz, 2H), 2.35 (d, J = 4.6 Hz, 12H); 13C NMR (126 
MHz, CDCl3) δ 169.1 (d, J = 1.8 Hz), 142.6 – 142.2 (m), 141.0, 138.7, 135.3 (d, J = 10.8 
Hz), 134.9, 134.2 (d, J = 18.4 Hz), 132.9 (d, J = 62.2 Hz), 130.5 (dd, J = 14.7, 4.6 Hz), 
130.4, 129.2, 128.9 (d, J = 10.1 Hz), 128.0 (d, J = 6.1 Hz), 126.7 (d, J = 11.0 Hz), 126.4 
(d, J = 30.4 Hz), 125.9, 124.8, 57.9, 48.6, 21.5 (dd, J = 21.6, 9.6 Hz); 31P NMR (121 
MHz, CDCl3) δ –26.5; IR (Neat Film, NaCl) 3054, 1658, 1501, 908, 748 cm-1; HRMS 
N
H
N
H
O O
PAr2 Ar2P
Ar = 2-CH3-C6H4
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(MM: ESI-APCI) m/z calc’d for C58H51N2O2P2 [M+H]+: 869.3420, found 869.3433; [α]25 
– 84.1 (c 1.83, CHCl3). 	
3.4.3  Exploratory Allylic Alkylation Screen 
Initially, we ran a series of screens to determine the best combination of ligand 
and solvent that provided the highest %ee for the allylic alkylation.  The following 
procedure was followed to conduct these screens.  This procedure is similar to that 
previously used by the Stoltz group.6a To separate enantiomers, the allylic alkylation 
products were derivitized using a cross metathesis with Grubbs-second generation 
catalyst and methyl acrylate.  This procedure is similar to that previously used by the 
Stoltz group.17 
General Screening Procedure (from Table 1 and Table 2):  
In a nitrogen-filled glove box, 38.0 mg Pd(dba2) was taken up in 10 mL THF.  To 
each of 16 half-dram vials, 0.5 mL of this solution (1.90 mg Pd(dba)2, 1.65 µmol, 0.100 
equiv) was added.  The THF was then removed by evacuation using a Genevac 
centrifugal evaporator within the glove box.  To each of the vials was then added 500 µL 
of the reaction solvent followed by a small stirbar.  Stock solutions of ligand (0.0165 M) 
were made in each reaction solvent.  From these ligand stock solutions, 250 µL (4.13 
µmol, 0.125 equiv) were added to the corresponding reaction vials.  The resulting catalyst 
solutions were stirred in the glove box for 30 minutes at the indicated reaction 
temperature.  Stock solutions of reaction substrate (0.132 M) were made in each reaction 
solvent.  To the stirring catalyst solutions were added 250 µL (33.0 µmol, 1.00 equiv) of 
the corresponding substrate solution, resulting in a final reaction volume of 1.00 mL 
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(0.033 M with respect to substrate).  The reactions were sealed with a Teflon-lined cap 
and stirred for the indicated reaction duration.  The reactions were then removed from the 
glove box, diluted with 1 mL hexanes and filtered through a silica plug, concentrated in 
vacuo, taken up in CDCl3, and analyzed by crude 1H NMR to determine conversion. 
The crude reaction mixtures in CDCl3 were concentrated in vacuo in half-dram 
vials and returned to the glove box.  To each half-dram vial was added 500 µL of methyl 
acrylate solution in CH2Cl2 (0.66M, 0.33 mmol, 10 equiv), followed by a small stir bar.  
The reactions were stirred for approximately 15 minutes.  To the resulting solutions was 
added 500 µL each of a Grubbs second-generation Ru catalyst solution in CH2Cl2 (0.004 
M, 2 µmol, 0.06 equiv).  The reactions were then stirred at 40 °C for 3 hours, removed 
from the glove box, filtered through a silica plug, concentrated in vacuo, and analyzed by 
crude 1H NMR to determine conversion and chiral SFC to determine enantiomeric 
excess.  SFC conditions for each substrate can be found in a table at the end of the text 
portion of the SI. 
 
3.4.3.1  Characterization data for compounds relevant to exploratory 
screen 
 
(R)-3-(2-Allyl-2-methylhexanoyl)oxazolidin-2-one (87a) 
Prepared from 86a or 86b: 
1H NMR (500 MHz, CDCl3) δ 5.72 (ddt, J = 17.4, 10.1, 7.4 Hz, 1H), 5.10 – 5.01 (m, 2H), 
4.42 – 4.34 (m, 2H), 4.09 – 3.98 (m, 2H), 2.92 – 2.84 (m, 1H), 2.36 (ddt, J = 14.1, 7.2, 
O
Bu
Me
N O
O
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1.2 Hz, 1H), 2.10 (ddd, J = 13.7, 11.9, 4.6 Hz, 1H), 1.67 (ddd, J = 13.6, 12.4, 4.3 Hz, 
1H), 1.31 (s, 3H), 1.30 – 1.19 (m, 3H), 1.15 – 1.03 (m, 1H), 0.88 (t, J = 7.2 Hz, 3H); 13C 
NMR (126 MHz, CDCl3) δ 177.3, 152.4, 134.5, 117.8, 62.3, 49.0, 45.4, 41.0, 35.8, 27.0, 
23.2, 22.5, 14.1; IR (Neat Film, NaCl) 2958, 2928, 1777, 1685, 1382, 1200 cm-1; HRMS 
(FAB+) m/z calc’d for C13H22NO3 [M+H]+: 240.1600, found 240.1601. 
 
 
(R)-1-(2-Allyl-2-methylhexanoyl)indolin-2-one (87c) 
Prepared from 86c: 
1H NMR (500 MHz, CDCl3) δ 7.88 – 7.82 (m, 1H), 7.24 – 7.17 (m, 3H), 5.80 – 5.68 (m, 
1H), 5.12 – 5.03 (m, 1H), 5.05 – 5.00 (m, 1H), 2.97 (dd, J = 14.1, 7.4 Hz, 1H), 2.48 (dd, J 
= 14.1, 7.3 Hz, 1H), 2.18 (td, J = 12.6, 11.4, 4.3 Hz, 1H), 1.78 (td, J = 14.1, 3.8 Hz, 1H), 
1.43 (s, 3H), 1.35 – 1.23 (m, 3H), 1.23 – 1.11 (m, 1H), 0.87 (t, J = 6.9 Hz, 3H); 13C NMR 
(126 MHz, CDCl3) δ 177.3, 150.5, 143.0, 133.9, 129.4, 125.0, 124.6, 118.7, 116.1, 109.9, 
50.5, 41.2, 36.1, 27.0, 23.3, 22.4, 14.1; IR (Neat Film, NaCl) 2958, 2932, 1795, 1479, 
1299, 1027, 757 cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C17H22NO3 [M+H]+: 
288.1600, found 288.1603. 
 
 
Methyl (R,E)-5-methyl-5-(2-oxooxazolidine-3-carbonyl)non-2-enoate (88a) 
Prepared from 86a: 
O
Bu
Me
N O
O
O
Bu
Me
N O
O
MeO2C
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1H NMR (500 MHz, CDCl3) δ 6.85 (dt, J = 15.4, 7.7 Hz, 1H), 5.86 (dt, J = 15.5, 1.4 Hz, 
1H), 4.40 (t, J = 8.0 Hz, 2H), 4.04 (t, J = 8.0 Hz, 2H), 3.71 (s, 3H), 3.01 (ddd, J = 14.5, 
7.6, 1.5 Hz, 1H), 2.51 (ddd, J = 14.5, 7.9, 1.4 Hz, 1H), 2.01 (ddd, J = 13.8, 11.9, 4.8 Hz, 
1H), 1.76 (ddd, J = 13.8, 12.1, 4.7 Hz, 1H), 1.34 (s, 3H), 1.31 – 1.24 (m, 2H), 1.24 – 1.07 
(m, 2H), 0.87 (t, J = 7.3 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 176.7, 166.8, 152.5, 
145.4, 123.9, 62.4, 51.6, 49.0, 45.4, 39.8, 35.8, 27.0, 23.2, 22.4, 14.1; IR (Neat Film, 
NaCl) 2931, 2957, 1778, 1723, 1688, 1274, 1197 cm-1; HRMS (FAB+) m/z calc’d for 
C15H24NO5 [M+H]+: 298.1654, found 298.1650. 
 
 
Methyl (R,E)-5-methyl-5-(2-oxo-2,3-dihydrobenzo[d]oxazole-3-carbonyl)non-2-
enoate (88c) 
Prepared from 86c: 
1H NMR (500 MHz, CDCl3) δ 7.89 – 7.85 (m, 1H), 7.26 – 7.19 (m, 3H), 6.90 (dt, J = 
15.4, 7.7 Hz, 1H), 5.90 (dt, J = 15.5, 1.4 Hz, 1H), 3.70 (s, 3H), 3.08 (ddd, J = 14.3, 7.5, 
1.4 Hz, 1H), 2.66 (ddd, J = 14.3, 7.9, 1.4 Hz, 1H), 2.15 – 2.05 (m, 1H), 1.94 – 1.84 (m, 
1H), 1.46 (s, 3H), 1.36 – 1.14 (m, 4H), 0.86 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, 
CDCl3) δ 176.5, 166.6, 150.5, 144.5, 143.0, 129.2, 125.2, 124.8, 124.4, 116.2, 110.0, 
51.7, 50.3, 39.9, 36.0, 27.0, 23.1, 22.0, 14.0; IR (Neat Film, NaCl) 2256, 1796, 1722, 
1479, 1272, cm-1; HRMS (FAB+) m/z calc’d for C19H24NO5 [M+H]+: 346.1654, found 
346.1650. 
 
O
Bu
Me
N O
O
MeO2C
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3.4.4  Allylic Alkylation Substrate Library 
Representative Procedure: 
Unless otherwise noted, the allylic alkylation reactions proceeded as follows: Outside of 
a glove box, an oven-dried 2-dram vial equipped with a magnetic stir bar was charged 
with Pd(dba)2 (2.3 mg, 4.0 µmol, 4 mol%).  A second oven-dried two-dram vial was 
charged with allylenolcarbonate 86d–86q (0.1 mmol).  Finally, a third oven-dried 2-dram 
vial was charged with C-2 symmetric ligand 89 or 90 (7.0 µmol).  These three uncapped 
vials were brought into a nitrogen-filled glove box through a small antechamber with 4 x 
5 minute vacuum cycles with nitrogen back-filling.  To the vial containing compounds 
86d–86q was added or THF (0.3 mL) unless otherwise noted.  To the vial containing C-2 
symmetric ligand (89 or 90) was added THF (0.3 ml) unless otherwise noted.  To the vial 
containing Pd(dba)2 and a magnetic stir bar was added the entirety of the ligand solution 
and the reaction was capped, cooled to 20 °C and stirred for 30 min to form the catalyst.  
At this time, the entirety of the solution containing the substrate (86d–86q) was added to 
the catalyst mixture dropwise and the reactions were allowed to stir at 20 °C for 24h.  
The reaction mixtures were removed from the glove box through the small antechamber 
and diluted with hexanes (1mL).  The mixture was filtered through a short plug of silica 
gel and eluted with ethyl acetate.  The crude material was concentrated and purified by 
preparative TLC (EtOAc:hexanes mixtures) to provide the products as clear to slightly 
yellow oils (53–88% yield).  Purified products were converted to the corresponding 
methyl acrylate species via cross metathesis for SFC analysis. 
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Methyl (R)-(2-allyl-2-methylhexanoyl)(benzyl)carbamate (87d) 
Representative Procedure H.  Compound 87d was prepared from allylenolcarbonate 86d 
using General Procedure G (27.0 mg, 85% yield); 1H NMR (500 MHz, CDCl3) δ 7.34 – 
7.20 (m, 5H), 5.63 – 5.53 (m, 1H), 5.03 – 4.93 (m, 2H), 4.76 (s, 2H), 3.76 (s, 3H), 2.58 
(ddt, J = 13.7, 7.2, 1.3 Hz, 1H), 2.27 (ddt, J = 13.7, 7.6, 1.2 Hz, 1H), 1.78 (ddd, J = 13.4, 
12.3, 4.5 Hz, 1H), 1.52 (ddd, J = 13.3, 12.4, 4.5 Hz, 1H), 1.27 – 1.14 (m, 2H), 1.19 (s, 
3H), 1.16 – 1.04 (m, 1H), 1.06 – 0.91 (m, 1H), 0.83 (t, J = 7.3 Hz, 3H); 13C NMR (126 
MHz, CDCl3) δ 182.9, 155.6, 137.8, 134.6, 128.5, 128.3, 127.5, 117.8, 53.5, 50.6, 50.54, 
44.1, 39.6, 26.8, 23.4, 22.5, 14.1; IR (Neat Film, NaCl) 2932, 2872, 1738, 1681, 1444, 
1156, 998, 916 cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C19H28NO3 [M+H]+: 
318.2064, found 318.2064; [α]25 –2.36 (c 2.40, CHCl3, 92% ee). 
 
 
Ethyl (R)-(2-allyl-2-methylhexanoyl)(benzyl)carbamate (87e) 
Representative Procedure H.  Compound 87e was prepared from allylenolcarbonate 86e 
using General Procedure G (20.5 mg, 62% yield); 1H NMR (500 MHz, CDCl3) δ 7.36 – 
7.12 (m, 5H), 5.56 (ddt, J = 17.3, 10.1, 7.3 Hz, 1H), 5.02 – 4.87 (m, 2H), 4.72 (s, 2H), 
4.15 (q, J = 7.1 Hz, 2H), 2.57 (ddd, J = 13.7, 7.1, 1.3 Hz, 1H), 2.25 (ddd, J = 13.7, 7.1, 
1.3 Hz, 1H), 1.76 (td, J = 12.9, 4.5 Hz, 1H), 1.50 (td, J = 12.9, 4.5 Hz, 1H), 1.20 (t, J = 
7.1 Hz, 3H), 1.20 – 1.13 (m, 2H), 1,17 (s, 3H), 1.12 – 1.02 (m, 1H), 1.02 – 0.92 (m, 1H), 
O
Bu
Me
N
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0.79 (t, J = 7.3 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 183.1, 155.2, 138.0, 134.7, 
128.4, 128.3, 127.4, 117.8, 63.0, 50.6, 50.5, 44.1, 39.5, 26.8, 23.4, 22.5, 14.3, 14.1; IR 
(Neat Film, NaCl) 2958, 2872, 1738, 1693, 1455, 1376, 1345, 1206, 1018 cm-1; HRMS 
(MM: ESI-APCI) m/z calc’d for C20H30NO3 [M+H]+: 332.2220, found 332.2219; [α]25 –
3.19 (c 1.70, CHCl3, 94% ee).
 
 
 
 
tert-Butyl (R)-(2-allyl-2-methylhexanoyl)(benzyl)carbamate (87f) 
Representative Procedure H.  Compound 87f was prepared from allylenolcarbonate 86f 
using General Procedure G (10.8 mg, 88% yield, 0.034mmol scale): 1H NMR (500 MHz, 
CDCl3) δ 7.32 – 7.19 (m, 5H), 5.73 – 5.60 (m, 1H), 5.07 – 4.95 (m, 2H), 4.71 (s, 2H), 
2.66 (ddt, J = 13.6, 7.2, 1.3 Hz, 1H), 2.32 (ddt, J = 13.5, 7.6, 1.2 Hz, 1H), 1.84 (ddd, J = 
13.3, 12.0, 4.4 Hz, 1H), 1.56 (ddd, J = 13.2, 12.4, 4.5 Hz, 1H), 1.36 (s, 9H), 1.28 – 1.20 
(m, 2H), 1.26 (s, 3H), 1.20 – 1.12 (m, 1H), 1.07 (dddd, J = 15.0, 12.6, 7.3, 4.3 Hz, 1H), 
0.85 (t, J = 7.2 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 183.3, 153.9, 138.5, 134.9, 
128.4, 128.1, 127.3, 117.7, 82.7, 50.8, 50.3, 44.1, 39.5, 27.9, 26.9, 23.4, 22.5, 14.2; IR 
(Neat Film, NaCl) 2958, 2931, 2872, 1736, 1682, 1368, 1212, 987, 699 cm-1; HRMS 
(FAB+) m/z calc’d for C22H34NO3 [M+H]+: 360.2539, found 360.2527; [α]25 -2.89 (c 0.8, 
CHCl3, 90% ee). 
 
 
Benzyl (R)-(2-allyl-2-methylhexanoyl)(benzyl)carbamate (87g) 
O
Bu
Me
N
CO2tBu
Bn
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CO2Bn
Bn
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Representative Procedure H.  Compound 87g was prepared from allylenolcarbonate 86g 
using General Procedure G (21.0 mg, 53% yield); 1H NMR (500 MHz, CDCl3) δ 7.35 –
7.31 (m, 3H), 7.28 – 7.20 (m, 7H), 5.61 – 5.51 (m, 1H), 5.15 (s, 2H), 4.97 – 4.93 (m, 1H), 
4.93 – 4.91 (m, 1H), 4.78 (s, 2H), 2.58 (ddt, J = 13.6, 7.1, 1.2 Hz, 1H), 2.25 (ddt, J = 
13.6, 7.7, 1.2 Hz, 1H), 1.75 (ddd, J = 13.3, 12.1, 4.4 Hz, 1H), 1.50 (ddd, J = 13.3, 12.4, 
4.4 Hz, 1H), 1.18 (s, 3H), 1.16 – 1.12 (m, 2H), 1.10 – 1.02 (m, 1H), 1.02 – 0.91 (m, 1H), 
0.80 (t, J = 7.2 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 183.1, 155.0, 137.9, 135.0, 
134.6, 128.7, 128.7, 128.7, 128.5, 128.3, 127.5, 117.8, 68.7, 50.7, 50.6, 44.0, 39.4, 26.8, 
23.3, 22.5, 14.1; IR (Neat Film, NaCl) 3067, 2957, 2932, 2872, 1732, 1696, 1456, 1386, 
1347, 1192 cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C25H32NO3 [M+H]+: 394.2377, 
found 394.2376; [α]25 
 
–3.88 (c 1.91, CHCl3, 93% ee). 
 
 
Methyl (R)-(2-allyl-2-methylhexanoyl)(4-chlorophenyl)carbamate (87h) 
Representative Procedure H.  Compound 87h was prepared from allylenolcarbonate 86h 
using General Procedure G (20.7 mg, 62% yield); 1H NMR (500 MHz, CDCl3) δ 7.38 – 
7.33 (m, 2H), 7.14 – 7.10 (m, 2H), 5.77 – 5.66 (m, 1H), 5.09 – 5.00 (m, 2H), 3.75 (s, 3H), 
2.54 (ddt, J = 13.8, 7.2, 1.3 Hz, 1H), 2.28 (ddt, J = 13.8, 7.5, 1.2 Hz, 1H), 1.76 – 1.65 (m, 
1H), 1.55 – 1.47 (m, 1H), 1.29 – 1.20 (m, 4H), 1.19 (s, 3H), 0.86 (t, J = 6.9 Hz, 3H); 13C 
NMR (126 MHz, CDCl3) δ 182.3, 154.8, 137.1, 134.0, 133.9, 129.5, 129.3, 118.5, 53.8, 
51.0, 43.4, 39.1, 26.6, 23.3, 22.9, 14.1; IR (Neat Film, NaCl) 2957, 2933, 1742, 1731, 
O
Bu
Me
N
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1491, 1439, 1245, 1091 cm-1; HRMS (FAB+) m/z calc’d for C18H25NO3Cl [M+H]+: 
338.1523, found 338.1531; [α]25 2.64 (c 1.9, CHCl3, 90% ee). 
 
 
Methyl (R)-(2-allyl-2-methyloctanoyl)(benzyl)carbamate (87i) 
Representative Procedure H.  Compound 87i was prepared from allylenolcarbonate 86i 
using General Procedure G (24.0 mg, 69% yield); 1H NMR (500 MHz, CDCl3) δ 7.32 – 
7.27 (m, 3H), 7.26 – 7.22 (m, 2H), 5.58 (ddt, J = 17.3, 10.1, 7.3 Hz, 1H), 5.02 – 4.94 (m, 
2H), 4.76 (s, 2H), 3.76 (s, 3H), 2.58 (ddt, J = 13.7, 7.0, 1.2 Hz, 1H), 2.27 (ddt, J = 13.6, 
7.6, 1.2 Hz, 1H), 1.77 (ddd, J = 13.3, 12.0, 4.4 Hz, 1H), 1.51 (ddd, J = 13.3, 12.0, 4.4 Hz, 
1H), 1.19 (s, 3H), 1.28 – 1.14 (m, 6H), 1.16 – 1.06 (m, 1H), 1.05 – 0.95 (m, 1H), 0.86 (t, 
J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 182.88, 155.63, 137.81, 134.58, 128.45, 
128.30, 127.49, 117.79, 53.54, 50.60, 50.57, 44.12, 39.90, 31.79, 29.97, 24.52, 22.73, 
22.45, 14.22; IR (Neat Film, NaCl) 3067, 2950, 2930, 2858, 1738, 1694, 1455, 1445, 
1351, 1208, 1000 cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C21H32NO3 [M+H]+: 
346.2377, found 346.2375; [α]25 
 
–2.14 (c 2.18, CHCl3, 94% ee). 
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Methyl (S)-benzyl(2-(2-((tert-butyldimethylsilyl)oxy)ethyl)-2-methylpent-4-
enoyl)carbamate (87j) 
Representative Procedure H.  Compound 87j was prepared from allylenolcarbonate 86j 
using General Procedure G (32.1 mg, 76% yield); 1H NMR (500 MHz, CDCl3) δ 7.29 – 
7.18 (m, 5H), 5.52 (ddt, J = 17.2, 10.1, 7.3 Hz, 1H), 4.99 – 4.90 (m, 2H), 4.74 (s, 2H), 
3.73 (s, 3H), 3.54 – 3.44 (m, 2H), 2.58 (dd, J = 13.6, 7.1 Hz, 1H), 2.27 (dd, J = 13.6, 7.5 
Hz, 1H), 2.11 – 2.03 (m, 1H), 1.84 – 1.76 (m, 1H), 1.20 (s, 3H), 0.83 (d, J = 0.7 Hz, 9H), 
-0.03 (d, J = 1.8 Hz, 6H); 13C NMR (126 MHz, CDCl3) δ 182.1, 155.5, 137.8, 134.3, 
128.5, 128.2, 127.5, 118.1, 59.9, 53.6, 50.6, 49.2, 44.5, 41.9, 26.1, 22.7, 18.4, –5.2, –5.2;  
IR (Neat Film, NaCl) 2955, 2929, 2857, 1741, 1686, 1444, 1351, 1207, 1095, 837 cm-1; 
HRMS (FAB+) m/z calc’d for C23H38NO3 [M+H]+: 420.2570, found 420.2541; [α]25 
 
– 
6.23 (c 2.91, CHCl3, 94% ee). 
 
 
Methyl (S)-benzyl(2-methyl-2-phenylpent-4-enoyl)carbamate (87k) 
Representative Procedure H.  Compound 87k was prepared from allylenolcarbonate 86k 
using General Procedure G (26.0 mg, 77% yield); 1H NMR (500 MHz, CDCl3) δ 7.36 – 
7.30 (m, 4H), 7.30 – 7.23 (m, 3H), 7.20 – 7.15 (m, 1H), 7.06 – 7.01 (m, 2H), 5.34 (dddd, 
J = 16.8, 10.3, 8.1, 6.5 Hz, 1H), 4.95 (ddt, J = 8.7, 2.2, 1.2 Hz, 1H), 4.93 (h, J = 1.2 Hz, 
1H), 4.88 (s, 2H), 3.22 (s, 3H), 2.90 (ddt, J = 13.7, 8.2, 1.0 Hz, 1H), 2.55 (ddt, J = 13.6, 
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6.6, 1.4 Hz, 1H), 1.63 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 179.7, 154.5, 143.7, 137.5, 
134.3, 128.6, 128.5, 128.1, 127.6, 126.2, 125.9, 118.5, 54.0, 53.3, 50.1, 47.0, 23.8; IR 
(Neat Film, NaCl) 3064, 3007, 2954, 1755, 1674 cm-1; HRMS (MM: ESI-APCI) m/z 
calc’d for C21H23NO3 [M+H]
+: 338.1751, found 338.1754; [α]25 
 
+ 71.01 (c 2.36, CHCl3, 
76% ee). 
 
 
Methyl (R)-(2-allyl-2-ethylhexanoyl)(benzyl)carbamate (87l) 
Representative Procedure H.  Compound 87l was prepared from allylenolcarbonate 86l 
using General Procedure G (8.6 mg, 76% yield, 0.034 mmol scale).  Note: this reaction 
was run in EtOAc and not THF; 1H NMR (500 MHz, CDCl3) δ 7.34 – 7.20 (m, 5H), 5.62 
(ddt, J = 17.3, 10.1, 7.3 Hz, 1H), 5.07 – 4.97 (m, 2H), 4.78 (s, 2H), 3.75 (s, 3H), 2.53 – 
2.39 (m, 2H), 1.82 – 1.55 (m, 4H), 1.28 – 1.18 (m, 2H), 1.15 – 1.00 (m, 2H), 0.85 (t, J = 
7.3 Hz, 3H), 0.76 (t, J = 7.4 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 181.7, 155.6, 137.9, 
134.7, 128.5, 128.3, 127.5, 117.7, 54.0, 53.6, 50.8, 39.1, 35.0, 28.1, 26.7, 23.4, 14.1, 9.0; 
IR (Neat Film, NaCl) 2958, 2933, 2873, 1741, 1732, 1682, 1443, 1350, 1206, 699 cm-1; 
HRMS (MM: ESI-APCI) m/z calc’d for C20H29NO3 [M+H]+: 332.2220, found 332.2216; 
[α]25 +0.64 (c 0.7, CHCl3, 82% ee). 
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Methyl (R)-(2-allyl-2-ethyloctanoyl)(benzyl)carbamate (87m) 
Representative Procedure H.  Compound 87m was prepared from allylenolcarbonate 86m 
using General Procedure G (24.0 mg, 64% yield); 1H NMR (500 MHz, CDCl3) δ 7.36 – 
7.17 (m, 5H), 5.62 (ddt, J = 17.3, 10.1, 7.3 Hz, 1H), 5.09 – 4.95 (m, 2H), 4.78 (s, 2H), 
3.75 (s, 3H), 2.51 – 2.40 (m, 2H), 1.83 – 1.73 (m, 1H), 1.73 – 1.64 (m, 2H), 1.64 – 1.56 
(m, 1H), 1.31 – 1.17 (m, 6H), 1.17 – 1.02 (m, 2H), 0.87 (t, J = 7.0 Hz, 3H), 0.76 (t, J = 
7.4 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 181.7, 155.6, 137.9, 134.7, 128.5, 128.3, 
127.5, 117.7, 54.0, 53.6, 50.8, 39.1, 35.3, 31.8, 30.0, 28.1, 24.4, 22.8, 14.2, 9.0; IR (Neat 
Film, NaCl)2956, 2872, 1739, 1685, 1443, 1350, 1206, 1183, 998 cm-1; HRMS (MM: 
ESI-APCI) m/z calc’d for C22H34NO3 [M+H]+: 360.2533, found 360.2530; [α]25 +1.25 (c 
1.90, CHCl3, 93% ee).
		
 
 
 
Methyl (S)-(2-allyl-2-(3-phenylpropyl)octanoyl)(benzyl)carbamate (87n) 
Representative Procedure H.  Compound 87n was prepared from allylenolcarbonate 86n 
using General Procedure G (22.4 mg, 56% yield, 0.089 mmol scale); 1H NMR (500 MHz, 
CDCl3) δ 7.31 – 7.09 (m, 10H), 5.61 – 5.52 (m, 1H), 5.01 – 4.98 (m, 1H), 4.97 –4.96 (m, 
1H), 4.76 (s, 2H), 3.67 (s, 3H), 2.53 (t, J = 7.5 Hz, 2H), 2.43 (dq, J = 7.4, 1.3 Hz, 2H), 
1.79 – 1.37 (m, 6H), 1.29 – 1.13 (m, 6H), 1.13 – 0.96 (m, 2H), 0.86 (t, J = 7.1 Hz, 3H); 
13C NMR (126 MHz, CDCl3) δ 181.5, 155.5, 142.4, 137.8, 134.6, 128.6, 128.4, 128.4, 
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128.3, 127.5, 125.8, 117.8, 53.6, 53.5, 50.8, 39.6, 36.5, 35.7, 35.1, 31.8, 30.0, 26.3, 24.3, 
22.7, 14.2; IR (Neat Film, NaCl) 2954, 2930, 1738, 1682, 1444, 1350, 1205, 1176, 699 
cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C29H40NO3 [M+H]+: 450.3003, found 
450.2995; [α]25 –0.11 (c 2.0, CHCl3, 76% ee). 
 
 
(R)-3-(2-Allyl-2-ethylhexanoyl)oxazolidin-2-one (87o) 
Representative Procedure H.  Compound 87o was prepared from allylenolcarbonate 86o 
using General Procedure G (16.3 mg, 67% yield); 1H NMR (500 MHz, CDCl3) δ 5.69 
(ddt, J = 17.4, 10.1, 7.4 Hz, 1H), 5.11 – 5.01 (m, 2H), 4.38 (dd, J = 8.4, 7.6 Hz, 2H), 4.04 
(dd, J = 8.5, 7.6 Hz, 2H), 2.68 – 2.54 (m, 2H), 2.05 – 1.76 (m, 4H), 1.33 – 1.23 (m, 2H), 
1.21 – 1.04 (m, 2H), 0.88 (t, J = 7.3 Hz, 3H), 0.80 (t, J = 7.5 Hz, 3H); 13C NMR (126 
MHz, CDCl3) δ 177.5, 152.4, 134.5, 117.9, 62.3, 52.7, 45.6, 36.6, 31.8, 26.6, 25.1, 23.3, 
14.2, 8.8; IR (Neat Film, NaCl) 3076, 2960, 2931, 2874, 1778, 1682, 1468, 1384, 1202 
cm-1; HRMS (FAB+) m/z calc’d for C14H24NO3 [M+H]+: 254.1756, found 254.1756; 
[α]25 
 
0.02 (c 1.45, CHCl3, 69% ee). 
 
 
(R)-3-(2-Allyl-2-ethyloctanoyl)oxazolidin-2-one (87p) 
Representative Procedure H.  Compound 387p was prepared from allylenolcarbonate 86p 
using General Procedure G (20.1 mg, 72% yield); 1H NMR (500 MHz, CDCl3) δ 5.77 – 
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5.58 (m, 1H), 5.14 – 4.96 (m, 2H), 4.38 (t, J = 8.0 Hz, 2H), 4.04 (t, J = 8.0 Hz, 2H), 2.70 
– 2.48 (m, 2H), 2.05 – 1.73 (m, 4H), 1.33 – 1.05 (m, 8H), 0.87 (t, J = 6.7 Hz, 3H), 0.79 (t, 
J = 7.5 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 177.5, 152.4, 134.5, 117.9, 62.3, 52.8, 
45.6, 36.6, 32.1, 31.8, 29.9, 25.1, 24.4, 22.8, 14.2, 8.8; IR (Neat Film, NaCl) 2958, 2926, 
1779, 1682, 1467, 1383, 1228, 1194, 1107, 914 cm-1; HRMS (MM: ESI-APCI) m/z calc’d 
for C16H28NO3 [M+H]+: 282.2069, found 282.2078; [α]25 0.21 (c 1.67, CHCl3, 73% ee).
 
 	
3.4.5  Cross Metathesis Procedure 
Representative Procedure I. 
Unless otherwise noted, the cross metathesis procedure was executed as follows: The 
allylic alkylation substrates were loaded into a 2-dram vial equipped with a magnetic 
stirring bar and brought into a glove box.  A solution of methacrylate (0.06M, 10 equiv.) 
in dichloromethane was added and the vial was capped with a Teflon lined screw-cap.  
The reaction mixture was stirred for 30 minutes.  A solution of Grubbs generation II 
catalyst (6.6 mM, 5 mol%) in dichloromethane was added to the reaction.  The mixture 
was sealed the cap and heated to 45 °C with stirring.  After 5 hours, the reaction mixture 
was cooled to room temperature and removed from the glovebox.  The reaction mixture 
was filtered through a silica plug, eluting with diethyl ether, and concentrated.  The crude 
material was purified by preparative TLC (EtOAc/hexanes mobile phase) to afford the 
product, which was analyzed by SFC to determine the %ee of the allylic alkylation.  		 	
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Methyl (R,E)-5-(benzyl(methoxycarbonyl)carbamoyl)-5-methylnon-2-enoate (88d) 
Representative Procedure I.  Compound 88d was prepared using General Procedure H 
with 87d (26.9 mg, 85 µmol) to afford a clear oil (25.5 mg, 80% yield): 1H NMR (500 
MHz, CDCl3) δ 7.32 – 7.19 (m, 5H), 6.83 (dt, J = 15.5, 7.7 Hz, 1H), 5.81 (dt, J = 15.5, 
1.4 Hz, 1H), 4.77 (s, 2H), 3.76 (s, 3H), 3.71 (s, 3H), 2.76 (ddd, J = 14.0, 7.6, 1.5 Hz, 1H), 
2.44 (ddd, J = 14.0, 7.9, 1.4 Hz, 1H), 1.77 (ddd, J = 13.4, 12.2, 4.4 Hz, 1H), 1.55 (ddd, J 
= 13.4, 12.4, 4.6 Hz, 1H), 1.23 (s, 3H), 1.22 – 1.15 (m, 2H), 1.12 – 1.01 (m, 1H), 0.96 
(ttd, J = 11.9, 7.4, 4.4 Hz, 1H), 0.81 (t, J = 7.3 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 
182.0, 166.7, 155.5, 145.5, 137.6, 128.5, 128.2, 127.6, 123.8, 53.7, 51.6, 50.6, 50.6, 42.3, 
39.7, 26.8, 23.3, 22.4, 14.1; IR (Neat Film, NaCl) 2957, 2872, 1726, 1686, 1439, 1350, 
1272, 1195, 998 cm-1; HRMS (ESI) m/z calc’d for C21H33N2O5 [M+NH4]+: 393.2384, 
found 393.2376; [α]25 +12.17 (c 2.3, CHCl3, 92% ee). 	
	
Methyl (R,E)-5-(benzyl(ethoxycarbonyl)carbamoyl)-5-methylnon-2-enoate (88e) 
Representative Procedure I.  Compound 88e was prepared using General Procedure H 
with 87e (17.4 mg, 53 µmol) to afford a clear oil (17.4 mg, 85% yield): 1H NMR (500 
MHz, CDCl3) δ 7.33 – 7.19 (m, 5H), 6.84 (dt, J = 15.5, 7.7 Hz, 1H), 5.82 (dt, J = 15.5, 
1.4 Hz, 1H), 4.77 (s, 2H), 4.25 – 4.12 (m, 2H), 3.71 (s, 3H), 2.78 (ddd, J = 13.9, 7.5, 1.5 
Hz, 1H), 2.46 (ddd, J = 13.9, 7.9, 1.4 Hz, 1H), 1.80 (ddd, J = 13.4, 12.3, 4.4 Hz, 1H), 
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1.63 – 1.52 (m, 1H), 1.25 (s, 3H), 1.24 (t, J = 9.1, 3H), 1.23 – 1.16 (m, 2H), 1.14 – 1.03 
(m, 1H), 0.98 (ttd, J = 12.4, 7.5, 4.4 Hz, 1H), 0.82 (t, J = 7.3 Hz, 3H); 13C NMR (126 
MHz, CDCl3) δ 182.1, 166.8, 155.1, 145.6, 137.8, 128.5, 128.2, 127.5, 123.8, 63.1, 51.6, 
50.6, 50.5, 42.2, 39.6, 26.8, 23.3, 22.5, 14.3, 14.1; IR (Neat Film, NaCl) 1956, 2873, 
1727, 1688, 1436, 1376, 1345, 1272, 1193, 1019, 986 cm-1; HRMS (ESI) m/z calc’d for 
C22H35N2O5 [M+NH4]+: 407.2540, found 407.2538; [α]25 +9.70 (c 1.5, CHCl3, 94% ee). 	
 
Methyl (R,E)-5-(benzyl(tert-butoxycarbonyl)carbamoyl)-5-methylnon-2-enoate (88f) 
Representative Procedure I.  Compound 88f was prepared using General Procedure H 
with 87f (9.3 mg, 26 µmol) to afford a clear oil (8.5 mg, 79% yield): 1H NMR (500 MHz, 
CDCl3) δ 7.33 – 7.17 (m, 5H), 6.88 (dt, J = 15.5, 7.7 Hz, 1H), 5.84 (dt, J = 15.5, 1.4 Hz, 
1H), 4.71 (s, 2H), 3.72 (s, 3H), 2.83 (ddd, J = 13.9, 7.5, 1.5 Hz, 1H), 2.50 (ddd, J = 13.9, 
7.9, 1.4 Hz, 1H), 1.84 (ddd, J = 13.4, 12.1, 4.4 Hz, 1H), 1.59 (ddd, J = 13.4, 12.3, 4.5 Hz, 
1H), 1.35 (s, 9H), 1.29 (s, 3H), 1.27 – 1.19 (m, 2H), 1.13 (dddd, J = 17.0, 7.8, 6.6, 4.6 
Hz, 1H), 1.04 (tdd, J = 12.4, 8.3, 4.5 Hz, 1H), 0.84 (t, J = 7.3 Hz, 3H); 13C NMR (126 
MHz, CDCl3) δ 182.3, 166.9, 153.9, 145.9, 138.3, 128.4, 128.0, 127.3, 123.7, 83.0, 51.6, 
50.8, 50.3, 42.4, 39.6, 27.9, 26.9, 23.4, 22.5, 14.2; IR (Neat Film, NaCl) 2957, 2933, 
1728, 1682, 1370, 1272, 1150, 987, 699 cm-1; HRMS (FAB+) m/z calc’d for C24H36NO5 
[M+H]+: 418.2593, found 418.2593; [α]25 +10.60 (c 0.85, CHCl3, 90% ee). 
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Methyl (R,E)-5-(benzyl((benzyloxy)carbonyl)carbamoyl)-5-methylnon-2-enoate 
(88g) 
Representative Procedure I.  Compound 88g was prepared using General Procedure H 
with 87g (20.9 mg, 53 µmol) to afford a clear oil (18.2 mg, 76% yield): 1H NMR (500 
MHz, CDCl3) δ 7.36 – 7.31 (m, 3H), 7.29 – 7.20 (m, 7H), 6.81 (dt, J = 15.4, 7.7 Hz, 1H), 
5.75 (dd, J = 15.5, 1.4 Hz, 1H), 5.15 (s, 2H), 4.79 (s, 2H), 3.71 (s, 3H), 2.73 (ddd, J = 
14.0, 7.6, 1.4 Hz, 1H), 2.43 (ddd, J = 13.9, 7.9, 1.5 Hz, 1H), 1.76 (ddd, J = 13.5, 12.2, 4.5 
Hz, 1H), 1.61 – 1.48 (m, 1H), 1.22 (s, 3H), 1.14 (p, J = 7.2 Hz, 2H), 1.10 – 0.99 (m, 1H), 
0.94 (ttd, J = 12.3, 7.4, 4.3 Hz, 1H), 0.79 (t, J = 7.3 Hz, 3H); 13C NMR (126 MHz, 
CDCl3) δ 182.2, 166.8, 154.9, 145.5, 137.7, 134.9, 128.8, 128.8, 128.7, 128.5, 128.2, 
127.5, 123.8, 68.9, 51.6, 50.6, 50.5, 42.1, 39.5, 26.8, 23.2, 22.5, 14.1; IR (Neat Film, 
NaCl) 2955, 1725, 1688, 1386, 1346, 1272, 1192, 990, 698 cm-1; HRMS (ESI) m/z calc’d 
for C27H37N2O5 [M+NH4]+: 469.2697, found 469.2693; [α]25 +5.94 (c 1.7, CHCl3, 93% 
ee). 
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Methyl (R,E)-5-((4-chlorophenyl)(methoxycarbonyl)carbamoyl)-5-methylnon-2-
enoate (88h) 
Representative Procedure I.  Compound 88h was prepared using General Procedure H 
with 87h (19.8 mg, 59 µmol) to afford a clear oil (19.7 mg, 80% yield): 1H NMR (500 
MHz, CDCl3) δ 7.39 – 7.31 (m, 2H), 7.13 – 7.05 (m, 2H), 6.88 (dt, J = 15.4, 7.7 Hz, 1H), 
5.83 (dt, J = 15.3, 1.3 Hz, 1H), 3.74 (s, 3H), 3.73 (s, 3H), 2.73 (ddd, J = 14.3, 7.6, 1.5 Hz, 
1H), 2.44 (ddd, J = 14.1, 7.8, 1.4 Hz, 1H), 1.79 – 1.67 (m, 1H), 1.61 – 1.52 (m, 1H), 1.30 
– 1.14 (m, 4H), 1.24 (s, 3H), 0.86 (t, J = 6.8 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 
181.7, 166.7, 154.7, 144.8, 136.9, 134.1, 129.5, 129.3, 124.2, 54.0, 51.7, 51.2, 41.8, 39.4, 
26.6, 23.2, 22.9, 14.1; IR (Neat Film, NaCl) 2956, 2873, 1728, 1658, 1492, 1439, 1272, 
1247, 1198, 1092 cm-1; HRMS (FAB+) m/z calc’d for C20H26NClO5 [M+H-H2]+: 
395.1499, found 395.1476; [α]25 +7.94 (c 1.8, CHCl3, 90% ee). 	
 
Methyl (R,E)-5-(benzyl(methoxycarbonyl)carbamoyl)-5-methylundec-2-enoate (88i) 
Representative Procedure I.  Compound 88i was prepared using General Procedure H 
with 87i (17.3 mg, 51 µmol) to afford a clear oil (17.2 mg, 84% yield): 1H NMR (500 
MHz, CDCl3) δ 7.34 – 7.19 (m, 5H), 6.83 (dt, J = 15.5, 7.7 Hz, 1H), 5.81 (dt, J = 15.5, 
1.4 Hz, 1H), 4.77 (s, 2H), 3.76 (s, 3H), 3.71 (s, 3H), 2.75 (ddd, J = 14.0, 7.5, 1.4 Hz, 1H), 
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2.45 (ddd, J = 13.9, 8.0, 1.4 Hz, 1H), 1.77 (ddd, J = 13.4, 12.1, 4.4 Hz, 1H), 1.61 – 1.46 
(m, 1H), 1.30 – 1.13 (m, 6H), 1.23 (s, 3H), 1.13 – 1.03 (m, 1H), 1.02 – 0.91 (m, 1H), 0.86 
(t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 182.0, 166.8, 155.5, 145.5, 137.6, 
128.5, 128.2, 127.6, 123.8, 53.7, 51.6, 50.6, 50.6, 42.3, 40.0, 31.7, 29.9, 24.5, 22.7, 22.4, 
14.2; IR (Neat Film, NaCl) 2954, 2930, 2858, 1728, 1688, 1441, 1350, 1272, 1779, 998 
cm-1; HRMS (ESI) m/z calc’d for C23H37N2O5 [M+NH4]+: 421.2697, found 421.2688; 
[α]25 +10.91 (c 1.6, CHCl3, 94% ee). 	
 
Methyl (S,E)-5-(benzyl(methoxycarbonyl)carbamoyl)-7-((tert-
butyldimethylsilyl)oxy)-5-methylhept-2-enoate (88j) 
Representative Procedure I.  Compound 88j was prepared using General Procedure H 
with 87j (31.7 mg, 76 µmol) to afford a clear oil (28.5 mg, 79% yield): 1H NMR (500 
MHz, CDCl3) δ 7.29 – 7.17 (m, 5H), 6.79 (dq, J = 15.4, 7.8 Hz, 1H), 5.77 (dt, J = 15.5, 
1.4 Hz, 1H), 4.75 (s, 2H), 3.72 (s, 3H), 3.67 (s, 3H), 3.54 – 3.44 (m, 2H), 2.78 (ddd, J = 
14.0, 7.6, 1.5 Hz, 1H), 2.47 (ddd, J = 14.0, 7.9, 1.5 Hz, 1H), 2.06 (ddd, J = 13.9, 7.8, 6.2 
Hz, 1H), 1.86 (ddd, J = 13.9, 7.9, 6.3 Hz, 1H), 1.24 (s, 3H), 0.82 (s, 9H), -0.03 (s, 3H), -
0.03 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 181.2, 166.7, 155.4, 145.3, 137.6, 128.6, 
128.1, 127.6, 124.0, 59.8, 53.7, 51.6, 50.6, 49.3, 42.6, 41.8, 26.1, 22.7, 18.4, -5.2, -5.3; IR 
(Neat Film, NaCl) 2955, 2857, 1728, 1688, 1440, 1351, 1256, 1195, 1094, 994 cm-1; 
HRMS (FAB+) m/z calc’d for C25H40NO6Si [M+H]+: 478.2625, found 478.2646; [α]25 
+2.20 (c 2.6, CHCl3, 94% ee). 
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Methyl (S,E)-6-(benzyl(methoxycarbonyl)amino)-5-methyl-6-oxo-5-phenylhex-2-
enoate (88k) 
Representative Procedure I.  Compound 88k was prepared using General Procedure H 
with 87k (26.0 mg, 77 µmol) to afford a clear oil (23.9 mg, 78% yield): 1H NMR (500 
MHz, CDCl3) δ 7.35 – 7.30 (m, 4H), 7.30 – 7.23 (m, 3H), 7.22 – 7.13 (m, 1H), 7.05 – 
6.97 (m, 2H), 6.57 (ddd, J = 15.4, 8.3, 6.9 Hz, 1H), 5.71 (dt, J = 15.5, 1.4 Hz, 1H), 4.89 
(s, 2H), 3.67 (s, 3H), 3.22 (s, 3H), 3.01 (ddd, J = 13.9, 8.4, 1.2 Hz, 1H), 2.67 (ddd, J = 
13.9, 6.9, 1.6 Hz, 1H), 1.68 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 179.0, 166.6, 154.3, 
145.1, 142.7, 137.4, 128.5, 128.5, 128.3, 127.7, 126.6, 125.8, 124.3, 54.1, 53.4, 51.5, 
50.1, 45.9, 23.4; IR (Neat Film, NaCl) 2953, 1725, 1674, 1496, 1441, 1351, 1315, 1274, 
1203, 1004, 700 cm-1; HRMS (ESI) m/z calc’d for C23H29N2O5 [M+NH4]+: 413.2071, 
found 413.2065; [α]25 +67.74 (c 2.2, CHCl3, 76% ee). 	
 
Methyl (R,E)-5-(benzyl(methoxycarbonyl)carbamoyl)-5-ethylnon-2-enoate (88l) 
Representative Procedure I.  Compound 88l was prepared using General Procedure H 
with 87l (7.3 mg, 22 µmol) to afford a clear oil (7.3 mg, 85% yield): 1H NMR (500 MHz, 
CDCl3) δ 7.36 – 7.16 (m, 5H), 6.83 (dt, J = 15.4, 7.7 Hz, 1H), 5.84 (dt, J = 15.5, 1.4 Hz, 
1H), 4.80 (s, 2H), 3.76 (s, 3H), 3.72 (s, 3H), 2.62 (qdd, J = 14.4, 7.7, 1.5 Hz, 2H), 1.84 
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(dq, J = 14.8, 7.4 Hz, 1H), 1.75 (ddd, J = 13.8, 12.2, 4.7 Hz, 1H), 1.66 (dt, J = 14.3, 7.4 
Hz, 1H), 1.59 (ddd, J = 13.8, 12.2, 4.7 Hz, 1H), 1.22 (p, J = 7.2 Hz, 2H), 1.15 – 0.97 (m, 
2H), 0.84 (t, J = 7.3 Hz, 3H), 0.76 (t, J = 7.4 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 
180.8, 166.8, 155.5, 145.8, 137.7, 128.5, 128.2, 127.6, 123.6, 54.2, 53.7, 51.6, 50.8, 37.6, 
35.2, 28.3, 26.7, 23.3, 14.1, 9.0; IR (Neat Film, NaCl) 2957, 2874, 1727, 1682, 1442, 
1351, 1190, 700 cm-1; HRMS (ESI) m/z calc’d for C22H35N2O5 [M+NH4]+: 407.2540, 
found 407.2537; [α]25 +1.32 (c 0.66, CHCl3, 82% ee). 	
 
Methyl (R,E)-5-(benzyl(methoxycarbonyl)carbamoyl)-5-ethylundec-2-enoate (88m) 
Representative Procedure I.  Compound 88m was prepared using General Procedure H 
with 87m (19.0 mg, 53 µmol) to afford a clear oil (18.7 mg, 85% yield): 1H NMR (500 
MHz, CDCl3) δ 7.36 – 7.14 (m, 5H), 6.83 (dt, J = 15.4, 7.7 Hz, 1H), 5.83 (dd, J = 15.5, 
1.6 Hz, 1H), 4.79 (s, 2H), 3.75 (s, 3H), 3.72 (s, 3H), 2.62 (qdd, J = 14.6, 7.7, 1.5 Hz, 2H), 
1.84 (dq, J = 14.8, 7.4 Hz, 1H), 1.78 – 1.70 (m, 1H), 1.69 – 1.54 (m, 2H), 1.30 – 1.15 (m, 
6H), 1.15 – 0.97 (m, 2H), 0.86 (t, J = 7.0 Hz, 3H), 0.75 (t, J = 7.4 Hz, 3H); 13C NMR 
(126 MHz, CDCl3) δ 180.8, 166.8, 155.5, 145.8, 137.7, 128.5, 128.2, 127.5, 123.6, 54.2, 
53.7, 51.6, 50.7, 37.6, 35.5, 31.7, 29.9, 28.3, 24.5, 22.7, 14.2, 9.0; IR (Neat Film, NaCl) 
2955, 1727, 1683, 1441, 1351, 1176 cm-1; HRMS (ESI) m/z calc’d for C25H39N2O5 
[M+NH4]+: 435.2853, found 435.2853; [α]25 +2.25 (c 1.7, CHCl3, 93% ee). 
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Methyl (S,E)-5-(benzyl(methoxycarbonyl)carbamoyl)-5-(3-phenylpropyl)undec-2-
enoate (88n) 
Representative Procedure I.  Compound 88n was prepared using General Procedure H 
with 87n (21.6 mg, 48 mmol) to afford a clear oil (19.8 mg, 84% yield): 1H NMR (500 
MHz, CDCl3) δ 7.30 – 7.14 (m, 8H), 7.13 – 7.07 (m, 2H), 6.79 (dt, J = 15.4, 7.6 Hz, 1H), 
5.79 (dt, J = 15.4, 1.3 Hz, 1H), 4.78 (s, 2H), 3.72 (s, 3H), 3.67 (s, 3H), 2.60 (dt, J = 7.7, 
1.3 Hz, 2H), 2.53 (t, J = 7.4 Hz, 2H), 1.84 – 1.68 (m, 2H), 1.65 – 1.51 (m, 2H), 1.51 – 
1.35 (m, 2H), 1.29 – 1.13 (m, 6H), 1.12 – 0.93 (m, 2H), 0.86 (t, J = 7.1 Hz, 3H); 13C 
NMR (126 MHz, CDCl3) δ 180.6, 166.7, 155.4, 145.6, 142.1, 137.6, 128.5, 128.5, 128.4, 
128.2, 127.6, 125.9, 123.7, 53.8, 53.7, 51.6, 50.7, 38.2, 36.3, 35.8, 35.2, 31.7, 29.9, 26.3, 
24.4, 22.7, 14.2; IR (Neat Film, NaCl) 3028, 2930, 2858, 1727, 1683, 1442, 1350, 1273, 
1170, 699 cm-1; HRMS (ESI) m/z calc’d for C31H45N2O5 [M+NH4]+: 525.3323, found 
525.3329; [α]25 +0.25 (c 1.8, CHCl3, 76% ee). 
	
Methyl (R,E)-5-ethyl-5-(2-oxooxazolidine-3-carbonyl)non-2-enoate (88o) 
Representative Procedure I.  Compound 88o was prepared using General Procedure H 
with 87o (15.2 mg, 60 µmol) to afford a clear oil (14.6 mg, 78% yield): 1H NMR (500 
MHz, CDCl3) δ 6.84 (dt, J = 15.4, 7.7 Hz, 1H), 5.88 (dt, J = 15.5, 1.5 Hz, 1H), 4.48 – 
4.31 (m, 2H), 4.05 (dd, J = 8.5, 7.6 Hz, 2H), 3.72 (s, 3H), 2.83 – 2.63 (m, 2H), 2.14 – 
1.95 (m, 2H), 1.82 – 1.67 (m, 2H), 1.28 (h, J = 7.1 Hz, 2H), 1.22 – 1.12 (m, 1H), 1.06 
O
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(ttd, J = 12.3, 7.3, 4.5 Hz, 1H), 0.87 (t, J = 7.3 Hz, 3H), 0.79 (t, J = 7.5 Hz, 3H); 13C 
NMR (126 MHz, CDCl3) δ 176.6, 166.8, 152.4, 145.5, 123.8, 62.4, 52.9, 51.6, 45.6, 35.6, 
32.2, 26.7, 25.5, 23.2 14.1, 8.8; IR (Neat Film, NaCl) 2959, 2875, 1778, 1722, 1682, 
1470, 1436, 1385, 1257, 1195, 1175, 1109, 1045 cm-1; HRMS (FAB+) m/z calc’d for 
C16H26NO5 [M+H]+: 312.1811, found 312.1791; [α]25 +0.50 (c 1.3, CHCl3, 69% ee). 
 
 
Methyl (R,E)-5-ethyl-5-(2-oxooxazolidine-3-carbonyl)undec-2-enoate (88p) 
Representative Procedure I.  Compound 88p was prepared using General Procedure H 
with 87p (16.5 mg, 59 µmol) to afford a clear oil (16.3 mg, 82% yield): 1H NMR (500 
MHz, CDCl3) δ 6.91 – 6.74 (m, 1H), 5.87 (dt, J = 15.5, 1.5 Hz, 1H), 4.39 (t, J = 8.0 Hz, 
2H), 4.05 (t, J = 8.0 Hz, 2H), 3.71 (s, 3H), 2.86 – 2.62 (m, 2H), 2.14 – 1.91 (m, 2H), 1.84 
– 1.66 (m, 2H), 1.31 – 1.12 (m, 7H), 1.12 – 1.00 (m, 1H), 0.86 (t, J = 6.8 Hz, 3H), 0.79 (t, 
J = 7.5 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 176.6, 166.8, 152.4, 145.6, 123.7, 62.4, 
52.9, 51.6, 45.6, 35.6, 32.4, 31.7, 29.7, 25.6, 24.4, 22.7, 14.2, 8.8; IR (Neat Film, NaCl) 
2956, 2929, 2858, 1779, 1723, 1682, 1469, 1385, 1254, 1194, 1110, 1046 cm-1; HRMS 
(FAB+) m/z calc’d for C18H30NO5 [M+H]+: 340.2124, found 340.2116; [α]25 +2.41 (c 1.5, 
CHCl3, 73% ee). 
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3.4.6  Determination of Enantiomeric Excess 
Table 3.4. Methods for the determination of enantiomeric excess. 
 
compound assay methodand conditions
retention time
of major isomer
(min)
retention time
of minor isomer
(min)
%eeentry
1
O
Bu
Me
NMeO2C O
O
88a
O
Bu
Me
NMeO2C O
O
88c
O
Bu
Me
N
CO2Me
Bn
MeO2C
2
3
O
Bu
Me
N
CO2Et
Bn
MeO2C
88d
88e
O
Bu
Me
N
CO2tBu
Bn
MeO2C
88f
O
Bu
Me
N
CO2Bn
Bn
MeO2C
88g
4
5
6
7
SFC, 5% iPrOH in CO2
2.5 mL/min, OD-H col.
6.80 9.33 94
SFC, 5% iPrOH in CO2
2.5 mL/min, OD-H col.
7.00 9.65 92
SFC, 15% iPrOH in CO2
2.5 mL/min, OD-H col.
4.45 5.69 93
SFC, 2% iPrOH in CO2
2.5 mL/min, OJ-H col.
3.05 3.64 90
SFC, 5% iPrOH in CO2
2.5 mL/min, OD-H col.
5.55 6.82 57*
*used Ph-ANDEN ligand
SFC, 5% iPrOH in CO2
2.5 mL/min, AD-H col.
5.31 5.87 70
O
Bu
Me
N
CO2MeMeO2C
88h
Ar = 4-ClC6H4
Ar
SFC, 5% iPrOH in CO2
2.5 mL/min, OD-H col.
6.28 8.73 90
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compound assay methodand conditions
retention time
of major isomer
(min)
retention time
of minor isomer
(min)
%eeentry
9
88j
88l
10
11
O
Hex
N
CO2Me
Bn
MeO2C
88m
88n
880
12
13
14
15
88p
O
Hex
Et
N
CO2Me
Bn
MeO2C
Ph
O
Bu
Et
N
CO2Me
Bn
MeO2C
O
Me
N
CO2Me
Bn
MeO2C
TBSO
O
Bu
Et
NMeO2C O
O
O
Hex
Et
NMeO2C O
O
SFC, 10% iPrOH in CO2
2.5 mL/min, AD-H col.
6.55 5.71 76
SFC, 6% iPrOH in CO2
2.5 mL/min, OD-H col.
7.73 10.18 73
SFC, 7% iPrOH in CO2
2.5 mL/min, OD-H col.
5.67 7.40 93
SFC, 5% iPrOH in CO2
2.5 mL/min, OD-H col.
8.13 10.61 69
SFC, 10% iPrOH in CO2
2.5 mL/min, OD-H col.
4.00 4.83 94
SFC, 10% iPrOH in CO2
2.5 mL/min, OD-H col.
3.58 4.39 82
88k
O
Ph
Me
N
CO2Me
Bn
MeO2C SFC, 7% iPrOH in CO2
2.5 mL/min, AD-H col.
8.77 9.66 76
88i
8
O
Hex
Me
N
CO2Me
Bn
MeO2C SFC, 7% iPrOH in CO22.5 mL/min, OD-H col.
6.09 8.25 94
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3.4.7  Determination of Absolute Stereochemistry 
 
 
 
(S)-N-Benzyl-2-(2-((tert-butyldimethylsilyl)oxy)ethyl)-2-methylpent-4-enamide (110) 
To an oven-dried round-bottom flask and magnetic stir bar was added 87j (60 mg, 0.143 
mmol) followed by anhydrous THF (1.4 mL).  The solution was stirred under nitrogen at 
room temperature.  A solution of NaOH in anhydrous methanol (0.17 mL, 1.0 M) was 
added dropwise by syringe.  The reaction was stirred at room temperature for 45 min.  
Afterward, the reaction mixture was diluted with ethyl acetate and quenched with water.  
The mixture was partitioned between water and ethyl acetate and the aqueous layer was 
extracted two additional times with ethyl acetate.  The combined organic layers were 
washed with brine (50 mL), dried with sodium sulfate, and filtered.  This mixture was 
concentrated in vacuo and purified by flash chromatography (10/90 to 12/88 
EtOAc/hexanes) to provide the product as an amorphous white solid (30.2 mg, 58% 
yield); 1H NMR (500 MHz, CDCl3) δ 7.36 – 7.24 (m, 5H), 6.37 (s, 1H), 5.80 – 5.69 (m, 
N
O
OTBS
Me
MeO2C
BzN
O
O
O
BzN
Me
O
HN
Me
O
98% ee
BnHN
O
OH
MeNaOH in
 MeOH BnN
Me
O
87% ee
from 92
92% yield
MeOH, 0 °C
(i) MsCl, TEA
(ii) NaHMDS
Pd2dba3 (5 mol%)
(S)-(CF3)3-t-BuPHOX
(12.5 mol%)
PhMe, 40 °C
90% yield
NaH
BnBr
59%
[α] = –30.1°
[α] = 26.2°
46% yield
NaOH
87j 95 96
999897
Bn
58% yield
THF, RT
BnHN
O
OTBS
Me
110
THF, RT
TBAF
90% yield
BnHN
O
OTBS
Me
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1H), 5.08 – 5.06 (m, 1H), 5.06 – 5.03 (m, 1H), 4.49 – 4.38 (m, 2H), 3.68 (td, J = 6.7, 1.5 
Hz, 2H), 2.40 (ddt, J = 13.7, 7.1, 1.2 Hz, 1H), 2.27 (ddt, J = 13.7, 7.7, 1.1 Hz, 1H), 1.93 
(dt, J = 13.7, 6.7 Hz, 1H), 1.69 (dt, J = 14.1, 6.7 Hz, 1H), 1.20 (s, 3H), 0.86 (s, 9H), 0.02 
– -0.00 (m, 6H); 13C NMR (126 MHz, CDCl3) δ 176.4, 138.8, 134.3, 128.8, 127.9, 127.5, 
118.3, 60.1, 44.7, 44.7, 43.7, 41.4, 26.1, 22.3, 18.4, -5.3, -5.3; IR (Neat Film, NaCl) 3343, 
2955, 2929, 2856, 1640, 1531, 1254, 1095, 836 cm-1; HRMS (FAB+) m/z calc’d for 
C21H36NO2Si [M+H]+: 362.2514, found 362.2515; [α]25 –2.93 (c 2.5, CHCl3, 94% ee). 
 
 
(S)-N-Benzyl-2-(2-hydroxyethyl)-2-methylpent-4-enamide (95) 
To an oven-dried 2-dram vial and magnetic stir bar was added S11 (30 mg, 0.083 mmol) 
followed by anhydrous THF (0.5 mL).  The solution was stirred under nitrogen at room 
temperature.  A solution of TBAF in anhydrous THF (0.17 mL, 1.0 M) was added 
dropwise by syringe.  The reaction was stirred at room temperature for 2 h.  Afterward, 
the reaction mixture was quenched with saturated ammonium chloride.  The mixture was 
partitioned between water and dichloromethane and the aqueous layer was extracted two 
additional times with dichloromethane.  The combined organic layers were washed with 
brine (50 mL), dried with sodium sulfate, and filtered.  This mixture was concentrated in 
vacuo and purified by flash chromatography (60/40 EtOAc/hexanes) to provide the 
product as an oil (19.5 mg, 58% yield): 1H NMR (500 MHz, CDCl3) δ 7.38 – 7.24 (m, 
5H), 6.10 (s, 1H), 5.78 – 5.69 (m, 1H), 5.11 – 5.09 (m, 1H), 5.09 – 5.05 (m, 1H), 4.45 (d, 
J = 5.5 Hz, 2H), 3.78 (dt, J = 11.8, 6.1 Hz, 1H), 3.74 – 3.65 (m, 1H), 2.56 (s, 1H), 2.48 
BnHN
O
OH
Me
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(ddt, J = 13.7, 7.0, 1.3 Hz, 1H), 2.22 (ddt, J = 13.7, 7.7, 1.2 Hz, 1H), 2.00 (ddd, J = 14.4, 
7.3, 5.5 Hz, 1H), 1.70 (ddd, J = 14.4, 6.6, 5.4 Hz, 1H), 1.22 (s, 3H); 13C NMR (126 MHz, 
CDCl3) δ 177.5, 138.3, 133.7, 128.9, 127.9, 127.7, 118.9, 59.3, 44.5, 44.4, 44.0, 41.5, 
22.2; IR (Neat Film, NaCl) 3335, 2927, 1634, 1538, 1249 cm-1; HRMS (MM: ESI-APCI) 
m/z calc’d for C15H21NO2 [M+H]+: 248.1645, found 248.1651; [α]25 –61.06 (c 1.63, 
CHCl3, 94% ee). 
 
 
(S)-3-Allyl-1-benzyl-3-methylpyrrolidin-2-one ((S)-96): 
To an oven-dried 2-dram vial and magnetic stir bar was added 95 (19.5 mg, 0.079 mmol) 
followed by anhydrous THF (0.20 mL).  The solution was stirred under nitrogen at 0 °C.  
Triethylamine (12 µL, 0.087 mmol) was added dropwise by syringe followed by a 
solution of methanesulfonyl chloride in THF (0.10 mL, 0.79 M).  The reaction was stirred 
at 0 °C for 0.5 h.  A separate oven-dried 2-dram vial and magnetic stir bar was charged 
with NaHMDS (46 mg, 0.253 mmol) and THF (0.25 mL).  The reaction mixture was 
canulated into the NaHMDS solution at 0 °C over 5 minutes.  This solution was warmed 
to room temperature and stirred overnight.  Afterward, the reaction mixture was 
quenched with saturated ammonium chloride.  The mixture was partitioned between 
water and ethyl acetate and the aqueous layer was extracted two additional times with 
ethyl acetate.  The combined organic layers were washed with brine (50 mL), dried with 
sodium sulfate and filtered.  This mixture was concentrated in vacuo and purified by 
preparative TLC (40/60 EtOAc/hexanes) to provide the product as an oil (8.4 mg, 46% 
BnN
Me
O
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yield); 1H NMR (500 MHz, CDCl3) δ 7.39 – 7.22 (m, 5H), 5.82 –5.74 (m, 1H), 5.18 – 
5.06 (m, 2H), 4.53 – 4.42 (m, 2H), 3.20 – 3.10 (m, 2H), 2.37 (ddt, J = 13.7, 6.7, 1.3 Hz, 
1H), 2.25 (ddt, J = 13.8, 8.2, 1.1 Hz, 1H), 2.03 (ddd, J = 12.8, 8.2, 6.4 Hz, 1H), 1.73 
(ddd, J = 12.9, 8.0, 5.5 Hz, 1H), 1.20 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 178.6, 
136.7, 134.1, 128.7, 128.1, 127.6, 118.4, 46.8, 44.1, 43.4, 42.3, 30.4, 23.2; IR (Neat Film, 
NaCl) 3002, 2962, 1686, 1454, 1431, 1291, 917, 701 cm-1; HRMS (MM: ESI-APCI) m/z 
calc’d for C15H20NO [M+H]+: 230.1539, found 230.1549; [α]25 26.10 (c 0.70, CHCl3, 
94% ee). 
 
 
(R)-3-Allyl-3-methylpyrrolidin-2-one (99): 
To a round-bottom flask and magnetic stir bar was added 986a (98% ee) (80 mg, 0.33 
mmol) followed by MeOH (4.0 mL).  The solution was stirred under nitrogen at 0 °C.  A 
solution of NaOH (0.61 mL, 2.0 M, 1.2 mmol) was added dropwise by syringe.  The 
reaction was stirred at 0 °C for 1.5 h.  The mixture was partitioned between brine and 
diethyl ether.  The organic layer was washed with saturated sodium bicarbonate solution 
followed by brine, dried with sodium sulfate, and filtered.  This mixture was concentrated 
in vacuo and purified by flash chromatography (80/20 to 100/0 EtOAc/hexanes) to 
provide the product as an amorphous white solid (28.3 mg, 62% yield); 1H NMR (500 
MHz, CDCl3) δ 6.49 (s, 1H), 5.84 – 5.70 (m, 1H), 5.13 – 5.09 (m, 1H), 5.08 (p, J = 1.2 
Hz, 1H), 3.34 – 3.19 (m, 2H), 2.33 – 2.25 (m, 1H), 2.19 (ddt, J = 13.6, 8.2, 1.1 Hz, 1H), 
2.15 – 2.06 (m, 1H), 1.86 – 1.76 (m, 1H), 1.15 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 
HN
Me
O
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182.9, 134.1, 118.4, 43.1, 42.0, 39.0, 33.0, 22.8; IR (Neat Film, NaCl) 3233, 3077, 2928, 
1697, 1295, 915 cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C8H14NO [M+H]+: 
140.1070, found 140.1071; [α]25 –33.10 (c 2.27, CHCl3, 98% ee). 
 
 
(R)-3-Allyl-1-benzyl-3-methylpyrrolidin-2-one ((R)-96): 
To an oven-dried 2-dram vial and magnetic stir bar was added 99 (28.3 mg, 0.203 mmol) 
followed by anhydrous DMF (1.0 mL).  The solution was stirred under nitrogen at 0 °C.  
Sodium hydride (8.1 mg, 0.203 mmol) was added portion-wise over two minutes.  The 
reaction was stirred at 0 °C for 40 min.  To this solution was added benzyl bromide (30 
µL, 0.256 mmol) dropwise through by syringe.  This solution was warmed to room 
temperature and stirred for 2 h.  Afterward, the reaction mixture was quenched with 
saturated ammonium chloride.  The mixture was partitioned between water and ethyl 
acetate and the aqueous layer was extracted two additional times with ethyl acetate.  The 
combined organic layers were washed with brine (50 mL), dried with sodium sulfate, and 
filtered.  This mixture was concentrated in vacuo and purified by preparative TLC (40/60 
EtOAc/hexanes) to provide the product as an oil (27 mg, 59% yield).  Characterization 
data matched previously synthesized material; [α]25 –33.10 (c 2.27, CHCl3, 98% ee). 
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O
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 13C NMR (126 MHz, CDCl3) of compound 87a. 
 
Infrared spectrum (Thin Film, NaCl) of compound 87a. 
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 13C NMR (126 MHz, CDCl3) of compound 87c. 
 
Infrared spectrum (Thin Film, NaCl) of compound 87c. 
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 13C NMR (126 MHz, CDCl3) of compound 87d. 
 
Infrared spectrum (Thin Film, NaCl) of compound 87d. 
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 13C NMR (126 MHz, CDCl3) of compound 87e. 
 
Infrared spectrum (Thin Film, NaCl) of compound 87e. 
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 13C NMR (126 MHz, CDCl3) of compound 87f. 
 
Infrared spectrum (Thin Film, NaCl) of compound 87f. 
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 13C NMR (126 MHz, CDCl3) of compound 87g. 
 
Infrared spectrum (Thin Film, NaCl) of compound 87g. 
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 13C NMR (126 MHz, CDCl3) of compound 87h. 
 
Infrared spectrum (Thin Film, NaCl) of compound 87h. 
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 13C NMR (126 MHz, CDCl3) of compound 87i. 
 
Infrared spectrum (Thin Film, NaCl) of compound 87i. 
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 13C NMR (126 MHz, CDCl3) of compound 87j. 
 
Infrared spectrum (Thin Film, NaCl) of compound 87j. 
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 13C NMR (126 MHz, CDCl3) of compound 87k. 
 
Infrared spectrum (Thin Film, NaCl) of compound 87k. 
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 13C NMR (126 MHz, CDCl3) of compound 87l. 
 
Infrared spectrum (Thin Film, NaCl) of compound 87l. 
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 13C NMR (126 MHz, CDCl3) of compound 87m. 
 
Infrared spectrum (Thin Film, NaCl) of compound 87m. 
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 13C NMR (126 MHz, CDCl3) of compound 87n. 
 
Infrared spectrum (Thin Film, NaCl) of compound 87n. 
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 13C NMR (126 MHz, CDCl3) of compound 87o. 
Infrared spectrum (Thin Film, NaCl) of compound 87o. 
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 13C NMR (126 MHz, CDCl3) of compound 87p. 
 
Infrared spectrum (Thin Film, NaCl) of compound 87p. 
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 13C NMR (126 MHz, CDCl3) of compound 88a. 
Infrared spectrum (Thin Film, NaCl) of compound 88a. 
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 13C NMR (126 MHz, CDCl3) of compound 88c. 
Infrared spectrum (Thin Film, NaCl) of compound 88c. 
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 13C NMR (126 MHz, CDCl3) of compound 88d. 
Infrared spectrum (Thin Film, NaCl) of compound 88d. 
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 13C NMR (126 MHz, CDCl3) of compound 88e. 
Infrared spectrum (Thin Film, NaCl) of compound 88e. 
APPENDIX 3 – Spectra Relevant to Chapter 3 439 
 1 H
 N
M
R
 (5
00
 M
H
z,
 C
D
C
l 3)
 o
f c
om
po
un
d 
88
f. 
O
BuM
e
N
CO
2tB
u
Bn
M
eO
2C
APPENDIX 3 – Spectra Relevant to Chapter 3 440 
 13C NMR (126 MHz, CDCl3) of compound 88f. 
Infrared spectrum (Thin Film, NaCl) of compound 88f. 
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 13C NMR (126 MHz, CDCl3) of compound 88g. 
Infrared spectrum (Thin Film, NaCl) of compound 88g. 
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 13C NMR (126 MHz, CDCl3) of compound 88h. 
 
Infrared spectrum (Thin Film, NaCl) of compound 88h. 
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 13C NMR (126 MHz, CDCl3) of compound 88i. 
 
Infrared spectrum (Thin Film, NaCl) of compound 88i. 
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 13C NMR (126 MHz, CDCl3) of compound 88j. 
Infrared spectrum (Thin Film, NaCl) of compound 88j. 
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 13C NMR (126 MHz, CDCl3) of compound 88k. 
Infrared spectrum (Thin Film, NaCl) of compound 88k. 
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 13C NMR (126 MHz, CDCl3) of compound 88l. 
Infrared spectrum (Thin Film, NaCl) of compound 88l. 
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 13C NMR (126 MHz, CDCl3) of compound 88m. 
Infrared spectrum (Thin Film, NaCl) of compound 88m. 
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 13C NMR (126 MHz, CDCl3) of compound 88n. 
Infrared spectrum (Thin Film, NaCl) of compound 88n. 
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 13C NMR (126 MHz, CDCl3) of compound 88o. 
 
Infrared spectrum (Thin Film, NaCl) of compound 88o. 
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 13C NMR (126 MHz, CDCl3) of compound 88p. 
Infrared spectrum (Thin Film, NaCl) of compound 88p. 
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 13C NMR (126 MHz, CDCl3) of compound 93. 
Infrared spectrum (Thin Film, NaCl) of compound 93. 
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 19F NMR (282 MHz, CDCl3) of compound 93. 
 31P NMR (121 MHz, CDCl3) of compound 93. 
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 13C NMR (126 MHz, CDCl3) of compound 94. 
Infrared spectrum (Thin Film, NaCl) of compound 94. 
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 31P NMR (121 MHz, CDCl3) of compound 94. 
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 13C NMR (126 MHz, CDCl3) of compound 95. 
Infrared spectrum (Thin Film, NaCl) of compound 95. 
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 13C NMR (126 MHz, CDCl3) of compound 96. 
 
Infrared spectrum (Thin Film, NaCl) of compound 96. 
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 13C NMR (126 MHz, CDCl3) of compound 99. 
Infrared spectrum (Thin Film, NaCl) of compound 99. 
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 13C NMR (126 MHz, CDCl3) of compound 102. 
Infrared spectrum (Thin Film, NaCl) of compound 102. 
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 19F NMR (282 MHz, CDCl3) of compound 102. 
 
 31P NMR (121 MHz, CDCl3) of compound 102. 
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 13C NMR (126 MHz, CDCl3) of compound 103. 
 
Infrared spectrum (Thin Film, NaCl) of compound 103. 
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 19F NMR (282 MHz, CDCl3) of compound 103. 
 31P NMR (121 MHz, CDCl3) of compound 103. 
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 13C NMR (126 MHz, CDCl3) of compound 104. 
Infrared spectrum (Thin Film, NaCl) of compound 104. 
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 19F NMR (282 MHz, CDCl3) of compound 104. 
 
 31P NMR (121 MHz, CDCl3) of compound 104. 
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 13C NMR (126 MHz, CDCl3) of compound 108. 
Infrared spectrum (Thin Film, NaCl) of compound 108. 
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 31P NMR (121 MHz, CDCl3) of compound 108. 
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 13C NMR (126 MHz, CDCl3) of compound 110. 
 
Infrared spectrum (Thin Film, NaCl) of compound 110. 
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APPENDIX 4 
A Highly Efficient Protocol for the 
Palladium-Catalyzed Asymmetric Decarboxylative 
Allylic Alkylation Using Low Catalyst Loading† 
 
4.1  INTRODUCTION AND BACKGROUND 
Despite the importance of palladium-catalyzed decarboxylative asymmetric 
alkylation in total synthesis, its application on an industrial scale is hampered by the need 
for high catalyst loadings (2.5–5.0 mol %).  The high cost of palladium significantly 
increases the cost of each reaction.  Furthermore, high catalyst loadings also increase the 
risk of poisoning downstream chemistry or contaminating active pharmaceutical 
ingredients.1  
These drawbacks have prevented application of the enantioselective allylic 
alkylation on a larger scale.  The application of transition metal catalysis to industry-scale 
                                                
†  This research was performed in collaboration with Dr. Alex Marziale, Dr. Robert A. 
Craig, II, Kelly Kim and Dr. Marc Liniger and has been published.  See: Marziale, A. N.; 
Duquette, D. C.; Craig, R. A., II; Kim, K. E.; Liniger, M.; Stoltz, B. M.  Adv. Synth. 
Catal. 2015, 357, 2238–2245. 
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synthesis requires transformations that are safe, robust, cost-effective, and scalable.2  
Consequently, there remains a significant need to develop new reaction protocols that 
employ lower catalyst concentrations and hence facilitate the scale-up of such 
transformations. 
Consequently, we began to question the existing protocols and reinvestigated 
critical reaction parameters such as the palladium source, catalyst loading, solvent and 
temperature, with respect to the scalability of our reaction and its compatibility with 
industry requirements.  This chapter describes a new protocol we developed towards 
these ends. 
 
4.2  RESULTS AND DISCUSSION 
4.2.1  Exploring New Palladium Sources and Optimization 
We first turned our attention to the palladium source in an effort to replace the 
oxygen-sensitive Pd2(dba)3 used in our original conditions.  Therefore, the original 
catalytic enantioconvergent decarboxylative allylic alkylation of allyl 1-methyl-2-
oxocyclohexanecarboxylate was chosen as a model reaction (Scheme 4.1).3 
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Scheme 4.1. The catalytic enantioconvergent decarboxylative allylic alkylation. 
 
The catalytic cycle of the allylic alkylation operates starting from a zerovalent 
palladium source and is believed to involve a palladium (0/II) redox cycle.4  While 
utilization of Pd2(dba)3 renders in situ reduction of the catalyst obsolete, its application is 
not only hampered by increased sensitivity to oxygen, but the dibenzylideneacetone 
ligand is also challenging to separate from non-polar reaction products.  
In their original reports Tsuji and co-workers performed the allylic alkylation 
reactions in the presence of Pd(OAc)2 and PPh3.5 We adopted this strategy and started 
screening a variety of Pd(II) sources in combination with the chiral phosphinooxazoline 
ligands (S)-t-BuPHOX 36 and (S)-(CF3)3-t-BuPHOX 8.7 
When comparing Pd(OAc)2 and Pd(dba)2 at 1.0 mol % palladium in combination 
with a tenfold excess of PHOX ligands 3 or 8 respectively, in TBME at 80 °C we were 
pleased to find that both palladium sources exhibited comparable catalytic performance 
(Table 4.1).  At lower palladium concentrations, however, Pd(OAc)2 was clearly superior, 
delivering quantitative yields and good enantioselectivity at only 0.1 mol % Pd (entries 5 
O
O
O
Pd(OAc)2
(S)-t-BuPHOX (3)
or
(S)-(CF3)3-t-BuPHOX (8)
solvent
O
1a 2a
Ph2P N
O
tBu
3
(S)-t-BuPHOX
(4-CF3C6H4)2P N
O
tBu
8
(S)-t-BuPHOX
CF3
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and 6).  When 0.1 mol % Pd(dba)2 was used to form the catalyst, a dramatic decrease in 
yields was observed (entires 7 and 8). 
Table 4.1. Initial screening efforts with a Pd(OAc)2 precatalyst. 
 
We then became interested to see if other palladium(II) sources were equally 
suited to catalyze the decarboxylative allylic alkylation. Consequently, a total of eight 
different commercially available Pd(II) precursors were examined in our model reaction 
in the presence of ligand 3.8  While with Pd(OAc)2 a quantitative yield for the desired 
allylic alkylation product was obtained, none of the other palladium sources promoted 
any conversion of the substrate. We reason that the limited solubility of these palladium 
salts in TBME likely prevented catalysis. 
Limited to Pd(OAc)2 as the only viable palladium precursor, we turned our 
attention to minimizing the catalyst loading. A screening of six different catalyst 
loadings, ranging from 0.05 mol % to 1.0 mol %, was performed (Table 4.2). All 
O
O
O
Pd(OAc)2 / Pd(dba)2
ligand 3 / 4
TBME, 80 °C, 16h
O
1a 2a
Entry Ligand[mmol]
Pd source
[mmol]
Yield
[%]
ee
[%]
1 3 [10.0] Pd(OAc)2 [1.0] 99 86
2 8 [10.0] Pd(OAc)2 [1.0] 99 82
3 3 [10.0] Pd(dba)2 [1.0] 99 84
4 8 [10.0] Pd(dba)2 [1.0] 90 82
5 3 [10.0] Pd(OAc)2 [0.1] 99 79
6 8 [10.0] Pd(OAc)2 [0.1] 99 83
7 3 [10.0] Pd(dba)2 [0.1] 12 n.d.
8 8 [10.0] Pd(dba)2 [0.1] 14 n.d.
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reactions were conducted in the presence of a tenfold excess of ligand with respect to 
palladium, in TBME at 40 °C.9 
Table 4.2.  Optimization of catalyst loading. 
 
Under these reaction conditions, palladium loadings as low as 0.10 mol % were 
sufficient to deliver the desired allylic alkylation product in 90% yield and high 
enantioselectivity (Table 4.2, entry 5).  To obtain a quantitative yield of ketone 2a, the 
catalyst loading was increased to 0.15 mol % of Pd(OAc)2 (Table 4.2, entry 4). 
Enantioselective allylic alkylation reactions are typically performed in solvents such as 
THF, DCM, dioxane or diethylether.3, 9b, 9c, 10   While these solvents are common for 
academic laboratory scale, their use prohibits conducting the reaction in an industry 
setting.11 We sought to overcome this limitation and performed a solvent screening with a 
total of ten different solvents that are considered to be safe, sustainable, and cost-efficient 
(Table 4.3).10, 12  
  
O
O
O
Pd(OAc)2
(S)-t-BuPHOX (3)
TBME, 40 °C
O
1a 2a
Entry Pd[mol %]
(S)-t-BuPHOX
[mol %]
Yield
[%]
ee
[%]
1 1.0 10.0 99 90
2 0.50 5.0 99 90
3 0.25 2.50 99 90
4 0.15 1.50 99 89
5 0.10 1.0 90 89
6 0.05 0.50 10 89
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Table 4.3.  Optimization of the reaction medium. 
 
Conversion of allyl 1-methyl-2-oxocyclohexane-carboxylate in TBME resulted in 
high yields and good enantioselectivity (Table 4.3, entry 1).  When the reaction was 
performed in various alkyl acetates the yields dropped dramatically, to 12%, 28%, and 
17% respectively (Table 4.3, entires 2, 4 and 5).  Similarly low yields were observed for 
reactions performed in acetonitrile, dimethylacetamide, 2-Me-THF, and acetone (Table 
4.3, entries 3, 6, 8 and 10).  Moderate conversion was found when the reaction was 
performed in toluene (Table 4.3, entry 7).  Consequently, all further experiments were 
carried out in TBME. 
At this point, we considered that the palladium concentration could be lowered 
further by performing the reaction at higher temperatures, and we were interested in the 
influence of increased reaction temperature on stereoselectivity.  All experiments were 
O
O
O
Pd(OAc)2 (0.1 mol %)
(S)-t-BuPHOX (1.0 mol %)
solvent, 40 °C, 16h
O
1a 2a
Entry solvent Yield[%]
ee
[%]
1 TBME 88 89
2 12* 74
3 trace -
4 Isopropyl acetate 28 64
5 Isobutyl acetate 17 -
6 Dimethylacetamide trace -
EtOAc
MeCN
7 52 80
8 2-Me-THF 21 89
9 t-AmylOH -* -
10 Acetone -* 57
Toluene
*Reaction run at 60 °C
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performed in TBME with a tenfold excess of ligand 3 (Table 4.4).  A palladium loading 
as low as 0.075 mol % afforded ketone 2a in 99% yield when the reaction was performed 
at 80 °C, which corresponds to a turnover number of 1320 for the in situ formed catalyst.  
Nevertheless, a slightly lower enantioselectivity of 84% was observed in this case (Table 
4.4, entry 1).  At 60 °C and 40 °C, palladium loadings of 0.10 and 0.125 mol % 
respectively were sufficient to deliver the desired product in quantitative yield and high 
enantioselectivity (Table 4.4, entries 2 and 3). 
Table 4.4.  Optimization of the palladium loading at varying temperatures. 
 
We then applied the protocol to the 10 and 20 mmol scale synthesis of alpha-
quaternary ketones 2a and 112 (Scheme 4.2).  Both reactions were performed in TBME 
with a tenfold excess of ligand 3.  In experiment 1, 1.96 g (10.0 mmol) of cyclohexanone 
1a was converted in the presence of 0.15 mol % (3.37 mg) of Pd(OAc)2 at 60 °C.  The 
corresponding product 2a was isolated by distillation in 95% yield and 89% ee.  
Similarly, tetralone substrate 111 was applied on a 20 mmol scale (4.89 g) in the 
enantioselective allylic alkylation at 40°C.  The desired product 112 was purified by flash 
chromatography and isolated in 95% yield and 88% ee. 
  
O
O
O
Pd(OAc)2
(S)-t-BuPHOX
TBME, 16h
O
1a 2a
Entry Pd[mol %]
Yield
[%]
ee
[%]
1 0.075 99 84
2 99 88
3 99 89
0.1
0.125
T
[° C]
80
60
40
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Scheme 4.2.  Application of the developed protocol on scale. 
 
Satisfied with the scalability of our new allylic alkylation conditions, we turned 
our attention to reducing the ligand loading. A series of six experiments employing 
different quantities of ligand, from 0.20 mol % to 1.00 mol %, in the presence of 0.10 
mol % Pd(OAc)2 were performed (Table 4.5).  A ligand loading of 0.4 mol %, which 
corresponds to a 4-fold excess of ligand with respect to palladium, was sufficient to 
provide the desired product in quantitative yield and high enantioselectivity (Table 4.5, 
entry 4).  Only at a loading of 0.20 mol % of ligand 3 was a slight decrease in 
enantioselectivity observed (Table 4.5, entry 5). 
  
O
O
O
Pd(OAc)2 (0.15 mol %)
(S)-t-BuPHOX
TBME, 60 °C, 16h
O
1a 2a
0.01 mmol scale
95% yield, 89% ee
O
O
O
Pd(OAc)2 (0.125 mol %)
(S)-t-BuPHOX
TBME, 40 °C, 16h
O
111 112
0.02 mmol scale
95% yield, 88% ee
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Table 4.5.  Optimization of ligand loading. 
 
Finally, we investigated the influence of concentration on reactivity.  A brief 
study across five different substrate concentrations was executed (Table 4.6).  We were 
pleased to find that the decarboxylative alkylation reaction could be performed in high 
concentrations of up to 0.4 M without any negative impact on yield or enantiomeric 
excess (Table 4.6, entry 1). When the reaction was performed at higher dilution (0.033 
mol/l) a slight decrease in yield and optical purity was observed (Table 4.5, entry 5). 
Table 4.6.  Optimization of reaction concentration. 
 
O
O
O
Pd(OAc)2 (0.1 mol %)
(S)-t-BuPHOX
TBME, 60 °C, 16h
O
1a 2a
Entry (S)-t-BuPHOX[mol %]
Yield
[%]
ee
[%]
1 1.00 99 88
2 99 89
3 99 88
0.80
0.60
4 99 88
5 99 86
0.40
0.20
O
O
O Pd(OAc)2 (0.125 mol %)
(S)-t-BuPHOX (0.125 mol %)
TBME, 60 °C, 16h
O
1a 2a
Entry concentration[M]
Yield
[%]
ee
[%]
1 0.4 99 88
2 99 88
3 99 89
0.2
0.1
4 99 89
5 91 87
0.05
0.033
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4.2.2  Substrate Scope 
After optimizing all critical reaction parameters for the conversion of 
cyclohexanone substrate 1a, we sought to investigate the substrate scope of this novel 
protocol.  To demonstrate its broad applicability, a total of ten compounds were subjected 
to the improved reaction parameters (Table 4.6). 
Table 4.7.  Substrate scope of the new protocol. 
 
  
Entry Product Yield[%]
ee
[%]
1
89 88
O
2a
2
99 89
O
112
Protocol Pd[mol %]
old
new
5.00
0.125
97 92
85 89
old
new
8.00
0.125
3
O
5a
85 99
81 95
old
new
10.0
0.50
BzN
4
O
Et
5k
97 99
85 97
old
new
10.0
0.30
BzN
5
O
F
5l
89 99
80 99
old
new
10.0
0.125
BzN
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Table 4.7.  Substrate scope of the new protocol (cont’d). 
 
Asymmetric allylic alkylation to generate products 2a and 112 was discussed 
previously in detail (Table 4.7, entries 1–2).  Lactam (5a, 5k and 5l) and piperidone 
products (7a) were obtained in good yields and enantioselectivities (Table 4.7, entries 3–
6).  The protocol could also be applied to seven-membered rings; however, despite a near 
Entry Product Yield[%]
ee
[%]Protocol
Pd
[mol %]
6
O
7a
91 94
99 88
old
new
10.0
0.125
BzN
O
7
83 87
97 70
old
new
5.00
0.10
O
113
8
83 93
95 90
old
new
5.00
0.125
N
O
114
R = p-MeO-C6H4
R
O
9 O
O
115
- -
79 90
old
new
-
0.10
O
10
O
116
78 99
97 99
old
new
5.0
0.25
O
For experimental details, see: Marziale, A. N.; Duquette, D. C.; Craig, R. A., II; 
Kim, K. E.; Liniger, M.; Stoltz, B. M.  Adv. Synth. Catal. 2015, 357, 2238–2245.
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quantitative yield, a reduced enantiomeric excess of 70% was observed for ketone 113 
(Table 4.7, entry 7).  In contrast, seven-membered caprolactam 114 was isolated in 95% 
yield and 90% ee (Table 4.7, entry 8).  Notably, cyclohexyl ketal 115 was generated in 
79% yield and good enantioselectivity through intermolecular allylic alkylation of the 
corresponding silyl enol ether and allyl methanesulfonate (Table 4.7, entry 9). 
Finally, cyclohexanedione 116, which is a critical intermediate in the synthesis of 
(–)-cyanthiwigin F,13 could be accessed through double enantioselective allylic alkylation 
of the corresponding bis(β-ketoester) in excellent yield and near perfect enantioselectivity 
using only 0.25 mol % palladium (Table 4.7, entry 10).  This corresponds to 5% of the 
palladium loading used in the original protocol.  Despite the considerable reduction in 
catalyst concentration, the yield for this reaction was improved to 97% (Table 4.7, entry 
10). 
 
4.3  CONCLUDING REMARKS 
In conclusion, we have reported a novel and highly efficient protocol for the 
decarboxylative enantioselective allylic alkylation using palladium acetate and loadings 
below 0.50 mol %.  For simple quaternary ketone products metal loadings as low as 
0.075 mol % effectively catalyzed the reaction and generated the desired products in high 
yields and enantioselectivities. Thereby, turnover numbers of up to 1320 could be 
reached.  Furthermore, a variety of critical reaction parameters such as temperature, 
concentration, ligand stoichiometry, and choice of solvent were optimized to increase the 
scalability and lower the cost basis for palladium catalyzed allylic alkylation reactions.  
The method is broadly applicable among a variety of substrate classes and is tolerant of 
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most functional groups because of the neutral reaction conditions and modest reaction 
temperatures.  We anticipate these advances will promote the continued use of palladium-
catalyzed allylic alkylation reactions as means of installing quaternary sterocenters in 
multi-step syntheses in academic laboratories, and hope to see these reactions used to 
synthesize valuable molecules in the chemical and pharmaceutical industry. 
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APPENDIX 5 
Synthesis of (±)-Grandifloracin and Acylated Analogues† 
 
5.1  INTRODUCTION AND BACKGROUND 
Pancreatic cancer is one of the most severe forms of cancer, with a 5-year survival 
rate of only 3–5%.  This high mortality rate has not improved during the last four decades 
of chemotherapeutic research.1  To date, there has not been any report of an effective 
treatment against the disease, and the agents used against other types of cancer have been 
shown to have little to no effect on pancreatic cancer.2  It has been hypothesized that this 
might be the result of pancreatic cancer cells being hypovascular and thereby able to 
proliferate in a nutrient-deficient and hypoxic environment.3  The lack of viable 
treatments for, and the severity of pancreatic cancer create a pressing need to develop 
new drugs to combat the disease.4  
One means to overcome these challenges is to develop anti-austerity agents.  
These drugs target the biochemical pathways that allow cancer cells to thrive under low 
                                                
†  This research was performed in collaboration with Magnus Bergner and Linda Chio 
and has been published.  See: Bergner, M.; Duquette, D. C.; Chio, L.; Stoltz, B. M.  Org. 
Lett. 2015, 17, 3008. 
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nutrition, thereby reducing or halting the cancerous cells’ ability to survive in 
hypovascular conditions without affecting the surrounding cells.4 A recent breakthrough 
came in 2012 when the Awale group extracted (+)-grandifloracin from the stem of 
Uvaria dac.5  (+)-Grandifloracin was shown to be a potent anti-austerity agent against 
pancreatic cancer cell lines, PANC-1 (PC50 14.5 µM), PSN-1 (PC50 32.6 µM), MIA 
PaCa-2 (PC50 17.5 µM) and KLM-1 (PC50 32.7 µM).6  Interestingly, the first isolation of 
grandifloracin from Uvaria grandiflora in 19977 was later shown to be the (–)-
enantiomer of grandifloracin.8 
In a comprehensive study of (+)-grandifloracin, its mode of action was 
determined to be the induction of autophagic programmed cell death in PANC-1 cells 
rather than through typical apoptotic modes.9  This evidence strongly supports the 
potential efficacy of anti-austerity agents in the treatment of pancreatic cancer. 
The first synthesis of grandifloracin in racemic form was reported in 2007 by 
Quideau and coworkers.10  This synthesis hinged on a hydroxylative dearomatization of 
2-hydroxybenzyl benzoate, which subsequently underwent a spontaneous Diels-Alder 
cyclodimerization to directly yield (±)-grandifloracin, albeit in a modest 30% yield.  A 
subsequent asymmetric syntheses of (+)-grandifloracin by Lewis and coworkers similarly 
made use of a spontaneous Diels-Alder reaction of a chiral cyclohexa-2,4-dienone 
obtained after a five step sequence following the microbial oxidative dearomatization of 
benzoic acid.7  Notably, Toste and coworkers have also reported the synthesis of a 
fluorinated (–)-grandifloracin derivative11 utilizing an asymmetric dearomative 
fluorination and cyclodimerization of silyloxymethylphenol, followed by deprotection 
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and acylation in a single step.  However, they note that the corresponding benzoate ester 
only gave trace conversion in the fluorination step. 
While the linchpin Diels-Alder cyclodimerization is highly efficient in 
constructing the backbone of grandifloracin, its use can also be limiting for potential 
diversification for the study of structure-activity relationships.  In each of the syntheses of 
the natural product, the hydroxymethyl group is protected as a benzoate ester prior to the 
cyclodimerization step.  As such, any derivative must either be obtained by a 
deprotection-acylation sequence, adding extra steps to such a library synthesis, or by 
carrying each individual acyl group through the Diels-Alder step.  This is potentially 
troublesome, as electronically differentiated substrates can perform with substantially 
varying yields.12  As such, when planning our synthesis, we sought to carry a free 
hydroxymethyl group through the cyclodimerization in order to facilitate subsequent 
derivatization for biological study of analogues of the natural product. 
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5.2  RESULTS AND DISCUSSION 
5.2.1  Retrosynthetic Analysis 
Scheme 5.1.  Retrosynthetic analysis of (±)-grandifloracin. 
 
 
 
 
 
 
 
 
 
 
The aim of this project was to develop an even more efficient synthetic route to 
(±)-grandifloracin than previously employed that would permit late-stage diversification 
of a key intermediate.  To achieve this, we devised a strategy (Scheme 5.1) in which 
removal of the benzoyl groups of grandifloracin (117) yields the core-structure as a diol 
(118), which would be amenable to derivatization by selective acylation of the free 
hydroxymethyl groups. This key tetraol was anticipated to arise from a double epoxide-
opening of the known bis-spiroepoxy-dienedione 119.13  This key intermediate can be 
readily prepared through an oxidative dearomatization of salicylic alcohol (120) and 
subsequent Diels–Alder homodimerization. 
  
O
O
OH
OBzOH
BzO
(±)-Grandifloracin (117)
O
O
OH
OHOH
HO
O
O O O
OH OH
salicylic alcohol (120)
OH O
salicylic acid (121)
OH
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5.2.2  Synthesis of (±)-Grandifloracin 
Scheme 5.2.  Synthesis of (±)-grandifloracin. 
 
 
 
Salicylic acid (121) was reduced by LiAlH4 to give the corresponding salicylic 
alcohol (120, 93% yield).  The alcohol was then subjected to known oxidative 
dearomatization with sodium periodate (NaIO4) in water to afford 
spiroepoxycyclohexadienone (122).12  Diene 122 spontaneously undergoes a Diels–Alder 
dimerization to yield the dispirooxirane 119 in a remarkably stereoselective and efficient 
overall process (89% yield of a >10:1 mixture of diastereomers).  The two epoxides were 
smoothly opened by gentle heating in water over two days to yield the core tetraol 118 
(77% yield).14  The tetraol was treated with benzoyl chloride to furnish (±)-grandifloracin 
(50% yield), completing the total synthesis in only four steps from salicylic acid in an 
overall yield of 32% (Scheme 5.2).  Gratifyingly, we were able to identify suitable 
chromatographic conditions to allow separation of (+)- and (–)-grandifloracin by 
OH O
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OH OH
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H2O, 4 °C, 24 h
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preparative chiral HPLC.  Even after separation of the two enantiomers, the yield for each 
antipode is still significantly higher than the previously reported enantioselective total 
synthesis of (+)-grandifloracin.7 
Scheme 5.3.  Telescoped synthesis of (±)-grandifloracin. 
 
 
This rapid and efficient four-step synthesis of (±)-grandifloracin (1) was further 
improved by eliminating intermediate recrystallization steps (Scheme 5.3).  Salicylic 
alcohol was telescoped through the synthetic route without any purification until the final 
compound. This resulted in a yield of 52% over the last three steps, and an excellent 
overall 48% yield.  This procedure allowed us facile access to over 200 mg of the 
racemic natural product, and was amenable to even larger scale for the synthesis of 
analogs (vide infra). 
5.2.3  Synthesis of Acylated Analogues of (±)-Grandifloracin 
To investigate the effect of the acyl substituents present on the natural product, a 
small library of analogues was synthesized (Table 5.1).  Introduction of a methyl group in 
the para, meta or ortho position (123a-c) of the phenyl group was well tolerated in the 
acylation reaction, proceeding in roughly the same yields as with benzoyl chloride.  
Replacement of the phenyl ring with a cyclic alkyl group (123f-g) slightly increased the 
yield of acylation.  While the introduction of an electron-donating para-methoxy group 
(123d) substantially increased the yield of the acylation reaction, the introduction of an 
electron-withdrawing para-cyano group (123e) significantly lowered the yield. This trend 
OH OH
120
1. NaIO4, H2O, 4 °C, 4 h
2. H2O, 60 °C, 48 h
3. BzCl, Cs2CO3, CH3CN
    50 °C, 2 h
O
O
OH
OBzOH
BzO
(±)-Grandifloracin (117)
52% overall yield
single purification
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was also observed when we attempted to synthesize the para-nitro analogue, which failed 
due to lack of reactivity.  The moderate yield in the acylation step is believed to arise 
from competing elimination of the α-hydroxy group of the B-ring.15 
Table 5.1.  Synthesis of acylated analogues of (±)-grandifloracin. 
 
 
 
 
 
 
 
 
 
 
5.3  CONCLUDING REMARKS 
In summary, we have completed a highly efficient synthesis of (±)-grandifloracin, 
which is amenable to late-stage diversification for the synthesis of analogues.  In a recent 
study, analogue 123d has been shown to have an increased anti-proliferative effect 
compared with grandifloracin on PANC-1 and HT-29 (human colon cancer) cells, both in 
nutrient rich (10% fetal bovine serum) and in nutrient deprived conditions (0.5% fetal 
bovine serum).16  This indicates that there is an incentive to develop further 
grandifloracin analogues for the study and treatment of pancreatic cancer. 
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OHOH
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CH3CN
50 °C, 2 h
O
O
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OOH
O
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R Cl
O
R
O
RO
product R yield [%]
1 123a 482-Me-C6H4
2 123b 513-Me-C6H4
3 123c 554-Me-C6H4
4 123d 694-OMe-C6H4
5 123e 254-CN-C6H4
6 123f 58
7 123g 55
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APPENDIX 6 
Progress Towards the Total 
Synthesis of Hamigerans C and D 
 
6.1  INTRODUCTION AND BACKGROUND 
The hamigeran family of natural products was isolated in 1999 from marine 
sponge Hamigera tarangaensis by Cambie and coworkers (Figure 6.1).1  While all four 
members of the family possess moderate cytotoxicity in P-388 leukemia cells (IC50 = 
31.6, 13.5, 16.0 and 8.0 µM for hamigerans A, B, C and D, respectively), hamigeran B 
(125) displays 100% in vitro inhibition against both Herpes and Polio viruses. 
Figure 6.1.  The hamigeran family of natural products. 
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Due to this attractive biological activity and the synthetically challenging 6-6-5 
tricyclic structure bearing three consecutive stereocenters on the congested A-ring, 
hamigeran B has been the target of continual efforts of many synthetic organic chemists.  
Hamigeran B (along with hamigeran A and several analogs) was first synthesized in 2003 
by Nicolau and coworkers2a,b and since has succumbed to a number of syntheses,2 
including epimeric and formal syntheses.  In contrast, no syntheses of hamigerans C or D 
(126 and 127), which share a unique 6-7-5 tricyclic core, have been reported in the 
literature, presumably in part to the relative scarcity of methods for the synthesis of 7-
membered rings as compared to their 6-membered counterparts. 
The Stoltz group has developed a methodology for the asymmetric synthesis of γ-
quaternary acylcyclopentenes (Scheme 6.1, 131) by a retro-aldol/aldol condensation 
sequence resulting in a two-carbon contraction of vinylogous esters of cycloheptenone 
(129).3  The versatility of this intermediate and the excellent scalability of this sequence 
inspired us to pursue the synthesis natural products with cores containing densely-
functionalized cyclopentanes with quaternary carbon stereocenters, making hamigerans C 
and D ideal targets. 
Scheme 6.1.  Synthesis of acylcyclopentenes by ring contraction. 
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6.2  RESULTS AND DISCUSSION 
6.2.1  Synthesis of a Model System and Retrosynthetic Analysis 
Studies toward the syntheses of hamigerans C and D were initiated during our 
investigations of the asymmetric synthesis of γ-quaternary acylcyclopentenes.3  From 
acylcyclopentene 131, we were able to assemble the 6-7-5 carbocyclic core of 
hamigerans C and D (134) in good overall yield over four synthetic steps, featuring  two 
sequential Heck cross-coupling reactions (Scheme 6.2). 
Scheme 6.2.  Synthesis of the 6-7-5 carbocyclic core of hamigerans C and D.3 
 
Notably lacking on tricycle 134, however, is substitution on the aromatic C-ring 
and any functional handle on the benzannulated cycloheptyl B-ring of the natural 
products.  The latter is due to the (E)-selectivity in the coupling of 9 with o-iodophenol.  
The resulting olefin must be hydrogenated in order to perform the second Heck coupling, 
resulting in loss of the otherwise useful olefin moiety.  As such, we envisioned a 
retrosynthetic strategy that would allow us to perform the first cross-coupling reaction to 
yield a (Z)-olefin with an appropriately substituted aromatic ring (Scheme 6.3). Such a 
strategy would allow us to obtain a tricyclic intermediate (137) with all of the necessary 
1) Pd(OAc)2 (10 mol %), TBAI              
    Et3N, o-iodophenol, DMF
2) Rh(PPh3)3Cl (10 mol %)
    toluene, H2 (1 atm)
       (88% yield, two steps)
O
O
O
H
HO
O
TfO
Comin's Reagent,
DMAP, CH2Cl2
(78% yield)
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Me2NC(O)Me, 115 °C
(77% yield)
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functional handles in place to complete the first total syntheses of both of these natural 
products. 
Scheme 6.3.  Retrosynthetic analysis of hamigerans C and D. 
 
6.2.2  Synthesis of Negishi Coupling Partners 
Our first synthetic efforts were directed toward synthesis of Negishi coupling 
partners 139 and 140.  We desired a differentially protected orcinol derivative, as one 
phenol group would need to be deprotected and converted to an aryl triflate for the 
planned Heck cross-coupling, while the other phenol would be need to be robustly 
protected as a methyl ether to be revealed late in the synthesis as the phenol present in 
hamigeran C or the phenol precursor to the oxazine moiety of Hamigeran D.  Synthesis of 
the O-methyl-O'-tetrahydro-2-pyranylorcinol 139 was accomplished by dimethylation 
and mono-demethylation of orcinol (141),4a followed protection as a THP ether5b in 64% 
yield over three steps (Scheme 6.4). 
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Scheme 6.4.  Synthesis of Negishi cross-coupling partner 139. 
 
 Synthesis of (Z)-vinyl iodide 140 represented synthesis of a novel target from 
acylcyclopentene 131.  Following the established procedure for ketal protection of the 
enone,3 the resulting diene could be selectively ozonolyzed to yield aldehyde 144 in 66% 
yield over 2 steps.  However, yields obtained using the (Z)-iodomethylenation procedure 
reported by Stork5 proved unreliable upon several repeated experiments (Scheme 6.5). 
Scheme 6.5.  Initial efforts towards Negishi cross-coupling partner 140. 
 
While mass-balance for this transformation was consistent, varying amounts of 
starting material contaminated by deprotection side-products were reisolated, with yields 
of the desired vinyl iodide 140 ranging from 33–67%.  Moreover, the 5:1 ratio of Z:E 
isomers (as determined by integration of the terminal vinyl proton in the 1H NMR 
spectrum) could not be separated by chromatography through gel of silica, alumina, or 
silver nitrate-impregnated silica with a wide variety of eluent combinations.  We saw this 
as an early opportunity to address optimization of our synthetic route, as formation of 
(Z)-olefin 138 was considered paramount to our ability to access an intermediate with 
functionality on the B-ring such as 136. 
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 As unreacted starting material appeared to be the cause of loss of yield in this 
transformation, we considered that, given the quaternary center proximal to the aldehyde 
of 144, nucleophilic approach by the Wittig reagent was extremely hindered.  We 
reasoned that the Wittig reagent was instead acting as a base, deprotonating the α-
position of 144 to yield an unreactive enolate.  We began optimization studies by 
increasing the temperature at which aldehyde was added to the solution of Wittig reagent 
(Table 6.1). 
Table 6.1.  Optimization of synthesis of 144: solvent and temperature effects. 
 
Raising the temperature of addition to 40 °C and maintaining that temperature 
throughout the reaction yielded a consistent boost in yield (66–87%) without any 
detriment to the (Z)-selectivity.  Reaction at 30 °C also appeared to be an improvement, 
though longer reaction times resulted in increased appearance of side products resulting 
from deprotection of the ketal.  By increasing the temperature to 50 °C and performing 
the reaction in benzene, we were able to achieve a good yield, but noted a dramatic 
decrease in selectivity from 5:1 to 1.3:1 in favor of the (Z)-olefin. 
 Satisfied with the improved yields obtained by performing the reaction with an 
addition temperature of 40 °C, we sought to improve the (Z)-selectivity by modifying the 
O
H
O
O ICH2PPh3I, NaHMDS
solvent, temperature O
OI
Solvent
THF
THF
THF
Benzene
Temperature
0→50 °C
40 °C
30 °C
50 °C
Z:E Ratio
5:1
5:1
5:1
1.3:1
Yield
33–67%
66–87%
63%
85%
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nature of the Wittig reagent.  We imagined that modification of the aggregation state of 
the deprotonated Wittig salt by modifying the counterion or base used or by chelation of 
the counterion by hexamethylphosphoramide (HMPA), could benefit the selectivity of 
the reaction (Table 6.2). 
Table 6.2.  Optimization of synthesis of 144: alternate Wittig reagents. 
 
Unfortunately, substitution of sodium hexamethyldisilylamide (HMDS) for 
lithium or sodium HMDS both resulted in a decrease in selectivity for the desired (Z)-
olefin, as did addition of HMPA or the use of sodium t-butoxide.  Moreover, tuning of 
the sterics of the Wittig reagent itself by substituting (iodomethyl)triphenylphosphonium 
iodide for the less bulky (bromomethyl)triphenylphosphonium bromide or 
(iodomethyl)tri-n-butylphosphonium iodide also resulted in a decrease in selectivity.  To 
our surprise, the more sterically-hindered (iodomethyl)tri-o-tolylphosphonium iodide 
gave a modest selectivity of 0.9:1 in favor of the undesired (E)-olefin.  As such, we 
returned to the use of our original Wittig reagent and base and proceeded with our 
synthetic studies. 
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6.2.3  Synthesis of an Elaborated Core of Hamigerans C and D 
With the proposed Negishi cross-coupling partners in hand, we began 
investigations of this reaction.  We anticipated being able to affect a selective 
deprotonation of 143 ortho- to the two ether substituents with n-butyllithium, followed by 
transmetallation with zinc(II) chloride to afford the Negishi coupling partner for 
vinyliodide 144 (Scheme 6.6.). 
Scheme 6.6.  Negishi cross coupling of 143 and 144. 
 
Gratifyingly, this reaction proceeded in good yield to afford 145 as a single 
product with respect to the deprotonation of 143.  Removal of both acetal and THP 
protecting groups proceeded smoothly using Montmorillonite K-10 clay in methanol at 
50 °C, the crude product of which was >95% pure by 1H NMR and could be used directly 
in the following step.  We also found that triflation of the intermediate phenol could be 
affected using trifluoromethanesulfonyl anhydride and DMAP over a slightly longer 
reaction time but without loss of yield when compared to the more costly Comin’s 
reagent (N-(5-chloro-2-pyridyl)bis(trifluoromethanesulfonimide)), furnishing the desired 
aryl triflate 146 in 55–62% yield from Negishi coupling partners 143 and 145 over three 
steps. 
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Scheme 6.7.  Intramolecular Heck reaction of 146. 
 
Aryl triflate 146 was subjected to conditions developed for the model Heck 
reaction (Scheme 6.2), modified to be run in a microwave reactor, yielding excellent 
results on small scale (Scheme 6.7).  However, upon scale up, cleavage of the triflate 
caused a significant decrease in yield, and a large amount of an undesired acylated side-
product was obtained. 
6.2.4  Attempts Toward a Negishi-Heck Cascade Reaction 
Considering that we performed two palladium(0)-catalyzed cross-coupling 
reactions in the span of four synthetic steps, resulting in a longer synthesis and lower 
overall yield, we began to consider the possibility of performing both metal-catalyzed C–
C bond-forming reactions in a single step.  In considering the use of a Negishi cross-
coupling as the first of the two bond-forming events, we realized that deprotonation 
ortho- to a triflate, iodide or bromide would result in formation of benzyne,6 which would 
lead to undesired side-reactivity.  As such, our approach would demand use of a worse 
nucleofuge, X, than a halide that could still undergo C–X oxidative insertion by a 
transition metal (Scheme 6.8). 
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Scheme 6.8.  Proposed Negishi-Heck cascade reaction. 
 
Nickel-catalyzed cross-couplings of various phenol derivatives have become an 
area of intense research, with Kumada, Negishi and Suzuki-type couplings of aryl methyl 
ethers, carbamates, sulfamates and pivalates prevailing.7 Inamoto and coworkers have 
reported the coupling of aryl bromides and iodides with n-butylacrylate using nickel(II) 
diacetylacetonate and N-heterocyclic carbene ligands to yield Heck-type products.8a 
Watson and coworkers have also reported the coupling  of pivalates with styrene 
derivatives furnishing 1,2-diarylalkenes in good yield with nickel(0) dicyclooctadiene 
(cod) and 1,1'-bis(diphenylphosphino)ferrocene (dppf).8b  Given this precedent, we 
imagined being able to first affect an Negishi cross-coupling between aryl zinc species 
149 and our (Z)-vinyl iodide 144, followed by an intramolecular Heck reaction by 
oxidative insertion into an unactivated aryl-oxygen bond to directly yield the desired 
tricyclic core of hamigerans C and D 148 in a single step.  However, attempts to affect 
the nickel-catalyzed Heck cross coupling of n-butylacrylate and phenyl methyl ether, 
pivalate, dimethyl sulfamate or dimethyl carbamate resulted in no detection of product 
149 by HPLC-MS (compared to a standard of genuine product) using either Ni(cod)2 or 
Ni(acac)2 as a nickel source and using the N-heterocyclic carbene derived from 150 or 
tricyclohexylphosphine as a ligand (Scheme 6.9a).  Attempts to use nickel(0) complexes 
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H
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from nickel(II) complexes in situ with or without zinc as a reductant9 in a variety of 
solvents similarly did not affect the desired transformation (Scheme 6.9b).  We observed 
that only using iodobenzene and Ni(cod)2 were we able to detect any coupling product. 
Scheme 6.9.  Unsuccessful attempts at a Ni-catalyzed Heck reaction. 
 
Given these discouraging results, we considered another possibility.  If we were to 
require a halide as a Heck coupling partner for the second cross-coupling, perhaps we 
could find an aryl zinc species that would not eliminate an ortho-halide to form benzyne. 
Uchiyama and coworkers have reported that ortho-deprotonation of aryl bromides with 
lithium di-t-butyl(2,2,6,6-tetramethylpiperidino) zincate (t-Bu2Zn•Li(TMP)) does not 
result in elimination to form benzyne, even when warmed to room temperature (Scheme 
6.10). 
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Scheme 6.10.  Literature precedence for use of zincates in the Negishi cross-
coupling. 
 
 The resulting zincate species 160 can react with electrophiles such as molecular 
iodine or aldehydes to form the expected products in good to excellent yields (Scheme 
10a).10a  Encouragingly, Hevia has reported the use of these zincate intermediates in 
Negishi-type cross-coupling reactions to form bi-heteroarylspecies (e.g. 161) in moderate 
to good yields (Scheme 10b).10b  As such, we envisioned an o-bromo zincate species such 
as 160 to be an excellent candidate for our proposed Negishi–Heck cascade. 
Following literature precedent, 3-methyl-2-nitrophenol was methylated,11a and the 
resulting nitro anisole was  reduced with tin(II) chloride in methanol.11b  Para-
bromination of the resultant aniline with benzyltrimethylammonium tribromide an 
subsequent reduction of the aniline with hypophosphorous acid under Sandmeyer 
conditions11c yielded the desired 3-bromo-5-methylanisole 162 in 89% yield over four 
steps.  Upon subjection of 162 to Uchiyama’s deprotonation protocol and Hevia’s cross-
coupling conditions,10 complete consumption of both starting materials and formation of 
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several products were observed.  However, neither the exact mass for ketal 148 nor 
deprotected ketone 147 could not be found by HPLC-MS of the crude reaction mixture, 
and no product was isolated, though further investigations were precluded by material 
limitations. 
Scheme 6.11.  Attempts at a zincates Negishi cross-coupling. 
 
6.2.5  Elaboration of the Hamigeran C and D Core 
 With functionalized tricyclic core of hamigerans C and D (147) in hand, we 
turned our attention to oxidation of the B-ring to install the two necessary oxygen atoms 
present in both natural products.  While we initially anticipated a facile dihydroxylation 
of the electron-rich styrene, this transformation proved non-trivial.  In fact, treatment of 
147 with AD–mix α or β or stoichiometric osmium tetroxide in either t-butanol/water or 
a quaternary solvent mixture of water, t-butanol, carbon tetrachloride and acetone used by 
Clive in the dihydroxylation of a similar intermediate in his hamigeran B synthesis2d all 
failed to furnish any product of oxidation (Scheme 6.12). 
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Scheme 6.12.  Initial round of oxidation attempts. 
 
Wittig olefination with bromomethyltriphenylphosphonium bromide and n-
butyllithium in refluxing benzene yielded triene 164 in 84% yield, but attempts to 
selectively oxidize the styrenyl olefin of 164 with t-butyl hydroperoxide and dichloro 
ruthenium(II) cymene dimer12 (Scheme 12, 165) resulted in rapid overoxidation of 
starting material, as evidenced by the disappearance of all signals in the olefin region of 
the crude 1H NMR spectrum.  Attempts to selectively oxidize the styrenyl olefin of 164 
with electrophilic epoxidizing reagents such as m-CPBA resulted in only oxidation of the 
enone moiety, while use of the Jacobsen (R,R)-Mn(salen) epoxidation catalyst 169 in 
hopes of selectively oxidizing the cis-olefin of triene 167 also failed (Scheme 6.13). 
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Scheme 6.13.  Second round of oxidation attempts. 
 
At last, epoxidation of enone 147 was affected in a mixture of aqueous bleach and 
dichloromethane with (R,R)-(Mn)salen epoxidation catalyst 169 to afford epoxide 166 in 
89% yield and 7.5–10:1 d.r. (Scheme 16.4) 
Scheme 6.14.  Successful oxidation of the hamigeran C and D core. 
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We next turned our attention to the opening of epoxide 166 in order to protect this 
presumably sensistive functional group to allow the necessary manipulations of the A-
ring.  To our surprise, a number of Lewis and Brønsted acids as well as Brønsted bases in 
a number of solvents failed to afford expected diol 163 even at elevated temperatures 
(Scheme 6.15). 
Scheme 6.15.  Unsuccessful attempts at epoxide opening. 
 
After the failure of extensive screening to yield reliable hydrolysis conditions, we 
discovered that treatment of 166 with catalytic gold(III) chloride in dry acetone13 directly 
yielded protected diol 170 by in 74% yield as a single diastereomer (Scheme 6.16).  The 
final carbon of hamigerans C and D could be installed by submitting acetal 170 to 
previously established Wittig conditions (Scheme 6.12) to yield diene 171. 
Scheme 6.16.  Epoxide opening and installation of the final carbon of Hamigerans C and D. 
 
 With advanced intermediate 171 in hand, we set our sights on setting the final 
isopropyl stereocenter of the A-ring.  We anticipated that hydrogenation of diene 171 
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would furnish the desired stereocenter based on the concavity of the tricyclic core 
assembled.  Initial attempts to hydrogenate diene 171, however, resulted only in isolation 
of the product of hydrogenation of the more accessible olefin, 172 (Scheme 6.17). 
Scheme 6.17.  Failed hydrogenation attempts of diene 171. 
 
Under more forcing conditions with a number of catalysts and solvents, products 
resulting from hydrogenolysis of the acetal moiety were observed, typically as a mixture 
consisting mostly of trisubstituted olefin 173 with a small amount of fully hydrogenated 
174 (diastereomeric ratio of 174 was not determined due to the small amount observed 
and the difficulty of separating the two extremely non-polar products). 
 Further inspection of mono-olefin intermediate of the hydrogenation 172 reveals 
that, upon hydrogenation, the isopropyl moiety must rotate such that the hydrogen is 
facing into the convex face of the molecule to prevent a severe steric interaction.  This 
results in the occlusion of the olefin β-face by both the isopropyl group as well as the 
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nearby quaternary carbon, while the α-face is inaccessible due to the concavity of the 
molecule’s core (Figure 6.2). 
Figure 6.2.  Analysis of challenges in the attempted hydrogenation reactions. 
 
We imagine that this hurdle could be overcome by instead setting this stereocenter 
by protonation of enolate 175.  Due to the absence of the isopropyl substituent, the β-face 
of the olefin is significantly more accessible than in that of 172.  Thus, by setting this 
stereocenter before imposing the steric demands of the isopropyl group, we hope to be 
able to circumvent the problem that it appears we created for ourselves in our attempts to 
hydrogenate 172. 
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6.3  CONCLUDING REMARKS 
In conclusion, we have synthesized advanced intermediate 171, bearing all of the 
carbon atoms present in Hamigerans C and D and all of the necessary functional handles 
required to complete their synthesis.  We have proposed a method to circumvent the 
problems encountered in hydrogenation to set the final stereocenter, at which point 
elaboration of the aromatic C ring and oxidation state manipulations are all that would be 
required to complete these syntheses.  We have also proposed a tandem Negish-Heck 
reaction that, while of yet unsuccessful, could represent a useful method for the synthesis 
of benzannulated molecules.  We hope that completion of the synthesis of these 
molecules could allow for further biological testing, and set precedence for the synthesis 
of similar 6-7-5 tricyclic systems. 
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